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Abstract 
In Gram negative bacteria, resistance to β-lactam antibiotics is predominantly mediated 
by β-lactamases. CTX-M-14 is one of the most frequently identified extended spectrum 
β-lactamases (ESBLS) worldwide and is produced by Enterobacteriaceae isolated from 
humans and animals. In 2004, an IncK plasmid (named pCT) carrying blaCTX-M-14 was 
isolated from cattle in the UK. This plasmid was shown to successfully persist and 
spread within diverse E. coli strains from livestock and the environment on a dairy farm. 
The aim of this study was to determine the extent of pCT dissemination, and to 
investigate the factors which allow pCT to stably persist within bacterial populations.  
Complete DNA sequencing and annotation revealed that plasmid pCT was 93,629 bp in 
size and encoded all three IncI group associated regions, the repYZ, tra and pil loci. No 
genes known to play a role in determining virulence were identified, and sequencing 
revealed blaCTX-M-14 as the only antimicrobial drug resistance gene on pCT. Comparison 
of the pCT genome to other blaCTX-M encoding plasmids showed no conserved regions 
with the exception of the antibiotic resistance gene itself. From this information, a PCR 
assay for rapid and high-throughput detection of pCT was designed, and applied to a 
collection of isolates from several countries. These assays showed that pCT has 
disseminated worldwide in bacteria from humans, animals and the environment. 
pCT was stably maintained in the absence of β-lactam antibiotic pressure in four different 
bacterial host strains over ~70 generations, and conferred neither a fitness advantage 
nor disadvantage to two host E. coli strains. Within a third E. coli host strain however, 
pCT did confer a fitness cost, although this was shown to be in part due to the presence 
of the antibiotic resistance gene blaCTX-M-14. The addition of pCT also had no significant 
effect on any bacterial host phenotype investigated, other than susceptibility β-lactams.  
Seven pCT genes of interest in relation to plasmid success were identified, including the 
antibiotic resistance gene blaCTX-M-14, conjugation related genes, a putative sigma factor 
and a putative toxin-antitoxin system pndACB. These genes were inactivated using an 
adapted recombination method designed during this study to investigate their role in the 
„success‟ of this plasmid. Inactivation of conjugation pilus genes traXY prevented 
successful plasmid transfer in all conditions tested; however, the inactivation of the 
second pilus loci only reduced the frequency of conjugation in liquid to some of the 
recipient strains. Inactivation of the five other pCT genes had no consistent effect on the 
host bacterial strain persistence or dissemination. 
In conclusion, pCT was shown to be a globally successful plasmid, distributed in E. coli 
isolated from humans, animals and the environment. The persistence and spread of this 
plasmid is postulated to be due to a combination of subtle factors such as stability within 
a range of hosts, a lack of a fitness burden conferred to new host strains, and the 
proficient conjugation of pCT in liquid and on solid media, rather than any one particular 
gene or phenotypic benefit conferred to the host. 
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DNA Deoxyribonucleic acid 
dNTP Deoxynucleotide triphosphate 
EAEC Enteroaggregative E. coli 
EDTA Ethylenediaminetetraacetic acid 
EPEC  Enteropathogenic E. coli 
ESBL Extended spectrum β-lactamase 
EtBr Ethidium Bromide 
FOX Cefoxitinase 
g Gram 
g Gravity 
GES Guiana extended spectrum 
GFP Green Fluorescent Protein 
H2S Hydrogen sulphide 
HBSS Hanks balanced salt solution 
HCl Hydrochloric acid 
IMI Imipenem hydrolysing 
IMP Imipenemase 
Inc Incompatibility 
INT-407 Human intestinal epithelial cell line 
ISO Iso-sensitest 
kan Kanamycin 
kb Kilobase 
KDa Kilodalton 
KH2PO4 Monopotassium phosphate 
KPA Klebsiella pneumoniae group A 
KPC K. pneumoniae carbapenemase 
kV Kilovolts 
L Litre 
LB Luria Bertani 
M Molar 
MDa Mega Daltons 
MDR Multi-Drug resistant 
 
 
Abbreviation Definition 
MEM Minimum Essential Medium  
mg Milligram 
MOX Moxalactamase 
MIC Minimum Inhibitory Concentration 
min Minute 
ml Millilitre 
mM Millimolar 
mRNA Messenger Ribonucleic acid 
Na2HPO4 Disodium hydrogen phosphate 
NaCl Sodium chloride 
NDM New-Delhi metallo 
NCTC National collection of typed cultures 
NEAA Non essential amino acids 
ng Nanogram 
NMI Not metalloenzyme carbapenemase 
no Number 
OD Optical density 
OXA Oxacillinase 
P Probability 
PBP Penicillin binding protein 
PBS Phosphate buffered saline 
PER P. Nordmann, E. Ronco R. Labia 
PSE Pseudomonas-specific enzymes 
PCR Polymerase chain reaction 
pI Isoelectric point 
rif Rifampicin 
RNA Ribonucleic acid 
rpm Revolutions per minute 
RT-PCR Reverse transcriptase PCR 
SD Standard deviation 
SDW Sterile distilled water 
sec Second 
SHV Sulfhydryl varient 
SME Serratia marcescens enzyme 
TBE Tris-Borate EDTA buffer 
TE Tris EDTA buffer 
TEM Temoniera 
TNE Tris (NaCl) EDTA buffer 
Tris Tris(hydroxymethyl)aminomethane 
UV Ultra Violet 
V  Voltage 
VIM Verona integron encoded metallo 
XLD Xylose Lysine Deoxycholate agar 
Ω Ohm (measure of resistance) 
µF Microfarad (measure of capacitance) 
µg Microgram 
µl Microlitre 
µm Micrometer 
C Degrees centigrade 
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1. Introduction 
1.1 Enterobacteriaceae 
The Enterobacteriaceae are a group of Gram-negative, rod shaped bacteria within 
the Gamma Proteobacteria. Enterobacteriaceae members are all facultative aerobes, 
are non-sporulating, are either non motile or motile by peritrichous flagella, and 
include the generas Escherichia, Salmonella, Klebsiella, Proteus, Yersinia and 
Enterobacter. While the Enterobacteriaceae are a relatively homogeneous group 
they are able to occupy a range of different ecological niches and cause a variety of 
different human pathologies. Many Enterobacteriaceae species are ubiquitous in the 
environment and can be identified from soils, water and decaying vegetation. 
Members such as Escherichia coli, Proteus spp. Enterobacter spp. or Klebsiella spp. 
are found as part of the normal intestinal flora of healthy humans and animals (Costa 
et al., 2008). However, species regarded as commensals can infrequently cause 
opportunistic disease in their hosts, most commonly in the immuno-compromised or 
when the bacteria are found outside the gastrointestinal tract (Ronald, 2002; Kaper et 
al., 2004). Certain Salmonella enterica serovars are commensal bacteria in poultry 
and reptiles, but are pathogenic to humans, causing gastroenteritis (Hohmann, 
2001). Others are host restricted and cause severe pathology in humans, such as 
Salmonella enterica serovar Typhi and also Shigella spp., which clusters 
indistinguishably with E. coli sub-species during phylogenetic analysis (Crump et al., 
2004; von Seidlein et al., 2006; Lan and Reeves, 2002). An important feature of the 
Enterobacteriaceae, relevant to this study, is the ability of mobile genetic elements to 
transfer between them. This allows the sharing and dissemination of an extensive 
accessory  genome  between  diverse  bacterial  species  and  across  a  range  of  
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environmental niches that they occupy (Jones and Sneath, 1970; Sanderson, 1976).  
1.1.1 E. coli 
E. coli is perhaps the Enterobacteriaceae species most intrinsically associated with 
humans. Neonates are typically colonised with E. coli strains within hours of birth, 
and a diverse range of strains remain in the human colon as part of the healthy flora 
(Gill et al., 2006; Palmer et al., 2007). However, there are several E. coli subtypes or 
„pathotypes‟ which harbour virulence genes encoding, for example, the production of 
toxins, colonisation factors and adhesins which increase the likelihood that the E. coli 
clone will cause disease in humans (Rasko et al., 2008). Three clinical syndromes 
are commonly associated with infection by particular pathotypes, urinary tract 
infections, systemic infections including meningitis and sepsis, and diarrhoeal 
disease (Kaper et al., 2004). While the number of E. coli urinary tract infections 
caused every year are unknown due to underreporting and difficulties in diagnosis, 
UTIs are considered the most prevalent bacterial infections, and E. coli the most 
common cause, therefore the disease burden is thought to be extensive (Foxman, 
2002). E. coli is also a significant cause of bacteraemia and was identified as the 
causative agent in 27,055 cases in the UK in 2010, accounting for ~30% of all 
bacteraemia cases that year (HPA, 2011).  Among the diarrhoeagenic E. coli there 
are at least six well described categories; enteroaggregative E. coli (EAEC), 
enteropathogenic E. coli (EPEC), enteroinvasive E. coli (EIEC), enterohemorrhagic 
E. coli (EHEC), enterotoxigenic E. coli (ETEC) and Shigella dysentery which have 
distinct clinical presentations. ETEC is an important cause of diarrhoea in the 
developing world, particularly in children under five where infection by this bacteria 
causes millions of cases of gastroenteritis and tens of thousands of deaths each year 
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(Black, 1993). ETEC is also thought to account for approximately a third of „traveller‟s 
diarrhoea‟ cases in travellers from developed countries (Shah et al., 2009). EHEC, 
due to a low infective dose, severe disease presentation and resultant sequalae, is 
also a relevant pathogen in the developed world where these strains have been 
responsible for numerous outbreaks (Pennington, 2010); and Shigellosis  causes 
over 125 million cases of dysentery annually, 5-15% of which result in a fatality 
(Barhan et al., 2010).  Many of these pathotypes are able to reside as commensals in 
the gastrointestinal tract of animals. As E. coli are also a major constituent of the 
normal flora and excreta of livestock (Sorum and Sunde, 2001), these strains can be 
found in the farm environment, and may become part of the food chain within 
contaminated water, food from animal origin or fresh food products such as leafy 
salads (O'Brien et al., 2001; Erickson and Doyle, 2007; Berger et al., 2010). Many E. 
coli infections do not require treatment with antibiotics as they may be self limiting 
therefore requiring simple fluid replacement, or in the case of ETEC strain antibiotics 
may aggravate the symptoms of the disease (Guerrant et al., 2001; Porter et al., 
2011). However persistent or systemic infections require antibiotic treatment in order 
to resolve the bacterial infection (BNF60, 2011). 
1.2 Antibiotics 
Antibiotics are defined as substances which selectively destroy or inhibit the growth 
of microorganisms. This description encompasses an array of molecules with diverse 
modes of action including the prevention of bacterial protein synthesis (e.g. 
aminoglycosides, tetracyclines, macrolides and chloramphenicol); inhibition of nucleic 
acid synthesis (sulphonamides, quinolones, rifamycins); disrupted cell membrane 
function (polymyxins) and inhibition of bacterial cell wall synthesis (β-lactams and 
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glycopeptides). Drugs belonging to each antibiotic class contribute to both human 
and veterinary treatment regimes. In UK clinical medicine β-lactams are the most 
frequently prescribed antibiotic (Figure 1.1), comprising 66% of community 
treatments, 77% of antibiotics used in hospital and equating to ~198 tonnes of active 
ingredient per year (DEFRA, 2007; NHS, 2011). Tetracycline is the predominant 
antibiotic used in veterinary medicine, accounting for 45% of antibiotics used in 
animals and equating to a UK national usage of approximately 174 tonnes of active 
substance a year (Figure 1.1A) (DEFRA, 2007). β-lactams are also important 
antimicrobials in veterinary treatment regimes, accounting for approximately 19% of 
antibiotics administered to animals in the UK (Figure 1.1A) (DEFRA, 2007). While 
commonly used cephalosporins used for human therapy are not used in the 
treatment of animals and vice-versa, many bacterial antibiotic resistance 
mechanisms confer a reduced susceptibility to both types of β-lactam (Li et al., 
2007). Therefore the use of veterinary licensed third and fourth generation 
cephalosporins such as ceftiofur and cefquinome respectively, may have implications 
for the prevalence of bacteria resistant to other clinically relevant third generation 
cephalosporins.  
1.2.1 β-lactams 
Due to their extensive use, β-lactam antibiotics have been described as the most 
important group of antimicrobials in both human and veterinary medicine (Li et al., 
2007; Llarrull et al., 2011) (Figure 1.1). The molecules share the structural feature of 
a four membered β-lactam ring (Figure 1.2) and target enzymes known as penicillin 
binding proteins (PBPs) or peptidoglycan transpeptidases and transglycosylases 
(Sauvage et al., 2008). By preventing these enzymes catalysing the cross-linking of  
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Figure 1.1. Common antibiotic classes used to treat humans and animals 
 
  
A 
B 
A, Trends in the number (in millions) of items of non-topical antibiotic prescribed 
clinically in England between October to September 1997-2009 (Adapted from 
NHS, 2011). 
 
B, Tonnes of base active ingredient of each class of antimicrobial used in the UK in 
humans in community and hospital acquired infections, and used in animals in 
2007 (Adapted from DEFRA, 2007).   
Tetra, Tetracylcine; T/S, Trimethoprim/Sulphonamide, Beta, β-lactams;  
Amino, Aminoglycosides; Macro, Macrolides; Quin, Quinolones. 
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Figure 1.2. The structure of β-lactam antibiotics and action of β-lactamases 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
A) Structure of the β-lactam ring found in all β-lactam antibiotic, 
B) The position where the β-lactam ring is hydrolysed by β-lactamases, 
C) The chemical structure of cefotaxime,  
D) The chemical structure of cefotaxime after hydrolysis by a CTX-M β-lactamase. 
(C and D adapted from Delmas et al., 2010)  
A B 
β-lactamase 
β lactam ring 
C D 
Cefotaxime 
Hydrolysed 
Cefotaxime 
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the peptidoglycan bacterial cell wall, rigidity of the structure is not achieved resulting 
in a bacteriostatic effect which can often result in bacterial cell death (Tipper, 1985).  
1.2.2 Mechanisms of resistance to antibiotics 
When antibiotics were first introduced in medicine over 60 years ago, bacteria with 
the ability to resist these antimicrobial effects were immediately discovered 
(Abraham, 1940; Abraham, 1987). Today, bacterial resistance to antibiotics is 
considered one of the most important contemporary healthcare issues; leading to an 
increase in treatment failure with adverse outcomes e.g. increased patient morbidity 
and mortality if an inappropriate antibiotic is administered (Hirsch and Tam, 2011; 
Shorr et al., 2011). Antibiotic resistance also has dramatic cost implications such as 
the cost of isolation of patients and infection control (Pitout, 2008; Talbot, 2008); or 
loss of cheaper agents for effective treatment (Hawkey, 2008).   
There are essentially four mechanisms by which bacteria may become resistant to 
antibiotic action: (i) modification of the antibiotic target, preventing successful 
interaction; (ii) metabolic bypass; (iii) reduction in the concentration of the drug within 
the cell either by reduced uptake or efflux of the antibiotic; and (iv) inactivation of the 
antibiotic, commonly mediated by the production of an enzyme (Cundliffe, 1989). 
Both nosocomial and community acquired Gram negative bacterial infections are 
frequently treated with β-lactams (NHS, 2011); these bacteria are commonly resistant 
to antimicrobials (Pitout, 2008). Resistance to β-lactams is mediated by four 
mechanisms; restriction of antimicrobial concentration within the bacterial cell (e.g. 
via porin loss or active efflux); a decrease in affinity of the β-lactam for the target PBP 
enzymes; or hydrolysis of the drug by a β-lactamase enzyme (Figure 1.2) (Piddock et 
al., 1997; Pfeifer et al., 2010). The latter of these mechanisms is by far the most 
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common in Enterobacteriaceae (Rodriguez-Bano and Pascual, 2008; Bush and 
Jacoby, 2010) due in part to the dissemination of these genes by mobile genetic 
elements.  
1.2.2.1 Mobilisation of antibiotic resistance genes 
There are several elements that are able to mobilise antibiotic resistance genes from 
one genetic location to another. These include (i) bacteriophages or „phage‟, which 
may excise extra DNA located adjacent to integrated prophage in one bacterium, and 
integrate this genetic material within the chromosome of another on re-infection 
(Brussow et al., 2004); (ii) insertion elements and transposons, short DNA sequences 
able to translocate genes using an enzyme „transposase‟ which allows excision and 
integration of genetic material using homologous recombination (Normark and 
Normark, 2002); (iii) conjugative transposons which go a step further and allow the 
excised mobilised genes to transfer to another bacterium and integrate within the 
chromosome via horizontal transfer (Slater et al., 2008) and (iv) plasmids, some of 
which allow the translocation of genetic material from one host cell to another via 
conjugation (Section 1.4). Other genetic elements, such as integrons, are able to 
recognise and capture genetic material through an integrase protein, however can 
only mobilise accumulated DNA when associated with one of the genetic elements 
listed above (Fluit and Schmitz, 2004).  
1.3 β-lactamases 
β-lactamases are enzymes produced by many bacteria, thought to be an evolutionary 
response to β-lactam antibiotics synthesised by environmental organisms within soil 
(Bradford, 2001). These enzymes achieve inactivation of β-lactam antibiotics by 
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cleavage of the amide bond resulting in hydrolysis of the β-lactam ring (Figure 1.2) 
(Bush et al., 1995; Bonnet, 2004). β-lactamases are structurally similar to PBPs and 
are postulated to have evolved either from these cell-wall enzymes or to share a 
common ancestor (Joris et al., 1988; Massova and Mobashery, 1998). β-lactamases 
were first recognised in the form of penicillinases, which were able to hydrolyse the 
very first β-lactam benzyl penicillins used to treat Gram-positive bacterial infections 
(Abraham, 1940). In response, pharmaceutical companies produced penicillinase 
stable antibiotics such as methicillin and flucloxacillin. Within one year of use in 
patients, β-lactamases able to hydrolyse these new drugs were also found in clinical 
isolates (Jevons, 1961). The treatment of Gram negative infections was 
revolutionised by the introduction of semi-synthetic penicillins such as ampicillin, 
which have a β-lactam ring attached to a synthetic side chain and so increased 
activity against the Enterobacteriaceae (Rolinson, 1998). Unfortunately, ampicillin-
resistant Gram-negative bacteria were quickly isolated and shown to carry a β-
lactamase (blaTEM gene) on a plasmid (Bradford, 2001). More sophisticated β-lactam 
drugs were then developed. These compounds could resist hydrolysis from both 
TEM and also SHV β-lactamases; these agents were named third generation 
cephalosporins or oxyimino-cephalosporins. The third generation cephalosporins 
have a very broad spectrum of activity and are used extensively in human medicine 
and to a lesser extent in veterinary practice (Goossens et al., 2005; Li et al., 2007).  
Mobilisation of novel β-lactamase genes from environmental bacteria and evolution 
of blaTEM and blaSHV genes gave rise to enzymes able to inactivate these newer 
cephalosporins. This group of enzymes were collectively named the extended 
spectrum β-lactamases or „ESBLs‟. Plasmid mediated SHV β-lactamases are thought 
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to have originated from several „escapes‟ of the chromosomal blaSHV gene of 
Klebsiella pneumoniae (Gniadkowski, 2008). Point mutations in this gene have led to 
enzymes with extended substrate spectrums. The origins of plasmid based blaTEM 
genes are currently unknown, however, they are postulated to have originated from a 
chromosomal progenitor (Livermore, 2008).  
More recently a new group of β-lactamase enzymes called carbapenemases (Table 
1.1; groups 2c, 2df and 3) have also emerged, which are able to hydrolyse the widely 
used and often last resort carbapenem antibiotics (Walsh, 2008; Bush, 2010).  
1.3.1 Classification of β-lactamases 
Many β-lactamase classification systems have been adopted in order to categorise 
these enzymes. However, as more diverse enzymes are discovered, and more is 
learned about their phylogeny, these systems have increased in complexity.  
The most commonly used classifications of β-lactamases are by Ambler (Groups A-
D) based on molecular structure and amino acid sequence (Ambler et al., 1991), and 
by Richmond and Sykes (Richmond and Sykes, 1973). Richmond and Sykes classify 
β-lactamases based on their clinical functional properties, whether they are inhibited 
by β-lactamase inhibitors such as clavulanic acid and the drugs which are 
preferentially hydrolysed. The Bush Jacoby and Medeiros classification combines 
both of these systems (Bush et al., 1995) and has been updated to include recently 
discovered enzymes (Bush and Jacoby, 2010) allowing better differentiation between 
groups (Table 1.1). Fundamentally, β-lactamases can be divided between those 
enzymes which contain a serine active site residue (Ambler classes A, C and D) and 
those with a catalytic zinc centre called metallo β-lactamases (Ambler class B). The 
serine containing enzymes can be further subdivided into those that are inhibited by  
 Table 1.1. β-lactamase classification (adapted from Bush, 2010 and Pfeifer et. al., 2010) 
Active site 
residue 
Ambler 
class 
Group* β-lactamases Exemplars Common host 
species 
Agents 
inactivated 
Inhibited by 
clavulanic acid 
Serine 
A 
2a Penicillinases  
 
Staphylococcus aureus 
 
Enterobacteriaceae 
 
Enterobacteriaceae 
 
 
 
 
Enterobacteriaceae 
 
Enterobacteriaceae 
 
 
 
Enterobacteriaceae 
Penicillin  
2b Penicillinases and 
cephalosporinases 
TEM-1, TEM-2, SHV-1, 
SHV-11 
 
Ampicillin 
 
2be Extended spectrum 
beta-lactamases 
TEM-3 – TEM167 
SHV-2 – 117 
All CTX-Ms 
PER/VER/GES 
 
Penicillins and 3
rd
 
generation 
cephalosporins  
 
2br Inhibitor resistant 
penicillinases 
TEM-30 – 41, 44, 45, 51 
and 54; SHV-10 
 
Penicillins Reduced 
2c Carbapenemases PSE/NMC/IMI/KPA-1/2/3 
GES-2 and SHV-38 
SME/KPC 
Penicillins and 
carbapenems 
 
2e/f Cephalosporinases  Cephalosporins 
/monobactams 
 
 
C 1 
AmpC cephamycinases 
(chromosomal) 
AmpC 
Enterobacter spp. 
Citrobacter spp. 
Cefoxitin/ 3
rd
 gen. 
cephalosporins 
 
X 
D 
 
2d AmpC cephamycinases 
(plasmid encoded) 
CMY, DHA, MOX, FOX, 
ACC 
 
Enterobacteriaceae 
Cefoxitin and  3
rd
 
generation 
cephalosporins 
 
 
Broad spectrum            
β-lactamases 
 
OXA-1, OXA-9 Enterobacteriaceae, 
 A. baumannii 
 
Enterobacteriaceae,  
A. baumannii 
Oxacillin, 
ampicillin 
 
 
 
 
2df 
ESBL OXA  
Penicillin and  3
rd
 
generation 
cephalosporins 
 
 
Carbapenemases OXA-48, OXA-23, 24,25 Enterobacteriaceae,  
A. baumannii 
Carbapenems 
  
 
Metallo B 3 Carbapenemases VIM, IMP, NDM-1 
Enterobacteriaceae,   
P. aeruginosa,    
A. baumannii 
All β-lactams 
except 
monobactams 
X 
*Bush Jacoby and Medeiros classification. TEM, Temoniera; SHV, sulfhydryl varient; CTX-M, cefotaximase - Munich; PER, P. Nordmann, E. Ronco R. Labia; VER, Versailles; GES, 
Guiana extended spectrum; PSE, Pseudomonas-specific enzymes ; NMC/IMI, not metalloenzyme carbapenemase/imipenem-hydrolysing beta; KPA, Klebsiella pneumoniae group A; 
SME, Serratia marcescens enzyme; KPC, K. pneumoniae carbapenemase; OXA,oxicillinase; CMY, cephamycinases; DHA, Dhahran hospital Saudi Arabia; MOX, moxalactamase; 
FOX, cefoxitinase; ACC, Ambler class C; VIM, Verona integron encoded metallo; IMP, imipenemase; NDM, New-Delhi Metallo.
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clavulanic acid and other β-lactamase inhibitors (Ambler classes A and D) and those 
that are not (Ambler class C, group 1) (Bush and Jacoby, 2010). Groups A and D are 
further distinguished by their difference in amino acid and DNA sequence and 
disparity in activity to different substrates (Hall and Barlow, 2004).  
1.3.2 Extended spectrum β-lactamases (ESBLs) – Ambler class A/ Group 2be 
The term „extended broad spectrum β-lactamases‟ was first applied in 1987 to TEM 
and SHV enzyme variants with the ability to hydrolyse cephalosporins with a C7 side 
chain containing an oxyimino group (Jarlier et al., 1988). These enzymes are thought 
to have derived from blaTEM-1/2 and blaSHV-1 β-lactamase genes, which acquired point 
mutations within the DNA sequence encoding the active-site of the enzyme. This 
allowed a physical expansion of the active site and so a broadening of the range of 
substrates these enzymes are able to hydrolyse (Gniadkowski, 2008). However, the 
mutations conferred an enzyme with a reduced catalytic efficiency compared with the 
„parental‟ enzymes against penicillins, and gave increased susceptibility to                        
β-lactamase inhibitors (Bradford, 2001).  
Since the late 1980s, other classes of β-lactamases derived from enzymes other than 
TEM/SHVs have been discovered; these also have activity against the oxyimino-
cephalosporins. As a result the term „ESBL‟ was extended to include these other 
enzymes (Livermore, 2008). Currently, an ESBL is defined as any β-lactamase 
capable of inactivating penicillins, first, second and third generation cephalosporins 
and aztreonam; but not cephamycins or carbapenems. These enzymes are inhibited 
by β-lactamase inhibitors such as amoxicillin-clavulanate, tazobactam or sulbactam 
(Paterson and Bonomo, 2005).  
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Following the appearance of TEM/SHV ESBL variants in the mid 1980s, these 
enzymes spread globally in the 1990s (Cantón and Coque, 2006). Both TEM and 
SHV groups expanded in the number of variants identified, and became a significant 
clinical treatment issue causing increased mortality as a result of treatment failure 
(Miro et al., 2005). Risk factors for acquiring an infection with a bacterium producing 
a TEM or SHV ESBL include admittance to ICU; recent surgery or long term hospital 
stay; placement of a catheter and previous cephalosporin treatment. Therefore, 
infections with strains carrying TEM/SHV enzymes have been largely nosocomial 
related (Canton et al., 2008).  
The dominance of these enzymes has been succeeded by the dramatic emergence 
of another group of ESBLs named the CTX-Ms which have spread rapidly since 
1995. These are now the most widespread and diverse group of ESBLs isolated 
worldwide (Bonnet, 2004; Hawkey and Jones, 2009). 
1.3.3 CTX-M β-lactamases 
The first CTX-M β-lactamase was identified in Japan in 1986 during a 
pharmacokinetic study of β-lactam antibiotics in a dog. The enzyme was identified in 
an isolate from a stool sample, and named FEC-1 (Matsumoto et al., 1988). It was 
not until 1989 when Bauernfeind et al., (1990) reported a non TEM/SHV β-lactamase 
producing isolate resistant to cefotaxime, that the group acquired its name „CTX-
Mases‟ or „CTX-Ms‟ with reference to the preferential hydrolytic activity of members 
for cefotaxime (Lartigue et al., 2004) and the location of the group, „Munich‟. This 
enzyme was named CTX-M-1 and was later assigned to „Group 1‟ when it became 
apparent CTX-Ms could be sub-categorised based on amino acid sequences. 
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Simultaneously, cefotaxime resistant Salmonella Typhimurium strains began 
disseminating in Argentina (Bauernfeind et al., 1992).  
In 1992, Bernard et al. reported an E. coli isolated in 1989 which was resistant to 
cefotaxime; the enzyme responsible was cloned and named MEN-1. Sequence 
analysis of blaMEN-1 showed 39% identity with blaTEM and blaSHV variants (Barthelemy 
et al., 1992). Later analysis and DNA sequencing showed that blaMEN-1 and blaCTX-M-1 
were identical, and that blaToho-1 sequenced in Japan (Ishii et al., 1995) was of the 
same genotype (renamed blaCTX-M-2). FEC-1 was also found to be identical to an 
enzyme found from an isolate from Poland named CTX-M-3 in 1996 (Gniadkowski et 
al., 1998).  
Since 1998, the CTX-M family has continued to increase rapidly (Navarro and Miro, 
2002) with 117 different variants currently recognised   
(http://www.lahey.org/studies/webt.htm; as of September 2011). Almost all isolates 
found to produce these β-lactamases are Enterobacteriaceae such as E. coli (found 
most frequently), Salmonella spp., Klebsiella spp., Shigella spp., Citrobacter spp., 
Enterobacter spp. and Proteus spp. However, CTX-M producing Pseudomonas spp., 
Vibrio cholerae El Tor (Petroni et al., 2002), Serratia marcescens (Mlynarczyk et al., 
2009), Acinetobacter baumanni (Radice et al., 2002), Aeromonas hydrophilia, 
Providencia stuartii, Burkholderia cepacia, Stenotrophomonas maltophilia (Kiratisin 
and Henprasert, 2010) and Morganella morganii (Ogbolu et al., 2011; Soleimanian et 
al., 2011) have also been reported. 
1.3.3.1 Activity and structure of CTX-M β-lactamases 
The CTX-M enzymes are characterised by their preferential hydrolysis of cefotaxime 
over ceftazidime, in most cases this activity is up to 35 times greater (Bonnet, 2004). 
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As a group they are inhibited by tazobactam more efficiently than by sulbactam and 
amoxicillin-clavulanate (Paterson and Bonomo, 2005), and have reduced activity 
against penicillin compared with TEM or SHV variants (Lartigue et al., 2004). The 
molecular structure of these enzymes comprises an α helical domain and a mixed α 
helices / β sheet domain, with the active β-lactam binding site between them (Figure 
1.3).  
The majority of CTX-M enzymes contain 291 amino acid residues and have a 
molecular mass of ~28 kDa (Bonnet, 2004). These enzymes also contain an Ω loop 
near the active site (Navarro and Miro, 2002). The DNA sequence encoding this 
locus is where mutations may lead to enhanced activity against ceftazidime; such as 
mutations seen in blaCTX-M-15, blaCTX-M-16, blaCTX-M-19 and blaCTX-M-27 (Bonnet et al., 
2001; Karim et al., 2001; Bonnet, 2004). blaCTX-M-15 is thought to be the result of a 
mutated blaCTX-M-3 gene which has a Gly-240-Asp substitution leading to an eight fold 
higher action against ceftazidime (Poirel et al., 2001). The 117 identified CTX-M 
variants cluster into five different phylogenetic groups based on their amino acid 
sequences. Each group is named after the first enzyme identified within this cluster 
(Groups 1, 2, 8, 9 and 25). Within groups, each member shares >95% amino acid 
homology and are thought to have a common ancestor; whereas members belonging 
to distinct groups share <90% identity (Bonnet, 2004).  
1.3.3.2 Origins of blaCTX-Ms 
Unlike blaTEM and blaSHV gene, blaCTX-M β-lactamase genes are thought to have 
progenitors with an innate ability to hydrolyse oxyamino-cephalosporins (Hawkey, 
2008). These blaCTX-M progenitor chromosomal genes can be found in the genus 
Kluyvera, an environmental Enterobacteriaceae bacterium predominantly found in  
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Figure 1.3. Ribbon diagram of CTX-M-9  
 
 
  
 
 
 
 
  
As with all serine β-lactamases the molecular fold consists of an α-helical domain 
(left) and a mixed α ⁄ β-domain (right). The serine β-lactam-binding site (Shown by 
the purple arrow) is located in a cleft between the two domains. Positions 167 and 
240, where amino-acid substitutions enhancing ceftazidimase activity occur, are 
located either in the Ω-loop (in green, at the bottom of the binding site) or in the 
terminal part of the B3 β-strand. 
Adapted from Rossolini et al., (2008). 
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soil, water sewage or food products of animal origin such as milk (Farmer et al., 
1981; Pavan et al., 2005). Kluyvera spp. can also be found as part of the human gut 
flora (associated with low total bacterial counts) but are rarely reported from clinical 
specimens (Farmer et al., 1981; Sarria et al., 2001). Phlyogenetic analysis of the 
Kluyvera β-lactamase genes have shown that mobilisation of these different Kluyvera 
genes may have led to the various groups of blaCTX-M. For example, β-lactamase 
genes from K. ascorbata (blaKLUA) share 99% identity with those members of CTX-M 
Group 1 and 2 (Rodriguez et al., 2004), K. georgiana blaKLUY genes show 100% DNA 
homology with blaCTX-M Group 9 gene blaCTX-M-14 (Olson et al., 2005) and to a lesser 
extent K. cryocrescens gene blaKLUC-1 and K. georgiana blaKLUG-1 have 99% amino 
acid homology with blaCTX-M-8 (Poirel et al., 2002). The origins of blaCTX-M groups 25 
and 45 are unknown, but are also thought to have originated from Kluyvera spp. 
(Rossolini et al., 2008). Within the recent literature CTX-M-14 and CTX-M-3 are the 
accepted progenitors of their respective groups (Group-9 and Group-1). This 
suggests subsequent diversification from these progenitor variants has led to the 
evolution of the other blaCTX-M alleles within these groups (Novais et al., 2010). 
1.3.3.3 Epidemiology of blaCTX-Ms 
In different geographical areas of the world, the predominant blaCTX-M genes identified 
in CTX-M producing isolates varies considerably (Canton et al., 2008; Hawkey and 
Jones, 2009). The global distribution of CTX-M variants is shown in Figure 1.4. There 
are currently no plausible explanations for variation across global regions.  
 Figure 1.4. Global distribution of blaCTX-M variants and their relative proportions within each region 
 
Adapted from Hawkey and Jones (2009)  
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The first CTX-M producing bacterium identified in the UK was isolated from a patient 
in Leeds in 2000 (Alobwede et al., 2003), produced by a Klebsiella oxytoca carrying a 
blaCTX-M-9 gene. This was followed in 2001-2002 by an outbreak in Birmingham 
caused by a CTX-M-25 producing strain of K. pneumoniae (Brenwald et al., 2003). 
By 2003, when Munday et al., conducted a study on isolates from York identifying 
prevalent ESBL types, CTX-M producers were common. They found blaCTX-M variants 
blaCTX-M-9, blaCTX-M-14 and blaCTX-M-15 during the study, however failed to detect any 
CTX-M producing isolates in a collection of earlier strains isolated between 1990-
1991 (Piddock et al., 1997; Munday et al., 2004). At present, in the UK a large range 
of CTX-M enzymes are produced by bacteria including the only representative of 
Group 8, CTX-M-40 (Hopkins et al., 2006), CTX-M-25, 26, 9, 1, 3, 10, 14 and 15 
(Munday et al., 2004). CTX-M-15 β-lactamase producing bacteria are the most 
commonly isolated in the UK (Rossolini et al., 2008), with CTX-M-14 the second most 
prevalent (Warren et al., 2008). In 2010, 10% of E. coli isolated from human blood 
cultures were resistant to cephalosporins compared with 6% in 2004, indicating the 
significant problem these isolates are causing in the UK (HPA, 2011). 
1.3.3.4 Clonal expansion of strains carrying blaCTX-Ms 
The global spread of blaCTX-M-15, currently the most commonly identified ESBL 
worldwide, can be partly attributed to the extensive clonal expansion of one particular 
E. coli sequence type, ST131, with which a selection of blaCTX-M-15 carrying plasmids 
have become associated (Lau et al., 2008; Clermont et al., 2009; Woodford et al., 
2009). E. coli B2-O25:H4-ST131 is primarily an extraintestinal pathogenic E. coli and 
a member of the highly virulent B2 E. coli phylogenetic subgroup 1 found globally 
isolated from humans, and more recently in companion and human associated 
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animals such as rats (Ewers et al., 2010; Guenther et al., 2010; Rogers et al., 2011). 
Typically these isolates are multidrug resistant, demonstrating resistance to 
ciprofloxacin, gentamicin, tobramycin and tazobactam and many harbour plasmids 
carrying blaOXA-1, blaTEM-1 and the quinolone resistance gene aac(6’)-Ib-cr in addition 
to blaCTX-M-15 (Pitout et al., 2009). Initially, an association was made between E. coli 
ST131 hosts and blaCTX-M-15 carrying IncFII plasmids, however since 2008, ST131 
isolates with plasmids carrying many other blaCTX-M variants have been reported 
(Clermont et al., 2009; Oteo et al., 2010), including blaCTX-M-2, blaCTX-M-3, blaCTX-M-27 
(Ruppe et al., 2009), blaCTX-M-32 and blaCTX-M-14. It appears that ST131 CTX-M-14 
producing strains are emerging in the geographical regions where blaCTX-M-14 is most 
commonly identified, such as Spain (Blanco et al., 2009; Mora et al., 2010) and Asia. 
Although a CTX-M-14 producing O25:H4-ST131 strain was the cause of an E. coli 
outbreak in a Japanese hospital in 2002 (Suzuki et al., 2009), there is still no 
evidence to date that CTX-M-14 ST131 producing strains are spreading via clonal 
expansion.  
1.3.3.5 Acquisition, carriage and reservoirs of CTX-M producing bacteria 
Until the end of the 1990s, infections by bacteria producing an ESBL were most 
commonly associated with hospital acquired infections particularly in the ICU and 
after surgical procedures or after the use of catheters (Paterson and Bonomo, 2005). 
Infections were predominately caused by isolates of Klebsiella spp. expressing blaTEM 
or blaSHV genes, and were associated with prior use of a cephalosporin (Canton et 
al., 2008). Since this time ESBL epidemiology has changed dramatically with the 
rapid emergence of CTX-M producing isolates. Whereas infections with TEM or SHV 
ESBL producers are largely nosocomial, CTX-M producing isolates have frequently 
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been identified in E. coli from the community (Woodford et al., 2004; Rodriguez-Bano 
et al., 2010), and are the most commonly isolated ESBLs from urinary tract 
pathogens (Pitout et al., 2004). Health-care settings, such as nursing homes, have 
also been strongly associated with CTX-M acquisition (Dhanji et al., 2010; March et 
al., 2010; Schoevaerdts et al., 2011), either resulting in infections or carriage of these 
isolates (Rooney et al., 2009). Despite a clear link between age (>65s) and carriage 
(Schoevaerdts et al., 2011), healthy people of all ages have been identified as 
carrying CTX-M producing bacterial strains (Tian et al., 2008; Sasaki et al., 2010) 
which are able to pass to others, particularly between co-habitors and even family 
pets (Johnson et al., 2008; Lo et al., 2010).  
Increased foreign travel is also believed to be a major contributor to the emergence 
and spread of blaCTX-M variants (Laupland et al., 2008; Pitout et al., 2009). Tängdén 
et al. (2010) showed 24/100 healthy volunteers who travelled to locations outside 
northern Europe including Africa, Asia, India, the Middle East and Southern Europe, 
returned with a previously undetected colonisation of a CTX-M producing isolate. It is 
not known whether these travel related acquisitions are due to colonisation by the E. 
coli isolates themselves or integration of blaCTX-M carrying plasmids within the host‟s 
resident flora.  
Other potential reservoirs where CTX-M producers can be found include soils 
(particularly when enriched using manure) (Heuer et al., 2008), sludge and sewage 
(Reinthaler et al., 2009) and water sources such as rivers (Chigor, 2010; Dhanji et 
al., 2010). These environmental reservoirs may have constant or fluctuating 
exposure to many different antibiotics and biocides and are composed of diverse 
bacterial populations and nutrient sources (Davies and Davies, 2010). Their role in 
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persistence, amplification, evolution and spread of resistance genes is currently still 
undetermined, but may be particularly relevant in the acquisition of blaCTX-Ms by 
bacteria isolated from animals.  
1.3.3.6 CTX-M producing bacteria from animals 
As previously described, the β-lactam antibiotics are an important group of 
antimicrobials in veterinary medicine (Li et al., 2007) (Figure 1.1). β-lactams are used 
outside the EU as a prophylactic in animal feed, in aquaculture and were previously 
used at sub-therapeutic levels to improve growth rates and feed efficiency in food 
animals (Aarestrup, 2004; Davies and Davies, 2010). It is estimated that the US uses 
more than 8000 tonnes of antimicrobials annually in food production and that the UK 
farming industry uses three tonnes of cephalosporins for therapeutic purposes alone 
each year (Carattoli, 2008); therefore exposure of food animals to these compounds 
is very high. Despite this, ESBL producing bacteria are much less frequently isolated 
from animals than humans, and strains prevalent in food animals in a given 
geographical area do not necessarily reflect the strains found in human populations 
(Carattoli, 2008; Hunter et al., 2010). Recently, blaCTX-M carrying strains have become 
the most commonly detected ESBL producing bacteria isolated from animals (Li et 
al., 2007). CTX-M producers have been identified globally in poultry (Brinas et al., 
2003; Dierikx et al., 2010; Sheldon, 2010), swine (Escudero et al., 2009; Smet et al., 
2009) and cattle populations (Liebana et al., 2006; Hunter et al., 2010) and have 
been isolated in poultry farms with no known exposure to β-lactam antibiotics (Smet 
et al., 2008; Bortolaia et al., 2010). 
β-lactam resistant E. coli can also be isolated from companion animals such as cats 
and dogs (Moreno et al., 2008; Ewers et al., 2010) and from wild animals such as 
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foxes, kestrels and sparrow-hawks (Costa et al., 2006; Costa et al., 2008). Currently, 
domesticated pets are thought to have higher carriage rates of resistant strains than 
livestock and due to their close contact with humans, pets may create an important 
ecological reservoir for ESBL producing bacteria (Skurnik et al., 2006). Therefore, the 
contamination of food products such as meat, dairy or eggs, and colonisation of flora 
of animal intestinal tracts may provide a reservoir of blaCTX-Ms (Warren et al., 2008), 
and a diverse environment for the transmission of plasmids carrying resistance 
genes to humans (Poppe et al., 2005; Ensor et al., 2006; Skurnik et al., 2006). 
Animals, particularly livestock, have historically been considered as reservoirs for 
antibiotic resistant bacteria and plasmids (Hartley et al., 1975; Timoney and Linton, 
1982; Hinton and Linton, 1983). However, the spread of these isolates and genetic 
elements from animals to humans or vice-versa has remained controversial, 
shrouded in political and economic issues. A body of evidence now exists showing 
transfer of either particular bacterial strains or plasmids between these hosts and 
environments; however the mechanisms and implications of this dissemination are 
largely unknown (Mulvey et al., 2009; Smet et al., 2009). 
1.3.4 CTX-M-14 
CTX-M-14, also known as CTX-M-18, UOE-2 and Toho-3 (Navarro and Miro, 2002) 
has become the second most common CTX-M enzyme isolated worldwide (Hawkey 
and Jones, 2009; Song et al., 2009; Furtado and Nicolau, 2010). A member of Group 
9, CTX-M-14 has only one amino acid difference from CTX-M-9 with a change of 
alanine to valine at position 231 (Ma et al., 2002). Analysis of the crystal structure of 
CTX-M-14 indicates these substitutions have led to specific interactions between 
enzyme and substrate which may be responsible for the improved activity of the 
24 
 
enzyme against some β-lactams, rather than active site expansion (Perez et al., 
2007) as seen in TEM and SHV variants. However, CTX-M-14 retains the 
characteristics of a classic CTX-M β-lactamase, and does not have the ability to 
hydrolyse ceftazidime.  
1.3.4.1 Emergence and epidemiology 
CTX-M-14 was first identified from an E. coli isolated from a patient in 1998 in China 
(Chanawong et al., 2002). The sequence was elucidated and deposited in Genbank 
as accession number AF252621.1 (now updated as AF252621.2) and was quickly 
followed by the detection of this enzyme in other parts of Asia, including Korea (the 
first published CTX-M-14 producer isolated in 1995) and in Japan (Pai et al., 2001). 
During the late 1990s more reports of blaCTX-M-14 came from China, France, Taiwan 
and Brazil (Bou et al., 2002; Dutour et al., 2002; Yu et al., 2002). In 2001, a CTX-M-
14 producing E. coli isolate was identified in Spain (Bou et al., 2002) and a  
Salmonella Enteritidis CTX-M-14 producer was isolated in the UK (Hopkins et al., 
2006). Since this time, a rapid increase in the number of CTX-M-14 producers has 
been observed worldwide (Figure 1.4) (Cao et al., 2002; Chanawong et al., 2002; 
Pallecchi et al., 2007; Bae et al., 2008; Lee et al., 2009) becoming the most prevalent 
ESBL in a number of countries including Spain and China. In the UK, CTX-M-14 has 
become the second most prevalent CTX-M enzyme type identified in ~10% of clinical 
ESBL producing E. coli (HPA, 2011). All CTX-M-14 producing isolates documented 
to date have been members of the family Enterobacteriaceae and in a wide variety of 
species within this group. 
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1.3.4.2 blaCTX-M-14 mobilisation  
As previously described, blaCTX-M Group 9 genes found on plasmids are thought to 
have originated from chromosomal K. georgiana β-lactamase gene blaKLUY-1, which 
shares 100% amino acid identity with group 9 progenitor, blaCTX-M-14 (Olson et al., 
2005). A 42 base-pair upstream region of blaCTX-M-14 is identical to those found 
upstream of blaKLUY-1; however blaCTX-M-14 is also found downstream of insertion 
element ISEcp1 not found in the Kluyvera chromosome.  
ISEcp1 belongs to the IS1380 insertion sequence family (Lartigue et al., 2006), 
consisting primarily of two imperfect inverted repeats and an open reading frame 
encoding a 420 amino acid transposase (Lartigue et al., 2004). In all plasmids 
containing blaCTX-M-14 investigated to date, all or part of this element has been found 
upstream of the blaCTX-M-14 gene (Eckert et al., 2006) and ISEcp1 can also be found 
upstream of blaCTX-M-3, blaCTX-M-10 and blaCTX-M-15 (Lartigue et al., 2004). It is believed 
this element has a major role in mobilisation of the blaCTX-M genes. Lartigue et al. 
(2006) demonstrated that blaCTX-M-2 could be mobilised in vivo from its natural 
progenitor K. ascorbata to a plasmid when ISEcp1B was placed upstream of this 
gene; however the reason for its strong association with blaCTX-M genes is still 
unknown (Poirel et al., 2005). blaKLUY-1 is very weakly expressed on the Kluyvera 
chromosome, therefore it is possible that this foreign insertion sequence acts as a 
strong promoter to give blaCTX-M-14 its characteristic phenotype when present on 
plasmids. However, no chromosomal origin or reservoir of ISEcp1 has yet been 
found (Poirel et al., 2003). Another insertion element, IS903, has been detected 
downstream of all studied blaCTX-M-14s, however is not believed to have a role in 
mobilisation of this gene (Poirel et al., 2005). 
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1.4 Plasmids 
Plasmids are extra-chromosomal circular fragments of DNA that replicate 
autonomously in host cells (Clowes, 1972). They are ubiquitous in most bacterial 
species and are found in virtually all ecosystems (Slater et al., 2008) including 
hydrothermal vents (Prieur et al., 2004) and arctic soil (Duodu et al., 2007). Plasmids 
encode genes essential for the initiation and control of their own replication and can 
encode a variety of traits that in certain circumstances may be advantageous to the 
host bacterial cell such as antibiotic resistance, heavy metal resistance or may carry 
genes for adaption and survival in particular environments (Johnson et al., 2007). 
Therefore, plasmids are believed to play a major role in bacterial adaption to 
environmental change and contribute to overall bacterial genome plasticity. Plasmids 
are also important when carried by medically relevant bacteria due to their ability to 
mobilise and disseminate antibiotic resistance genes and virulence genes, which 
may impact on the pathogenicity of a bacterium. Of note in relation to this study, is 
their role in the dissemination of genetic material encoding β-lactamase enzymes 
among Gram-negative Enterobacteriaceae.  
1.4.1 Characterisation of plasmids 
Naturally occurring plasmids are notoriously difficult to categorise due to their mosaic 
nature, propensity to recombine and the lack of any universally common genetic 
features (Coque et al., 2008; Call et al., 2009; Villa et al., 2010). However, a need for 
a common nomenclature and a grouping system to allow epidemiological and 
evolutionary studies stimulated the development of both phenotypic and subsequent 
genotypic schemes (Novick et al., 1976).  
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1.4.1.1 Incompatibility and rep typing 
The first and most widely recognised typing system is based on the phenotypic 
observation that two plasmids sharing common replication and partitioning elements 
are unable to stably proliferate within the same bacterial cell (Couturier et al., 1988). 
Classically, membership of an incompatibility group (Inc group) was ascertained by 
the introduction, by conjugation or transformation, of the candidate plasmid into a 
strain carrying a plasmid of known Inc type. If the resident plasmid was eliminated 
within the progeny the test plasmid would be assigned to this Inc group (Novick et al., 
1976; Datta and Hughes, 1983). Therefore, plasmids with the same replicon control 
are deemed „incompatible‟ (Novick, 1987). 
Due to the number of plasmid Inc types discovered and the time consuming and 
laborious nature of Inc typing, rapid and less demanding molecular assays were 
designed to identify replication genes corresponding to the incompatibility type 
(Carattoli et al., 2006). In 1988, Couturier et al. developed a hybridisation method 
which recognised 19 different replication gene types or „replicons‟. This method 
paved the way for PCR detection methods using the replication genes as target 
regions. The first PCR based categorisation method was limited to four Inc types 
(Gotz et al., 1996); Carattoli et al., (2005) further developed a functional and 
relatively easy PCR assay to characterise all the major Inc types, revolutionising the 
way plasmids are grouped (Carattoli et al., 2005; Carattoli et al., 2006). 
Despite the universal acceptance of the PCR method, many limitations remain. 
Sequencing of rep genes has shown that a few base-pair changes can alter the 
incompatibility type of a plasmid; therefore mutations in the PCR primer binding sites 
could change the Inc status, whilst the plasmid backbone remains unchanged. 
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Additionally, rep genes may be under considerable selective pressure within bacterial 
cells if interacting with other plasmids. Multiple types of rep gene have also been 
identified on single plasmid backbones allowing the plasmid membership of more 
than one group (Osborn et al., 2000). Due to the dynamic nature of this genetic 
region, determining the incompatibility type alone is limited in its ability to inform on 
the plasmid evolution and the plasmid type as a whole (Francia et al., 2004).  
1.4.1.2 MOB relaxase typing 
In order to overcome some of the limitations of rep typing, an alternative plasmid 
typing method has been developed, although it is not used widely. „MOB‟ typing is 
based on the genotype of the relaxase gene, believed to be the most universally 
common feature of both conjugative and mobilisable plasmids (Francia et al., 2004). 
The relaxase protein initiates and terminates conjugation by catalysing cleavage of 
the DNA during transfer to a recipient cell. Therefore, its activity is essential for this 
process to occur and a relaxase gene is present in all conjugative plasmids (Smillie 
et al., 2010). PCR primers for each of six groups are used to amplify regions of the 
relaxase for identification. Further analysis can be achieved by sequencing these 
amplimers, providing information on phylogeny and further discrimination between 
plasmids (Garcillan-Barcia et al., 2009).  
1.4.1.3 Plasmid multi-locus sequence typing (pMLST) 
Other methods of plasmid characterisation include the adoption of principles used for 
multi-locus sequence typing (MLST). By amplifying and sequencing selected 
„housekeeping‟ genes a sequence type can be generated for further categorisation.  
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Plasmid MLST (PMLST) has been applied to both IncI1 and IncHI1 plasmids with 
some success (Garcia-Fernandez et al., 2008; Phan et al., 2009). However, this 
method is not suitable for plasmid groups with either great diversity or homology due 
to the limited number of loci examined and the mosaic composition of distantly 
related plasmids (Villa et al., 2010).  
1.4.2 Incompatibility group I complex plasmids 
Currently, plasmids from twenty-six different Inc groups have been identified amongst 
Enterobacteriaceae species (Johnson et al., 2007). However, it is the IncI complex 
which has the most relevance to this study. Members of the IncI complex have 
narrow host ranges (Suzuki et al., 2010) and have replication systems which rely on 
inhibition of pseudoknot formation, providing antisense RNA-mediated inhibition 
including incompatibility groups I1, I2, Iγ; B, O and K (Asano et al., 1999). Other 
determining characteristics include the presence of two conjugation systems (tra and 
pil loci) encoding a „thick‟ and „thin‟ pilus and a multiple inversion system known as a 
shufflon, which facilitates variation of the thin pilus tip protein, determining specificity 
of host binding (Komano et al., 1995; Sampei et al., 2010). Despite their ubiquitous 
nature, little is known about the IncI complex group of plasmids and even less has 
been documented regarding groups B, O and K, which are thought to be most closely 
related to one another.  
1.4.2.1 Complete DNA sequences of IncI complex plasmids 
The genomes of over 800 plasmids from the γ-Proteobacteria have been fully 
sequenced (Carattoli, 2009) creating a wealth of information with which to compare 
genotypic attributes of different plasmids. The first IncI1 plasmids to be sequenced 
included R64 (AP005147) (Meynell and Datta, 1966; Sampei et al., 2010) isolated 
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from an S. Typhimurium strain and ColIb-P9 from a Shigella sonnei isolate 
(AB021078) (Mankovich et al., 1986). Both plasmids are often used as reference 
sequences for this group due to their comprehensive annotations. Other plasmids 
used for reference include those sequenced by the Sanger Institute 
(http://www.sanger.ac.uk/Projects/Plasmids/), for example IncB plasmid TP113 
(NCTC 50084) and IncK plasmid R387 (NCTC 50022). Many other IncI complex 
plasmid sequences are available (http://www.ncbi.nlm.nih.gov/nucleotide/) ranging 
from plasmids which have been isolated from pathogenic bacteria and/or carry 
antibiotic resistance genes, to those isolated from the environment; although few 
have been rigorously annotated. 
1.4.3  Epidemiology of plasmids carrying antibiotic resistance genes 
The significance of the ability of plasmids to mobilise antibiotic resistance genes 
between bacteria was first acknowledged in the 1960‟s in Wantanabe‟s work which 
identified the need for a replication and transfer system in addition to the movable 
antibiotic resistance genes on plasmids (Watanabe, 1963). This was followed by the 
discovery of plasmid mediated β-lactamase genes (Bradford, 2001) and by the 
demonstration, using early molecular techniques, that the same plasmid could be 
identified in different bacterial strains and species during an outbreak of Klebsiella 
pneumoniae (Sadowski et al., 1979). Since this time there has been an explosion in 
the frequency and diversity of β-lactamase genes found on plasmids and an increase 
in their clinical significance. Over 1000 resistance plasmids have now been typed into 
the 27 currently known incompatibility groups. However, despite the growing 
importance of this field, very little is known about the distribution, evolution and 
selective pressure of antimicrobial resistance carrying plasmids.  
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1.4.4 Plasmid evolution and evolutionary fitness  
Evolutionary fitness can be defined as the capability of an „evolutionary unit‟ to 
survive and reproduce within a given environment (Andersson and Hughes, 2010). 
Therefore, success of an individual plasmid within a bacterial population is dictated 
by many factors. These include the presence or absence of selective pressures, the 
stability of the plasmid within the bacterium and any fitness cost imposed on the host 
by the plasmid‟s residence. Despite the multi-factorial nature, bacterial and plasmid 
fitness is commonly assessed simply using differences in bacterial growth rates 
either in pure culture or in paired competition (Pope et al., 2010). For many years it 
was believed that all plasmids, particularly those carrying antibiotic resistance genes 
conferred a fitness burden on the bacterial host. So much so that in the absence of 
antibiotic pressure these plasmids would be outcompeted by their plasmid free 
counterparts reversing the dominance of resistance phenotypes (Andersson and 
Levin, 1999). Supporting evidence came from the many examples of chromosomal 
antibiotic resistance determinants which had negative fitness effects on their hosts 
(Björkman and Andersson, 2000), and studies examining the burden early molecular 
vectors initially had on laboratory strains of bacteria. Some in vivo studies also 
suggested that a selective pressure was required for plasmids to persist within the 
human intestinal tract (Anderson, 1974).  
In the majority of cases the presence of a plasmid within a naive bacterial host has 
resulted in some fitness cost (Lenski, 1998); this may be related to the metabolic cost 
of replication and maintenance of the plasmid (Dionisio et al., 2005), due to plasmid 
encoded protein expression, or may be caused by disruption of cellular regulation 
(Rozkov et al., 2004). However, experiments with plasmids pCYC184 and pBR322 
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have shown that a period of co-evolution of host and plasmid may alleviate these 
metabolic burdens (Lenski et al., 1994). There are examples in the literature where 
host chromosomal changes have facilitated this amelioration (Bouma and Lenski, 
1988); where mutation of both host and plasmid genes has been observed (Dahlberg 
and Chao, 2003); and examples of co-evolution yielding an evolutionary fitter 
individual when competed with the plasmid free parent (Enne et al., 2004).  
Studies in humans and animals have also shown that both antibiotic resistant 
bacterial strains and plasmids can be stably maintained within the gut in the absence 
of any antibiotic pressure (Smith, 1975; Petrocheilou et al., 1976; Chaslus-Dancla et 
al., 1987), and that amelioration and selection of more competitive strains can also 
occur in vivo in the human and poultry intestinal tract (Bjorkholm et al., 2001; Luo et 
al., 2005). Antibiotic resistance genes carried on plasmids are usually constitutively 
expressed. This means that any fitness burden or benefit conferred by the resistance 
gene will be indistinguishable from effects of the carrier plasmid upon the host, 
especially if the plasmid copy number per cell is greater than that of the host 
chromosome. Examples of inducible plasmid borne resistance genes have also been 
identified; the fitness burden is reduced in the absence of antibiotic as production of 
the enzyme is „switched off‟, for example inducible vancomycin resistance in S. 
aureus (Foucault et al., 2009). Other studies also demonstrate that it may not be 
enzyme production alone that is responsible for the fitness burden of these plasmid 
borne genes, and that signal sequences or transcription regulators may also have a 
role to play (Macvanin et al., 2004; Marciano et al., 2007).  
The cost of one antibiotic resistance gene may also be obscured by the presence of 
another on the same plasmid. An environment which favours selection of one 
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antibiotic resistance gene determinant will allow evolutionary success for all genes 
encoded on the plasmid. Co-selection is thought to have facilitated the spread of 
many plasmid-borne genes and has been demonstrated to aid the persistence of 
plasmids (Enne et al., 2001; Bean et al., 2009). It may be that co-selection has also 
driven the evolution of large multi-drug resistance plasmids now commonly identified 
(Woodford et al., 2009; Jiang et al., 2010). Although the parameters of plasmid 
fitness and success are largely unknown, plasmid encoded genes that play a role in 
promotion of successful persistence include those encoding post segregational killing 
systems, active partitioning systems (Summers, 1998; Hayes, 2003; Enne et al., 
2005) and the strict regulation of copy number (Dahlberg and Chao, 2003; Loftie-
Eaton and Rawlings, 2010).  
Transfer by conjugation is also considered a key factor in plasmid success both 
within and between bacterial populations (Bahl et al., 2007). However, the absence 
of an effective way to measure the effect of conjugation on population dynamics has 
hindered investigations (Haft et al., 2009). Stewart and Levin (1977) outlined the first 
comprehensive mathematical model of bacterial fitness based on a mass action 
principle which took into account numerous variables such as growth rates, transfer 
rates and plasmid loss (Stewart and Levin, 1977). However, the model does not 
include differences in bacterial growth phases, depression of pili formation e.g. after 
conjugation has just occurred, and does not account for environmental factors such 
as stress, liquid vs. solid surface mating and the presence of biofilms (Sorensen et 
al., 2005; Slater et al., 2008). It is widely believed that conjugation will occur at much 
higher frequencies in the environment than seen in the laboratory as the limited 
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studies performed in vivo have shown higher rates of plasmid transfer (Sorensen et 
al., 2005; Hunter et al., 2008). 
1.4.5 Plasmid control measures 
Currently, there are no therapeutic measures for plasmid control. This is likely to be 
due to a number of factors, i) the heterogenic nature of plasmids means a „broad 
spectrum‟ anti-plasmid molecule with action against all incompatibility types is 
unlikely to exist; ii) the presence of plasmid encoded post segregation killing 
mechanisms actively select against plasmid free cells; iii) many of the successful 
curing agents are toxic to humans and animals such as ethidium bromide or SDS, 
making them unsuitable for treatments; and iv) a lack of effective, high-throughput 
methods to assess loss of a plasmid both in vitro and in vivo (Amábile-Cuevas and 
Heinemann, 2004). However, there are three anti-plasmid strategies detailed within 
the literature which exploit the basic plasmid functions; inhibition of plasmid 
replication, use of the toxin in post segregational killing systems (PSK), and the 
inhibition of plasmid conjugation (Williams and Hergenrother, 2008).  
The inhibition of plasmid replication already exists in nature in the form of plasmid 
incompatibility where one plasmid will prevent the stable inheritance of another. 
Studies have shown that small molecules (such as apramycin) can mimic 
incompatibility by binding to the mRNA which controls replication in IncB plasmids, 
therefore preventing replication and eliminating the plasmid from a bacterial 
population (DeNap et al., 2004; Thomas et al., 2005). Hale et al., (2010) successfully 
„cured‟ plasmid p0157 using a competing plasmid (pCURE) which encoded a anti-
replication molecule and an „antidote‟ to neutralise toxins produced by the p0157 
PSK regions (Hale et al., 2010). Although very effective, this bespoke method is 
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currently plasmid specific and requires knowledge of replication and PSK mechanism 
encoded, therefore, is at present not suitable for anti-plasmid treatment.  
The second strategy simply prevents transcription, translation or binding of the anti-
toxin component of toxin-antitoxin (or PSK) systems, therefore freeing the toxin and 
causing cell death (Williams and Hergenrother, 2008). This method has the 
advantage that the bacterial cell is killed in addition to the removal of the plasmid 
from the population, and as PSK systems are found in most large conjugative 
plasmids, targeting the common PSK antitoxins may have a broad spectrum of 
action. Few compounds with antitoxin action have been identified so far, therefore 
the viability of this method is currently unknown.  
The prevention of plasmid conjugation is the third strategy proposed which although 
does not remove the plasmid from a population or kill bacterial cells, could be used 
as a prophylactic measure to prevent plasmid spread within particular environments, 
e.g. the gastrointestinal tract of humans or livestock animals. Essential conjugation 
initiation and termination proteins (relaxases) have been identified as a potential 
target for inhibition as they are found in all conjugative plasmids. Clinically and 
veterinary approved drugs, the bisphophonates and flavomycins, have been shown 
to inhibit the action of these proteins in-vitro and bisphophonates had some action in 
vivo, suggesting this may be a promising treatment option (Poole et al., 2006; Lujan 
et al., 2007). An alternative method for preventing conjugation is the use of 
bacteriophage therapy. Phage (for example M13) are able to bind to the conjugation 
apparatus either preventing the initiation of donor and recipient binding (Novotny et 
al., 1968; Jalasvuori et al., 2011) or causing the pilus to retract back into the cell 
(Jacobson, 1972) therefore preventing successful conjugation. Lin et al., (2011) 
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showed that phage coat proteins are able to attach to the tip of conjugation pilus and 
prevent conjugation without the presence of a replicating filamentous phage (Lin et 
al., 2011), therefore the administration of phage proteins may also be a tenable 
therapeutic anti-conjugation option in the future.  
1.4.6 Plasmid mediated blaCTX-M-14 
Nearly all blaCTX-M genes outside the Kluyvera spp. are located on plasmids, and 
variants blaCTX-M-9, blaCTX-M-14, blaCTX-M-15 and blaCTX-M-32 are associated with 
„epidemic‟ plasmids found in a number of geographical locations (Cantón and Coque, 
2006). Associations have been made between blaCTX-M-15 and IncF epidemic 
plasmids, particularly IncFII (Novais et al., 2007). In contrast, current reports indicate 
that blaCTX-M-14 can be found on a wide range of different plasmid types including Inc 
groups A/C; FIB and FII, I1, P, L/M and K (Pai et al., 2001; Hopkins et al., 2006; Bae 
et al., 2008; Marcade et al., 2008; Kang et al., 2009). These plasmids range in size 
from 35 kb (pBDE0502, from a clinical E. coli isolate from Korea) to 160 kb (pMG267, 
from a Klebsiella pneumoniae also from Korea) and are found within many different 
bacterial species (Bae et al., 2008; Pai et al., 2001). At the start of this project no 
blaCTX-M-14 carrying plasmids had been sequenced, but as of September 2011, three 
blaCTX-M-14 carrying plasmids have been deposited and annotated in Genbank. The 
sequence of plasmid pCT is described in this project (FN868832)(Cottell et al., 2011), 
pTN48, an IncFII/FIB plasmid was from an E. coli isolated in Paris (165,692 bp- 
FQ482074)(Billard-Pomares et al., 2011) and pKF3-70 was identified in a K. 
pneumoniae from China (70,057 bp - FJ4949913) (Yi et al., 2010).  
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1.4.6.1 blaCTX-M-14 on IncK plasmids 
Plasmids of the incompatibility group IncK have been identified in bacteria isolated 
from medical isolates, particularly in urinary tract infections since the early 1970s 
(Tschape and Tietze, 1980; Valverde et al., 2009). However, it is only recently that 
this under studied group has been associated with the dissemination of antibiotic 
resistance genes. IncK plasmids carrying blaCTX-M-14 are most commonly found in 
Spain where blaCTX-M-14 is the most frequently isolated ESBL. IncK plasmids carrying 
blaCTX-M-14 have been isolated from E. coli and Salmonella (Gonzalez-Sanz et al., 
2009) from animals (Blanc et al., 2006; Blanc et al., 2008), collected from patients 
and healthy humans, and found in environmental samples (Navarro et al., 2007; 
Diestra et al., 2008). To date, blaCTX-M-14 carrying IncK plasmids have also been 
documented in France and Australia, isolated from patient E. coli strains (Marcade et 
al., 2008; Zong et al., 2008) as well as in cattle in the UK (Teale et al., 2005). Due to 
the widespread distribution of these bacteria, many authors have referred to the 
spread of blaCTX-M-14 on IncK plasmids as a plasmid „epidemic‟, particularly in Europe 
(Baudry et al., 2009; Carattoli, 2009). It has been proposed that it is the same IncK 
plasmid that has disseminated throughout these environments. A recent study in 
Spanish hospitals identified and examined blaCTX-M-14 carrying plasmids from E. coli 
clinical samples (Valverde et al., 2009). Plasmid pRYC105 was the predominant 
plasmid found, identified in bacteria from patients, outpatients and from healthy 
volunteers from 2000-2005. This plasmid was identified in a number of different E. 
coli strains so its dissemination cannot be attributed to clonal expansion, therefore it 
is likely that it is the plasmid itself which has disseminated into these different 
environments.  
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1.5 Background to this study, E. coli isolate C159/11 and blaCTX-M-14 
carrying IncK plasmid pCT 
In 2004 Teale et al., (2004) isolated an E. coli from diarrhoeic calves on a dairy farm 
in Wales containing a blaCTX-M-14 β-lactamase on a 65 MDa plasmid. This E. coli had 
atypical biochemical characteristics such as a negative indole result and did not 
produce common E. coli toxins (Teale et al., 2005). C159/11 was resistant to 
ampicillin, 1st-4th generation cephalosporins, chloramphenicol, streptomycin, 
sulfamethoxazole, trimethoprim, tetracycline, sulfonamide, nalidixic acid and 
ciprofloxacin (Liebana et al., 2006). This isolate also contained another β-lactamase 
blaTEM-35 (IRT-4) gene, encoded on a second, smaller plasmid giving additional 
resistance to amoxicillin/clavulante combinations (Speldooren et al., 1998). Although 
the E. coli C159/11 was not the primary cause of the pathology and subsequent high 
mortality in the calves, a longitudinal study from December 2004 to July 2005 was 
initiated by the Veterinary Laboratories Agency to monitor the dissemination of this 
blaCTX-M-14 gene. Faecal samples and rectal swabs were taken from the then current 
calf population and from the milking cows on all three sampling occasions, swabs of 
the floor of the calf house and collecting yard and slurry testing was also carried out 
on the second and third visits (Teale et al., 2005). On the first sampling occasion 
64.6% of calf samples and 3.3% of milking cow samples contained a CTX-M-14 
producing isolate. On the second visit 61.8% of calves and 5.9% of cow samples 
were positive; and on the third occasion 92.7% of calf samples and 23.8% of milking 
cow samples tested positive for blaCTX-M-14. On the third visit the environmental 
samples also showed blaCTX-M-14 carrying E. coli in slurry and on the floor of 
surrounding areas. Over the duration of the study PFGE was used to identify six 
different E. coli clones containing the blaCTX-M-14 carrying plasmid, suggesting 
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dissemination was not due to clonal expansion of a single bacterial strain alone 
(Carattoli, 2008). Examination of the plasmids carrying blaCTX-M-14 from these isolates 
showed that they were indistinguishable by RFLP typing and classified in the 
incompatibility group IncK using PCR based replicon typing (Carattoli et al., 2005). 
Cephalosporins were not administered on the farm for the duration of the study, 
however, a variety of antimicrobials had been previously used including the fourth 
generation cephalosporin cefquinome (Teale et al., 2005). The original E. coli 
isolated, C159/11, is believed to be the first reported ESBL producing E. coli isolated 
from livestock in the UK. The plasmid isolated from C159/11 was characterised as 
being 65 MDa, or ~80 kb in size (Liebana et al., 2006). Subsequent conjugation 
experiments with this plasmid indicated that horizontal transfer is extremely efficient, 
which may have led to its dissemination to many different strains. In this project the 
plasmid isolated from E. coli C159/11 was called pCT.  
1.6 Hypotheses 
1) Successful persistence and dissemination of the C159/11 plasmid pCT within a 
population is related to an evolutionary fitness advantage transferred to the host 
bacterium by this plasmid. 
2) pCT confers altered fitness to host strains in competition.  
3) The blaCTX-M-14 gene plays an important role in the evolutionary success of pCT. 
4) Other genomic aspects of pCT will also play a role in evolutionary fitness of this 
plasmid. 
5) pCT-like plasmids with similar genomic attributes to pCT can be found hosted in 
bacteria isolated from humans, animals and the environment in a range of 
geographical regions. 
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1.7 Aims  
1) To inactivate blaCTX-M-14 on plasmid pCT. 
2) To develop a bioassay to allow the presence of pCT to be identified in various 
models. 
3) Whole genome sequencing of pCT. 
4) To compare the pCT sequence with other sequenced plasmids including those of 
similar incompatibility groups and plasmids carrying blaCTX-M genes. 
5) To determinate the prevalence of pCT-like plasmids using a multiplex PCR assay 
in bacteria isolated from humans, animals and the environment in a range of 
geographical locations. 
6) To investigate the fitness contributions of blaCTX-M-14 and other pCT genes. 
7) To assess fitness costs or benefits conferred by pCT in vitro and in vivo models. 
 
 
 
 
 
 
Chapter 2: 
 
 
Materials and 
Methods
41 
 
2. Materials and Methods 
2.1 Bacterial strains and growth conditions 
The blaCTX-M-14 carrying IncK plasmid investigated in my study was isolated from an E. 
coli isolate C159/11, obtained by the Veterinary Laboratory agency (VLA) from a 
cattle farm. This plasmid was named „pCT‟ and was studied in several bacterial hosts 
including Escherichia coli and Salmonella enterica serovar Typhimurium strains 
(Table 2.1). All bacterial strains used in this study (Tables 2.1, 2.2, 2.3 and 2.4) were 
routinely grown on Luria-Bertani (LB) agar (Sigma-Aldrich Ltd., UK, Cat. no. L2897) 
supplemented with appropriate antibiotics as required, and incubated aerobically 
overnight at 37C unless otherwise stated. Overnight broth cultures were grown in 10 
ml LB broth (Sigma-Aldrich Ltd., UK, Cat. no. L3522) supplemented with appropriate 
antibiotics where necessary, and typically incubated aerobically overnight at 37C 
with shaking at 225 rpm. When growing strains containing plasmid pCT (or other 
plasmids encoding blaCTX-M-14), both on agar and in broth, the medium was 
supplemented with 8 µg/ml of cefotaxime (Sigma-Aldrich, UK, Cat. no. C7912) to 
ensure plasmid maintenance. When growing strains containing mutated pCT the 
media was supplemented with 50 µg/ml of kanamycin (pCT2-8) (Sigma-Aldrich, UK, 
Cat. no. K4000) or 20 µg/ml of chloramphenicol (pCT9) (Sigma-Aldrich, UK Cat. no. 
C0378). Fresh stock solutions of these antibiotics were made on the day of use. 
ProtectTM beads (Technical Service Consultants Ltd., UK, Cat. no. TS70) were used 
for long term storage of strains. E. coli strains were stored at -800C and Salmonella 
strains at -20C. All isolates were initially grown on xylose lysine deoxycholate (XLD) 
selective agar (Sigma-Aldrich Ltd., UK, Cat. no. 95586) overnight at 370C. On XLD 
media, Salmonella spp. appear pink with black centres indicating the production of 
 Table 2.1. Bacterial host strains +/- wild-type pCT 
Laboratory 
Code 
Species/serovar Strain Description/ Phenotype Source/ Reference 
I753 E. coli C159/11 Veterinary isolate from the AHVLA (pCT) Teale et al. 2004  
Liebana et al. 2006 
I825 E. coli DH5α Genotype: F-, deoR, endA1, recA1, relA1, 
gyrA96, hsdR17(rk -, mk +), supE44, thi-1, 
phoAΔ, (lacZYA argF), U169 Φ80lacZΔM15 λ- 
Invitrogen, UK, Cat. no. 
18290-015 
I847 E. coli J53-2 NCTC 50167, K12 pro
- and meth- (lac+) rpoB, 
F- (Acridine orange used to cure F+ factor) 
Clowes and Rowley, 1954 
I823 E. coli 3950 C159/11 derived pCT „cured‟ strain  AHVLA* 
L354 S. Typhimurium SL1344 Salmonella enterica serovar Typhimurium 
Pathogenic veterinary strain from cattle 
Wray and Sojka, 1978 
L1078 S. Typhimurium SL1344 rifR L354 rifampicin resistant derivative This study 
I755 E. coli DH5α pCT I825 pCT transformant This study 
I855 E. coli J53-2 pCT I847 pCT transconjugant This study 
I834 E. coli 3950 pCT I823 pCT transconjugant This study 
L1079 S. Typhimurium SL1344 rifR pCT L1078 pCT transconjugant This study 
* Animal Health and Veterinary Laboratories Agency 
 
 
 Table 2.2. Other bacteria strains used in this study 
Lab code Species/serovar Strain Description/ Phenotype  Source/ Reference 
I597 E. coli DH5  NCTC 13400 NCTC 
I754 E. coli DH5 rifR NCTC 13400 rifampicin resistant This study 
I759 E. coli SW102 Chromosomal ʎ-red recombinase strain Sharan et al. 2009 
I879 E. coli SW102 pCT pCT SW102 transformant  This study 
L1019 S. Typhimurium  SL1344 
pUA66pacpP 
SL1344 with pUA66pacpP, aph-gfpmut2 
(kanamycin resistant and constitutively 
expresses a stable GFP) 
Zaslaver et al., 2006 
I355 E. coli DH5α pUC19 Ampicillin resistant control plasmid for 
transformations 
Invitrogen,                    
Cat. no. 18290-015 
I113 E. coli  NCTC 10418 NCTC  
I633 E. coli DH5α pKD4 Plasmid encoding an aph kanamycin 
resistance cassette 
Datsenko and Wanner, 
2006 
L109 S. Typhimurium SL1344 
tolC::aph 
L354 containing a chromosomal aph 
kanamycin resistance cassette 
Buckley et al., 2006 
L829 S. Typhimurium  L828 tolC::cat L828 containing a cat chloramphenicol 
resistance cassette 
Nishino et al., 2006 
L828 S. Typhimurium 14028s ATCC 14028S, positive control for              
biofilm formation 
ATCC 
I845 E. coli 042 Positive control for aggregation Kindly provided by Prof. 
Ian Henderson, U of B 
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Table 2.3. E. coli isolates investigated for the presence of pCT-like plasmids 
 
       
Origin Date Location Lab 
no. 
Strain/ 
plasmid 
Inc type Source 
       
Cattle 2004 England/Wales I753 C159/11 pCT K Liebana et al. 2006 
Cattle 2006 England/Wales I779 I779 F,K AHVLA UK 
Cattle 2008 England/Wales I780 I780 F,K AHVLA UK 
Cattle 2008 England/Wales I781 I781 FIA AHVLA UK 
Cattle 2009 England/Wales I782 I782 F AHVLA UK 
Cattle 2007 England/Wales I783 I783 Unknown AHVLA UK 
Cattle 2008 England/Wales I784 I784 Unknown AHVLA UK 
Cattle 2008 England/Wales I785 I785 Unknown AHVLA UK 
Cattle 2006 England/Wales  I786 I786 I1-γ AHVLA UK 
Cattle 2006 England/Wales I787 I787 Unknown AHVLA UK 
Cattle 2008 England/Wales I788 I788 Unknown AHVLA UK 
Cattle 2008 England/Wales I789 I789 Unknown AHVLA UK 
Cattle 2006 England/Wales I790 I790 Unknown AHVLA UK 
Cattle 2008 England/Wales I791 I791 F AHVLA UK 
Cattle 2008 England/Wales I792 I792 F AHVLA UK 
Cattle 2008 England/Wales I793 I793 F AHVLA UK 
Human no data England/Wales I804 L125 Unknown           P. Hawkey 
Human 2006 Germany I794 386 FII Cullik et al. 2010 
Human 2006 Germany I795 400 FII Cullik et al. 2010 
Human 2003-4 Spain I796 C574 K Vinue et al. 2008 
Human 2003-4 Spain I797 C559 K Vinue et al. 2008 
Human 2003-4 Spain I798 C567 K Vinue et al. 2008 
Human 2001-5 Spain I809 FEC383/ 
pRYC105 
 
K Valverde et al. 2009 
Human 2002 Spain I810 E36/ 
pRYC110 
 
HI2 Valverde et al. 2009 
Human 1998 China  I811 CH13/ 
pOZ174 
 
Unknown Chanawong et al. 2002 
Human 2005-7 Australia I813 JIE 052 B Zong et al. 2008 
Human 2005-7 Australia I814 JIE 081 FII Zong et al. 2008 
Human 2005-7 Australia I815 JIE 084 FII Zong et al. 2008 
Human 2005-7 Australia I816 JIE 088 I1 Zong et al. 2008 
Human 2005-7 Australia I817 JIE 182 B Zong et al. 2008 
Human 2005-7 Australia I818 JIE 201 K Zong et al. 2008 
Laboratory numbers of the E. coli DH5α pCT-like plasmids transformants can be found in Appendix 2. 
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Table 2.4. Bacterial strains containing mutant pCT plasmids (pCT2-9)  
Species/ 
serovar 
Host 
strain 
Plasmid 
Resistance 
phenotype 
Lab 
code 
E. coli 
DH5α 
(I825) 
pCT2 (blaCTX-M-14::aph) kan
R I877 
pCT2b (blaCTX-M-14::aph-gfpmut2) kan
R I826 
pCT3 (Sigma factor::aph) CTXR + kanR I827 
pCT4 (rci::aph) CTXR + kanR I828 
pCT5 (pilS::aph) CTXR + kanR I829 
pCT6 (ISEcp1::aph) CTXR + kanR I830 
pCT7 (traXY::aph) CTXR + kanR I846 
pCT8 (pndACB::aph) CTXR + kanR I877 
pCT9 (traXY::aph; pndACB::cat) CTXR,  kanR 
+ chlR 
I878 
J53-2 
(I847) 
pCT2 (blaCTX-M-14::aph) kan
R I856 
pCT2b (blaCTX-M-14::aph-gfpmut2) kan
R I857 
pCT3 (Sigma factor::aph) CTXR + kanR I858 
pCT4 (rci::aph) CTXR + kanR I859 
pCT5 (pilS::aph) CTXR + kanR I860 
pCT6 (ISEcp1::aph) CTXR + kanR I861 
pCT8 (pndACB::aph) CTXR + kanR I893 
3950  
(I823) 
pCT2 (blaCTX-M-14::aph) kan
R I835 
pCT2b (blaCTX-M-14::aph-gfpmut2) kan
R I836 
pCT3 (Sigma factor::aph) CTXR + kanR I837 
pCT4 (rci::aph) CTXR + kanR I831 
pCT5 (pilS::aph) CTXR + kanR I841 
pCT6 (ISEcp1::aph) CTXR + kanR I838 
pCT8 (pndACB::aph) CTXR + kanR I894 
     SW102(I759) pCT7 (traXY::aph) CTXR + kanR I880 
Salmonella 
enterica 
serovar 
Typhimurium 
SL1344 rifR 
(L1078) 
pCT2 (blaCTX-M-14::aph) kan
R L1244 
pCT2b (blaCTX-M-14::aph-gfpmut2) kan
R L1235 
pCT3 (Sigma factor::aph) CTXR + kanR L1236 
pCT4 (rci::aph) CTXR + kanR L1259 
pCT5 (pilS::aph) CTXR + kanR L1260 
pCT6 (ISEcp1::aph) CTXR + kanR L1245 
pCT8 (pndACB::aph) CTXR + kanR L1397 
CTX, cefotaxime; kan, kanamycin; chl, chloramphenicol. 
46 
 
hydrogen sulphide (H2S). E. coli ferments lactose and sucrose within the media, 
changing the pH and resulting in a yellow colour change in the agar. Gram stain and 
microscopic examination (at 100 x magnification with an oil immersion lens) was also 
used to confirm cell morphology and cell wall type of each strain. Gram stain 
reagents were purchased together in a kit (Fisher Scientific, Loughborough, Cat. no. 
P/L505/15).  
2.2 Determination of susceptibility to antibiotics 
The agar doubling-dilution method as described by the British Society for 
Antimicrobial Chemotherapy (BSAC) (Andrews, 2011) was used to determine the 
minimum inhibitory concentration (MIC) of a range of antibiotics (Table 2.5). 
Appropriate volumes of the antimicrobial stock were dispensed into universal 
containers to which 20 ml of molten Iso-sensitest agar (Oxoid, UK, Cat. no. CM0471) 
cooled to approx 50C was aseptically added. The antibiotic and agar were mixed 
and poured into sterile tri-vented Petri dishes and allowed to set. Plates were dried 
for 20 minutes in a 50C oven before inoculation. Overnight cultures of each bacterial 
strain to be tested were diluted 1:100 to give approximately 107 CFU/ml. Each agar 
plate was inoculated with 1 µl of the diluted culture giving approximately 104 
CFU/spot using a 100 pin multipoint inoculator (AQS manufacturing, UK). On each 
occasion E. coli NCTC 10418 (I113) was used as a control strain as recommended 
by BSAC. Inoculated plates were incubated overnight at 37C. The MIC was defined 
as the lowest concentration of the antimicrobial that inhibited 90% of visible growth of 
the organism after overnight incubation and was determined as the modal value from 
at least three independent experiments.  
 Table 2.5. Antimicrobials used in this study 
 
 
Agent Antimicrobial class Solubilised in Supplier Catalogue number 
 
Ampicillin 
 
Penicillin β lactam  
 
Sodium bicarbonate and water 
 
 
Sigma-Aldrich UK 
 
 
A5918 
Cefotaxime 3
rd generation cephalosporin β lactam 
 
Distilled water Sigma-Aldrich UK 
 
C7912 
Ceftiofur 3
rd generation cephalosporin β lactam Distilled water Sigma-Aldrich UK 
 
34001 
Chloramphenicol Phenicol 70% methanol Sigma-Aldrich UK 
 
C0378 
Ciprofloxacin Quinolone Acetic acid and water 
 
Sigma-Aldrich UK 
 
17850 
Erythromycin Macrolide 70% ethanol 
 
Sigma-Aldrich UK 
 
E5389 
Faropenem 
 
Carbapenem β-lactam Distilled water Sigma-Aldrich UK 
 
F8182 
Gentamicin Aminoglycoside Distilled water Sigma-Aldrich UK 
 
G1264 
Kanamycin Aminoglycoside Distilled water  Sigma-Aldrich UK 
 
K1876 
Rifampicin Rifamycin Methanol Sigma-Aldrich UK 
 
R3501 
Tetracycline Tetracycline Distilled water Sigma-Aldrich UK T3258 
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2.3 Plasmid DNA isolation 
2.3.1 Mini plasmid preparation 
Plasmid DNA from a range of isolates was routinely harvested using the QIAgen® 
Miniprep kit (QIAgen, UK, Cat. no. 27104) following the low copy number protocol to 
ensure maximum yield, as described by the manufacturer‟s instructions. Plasmid 
DNA was stored at -20C as aliquots of 10 µl. 
2.3.2 Maxi plasmid preparation 
The QIAgen® Large construct kit (QIAgen, UK, Cat. no. 12462) was used to extract a 
high yield of plasmid pCT from strain E. coli DH5α pCT (I755) following the 
manufacturer‟s instructions. For high speed centrifugation steps volumes of 50-250 
ml were placed in 250 ml polypropylene tubes (Beckman Coulter, High Wycombe, 
Cat. no. 356011) and centrifuged using a Beckman JA25.50 rotor (Beckman Coulter, 
High Wycombe, Cat. no. 363058). For volumes up to 50 ml polycarbonate tubes 
(Beckman Coulter, High Wycombe, Cat. no. 357002) were used in a JLA16.250 rotor 
(Beckman Coulter, High Wycombe, Cat. no. 363930).  
2.3.3 Isolation of high quality plasmid DNA for sequencing  
To harvest plasmid DNA of sufficient high quality for genome sequencing, an alkaline 
lysis SDS extraction (Birnboim and Doly, 1979) followed by a caesium chloride 
gradient clean up (Smith and Thomas, 1983) was used to extract pCT from E. coli 
DH5α pCT (I755). 
2.3.3.1 Birnboim and Doly maxi-preparation 
Cells from 400 ml of overnight LB broth culture supplemented with 8 µg/ml of 
cefotaxime were harvested using centrifugation for 15 minutes at 2,250 x g. The 
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bacterial cell pellet was re-suspended in 25 ml of ice cold Lysis solution 1 (25 mM 
Tris pH 8.5, 10 mM EDTA pH 8.0, 50 mM glucose) supplemented with RNase (20 
µg/ml) (Ambion, Texas, Cat. no. RM2290) to reduce the RNA yield in the final 
sample. Fifty microliters of freshly prepared Lysis solution 2 (0.2 M NaOH, 1% SDS) 
was then added and the sample inverted to ensure complete lysis. After incubation 
on ice for five minutes, 37.5 ml of Neutralising solution 3 (3 M sodium acetate pH 5.0) 
was added and solution mixed carefully by inversion, followed by a further five minute 
incubation on ice. Proteins and cell debris were removed by centrifugation at 10,000 
x g at 4C for 15 minutes. The supernatant was then passed through filter paper to 
remove any remaining cell debris. To precipitate the plasmid DNA from the filtered 
supernatant, 100 ml of isopropanol was added followed by centrifugation at 14,000 x 
g for 15 minutes at room temperature. The supernatant was subsequently discarded 
and DNA pellet resuspended in 3 ml of 1x TNE buffer (100 mM Tris pH 8.0, 50 mM 
NaCl, 5 mM EDTA pH 8.0). 
2.3.3.2 Caesium chloride density gradient centrifugation 
The exact volume of suspended plasmid DNA was measured in µl using a pipette, 
and 4.72 g of caesium chloride (CsCl) added. TNE x 1 buffer (100 mM Tris pH 8.0, 
50 mM NaCl, 5 mM EDTA pH 8.0) was then added to make an exact total volume of 
4.5 ml. The solution was gently inverted until the CsCl dissolved. Five hundred 
microlitres of 10 mg/ml ethidium bromide (EtBr) was also added and the solution 
divided exactly into two 3.5 ml ultra-centifugation tubes (Beckmann Coulter, High 
Wycombe, Cat. no. 349621) using a syringe or Pasteur pipette. Weighing ensured 
both tubes were of equal weight (within 0.1 g of each other) then 1 x TNE buffer was 
used to the fill tubes to the top. The application of heat using a QuickSeal® tube 
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topper (Beckmann Coulter, High Wycombe, Cat. no. 360976) sealed the tops of the 
tubes which were centrifuged for 24 hours at 20C at 801,920 x g in a Beckmann 
Coulter ultracentrifuge with a Type 100 Ti rotor and spacer (Beckmann Coulter, High 
Wycombe, Cat. no. 360270). After the removal of the heat sealed lids using scissors, 
the ultracentrifuge tubes were visualised under UV light and plasmid DNA, seen as 
fluorescent bands, was extracted using a needle and syringe.  
Ethidium bromide was removed from the plasmid DNA by adding isopropanol 
saturated with caesium chloride and water, and shaking vigorously. The separated 
isopropanol „top layer‟ containing the ethidium bromide was then removed and 
dicarded and this step repeated a minimum of three times. To the cleaned sample 
(400 µl) 400 µl of nuclease free water, 100 µl of 3 M Sodium Acetate and 530 µl of 
isopropanol was added and centrifuged for 10 minutes at 13,000 x g to further clean 
the plasmid DNA. Once the supernatant had been removed, the plasmid DNA was 
re-suspended in 1 x TNE buffer and 25 µl of 3 M sodium acetate and 500 µl of 
ethanol before centrifugation at 12,100 x g for 10 minutes. The pellet was washed 
further using 70% ethanol. Once air dried, plasmid DNA was re-suspended in 50 µl 
10 x TNE buffer. The DNA (3µl) was separated using electrophoresis on a 0.7% 
agarose gel and plasmid DNA quantified using a spectrophotometer.   
2.4 Complete plasmid sequence analysis  
2.4.1 Sequencing and annotation 
The plasmid DNA sequence was determined using a 454/Roche GS FLX 382 
analyser and assembled de novo using the 454/Roche Newbler assembly program 
(Chain et al., 2009). Initial annotation at the Sanger Institute used Artemis 
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(http://www.sanger.ac.uk/resources/software/artemis/). Further comparative analysis of 
the DNA sequence was completed as part of this project at The University of 
Birmingham. Graphic representation of the sequence in the form of a plasmid map 
was constructed using DNAstar (Lasergene, Madison). 
2.4.2 Comparative genomics 
Double ACT (http://www.hpa-bioinfotools.org.uk/pise/double_act.html) and the Artemis 
Comparison Tool (ACT) (http://www.webact.org/WebACT/home) were used to compare 
the pCT sequence to other plasmid sequences on a whole genome scale. Genogator 
(http://www.kato.mvc.mcc.ac.uk/genogator/doc/about.htm) was used to align particular 
regions or operons of pCT against the same regions in other plasmids and BLAST 
(National Center for Biotechnology Information) was used to examine particular coding 
sequences (CDSs) in more detail, for more comprehensive annotations and for 
further comparisons against plasmids of known sequence. 
2.5 Amplification and DNA sequencing of genomic elements on pCT 
PCR was used throughout this study to confirm the presence of plasmid pCT and the 
antibiotic resistance gene blaCTX-M-14 during routine checks and for confirmation of 
pCT transfer into new bacterial host strains. PCR was also used for detection of pCT-
like plasmids and to explore the insertion site of blaCTX-M-14 within each of the pCT-like 
plasmids identified.  
2.5.1 Polymerase chain reaction 
Target DNA for PCR was isolated by suspending colonies from test isolates in 50 µl 
of sterile distilled water and heating at 99C for 5 minutes, followed by centrifugation 
at 13,000 rpm in a micro-centrifuge to pellet the cell debris. All PCR assays were 
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carried out in a 50 μl volume consisting of 45 µl of PCR ReddyMix (containing a Taq 
polymerase) (ThermoScientific, USA, Cat. no. AB0794), 2 µl of the supernatant taken 
from boiled cell lysates, 1 µl of sterile distilled water and 1 µl each of forward and 
reverse primers. Primers were purchased from Invitrogen, UK (Table 2.3 and 2.4), 
used at a working concentration of 25 µM and stored at -20C. After initial treatment 
at 95C for 5 minutes, typically the PCR was carried out for 30 cycles consisting of 
denaturation at 95C for 30 seconds, annealing at 51C for 30 seconds and 
elongation at 72C for 40 seconds and 10 minutes at 72C. A contamination control 
containing master mix, primers and water (replacing template DNA) was included in 
all PCR reactions and results were observed using agarose gel electrophoresis. 
2.5.2 Agarose gel electrophoresis 
All PCR amplimers were separated by electrophoresis on 1% agarose gels, 
containing 1 g of electrophoresis grade agarose (Invitrogen Ltd, UK, Cat. no. 15581-
028) and 100 ml of 1% Tris-Boric acid-EDTA (TBE, 10 x TBE buffer contains 108 g 
Tris, 9.3 g EDTA and 55 g Boric acid per litre) (Invitrogen Ltd, UK, Cat. no. 15581-
028). Agarose was dissolved by heating and allowed to cool before ethidium bromide 
was added to a final concentration of 0.1 µg/ml. Typically, 5 µl of sample was added 
to each well along with a DNA sizing ladder Hyperladder I (Bioline, London, Cat. no. 
BIO-33025) and electrophoresis was used to separate samples at 100 V for one 
hour. Amplimers were visualised on a UV transilluminator and where appropriate, 
DNA quantified using a Gene Genius image analyser (Syngene, Cambridge, UK). 
Plasmid DNA was visualised using electrophoresis on 0.7% agarose gels (0.7 g of 
agarose in 100 ml of TBE buffer) at 80 V for 3 hours due to their large size and to 
separate plasmid DNA with any residue chromosomal DNA. 
 Table 2.6. Primers used for amplification of specific regions on pCT and detection of pCT-like plasmids 
Lab no. Primer Sequence 5‟ 3‟ Target Size (bp) pCT binding site Reference 
       
819 CTX-M-G9 (F) ATGGTGACAAAGAGAGTGCAAC blaCTX-M Group 9 variants 
 
876 
 
70259-70280 Batchelor et al., 2005 
820 CTX-M-G9 (R) TTACAGCCCTTCGGCGATG blaCTX-M Group 9 variants 
 
876 69405-69423 Batchelor et al., 2005 
837 ISEcp1A (F) GCAGGTCTTTTTCTGCTCC Insertion sequence ISEcp1  527 71728-71746 Karim et al., 2001 
838 ISEcp1B (R) ATTTCCGGAGCACCGTTTGC Insertion sequence ISEcp1 527/1037
a 
71220-71239 Karim et al., 2001 
839 B3A (F) AACGGCACAATGACGCTGGC Insertion sequence IS903 887 69913-69932 Navarro et al., 2007 
840 IS903 (R) TGTAATCCGGCAGCGTA Insertion sequence IS903 887 69045-69061 Navarro et al., 2007 
905 Pseudo (R) AACATTCGGCCGTTCACAGC pCT region downstream of blaCTX-M-14 1636 68644-68663 This study 
904 traK (F) GGTACCGGCATCGCACAGAA pCT region upstream of ISEcp1 1037 72238-72257 This study 
868 Sigma (F) ACAGCGTCTTCTCGTATCCA pCT putative sigma factor 1289 48590-48609 This study 
869 Sigma (R) GTTCTTCCAGCTGACGTAAC pCT putative sigma factor 1289 47320-47339 This study 
875 rci (F) AAGGTCATCTGCAGGAGT pCT shufflon recombinase 945 78364-78381 This study 
876 rci (R) GTGTGCGCAGCAACAATA pCT shufflon recombinase 945 77436-77453 This study 
916 pilN (F) GACAGGCAGAGAACACCAGA pCT pilN outer membrane protein 627 88267-88286 This study 
917 pilN (R) ATGCTGTTCCACCTGATGAG pCT pilN outer membrane protein 627 87659-87678 This study 
979 nikB (F) CGTGCMTGCCGTGARCTT IncI complex nikB relaxase gene  290 33077-33094 This study 
980 nikB (R) TCCCAGCCATCCWTCACC IncI complex nikB relaxase gene 290 33350-33367 This study 
983 pCT008 (F) CATTGTATCTATCTTGTGGG pCT pCT008-pCT009 region 428 3665-3684 This study 
984 pCT009 (R) GCATTCCAGAAGATGACGTT pCT pCT008-pCT009 region 428 4074-4093 This study 
Primer ISEcp1B can be paired with primer ISEcp1A (527bp) or with primer traK (1037bp). F, forward primer. R, reverse primer. 
 Table 2.7. Primers used in construction of mutant plasmids and conformation of recombination 
 
pCT gene Description 
Lab 
number 
Primer sequence 
Amplicon size 
(WT/inactivation) 
blaCTX-M-14 
Confirmation forward 819 ATGGTGACAAAGAGAGTGCAAC 876/1764/2361* 
Confirmation reverse 820 TTACAGCCCTTCGGCGATG 876/1764/2361* 
Recombineering 1 (aph) 823 TTTATGCGCAGACGAGTGCGGTGCAGCAAAAGCTGGCGGCGTGTAGGCTGGAGCTGCTTC 1574 
Recombineering 2 (aph) 824 CGGCCAGATCACCGCAATATCATTGGTGGTGCCGTAGTCGGGGAATTAGCCATGGTCCAT 1574 
Recombineering 1 (aph-gfpmut2) 1038 TTTATGCGCAGACGAGTGCGGTGCAGCAAAAGCTGGCGGCCAGGAGTCCAAGCGAGCTCT               2433 
Recombineering 2 (aph-gfpmut2) 1039 CGGCCAGATCACCGCAATATCATTGGTGGTGCCGTAGTCGAGGAGAGCGTTCACCGACAA       2433 
Sigma factor 
Confirmation forward 868 ACAGCGTCTTCTCGTATCCA 1289/1675 
Confirmation reverse 869 GTTCTTCCAGCTGACGTAAC 1289/1675 
Recombineering 1 (aph) 870 GGAGGGCGTCTCGCTAAAAAAACTTACTCAAACACATCAAGTGTAGGCTGGAGCTGCTTC 1574 
Recombineering 2 (aph) 871 GCATTACTTTTTATTCTCGTGAGACTCAAGGTCATTCGGTGGGAATTAGCCATGGTCCAT 1574 
rci 
Confirmation forward 875 AAGGTCATCTGCAGGAGT 945/1867 
Confirmation reverse 876 GTGTCGCAGCAACAATA 945/1867 
Recombineering 1 (aph) 877 GGGGGACATGCCGTATGAATCCTGTTGAACTGGTCCGAAAGTGTAGGCTGGAGCTGCTTC 1574 
Recombineering 2 (aph) 878 GCAGTGTCACGACAAACAGCCCGTTTCTGCACCCGACAGTGGGAATTAGCCATGGTCCAT 1574 
pilS 
Confirmation forward 1042 GCGGAAGGAAGTGAGCATAA 722/2053 
Confirmation reverse 1043 CAGTGACATGCTGAAGCAGT 722/2053 
Recombineering 1 (aph) 811 TGGTGACCAGATCAATACAGTTTTTCTTCGGCACATTGCTGTGTAGGCTGGAGCTGCTTC 1574 
Recombineering 2 (aph) 812 AACCTGCAGACAATCGCCACCAAAATGAAAGCCCAGAAAGGGAATTAGCCATGGTCCAT 1574 
ISEcp1 
Confirmation forward 837 GCAGGTCTTTTTCTGCTCC 1197/1677 
Confirmation reverse 872 CCCTTGTACGGATAGTTTTC 1197/1677 
Recombineering 1 (aph) 873 CAAATAAAATCAAGATGAATCATATAAAGACCATGCTCTGGTGTAGGCTGGAGCTGCTTC 1574 
Recombineering 2 (aph) 874 TTCCGACAACTTCATGATTACATATCTTGCGGTTTTGATTGGGAATTAGCCATGGTCCAT 1574 
traXY 
Confirmation forward 1113 GGAGAGTCCGGTCTGTATGA 2423/2138 
Confirmation reverse 1114 TGCAACCAGTGTGGTACAG 2423/2138 
Recombineering 1 (aph) 1115 GTATCCTGGTCTGCCTGTTACTGATGAGTACCATTGCAGCGTGTAGGCTGGAGCTGCTTC 1574 
Recombineering 2 (aph) 1116 CGGCACAAAACAGCAAAAACAGCAGGAAGTAGAGTGGTGGGGGAATTAGCCATGGTCCAT 1574 
pndACB 
Confirmation forward 1351 AAGGATTGTGGCGGACAGGA 486/1288/1751 
Confirmation reverse 1352 TGATGACGCACAGGACGGAA 486/1288/1751 
Recombineering 1 (aph or cat) 1353 CCCAGGCGATTTTTTTATCAATCAACCCAGGGCCCACTGTGTGTAGGCTGGAGCTGCTTC 1574/1111φ 
Recombineering 2 (aph or cat) 1354 ATTGAGGTCAGCCTTCGCAACAATCCGGCGGCAGATGTCCGGGAATTAGCCATGGTCCAT 1574/1111φ 
Amplicon size, * wild-type pCT/ pCT::aph/ pCT::aph-gfpmut2;  φ pndACB::aph I pndACB::cat. 
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2.5.3 Sequencing of amplimers 
PCR amplimers to be sequenced were purified using the QIAquick® PCR purification 
Kit (QIAgen, UK, Cat. no. 28104) following the manufacturer‟s instructions. Pure DNA 
(2 µl) was added to 4 µl of SDW and 4 µl of 0.8 pm/µl of primer (either forward or 
reverse). Sequences were determined at the functional genomics department at 
Birmingham University using a BigDye® Terminator v3.1 cycle sequencing kit 
(Applied Biosystems Ltd., USA). The resulting DNA sequences were analysed using 
homology searches (using the BLAST algorithm) and aligned to known or predicted 
sequence data using bioinformatics software MEGA 4 (Centre for Evolutionary 
Functional Genomics, USA).  
2.5.4 PCR assays to identify pCT-like plasmids 
Using the pCT sequence, primer pairs were designed to amplify novel specific 
regions of pCT to allow rapid identification of potential pCT-like plasmids in CTX-M-
14 producing bacteria (Table 3). PCR was first used to confirm the presence of a 
blaCTX-M group 9 gene. A multiplexed PCR assay was then used to amplify DNA 
encoding the pCT putative sigma factor, pilN gene and shufflon recombinase. 
Additional primer pairs were designed to a unique region of pCT when compared with 
other known sequences for amplification across CDSs pCT008-pCT009 and to pCT 
relaxase gene nikB for further discrimination of pCT-like plasmids. Template DNA 
from CTX-M-14 producing E. coli veterinary and clinical isolates (Table 2.3) was 
prepared by boiling a 100 µl bacterial suspension for 5 minutes to create cell lysates, 
1 µl of which was added to PCR ReddyMix Master mixture (Abgene, Epson UK) as in 
Section 2.5.1. PCR conditions were 30 cycles of 95 for 30C seconds, 53C for 30 
seconds and 72C for 40 seconds using primers in Table 2.6. To determine whether 
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the pCT blaCTX-M-14 shares a common insertion site with blaCTX-M-14 on other plasmids, 
PCR assays were designed to amplify sequence from blaCTX-M-14 into both the pCT 
flanking genes (a pseudogene and traK and into upstream and downstream insertion 
elements ISEcp1 and IS903 (Figure 2.1; Table 2.6). 
2.5.5 Relaxase (nikB) typing and phylogenetic analysis 
The categorisation and phylogenetic analysis of plasmids by the amplification and 
sequencing of plasmid encoded relaxase genes has been previously reported for IncI 
plasmids (Garcillan-Barcia et al., 2009; Valverde et al., 2009). A modified primer pair 
was designed to this region (nikB) using sequence data from pCT and other related 
sequenced plasmids (Table 2.6, primers 979/980) and used within the pCT detection 
assay as described in section 2.5.4. Resultant amplicons (indicating the presence of 
an IncI plasmid) were sequenced using BigDye® Terminator v3.1 cycle sequencing 
(Applied Biosystems Ltd., USA) at the functional genomics laboratory of the 
University of Birmingham. Sequences were aligned to the pCT nikB sequence using 
MEGA 4.0 (Tamura et al., 2007). For phylogenetic analysis, a neighbour-joining tree 
was constructed using the maximum composite likelihood method (Saitou and Nei, 
1987). The phylogenetic tree was linearised assuming equal evolutionary rates in all 
lineages. 
2.6 Transfer of pCT into new host strains 
2.6.1 Transformation of pCT into E. coli DH5α 
Pure pCT DNA was transformed into electro-competent E. coli DH5α cells 
(Invitrogen, UK, Cat. no. 18290-015) for analysis and manipulation as this strain 
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Figure 2.1. Primers used to determine the site of blaCTX-M-14 insertion on pCT-
like plasmids 
 
 
 
 
Primer 1 Primer 2 Expected product size (bp) 
Pseudo  CTX-M-G9 F 1636 
IS903 B3A 887 
IS903 CTX-M-G9 F 1235 
CTX-M-G9 R CTX-M-G9 F 876 
CTX-M-G9 R ISEcp1A 2343 
ISEcp1B ISEcp1A 527 
ISEcp1B traK 1037 
 
The dark pink arrow represents the blaCTX-M-14 coding region flanked on pCT by two 
insertional elements (shown as light pink arrows). External to this region is a pCT 
specific pseudogene shown as two brown arrows. Primer binding sites for each 
primer designed to this pCT genomic region are represented by small blue arrows 
labelled with the name of each primer. 
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provided a known background with which to analyse the plasmid further. pCT DNA 
(typically 2 µl) was added to 48 µl of E. coli DH5α cells and left on ice for 10 minutes; 
2 µl of plasmid pUC19 was also incubated with 48 µl of electro-competent cells to act 
as a positive control. The cell/plasmid mixtures were transferred to a chilled 2 mm 
electroporation cuvette (Gene flow, Staffordshire, Cat. no. E6-0060) and 
electroporated at 1.25 kV (25 µF, 200Ω, 5nm) (EasyjectT electroporator). A negative 
control containing cells only, without plasmid was also treated in this manner. After 
transformation the cells were recovered in 1 ml of room temperature LB broth and 
incubated for 2 hours at 37C. The recovery mixture was cultured on LB agar plates 
containing 8 µg/ml of cefotaxime to select for pCT transformants (or 50 µg/ml of 
ampicillin to select for pUC19 transformants) and plates were incubated aerobically 
for 24 hours at 37C and inspected for colonies.  Up to ten candidate transformants 
were sub-cultured onto individual LB agar plates supplemented with 8 µg/ml of 
cefotaxime and incubated overnight at 37C. A single colony from each plate was 
Gram stained and another colony inoculated into 10 ml of LB broth supplemented 
with 8 µg/ml cefotaxime and incubated overnight at 37C with shaking. Plasmid DNA 
was harvested from these overnight cultures using QIAgen® Miniprep kit (QIAgen®, 
UK, Cat. no. 27106) and visualised using gel electrophoresis. PCR was then used to 
confirm the presence of a Group 9 blaCTX-M gene (Section 2.5.1) in these candidate 
transformants.   
2.6.2 Selection of rifampicin resistant mutants 
Rifampicin resistant E. coli DH5α and S. Typhimurium SL1344 mutants were 
selected by growing strains on LB agar overnight at 37C then inoculating 10 ml of 
LB broth with a single colony of each strain, incubating broth cultures overnight at 
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37C with shaking at 225 rpm. Three broth cultures for each strain were then 
centrifuged at 10,000 x g for 15 minutes to harvest cells. One pellet was re-
suspended in 1 ml of LB broth to allow an approximate concentration of 108 cells/ml. 
The two remaining pellets were re-suspended in 100 µl of LB broth allowing an 
approximate concentration of 109 cells/ml. Serial dilution 1:10 of the remaining 
overnight broth culture (107 cells/ml) in LB broth created dilutions containing 106, 105, 
104, 103, 102, and 101 cells/ml. From each dilution, 200 µl was cultured in duplicate 
on LB agar plates supplemented with 100 µg/ml of rifampicin and a LB agar plate 
with no added antibiotic, and incubated overnight at 37C. The following day colonies 
on LB agar plates were counted to determine the viable count (colony forming 
units/ml) and compared with the number of colonies recorded on rifampicin (100 
µg/ml) selection plates. The frequency of resistance was calculated by dividing the 
number of colonies on each selective plate by the viable count (adjusting for 
dilutions). Candidate resistant mutants were sub-cultured onto LB agar plates 
supplemented with 100 µg/ml rifampicin and resistance confirmed by determining the 
MIC of rifampicin to these strains. 
2.6.3 Conjugation of pCT into E. coli J53-2, E. coli 3950 and S. Typhimurium 
SL1344 rifR 
pCT was transferred via conjugation from pCT donor E. coli DH5α pCT to bacterial 
hosts E. coli J53-2 (I847, rifampicin resistant), E. coli 3950 (I823, tetracycline 
resistant) and S. Typhimurium SL1344 rifR (L1078, rifampicin resistant) for further 
analysis. Donor and recipient strains were cultured overnight in LB broth at 370C and 
shaking and cells from 1 ml of each overnight culture were harvested by 
centrifugation for 10 minutes at 13,000 x g. E. coli DH5α pCT cells were resuspended 
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in 100 µl LB broth and 50 µl of this suspension was added to recipient strains cells 
resuspended in 50 µl of LB broth. The donor/recipient mixture was pipetted onto a 
0.45 µm/ 25 mm nylon membrane filter (Millipore, UK, Cat. no. HNWP02500) placed 
on a LB agar plate, and incubated for 12 hours at 37C. After this time the filter was 
removed and ascetically placed into a universal tube containing 1 ml of fresh LB 
broth. Cells were liberated from the filter by vortexing, then diluted appropriately in 
phosphate buffered saline (PBS) (Sigma, UK, Cat. no. D8537) to isolate single 
colonies. The mixture was then spread onto LB agar containing 8 µg/ml cefotaxime to 
select for pCT, and either 100 µg/ml of rifampicin or 50 µg/ml of tetracycline to select 
for the recipient strain, and incubated for 24 hours at 370C. As a control 100 µl of 
each donor and recipient overnight culture were spread on antibiotic containing agar 
to quantify the frequency of spontaneous mutation. Candidate colonies were also 
sub-cultured onto XLD agar to allow the identification of any randomly selected 
rifampicin resistant donor mutants. PCR was used to confirm the presence of a 
Group 9 blaCTX-M gene in these putative transconjugants as in Section 2.5.1.   
2.7 Further characterisation of pCT-like plasmids  
Isolates identified as carrying a pCT-like plasmid using the PCR assay described in 
2.5.4 were grown overnight in LB broth and transformed into E. coli DH5α electro-
competent cells (Invitrogen, UK, Cat. no. 18290-015) as described in section 2.6.1 for 
further analysis of these plasmids (Appendix 2). The MIC of a range of antibiotics 
(Table 2.5) required against these pCT-like plasmid transformants were determined 
as in Section 2.2 and the ability of these plasmids to conjugate was examined as in 
Section 2.6.3 from donor E. coli DH5α to E. coli recipient strain DH5α rifR. 
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2.8 Inactivation of genes on pCT 
A method was developed from the protocol used by Sharan and colleagues (2009) to 
allow specific inactivation of genes on pCT (Figure 2.2). This method was used to 
selectively inactivate genes on plasmid pCT by transforming pCT into an 
intermediate E. coli SW102 host strain which encodes a chromosomal ʎ-red 
recombinase (Table 2.2) creating strain SW102 pCT (I879).    
2.8.1 Design and generation of the DNA integrative cassette with the antibiotic 
resistance selective marker 
For each pCT gene region to be inactivated a primer pair was designed using the 
PRIMER v.2.00 software package (Scientific and Education Software, UK) with 40 bp 
of identity to the outermost regions of the pCT target gene and 20 bp homologous to 
the antibiotic resistance determinant to be amplified (either aph or cat) (Table 2.7). 
Kanamycin resistance gene aph was amplified from a lysate of S. Typhimurium 
SL1344 tolC::aph (L109) and the chloramphenicol resistance gene cat was amplified 
from a lysates of L828 tolC::cat (L829) by adding 2 µl of DNA suspension to a 50 µl 
reaction consisting of 45 µl of Reddymix (ThermoScientific, Waltham, USA, Cat. no. 
Ab-0575); 1 µl of forward primer; 1 µl of reverse primer and 1 µl of nuclease free 
water. PCR was as follows, an initial denaturing step at 950C for 5 minutes followed 
by 35 cycles of 95C of denaturation for 30 seconds; annealing at 50C for 30 
seconds and elongation at 72C for 120 seconds. This was followed by a final 
extension step at 72C for 10 minutes. The PCR amplimers were purified using the 
QIAgen® PCR purification Kit (Qiagen, UK, Cat. no. 27106) and eluted in 30 µl of 
nuclease free water. The size of the purified PCR amplimer was determined by 
electrophoresis of 5 µl of the sample on a 1% agarose gel.  
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Figure 2.2. Inactivation of selected pCT genes by homologous recombination 
with a PCR amplified DNA product. 
 
 
The inactivation of a selected plasmid gene. A) Primers with 5‟ 40bp homology to the plasmid 
gene of interest and 20bp designed to amplify either aph or aph-gfpmut2 were designed.  
B) PCR amplimers were transformed into strain SW102 already containing plasmid pCT.  
C) Activation of the ʎ-red recombinase facilitated the recombination of PCR amplimers with 
the plasmid gene. This resulted in the removal of genetic material from the plasmid gene and 
replacement with either aph or aph-gfpmut2.  
A 
B 
C 
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2.8.2 Design and generation of the DNA integrative cassette encoding gfp 
For amplification of the aph-gfpmut2 construct on plasmid pUA66pacpP, plasmid 
DNA was extracted from strain S. Typhimurium L1019 using the QIAgen® Miniprep 
kit (QIAgen, UK, Cat. no. 27104). Plasmid DNA was then incubated with restriction 
enzymes SpeI (Promega, UK, Cat. no. R6591) and PscI (Fermentas, UK, Cat. no. 
ER1871) in Fermentas Buffer Tango (Fermentas, UK, Cat. no. ER1871) at 37C for 
4½ hours and 65C for 20 minutes. Primers designed had 20 bp homology to the 
template pUA66pacpP and 40 bp sequence homology to the outermost regions of 
the target gene blaCTX-M-14 at the primer 5‟-end (Figure 2.2 A, Table 2.7). PCR was 
carried out as in section 2.8.1 using the digested plasmid as the DNA template. 
Resulting amplimers consisting of both aph and gfp were purified using the QIAgen® 
PCR purification Kit (Qiagen, UK, Cat. no. 27106) and visualised using 
electrophoresis on a 1% agarose gel.  
2.8.3 Recombineering and selection of mutant plasmids 
A colony of SW102 pCT (Table 2.2) was placed in 10 ml of LB broth and incubated 
with shaking overnight at 320C. From this overnight culture 500 µl was used to 
inoculate two 35 ml LB broths and shaken at 200 rpm at 32C until the optical density 
of the culture reached mid-logarithmic phase (OD600 = 0.5-0.6). One culture was 
placed in a shaking water-bath (200 rpm) at 42C for 15 minutes in order to activate 
the ʎ-red recombinase. The other culture remained at 32C for the same period to act 
as a control. Both flasks were then immediately placed in an ice bath and repeatedly 
mixed by hand for a further 10 minutes to cease production of the enzyme.  In order 
to transform these cells with the PCR amplicon for recombination, the bacteria were 
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made competent using 15% glycerol (150 ml of glycerol in 850 ml H2O). Cells were 
harvested by 4C centrifugation at 2250 x g for 15 minutes and resuspended in 30 ml  
of ice cold 15% glycerol to wash. This process was repeated twice and the resulting 
pellet of bacterial cells resuspended in 1ml of 15% glycerol. Centrifugation was then 
repeated at 13,000 x g in a micro-centrifuge at 4C. The harvested cell pellet was 
washed twice in 15% ice cold glycerol before re-suspending in a volume of 400 µl of 
glycerol. For electroporation of the PCR amplimer into the newly competent cells 
(both control and ʎ-red recombinase activated), DNA was added to cell suspension 
to make up a volume of 50 µl and left on ice for five minutes. 1 µl of plasmid pUC19 
was also added to 49 µl of competent cells (both control and activated) to assess the 
competence of the cells. The cell/plasmid mixtures were then transferred to a chilled 
2 mm electroporation cuvette (Gene flow, Staffordshire, Cat. no. E6-0060) and 
electroporation was carried out at 1.25 kV (25 µF, 200Ω) (EasyjectT electroporator). 
A negative control containing bacterial cell suspension only, without plasmid or PCR 
amplicon was also treated in this manner. After electroporation the cells were 
suspended in 1 ml of pre-warmed LB broth and incubated for three hours at 32C. 
300 µl of recovery mixture was transferred onto LB agar plates containing 50 µg/ml of 
kanamycin for inactivation of blaCTX-M-14; 50 µg/ml of kanamycin and 8 µg/ml of 
cefotaxime for inactivation of the other genes with the aph construct, and 50 µg/ml of 
chloramphenicol if inactivating with cat. Kanamycin (or chloramphenicol) resistance 
was used to select for mutant plasmids where recombination had taken place. 
Ampicillin (50 µg/ml) was also used to select for pUC19 transformants. All agar plates 
were incubated aerobically at 32C for 48 hours and then inspected for bacterial 
colonies. Colonies were sub-cultured onto fresh LB agar containing the appropriate 
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antibiotic. Plasmid DNA was then harvested using the QIAgen® Miniprep kit (Qiagen, 
UK, Cat. no. 27106) and electroporated into electro-competent E. coli DH5α cells 
(Invitrogen, UK, Cat. no. 18290-015) as described in section 2.6.1. 
2.8.4 Confirmation of gene inactivation 
To differentiate between wild-type pCT and mutant pCT which had undergone 
homologous recombination primers external to the insertion site (confirmation 
primers) were used to amplify the region across the deletion/insertion site (Table 2.7), 
yielding a different sized amplicon when compared to wild-type pCT in each case. 
PCR was carried out as described in section 2.5.1. and visualised as in 2.5.2. PCR 
that resulted in an amplicon of the expected size (Table 2.7) were purified using 
QIAquick® PCR purification Kit (QIAgen, UK, Cat. no. 28104) following the 
manufacturer‟s instructions and DNA sequenced and analysed as in Section 2.5.3. 
In the case of blaCTX-M-14::aph (pCT2) both mutant and wild-type plasmid were 
detected by PCR after electroporation into E. coli DH5α. Each day for five days a 
colony was spread onto a fresh LB agar plate containing 50 µg/ml of kanamycin and 
incubated at 37C. Isolated colonies were each day checked by PCR for the 
presence of wild-type pCT. After five days only the mutant plasmid could be detected 
using PCR and colonies were unable to grow in the presence of cefotaxime (in broth 
and on supplemented LB agar).  
2.8.4.1 Detection of β-lactamase production 
Strains DH5α pCT2 and DH5α pCT2b (Table 2.4) were also examined for the 
production of β-lactamases using a synthetic indicator nitrocefin (Montgomery et al., 
1979). Strains to be tested were grown aerobically overnight in 10 ml of LB broth at 
37C with shaking at 225 rpm. Bacterial cells were harvested from an overnight 
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culture by centrifugation and re-suspended in 200 µl of LB broth. An MSE Soniprep 
(Sanyo Biomedical, UK) was used to lyse cells within the suspension by sonicating 
for a total of two minutes (4 x 30 second pulses with 3 x 30 second intermissions with 
no pulse in between) to prevent overheating which may cause protein denaturation. 
Sonicated preparations were then added in a volume of 50 µl to wells in a 96 well 
round bottomed microtitre tray (Fisher Scientific, Loughborough, Cat. no. FB56412). 
Freshly made nitrocefin (10 µl in a concentration of 500 µg/ml) (Fisher Scientific, UK, 
Cat. no. SR112C) was added to each sonicate (to a final concentration of 83 µg/ml) 
and observed. A colour change from yellow to red within five minutes demonstrated a 
β-lactamase producing strain.  
2.8.5 Transfer of pCT mutant plasmids pCT2-6 and pCT8 to bacterial host strains E. 
coli J53-2, E. coli 3950 and S. Typhimurium SL1344 rifR  
The pCT mutant plasmids pCT2-6 and pCT8 were transferred to host strains E. coli 
J53-2, E. coli 3950 and S. Typhimurium SL1344 rifR for further study using the 
method in Section 2.6.3 (Table 2.4). Selection of strains containing blaCTX-M-14 
inactivated plasmids was on LB supplemented with 50 µl/ml kanamycin, selection for 
transconjugants containing the other mutant plasmids was on LB agar supplemented 
with 50 µg/ml of kanamycin and 8 µg/ml of cefotaxime with the appropriate antibiotic 
for the recipient strain. Transconjugants from each pairing were grown on XLD to 
ensure pCT transfer rather than spontaneous mutation in the donor strain. Colonies 
were also checked using PCR for the expected insertion within target genes to 
ensure the right pCT plasmid had been transferred.  
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2.9 Characterisation of plasmid stability and transfer  
2.9.1 Plasmid stability in vitro  
Plasmid persistence was measured by assessing the percentage of cells which lose 
the plasmid within an isogenic culture over time. From a 10 ml overnight LB broth 
culture of each strain, 100 µl was used to inoculate 100 ml of „pre-warmed‟ LB broth 
which was incubated at 37C with shaking at 180 rpm. Every two hours for 12 hours 
a 100 µl sample was removed to determine the total viable count. At hours 12, 24, 48 
and 72 hours 100 µl of culture was used to seed 100 ml of fresh „pre-warmed‟ LB 
broth. A further viable count was taken at 24, 48, 72 and 96 hours. Those plates 
containing between 20-200 colonies were replica plated using sterile velveteen 
squares onto an antibiotic free plate and agar containing either 8 µg/ml cefotaxime 
for wild-type pCT containing strains, 50 µg/ml of kanamycin for pCT2 and pCT2b 
(blaCTX-M-14::aph/gfpmut2) containing strains or 8 µg/ml cefotaxime and 50 µg/ml of 
kanamycin for strains containing pCT3-9. Colonies growing on the antibiotic free 
plate but not on the antibiotic selection plate indicated the proportion of bacteria to 
have lost plasmid.    
2.9.2 Plasmid conjugation frequencies  
Conjugation frequencies were measured for pCT and pCT mutant plasmids (pCT2-9) 
from donor strain E. coli DH5α (Table 2.1 and 2.4) to recipient strains E. coli J53-2 
(I847, rifampicin resistant), Salmonella enterica serovar Typhimurium SL1344 rifR 
(L1078, rifampicin resistant) and E. coli 3950 (I823, tetracycline resistant). In addition 
the pCT conjugation frequency was measured from donor E. coli C159/11 (I753) to 
various recipients and from donor DH5α pCT to recipient E. coli DH5α rifR (I754, 
68 
 
rifampicin resistant). Both donor and recipient strains were grown overnight in 10 ml 
of LB broth at 370C with shaking at 225 rpm. Overnight cultures were used to seed 
30 ml of fresh LB broth at a 4% inoculum and cultures were grown at 37C at 225 
rpm to an OD600 of 0.6 and adjusted if necessary. Viable counts were performed at 
this stage to establish the ratio of donor to recipient strains.  
To measure the conjugation frequency in liquid, 1 ml of adjusted recipient culture and 
500 µl of donor culture were added together in a universal tube and incubated at 
37C for 3 hours with shaking at 180 rpm. For solid surface conjugation, cells were 
harvested by centrifugation from 1 ml of adjusted donor and recipient culture. Donor 
cells were resuspended in 100 µl of fresh LB broth and recipient cells resuspended in 
50 µl of LB broth; 50 µl of each were then mixed and placed on a 0.45 µm/ 25 mm 
nylon membrane filter (Millipore, UK, Cat. no. HNWP02500) on an LB agar plate and 
incubated at 37C. After 3 hours the filter was removed into a universal tube and 1 ml 
of fresh LB broth added. Cells were liberated from the filter by vortexing. When 
measuring the conjugation frequency in the presence of sub-inhibitory concentrations 
of cefotaxime, the antibiotic was either added directly to the LB broth to a final 
concentration of 0.003 µg/ml or 0.006 µg/ml for liquid conjugation, or for conjugation 
on a solid surface, the appropriate volume of cefotaxime was added to LB agar on 
which filters were placed.    
Conjugation mixtures from both filter and liquid matings were diluted appropriately to 
isolate single colonies, and plated onto LB agar containing either 50 µg/ml of 
tetracycline or 100 µg/ml of rifampicin to select for the recipient strain and 8 µg/ml 
cefotaxime (for selection of pCT), 50 µg/ml of kanamycin (for selection of pCT2 and 
pCT2b), both cefotaxime and kanamycin for selection of pCT3-8, and 20 µg/ml of 
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chloramphenicol for selection pCT9. Conjugation frequencies were measured a 
minimum of three times and calculated using the formula: 
Conjugation frequency =  
                                
                                                                         
 
Unpaired Student‟s t-tests were used to determine any significant changes in 
conjugation frequency, determined as a value where P was less than 0.05. 
2.10 Effect of pCT and mutant pCT upon host phenotype 
2.10.1 Bacterial host growth rate  
The growth kinetics of each bacterial strain were measured by monitoring the optical 
densities of broth cultures over time. An overnight culture of each strain was adjusted 
in LB broth to contain approximately 105 cells/ml and a 200 µl aliquot of adjusted 
culture (three biological and four technical repeats) was placed in a 96 well round 
bottomed microtitre tray (Fisher Scientific, Loughborough, Cat. no. FB56412). Plates 
were incubated at 37C with shaking in double orbital mode, 3 mm movement at 200 
rpm with additional shaking for 3 seconds before each cycle using a FLUOstar 
OPTIMA (BMG Labtech, UK) and the optical density measured at 600 nm every 10 
minutes. The generation times of each strain were calculated by comparing the 
increase in optical densities during mid-logarithmic phase using the formula 
    
                  
 
where Xo is an approximation of the number of cells, calculated from the optical 
density (OD600 0.1 = 100,000 cells) at the start of the experiment, and Xt is the 
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estimated number of cells calculated from the optical density at the end of the time 
period. The generation times of strains were compared using an unpaired Student‟s 
t-test where a P value of <0.05 was considered a significant difference.  
2.10.2 Biofilm formation assays 
The ability of strains to form a biofilm was evaluated using two methods. Crystal 
violet staining was used to quantify the amount of biofilm produced and culture on LB 
agar containing Congo red was used to qualitatively assess the extracellular biofilm 
matrix produced.  
2.10.2.1 Crystal violet staining 
Overnight LB broth cultures of strains were grown at 37C with shaking at 225 rpm 
and diluted in LB broth without NaCl to an optical density of 0.1 (OD600 nm). A 200 µl 
aliquot of adjusted cultures were dispensed into a 96 well microtitre tray (Fisher 
Scientific, Loughborough, Cat. no. FB56412) and incubated for 48 hours at 30C with 
gentle agitation (using a tilting platform shaker). Any biofilms formed were washed in 
sterile distilled water then stained by the addition of 200 µl of 1% crystal violet to 
each well for 15 minutes. The crystal violet was then removed from each well and the 
biofilms washed again using sterile distilled water. The crystal violet retained by any 
biofilm present was solubilised using 70% ethanol and quantified by measuring the 
optical density (OD600) of the ethanol in each well using the FLUOstar OPTIMA (BMG 
labtech). Three biological and four technical repeats were examined for each strain. 
Values were blank corrected to wells containing LB broth only and the mean optical 
density recorded for each strain was compared using an unpaired Student‟s t-test. A 
significant difference in biofilm produced was determined as a P value less than 0.05. 
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2.10.2.2 Culture on agar containing Congo red  
Overnight bacterial cultures of each strain grown in LB broth at 37C with shaking at 
225 rpm were diluted 1:10,000 in PBS (Sigma, UK, Cat. no. D8537). A 5 µl aliquot of 
the diluted culture was dispensed onto LB agar without salt and supplemented with 
40 µg/ml of Congo red (Sigma Aldrich, UK, Cat. no. C6277-25G), and left to dry. 
Plates were then incubated at 30C for a minimum of 48 hours. Red dry and rough 
colonies were observed for strains producing cellulose but not curli; smooth and 
white colonies indicated strains producing no curli or cellulose. 
2.10.3 Settle assay to determine the aggregative ability of strains 
Bacterial strains +/- pCT and the pCT mutants were grown overnight in LB broth at 
37C with shaking at 225 rpm. Cultures were secured and left stationary on the 
bench for twelve hours to „settle‟.  At the beginning of each experiment and every 
hour thereafter, a 100 μl aliquot was taken from the very surface of each culture. This 
was diluted in 900 μl of fresh broth and the optical density at 600 nm was recorded. 
In each experiment E. coli 042 (I845) was used as a positive control. Each optical 
density (OD600) value was shown as a percentage of the initial OD600. 
2.10.4 Imaging of cells 
For imaging of bacterial strains using scanning electron microscopy, cells were 
prepared in two ways. To visualise cells from a solid surface each strain was cultured 
overnight on LB agar at 37C. A colony from each strain was then suspended in 10 µl 
of PBS (Sigma, UK, Cat. no. D8537) on a glass cover-slip, left to dry and then fixed 
by submersion of the glass side in 2.5% Glutaraldehyde and 0.1 M Phosphate buffer 
for 1 hour. Alternatively, overnight LB broth cultures were used to seed 30 ml of fresh 
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LB broth which were cultured to late-logarithmic phase (OD600 ~ 0.8-0.9). These cells 
were used to visualise bacteria grown in liquid as 1 ml of each culture was placed 
into 3 ml of 2.5% Glutaraldehyde and 0.1 M Phosphate buffer, also for 1 hour. 
Samples were then kindly prepared using dehydration, and mounted using platinum 
by Theresa Morris (School of Metallurgy and Materials, University of Birmingham). 
Imaging of bacterial cells used a FEI/ Philips XL30 FEG ESEM (Philips).  
2.10.5 Effect of pCT and the pCT2-9 upon the ability of bacterial host strains to cause 
infection 
The contribution of wild-type pCT and the pCT mutant plasmids pCT2-9 to the 
bacterial host strain‟s ability of to cause infection were assessed using two models of 
infection. The first measured the ability of S. Typhimurium SL1344 (+/- rifR; +/- 
plasmids) to adhere to, and invade, human embryonic intestinal cells (INT-407) within 
a monolayer. The second model measured the rate at which nematode C. elegans 
were killed when fed on cultures of S. Typhimurium SL1344 (+/- rifR) and E. coli 3950 
containing either no plasmid, wild-type pCT or the pCT mutant plasmids.  
2.10.5.1 Tissue culture model 
A Human embryonic intestine cell line INT-407 was kindly supplied by R. La Ragione 
at the Animal Health and Veterinary Laboratories Agency (AHVLA), Addlestone, 
Surrey for investigation of S. Typhimurium pathogenicity by previous members of the 
ARG research team (Buckley et al., 2006; Blair et al., 2009). The methods were 
based upon those described by Dibb-Fuller and colleagues (Dibb-Fuller et al., 1999). 
Each assay was repeated a minimum of three times and each repeat contained four 
technical repeats.  
73 
 
2.10.5.1.1 Preparation of INT-407 tissue culture cells  
INT-407 monolayers were grown in 250 ml tissue culture flasks (BD Falcon™, US, 
Cat. no. 353136) in complete tissue culture medium containing Minimum Essential 
Medium (MEM) (Sigma-Aldrich, UK, Cat. no. M2279) and supplemented with 10% 
heat inactivated foetal calf serum (Invitrogen, UK, Cat. no. 10108-165), 1% non-
essential amino acids (NEAA) (Sigma, UK, Cat. no. M7145), 1% L-glutamine (Sigma, 
UK, G7513) and 50 μg/ml gentamicin (Sigma, UK, Cat. no. G1397). For use in the 
adhesion and invasion assays monolayers were prepared in 24 well flat bottomed 
tissue culture plates (BD Falcon™, US, Cat. no. 353047). Each well was seeded with 
approximately 105 cells and incubated for 48 hours at 37C and 5% CO2. Before the 
infection assays the prepared monolayers were washed with 1 ml of pre-warmed 
Hanks Balanced Salt Solution (HBSS) (Sigma, UK, Cat. no. H9269) by pipetting 1 ml 
into each well and then removing and discarding the media, three times for each well 
to remove residual medium and antibiotic. 
2.10.5.1.2 Preparation of bacterial strains for the tissue culture assays 
Bacterial strains were grown overnight in 10 ml of LB broth containing appropriate 
antibiotics to ensure maintenance of the plasmid at 37C and shaking at 225rpm. 
Cells were harvested from each culture by centrifugation at 2250 x g for 10 minutes 
at room temperature and the supernatant discarded. Bacterial cells were washed by 
re-suspending the pellet in 10 ml of sterile PBS (Sigma, UK, Cat. no. D8537) and 
centrifugation at 2250 x g for a further 10 minutes at room temperature. Harvested 
cells were then re-suspended in approximately 10 ml of sterile PBS and adjusted to 
an optical density of 1.23 at 540 nm with PBS (approximately 1 x 107 CFU/ml). The 
bacterial cultures were then diluted 1:20 in inoculation medium and viable counts 
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were performed on this diluted bacterial culture. Inoculation media consisted of MEM 
medium supplemented with 1% L-glutamine (Sigma, UK, Cat. no. G7513) and 1% 
NEAA (Sigma, UK, Cat. no. M7145).  
2.10.5.1.3 Association assays 
To quantify the number of bacteria of each strain which associated with the INT-407 
cells within the monolayer, 1 ml of the prepared bacterial suspension was inoculated 
into each well and incubated for two hours at 37C and 5% CO2. To remove all non-
adherent bacteria, monolayers were washed four times with 1 ml of pre-warmed 
HBSS. Monolayers were disrupted by adding 1 ml of sterile 1% Triton-X 100 (Sigma, 
UK, Cat. no. X100) and a magnetic flea to each well and placed on a magnetic stirrer 
for 10 minutes. Serial 1:10 dilutions were made from each tissue culture well and 
three 20 μl drops of each dilution were plated onto LB agar as described by Miles et 
al., (1938). Agar plates were incubated overnight at 37C and counted to determine 
the number of colony forming units (CFU) per millilitre. 
2.10.5.1.4 Invasion assays 
To quantify the number of bacteria of each strain which invaded the INT-407 cell, 
invasion assays were carried out in parallel with the association assays using the 
same prepared bacterial suspension to inoculated each well. Monolayers were 
incubated for two hours at 37C and 5% CO2 and washed four times with 1 ml of pre-
warmed HBSS as previously described. Two mililitres of complete tissue culture 
medium containing 100 μg/ml of gentamicin (Sigma, UK, Cat. no. G1397) was then 
added to each well to kill bacteria which had not invaded without damaging or 
penetrating the eukaryotic cells, thus leaving the internal bacteria unharmed. The 
plate was incubated for a further two hours at 37C and 5% CO2. Monolayers were 
75 
 
washed four times with 1 ml of pre-warmed HBSS and then disrupted by adding 1 ml 
of sterile 1% Triton-X 100 (Sigma, UK, Cat. no. X100), a magnetic flea to each well 
and placing on a magnetic stirrer for 10 minutes. Serial 1:10 dilutions were made 
from each tissue culture well and three 20 μl drops of each dilution were plated onto 
LB agar as described by Miles et al., (1938). Agar plates were incubated overnight at 
37C and colonies counted to determine the number of colony forming units (CFU) 
per millilitre. 
2.10.5.1.5 Statistical analysis 
The number of bacteria able to associate and invade tissue culture cells was 
calculated for each strain by finding the mean CFU/ml (and standard deviation) for 
each biological replicate. The mean CFU/ml of the three biological repeats was then 
calculated to give the overall CFU/ml. The level of adhesion was determined by 
subtracting the mean CFU/ml for invasion from the mean CFU/ml for association. 
Each value was then expressed as a percentage of that given by the value obtained 
for the parental strain (either S. Typhimurium SL1344 rifR or S. Typhimurium SL1344 
rifR pCT) and a Student‟s t-test was used to determine whether the adhesion and 
invasion values of each strain were significantly different to that of the parental 
strains. P values of ≤0.05 were deemed to be statistically significant. A 95% 
confidence interval for the mean association of S. Typhimurium SL1344 with INT-407 
cells was calculated by a previous member of the laboratory. Only data from assays 
where a value for S. Typhimurium SL1344 fell within this range (1.2 x 106 to 1.1 x 107 
CFU/ml) were accepted.    
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2.10.5.2 C. elegans model 
Bristol N2 C. elegans were kindly donated by Dr Robin May at the University of 
Birmingham for use in this study. Nematodes were routinely cultured on a lawn of E. 
coli OP50 on nematode growth media (NGM) (Appendix 3) and stored at 20C. 
Approximately every four days between ten and thirty nematodes were removed and 
seeded onto a fresh E. coli OP50 NGM plate to maintain the culture.  
2.10.5.2.1 Preparation of bacterial strains and assay plates 
NGM agar was poured into 60 mm Petri dishes (Sterilin, UK, Cat. no. 123) and 
allowed to dry. Overnight cultures of each bacterial strain grown at 37C in LB broth 
were used to seed NGM assay plates by pipetting 20 µl of culture onto the middle of 
the plate and leaving to dry. Plates were then incubated overnight at 37C to allow 
proliferation of the bacterial strains. For each bacterial strain three cultures were 
used to inoculate twenty plates each to create three biological repeats. 
2.10.5.2.2 Preparation of C. elegans  
A recently starved E. coli OP50 NGM plate was washed repeatedly with M9 buffer 
(Appendix 3) to collect both nematodes and eggs from the plate and liquid made up 
to 1.5 ml with M9 buffer. Eggs and nematodes were then collected by centrifugation 
at 3,000 x g for 30 seconds and the supernatant was discarded. To kill all nematodes 
leaving only eggs, 80 µl 5 M sodium hydroxide and 160 µl sodium hypochlorite was 
added to the pellet and the mixture was shaken vigorously by hand for 2 minutes. M9 
was added to make the solution up to 1.5 ml and the mixture was centrifuged at 
3,500 rpm for 30 seconds. The pellet was then washed by re-suspending in 1 ml of 
M9 buffer and centrifuging at 4,500 x g five times to remove any trace of sodium 
hydroxide or sodium hypochlorite. The final pellet was resuspended in 200 µl of M9 
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buffer and aerated overnight using a Stuart tilting tube roller (Scientific Laboratory 
Supplies, Nottingham, Cat. no. MIX1980). The next day 200 µl of the mixture was 
placed around the outside of an E. coli OP50 seeded NGM 90 mm agar plate 
checking for the presence of L1 viable stage nematodes. Plates were incubated at 
20C for 48 hours to allow the nematodes to develop to stage 4 (L4).  
2.10.5.2.3  Killing assays 
Bacterial killing assays were conducted as previously described by Aballay and 
colleagues (2001), 60 larval stage 4 (L4) nematodes were used for each biological 
repeat of the bacterial strains. Twenty nematodes were placed on each assay plate 
inoculated with the bacterial test strain, incubated at 25C and scored daily for the 
number of C. elegans which had survived. Each plate was visualised using a Nikon 
SMZ800 Zoom Stereomicroscope (Nikon Instruments Inc, USA, SMZ-800). Dead 
nematodes were defined as those which failed to respond to mechanical stimulus, 
such individuals were removed once identified, and viability counting continued until 
all the nematodes had died. After each 48 hours of the fertile period, worms were 
transferred to fresh NGM plates seeded with bacteria from the same overnight culture 
as in the initial growth using a „pick‟ made from 0.25 mm platinum wire (Sigma 
Aldrich, UK, Cat. no. 349402-250G). A Kaplan Meier estimate was used to determine 
the probability of C. elegans survival over time. Survival curves were then generated 
by plotting the probability of survival against time. Survival curves were compared 
using the log rank test and chi-squared analysis to establish whether the difference 
between two curves was statistically significant (a P value less than 0.05 was 
considered statistically significant). 
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2.11 Pair-wise competitive growth in vitro 
Overnight bacterial cultures of the two bacteria strains to be placed in competition 
were grown at 37C in LB broth without antibiotic. Both cultures were adjusted using 
LB broth to an optical density of 1.0 (OD600) and 50 µl of each culture added to 100 
ml of „pre-warmed‟ fresh LB broth for incubation at 37C shaking at 180 rpm. 
Competition mixtures were passaged by removing 100 µl of culture at hours 12, 24, 
48 and 72 hours to inoculate 100 ml of fresh „pre-warmed‟ broth. Viable counts were 
carried out at the start of the experiment and every two hours for 12 hours, also at 
hours 24, 48, 72, and in later studies, 96 hours by spreading the competition mixture 
on LB agar without antibiotic. LB agar plates with 20-200 colonies were replica plated 
using velveteen squares onto an antibiotic free plate and onto agar supplemented 
with the appropriate selective antibiotic to distinguish between strains. The number of 
colonies growing on each type of agar plate were enumerated and revealed the 
relative proportion of each strain (Figure 2.3). Each competition experiment was 
carried out on three separate occasions. The number of generations was calculated 
using the viable count data using the formula 
                        
                       
      
    
The competition index (CI) was then calculated using the formula,  
      
                     
                     
 
 Where A is the mean ratio of the strains of the three experiments at the end of the 
assay, and B is the mean ratio at the beginning of the assay.  
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Figure 2.3. Typical pair-wise competitive growth method  
 
  
 
  
 
 
 
 
Chapter 3: 
 
Characterisation 
and epidemiology 
of plasmid pCT 
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3. Characterisation and epidemiology of plasmid pCT 
3.1 Background 
E. coli isolate C159/11, described by Teale et al. (2004) and Liebana et al. (2006) 
was resistant to several different classes of antibiotic. Resistance to third generation 
cephalosporins was mediated by a blaCTX-M-14 gene located on an IncK conjugative 
plasmid (named in the present study, pCT). The Animal Health and Veterinary 
laboratories Agency (Surrey, UK) showed that an IncK plasmid with an identical 
restriction fragment length polymorphism (RFLP) profile to pCT had spread 
throughout the index farm to six different E. coli strains, and that pCT could be 
transferred to E. coli and S. Typhimurium strains using conjugation (Liebana et al., 
2006). In 2008, at the start of the present study, no blaCTX-M-14 carrying plasmids and 
only one IncK plasmid had been fully sequenced and annotated. Therefore, little was 
known about the genetic context of blaCTX-M-14 outside the proximal insertion elements 
and even less known about the core genome of IncK plasmids.  
3.2 Hypotheses and Aims 
Analysis of the complete DNA sequence of pCT would reveal any additional 
candidate genes, besides blaCTX-M-14, which could contribute to the successful spread 
and persistence of this plasmid. The second hypothesis was that pCT-like plasmids 
would be found in other geographical locations and other environmental niches.  
The aims of this section were to: 
 Extract pCT from the natural host strain E. coli C159/11, and transfer this 
plasmid to other bacterial strains for further characterisation and investigation,  
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 Determine the complete DNA sequence of plasmid pCT and to interrogate the 
pCT genome by annotation and comparisons to other sequenced plasmids, 
 Use this sequencing data to design a molecular diagnostic tool to screen for 
pCT-like plasmids in CTX-M-14 producing bacteria. By screening isolates 
collected from different geographical regions the epidemiological distribution of 
pCT would be explored, thereby establishing its relevance in the dissemination 
of blaCTX-M-14. 
3.3 Preparation of bacterial strains containing pCT 
For use in all aspects of this project, plasmid pCT was transferred to three commonly 
used laboratory host strains E. coli DH5α (I825), E. coli J53-2 (I847) and Salmonella 
Typhimurium SL1344 rifR (L1078) and to the pCT „cured‟ natural E. coli host strain 
C159/11 named „3950‟ (I823).  
3.3.1 Transformation of E. coli DH5α with pCT 
pCT DNA isolated from wild-type E. coli host C159/11 was transformed into E. coli 
DH5α electro-competent cells. All transformants were confirmed to be E. coli using 
API20E strips and were resistant to cefotaxime. Plasmid DNA was harvested from 
one putative transformant, and analysed by eletrophoresis on an agarose gel. The 
extracted plasmid was of a similar size to one of the three plasmids isolated from 
strain E. coli C159/11 (Figure 3.1, plasmid band 1) but absent in the E. coli DH5α 
parental strain. A specific PCR designed to amplify Group 9 blaCTX-M genes and 
sequencing of the resultant amplicon confirmed the presence of a blaCTX-M-14 gene in 
the E. coli DH5α transformant (Figure 3.2; Appendix 1). This strain was named E. coli 
DH5α pCT and given the laboratory number I755.  
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Figure 3.1. Plasmid DNA isolated from E. coli C159/11 and the transformed         
E. coli DH5α pCT  
 
 
 
 
 
DNA was extracted using the QIAgen® Miniprep kit and analysed by electrophoresis 
in a 0.7% agarose gel.  
Plasmid band 1 shows plasmid pCT DNA, plasmid band 2 and 3 show DNA from two 
additional plasmids isolated from veterinary E. coli isolate C159/11 which were not 
transformed into E. coli DH5α when selecting on agar containing cefotaxime. 
Lane Code  Species Description 
Plasmid  
band present 
 
HL1 
 
 Hyperladder 1 size marker (Bioline) 
1 I753  E. coli C159/11 veterinary isolate (pCT)  1/2/3 
2 I755  E. coli DH5α transformant (pCT) 1 
3 I825  E. coli DH5α   
4   Negative control   
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Figure 3.2. blaCTX-M Group-9 PCR detection in putative pCT containing strains 
 
 
Lane Isolate Species Description 
HL1   Hyperladder 1 size marker (Bioline) 
1 I753 E. coli C159/11 Veterinary isolate 
2 I755 E. coli DH5α pCT Transformant  
3 L1079 S. Typhimurium SL1344 rifR pCT Transconjugant 
4 I825 E. coli DH5α  
 
Amplified DNA was analysed by electrophoresis in a 1% agarose gel. 
The amplification and visualisation of DNA indicated the presence of a blaCTX-M-9 
group gene within the tested strain. 
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3.3.1.1 Conjugation of pCT into E. coli and S. Typhimurium strains 
A S. Typhimurium strain with a chromosomal resistance marker was required to act 
as a pCT conjugation recipient strain and for further study of pCT in a S. 
Typhimurium bacterial host. Therefore, rifampicin resistant mutants of well 
characterised laboratory strain S. Typhimurium SL1344 were selected using LB agar 
supplemented with rifampicin (100 µg/ml). The frequency of mutation to a resistant 
phenotype was calculated as 7.78 X 10-7 per cell (indicative of a single point 
mutation) and the MIC of rifampicin required against the putative mutants was 
determined as > 256 µg/ml. A mutant colony was randomly selected and designated 
S. Typhimurium SL1344 rifR (L1078). Recipient stains E. coli J53-2 (I847) and E. coli 
3950 (E. coli C159/11 pCT „cured‟; I823) had chromosomal antibiotic resistance 
genes conferring resistance to rifampicin and tetracycline respectively.  
Conjugation of pCT from donor E. coli DH5α pCT (I755) to recipients S. Typhimurium 
SL1344 rifR, E. coli J53-2 and E. coli 3950 all produced colonies on selective agar, 
therefore six putative transconjugant colonies were selected from each experiment 
for further investigation. Verification of plasmid transfer was carried out by culturing 
donor, recipients and potential transconjugants on XLD plates. E. coli DH5α pCT 
donor cells grew on XLD as pink colonies (atypical for an E. coli K12 strain due to 
inactivation of lacZYA). Salmonella Typhimurium SL1344 rifR was identified as pink 
colonies with the production of H2S as a black pigment, and recipient strains E. coli 
3950 and E. coli J53-2 grew as yellow colonies. These differences in phenotype 
allowed discrimination between transconjugants and spontaneous donor cell 
mutants. From each conjugation, one randomly selected putative transconjugant was 
selected and PCR used to confirm the presence of a Group 9 blaCTX-M gene      
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(Figure 3.2). The S. Typhimurium SL1344 rifR pCT transconjugant was designated S. 
Typhimurium SL1344 rifR pCT (L1079), the E. coli J53-2 transconjugant, E. coli J53-2 
pCT (I855) and the E. coli 3950 transconjugant, E. coli 3950 pCT (I834). 
3.4 Antibiotic susceptibilities of pCT containing host strains 
Susceptibility to a range of antibiotics was determined for natural strain C159/11 
(pCT) (I753), pCT transformant and pCT transconjugants by measuring the minimum 
inhibitory concentrations. The range of antibiotics selected were chosen to represent 
different mechanisms of antibiotic action and to identify the resistance conferred by 
common plasmid mediated antibiotic resistance genes. According to breakpoints 
recommended by BSAC guidelines, E. coli C159/11 was resistant to the β-lactams 
ampicillin, cefotaxime and ceftiofur as well as chloramphenicol, tetracycline and 
ciprofloxacin (Table 3.1). C159/11 (I753) was susceptible to faropenem, gentamicin, 
erythromycin and rifampicin. The only transferable antibiotic resistance conferred by 
either the transformation or conjugation of plasmid pCT to the bacterial host stain 
was to the β-lactams, cefotaxime, ceftiofur and ampicillin (Table 3.1). 
3.5 Genomic analysis of plasmid pCT 
In order to determine the pCT genome, chain termination DNA sequencing at the 
Sanger Institute was used to amplify random fragments which, when assembled 
would reveal the complete plasmid sequence.  
3.5.1 Isolation of pCT plasmid DNA for sequencing 
High quality and high purity plasmid DNA was required for complete sequencing of 
pCT. Therefore, pCT was extracted from the E. coli DH5α pCT transformant (I755) 
using a combination of an alkaline SDS Maxi preparation (Figure 3.3A) followed by 
 Table 3.1. Minimum inhibitory concentrations of a range of antibiotics to strains with and without plasmid pCT 
 
   Minimum Inhibitory concentration (µg/ml) 
Species 
Lab 
code Strain CTX AMP CFR FAR CIP KAN GEN ERY TET CHL 
             
E. coli 
 
I753 C159/11 (WT) 32 512 64 1 128 2 0.5 32 128 32 
I825 DH5α 0.03 2 0.25 0.25 0.0015 0.5 0.12 32 1 1 
I755 DH5α pCT 16 256 32 0.5 0.0015 0.5 0.12 32 1 1 
I847 J53-2 0.06 8 0.5 1 0.0015 2 0.25 32 2 1 
I855 J53-2 pCT 16 256 32 1 0.0015 2 0.12 32 2 1 
I823 3950 0.03 8 0.5 0.5 64 1 0.25 32 128 16 
I834 3950 pCT 16 256 64 0.5 64 1 0.25 32 128 16 
S. Typhimurium 
L1078 SL1344 rifR 0.06 4 1 0.5 0.03 1 0.25 64 2 1 
L1079 SL1344 rifR pCT 64 512 64 0.5 0.0015 1 0.5 64 2 1 
 
CTX, cefotaxime; AMP, ampicillin; CFR, ceftiofur; CIP, ciprofloxacin; KAN, kanamycin; GEN, gentamicin; ERY, erythromycin, 
TET, tetracycline, CHL, chloramphenicol; FAR, faropenem. 
 
Bold type MIC values indicate resistance conferred by pCT. 
  Figure 3.3. Isolation of pCT plasmid DNA  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Lane Description 
 
HL1 
 
Hyperladder 1  
1 Plasmid DNA isolated using the Birnboim-Doly Maxi prep; Sample 1 
2 Plasmid DNA isolated using the Birnboim-Doly Maxi prep; Sample 2 
3 pCT DNA after alkaline lysis and CsCl gradient centrifugation (Sample 1 and 2 combined) 
4 pCT DNA product after isopropanol and ethanol washes 
 
Isolated plasmid DNA was analysed using electrophosis in a 0.7% agarose gel
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caesium chloride density gradient centrifugation. The latter procedure was to remove 
any remaining chromosomal DNA (Figure 3.3B). The DNA isolated after alkaline SDS 
extraction had extensive chromosomal DNA contamination, as shown at the bottom 
of the agarose gel as a smear (Figure 3.3A). After caesium chloride density gradient 
centrifugation (Figure 3.3, Lane 3) the visible chromosomal DNA was removed and a 
much clearer pCT band >10,000bp was seen. The DNA was cleaned resulting in a 
more defined plasmid band (Figure 3.3, Lane 4). Spectrophotometric analysis 
estimated the quantity of DNA used for sequencing in the 46 µl sample as 40.75 µg 
in total (~885 ng/µl). 
3.5.2 Complete DNA sequencing and annotation 
The plasmid DNA sequence was determined at the Sanger Institute using chain 
termination sequencing to generate 7 contigs. Initial annotation at the Sanger used 
the 454/Roche Newbler assembly program and Artemis. Further annotation as part of 
my project was completed using Artemis and BLASTn.  
3.5.3 General features of pCT 
Plasmid pCT is 93,629b bp in size and has an average G+C content of 52.67%. 
Within the sequence 115 open reading frames (ORFs) were putatively identified. Of 
these 115 ORFs, 7% were annotated as pseudogenes due to missing C or N 
terminals or genomic disruptions; 17% were postulated to encode hypothetical 
proteins of unknown function; and 76% showed either DNA or protein identity to 
sequences encoding proteins with known functions. Coding regions included genes 
for plasmid replication, conjugation and stability along with a number of mobile 
genetic elements (Figure 3.4 and Table 3.2). 
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Figure 3.4. Plasmid map of pCT  
 
Circular genomic map of plasmid pCT; coding regions are colour coded as follows, brown, 
pseudogenes; orange, hypothetic proteins; light pink, insertion sequences; light blue, tra 
locus; green, pil locus; dark pink, antibiotic resistance gene; yellow, putative sigma factor; 
red, replication associated genes. The arrows show the direction of transcription.  
The inner circles shows percentage GC (inner) and GC skew (outer).  
  
Table 3.2. Protein coding regions of pCT listed clockwise  
Gene 
name 
ID 
Direction 
of coding 
Co-ordinates 
No 
of aa 
DNA 
identity 
pO26-vir 
DNA identity 
ColIb-P9 
Protein 
Homolog 
Function Notes 
repY pCT_001  610-699 29 100% 100% RepY Positive regulator for repZ Leader peptide 
repZ pCT_002  687-1718 343 100% 100% RepZ Replication initiator protein  
 pCT_003  2050-2199 49 100% 95%  Uncharacterised protein  
repA* pCT_004  2193-2267 
2267-2440 
128 96% 94% RepA4 
 
Replication initiator protein repA4 found in R100 
 pCT_005  2416-2574 51 90% 98%  Hypothetical protein  
yacA pCT_006  2629-2898 89 94% 97% YacA Putative stabilisation 
protein 
Putative homologues 
in IncPβ plasmid B8 of 
toxin-antitoxin system yacB pCT_007  2895-3176 93 96% 97% YacB Putative stabilisation 
protein 
 pCT_008  3372-3713 113 0% 0%  Putative membrane protein  
 pCT_009  4013-4600 195 0% 0%  Putative serine 
acetlyltransferase 
 
yafB pCT_010  4882-5475 197 95% 95% YafB Metabolic proteins  
yagA pCT_011  5829-7175 448 99% 98% YagA Replication and repair 
protein 
 
* pCT_012  7710-8021 308 100% 0%  Hypothetical protein  
parA 
like 
pCT_013  8009-8635 209 100% 0% ParA Putative stability protein  
impB pCT_014  8847-10118 423 100% 99% ImpB UV protection protein Similar arrangement to 
imp locus found in 
plasmid TP110 
impA pCT_015  10118-10555 145 100% 99% ImpA UV protection protein 
impC pCT_016  10552-10800 82 100% 99% ImpC UV protection protein 
 pCT_017  10904-12124 1406 0% 0%  Transposase  
yccA pCT_018  12236-12505 89 100% 100% YccA Inner membrane protein  
 pCT_019  12474-13445 323 95% 97%  Hypothetical protein  
 pCT_020  13449-13754 101 98% 91%  DNA methylase protein  
 pCT_022  14514-14735 73 99% 90%  Hypothetical protein  
* pCT_023  14449-15183 144 95% 92%  Hypothetical protein  
ycfA* pCT_024  15183-15197 
15196-15228 
15225-15863 
15866-16000 
273 100% 0% YcfA 
 
Conserved hypothetical 
plasmid protein 
 
  
Gene 
name 
ID 
Direction 
of coding 
Co-ordinates 
No 
of aa 
DNA 
identity 
pO26-vir 
DNA identity  
ColIb-P9 
Protein 
Homolog 
Function Notes 
IS66 A pCT_025  16037-16714 225 0% 0% IS66 Transposase Also found in plasmid 
pEK204 disrupting the 
shufflon region 
IS66 B pCT_026  16714-17961 115 0% 0% IS66 Transposase 
IS66 C pCT_027  17081-18652 523 0% 0% IS66 Transposase 
klcA pCT_028  19125-19550 141 95% 93% KlcA Stable inheritance protein  
 pCT_029  19597-20019 140 98% 96%  Hypothetical protein  
* pCT_030  20071-20214 
20214-20369 
100 95% 94%  Hypothetical protein  
 pCT_031  20410-20856 157 97% 98%  Hypothetical protein  
ssb* pCT_032  20774-20938 143   Ssb ssDNA binding  
ssb pCT_033  20977-21504 175 99% 95% Ssb ssDNA binding Gene involved in 
replication  
 pCT_034  21761-21792 86 99% 95% YkfF conserved hypothetical 
plasmid protein 
 
ycjA pCT_035  21761-23812 654 94% 93% ParB Partitioning protein  
psiB pCT_036  23864-24301 145 99% 97% PsiB Plasmid SOS inhibition 
protein 
Gene involved in 
replication 
psiA pCT_037  24298-25017 239 99% 97% PsiA Plasmid SOS inhibition 
protein 
Gene involved in 
replication 
 pCT_038  25014-25610 198 98% 0%  Hypothetical protein  
ardA pCT_039  26972-26572 166 98% 100% ArdA Antirestriction protein Gene involved in 
replication  
* pCT_040  26754-26969 155 100% 97%  Hypothetical protein  
 pCT_041  27093-27308 71 99% 89%  Hypothetical protein  
 pCT_042  27305-27739 144 99% 98%  Hypothetical protein  
ygdA pCT_043  27736-28098 120 99% 90% YhdA Hypothetical protein  
ccgAII pCT_044  28200-28664 129 100% 0% CcgAII   
Transpo
sase 
pCT_045  28661-29551 296 98% 89%  Putative transposase  
ydgA pCT_046  29551-29796 81 93% 88%  Putative  
ygeA pCT_047  29827-30078 83 98% 98%  Putative  
ydhA* pCT_048  30163-30183 
30183-30533 
123 99% 97% YdhA   
ydiA pCT_049  30658-31506 282 99% 96% YdiA Putative   
  
Gene 
name 
ID 
Direction 
of coding 
Co-ordinates 
No 
of aa 
DNA 
identity 
pO26-vir 
DNA identity  
ColIb-P9 
Protein 
Homolog 
Function Notes 
yggA pCT_050  31593-31934 113 98% 97% YggA Putative  
nikA pCT_051  32161-32493 110 100% 71% (91%) NikA Relaxome component  
nikB pCT_052  32505-35225 906 100% 71% (91%) NikB Relaxase  
trbC pCT_053  35446-37746 766 99% 76% (85%) TrbC Putative prepillin  
trbB pCT_054  37727-38851 374 100% 69% (41%) TrbB ATPase  
trbA pCT_055  38848-40110 420 100% 72% (86%) TrbA Regulation  
 pCT_056  40742-41038 98 99% 86%  Hypothetical protein  
parB pCT_057  41427-41894 155 99% 0% ParB Partitioning protein No homology to other 
IncI parB genes 
Transpo
sase 
pCT_058  42085-42840 251 0% 0%  Putative transposase  
Transpo
sase 
pCT_059  42857-44392 511 0% 0%  Putative transposase  
 pCT_060  44698-45321 207 99% 0%  Hypothetical protein  
 pCT_061  45519-45734 71 100% 0%  Hypothetical protein  
 pCT_062  45738-46106 122 99% 0%  Hypothetical protein  
 pCT_063  46118-46309 63 98% 0%  Hypothetical protein  
 pCT_064  46397-46717 106 98% 0%  Hypothetical protein  
pndA pCT_065  46821-47114 97 100% 91% PndA Stabilisation protein Putative post 
segregational killing 
gene 
Sigma 
factor 
 
 
pCT_066  47259-48845 528 99% 0%  Putative sigma factor  Protein homology to 
SigB, (Sigma 70 
family) found in a 
Yersinia frederiksenii 
(ZP_04633307) excA pCT_067  49119-49772 215 100% 68% (49%) ExcA Surface exclusion protein 
traY pCT_068  49860-52058 721 100% 68% TraY Integral membrane protein 
traX pCT_069  52100-52669 189 100% 72% (23%) TraX Pilin  
traW pCT_070  52666-53706 346 100% 75% TraW Transfer related lipoprotein  
traV pCT_071  53829-54449 206 100% 69% TraV   
traU pCT_072  54449-57493 1014 100% 72% TraU Nucleotide binding protein  
traT pCT_073  57788-58501 237 100% 68% (66%) TraT   
traS pCT_074  58521-58772 83 100% 0% TraS   
  
Gene 
name 
ID 
Direction 
of coding 
Co-ordinates 
No 
of aa 
DNA 
identity 
pO26-vir 
DNA identity  
ColIb-P9 
Protein 
Homolog 
Function Notes 
traR pCT_075  58829-59227 132 100% 0% TraR   
traQ pCT_076  59274-59804 176 100% 74% TraQ   
traP pCT_077  59801-60514 237 100% 74% (22%) TraP   
traO pCT_078  60511-61848 445 100% 71% (41%) TraO Pore protein  
traN pCT_079  61852-62826 324 100% 75% (80%) TraN Secretin/pore protein   
traM pCT_080  62837-63532 231 100% 73% (73%) TraM   
traL pCT_081  63544-63894 116 100% 72% TraL   
sogL pCT_082  63911-67972 1353 100% 74% (54%) Sog 
 
L/TraC 
DNA primase  
* pCT_083  68326-68922 
72048-72083 
232 0% 0%  Uncharacterised protein 39.53% G/C unlike 
surrounding CDSs 
IS903B pCT_084  68888-69370 322 0% 0%  Putative transposase  
blaCTX-M-
14 
pCT_085  69405-70280 291 0% 0% CTX-M-14 β lactamase  blaCTX-M-14 249 bp 
downstream (not the 
usual 49 bp) ISEcp1 pCT_086  70530-71792 420 0% 0%  Transposase 
traK pCT_087  72204-72494 96 100% 69% TraK   
traJ pCT_088  72491-73639 382 100% 75% TraJ Nucleotide binding protein  
traI pCT_089  73623-74288 276 100% 72% (81%) TraI Transfer related lipoprotein  
traH pCT_090  74326-74913 195 100% 67% (32%) TraH   
traF pCT_091  75017-76219 400 100% 72% TraF   
traE pCT_092  76321-77142 273 100% 66% (72%) TraE   
Rci pCT_093  77355-78479 474 97%(16%) 72% (74%)  Rci Shufflon recombinase Although detailed in 
IncI plasmid R64, 
there is only moderate 
resemblance of this 
system to the pCT 
shufflon. The entire 
region has most DNA 
homology (60%) to the 
shufflon region of 
plasmid R721.  
Shufflon 
A 
pCT_094  78534-78893 119 99%(31%) 66% (68%)  PilV pilus protein A 
Shufflon 
D  
pCT_095  78898-79287 129 98% 0%  PilV pilus protein C'  
(alternative 3' tip) 
Shufflon 
C’ 
Shufflon 
C 
pCT_096  
 
pCT_097 
 
 
     
79298-79528 
79525-79788 
76 
 
87 
0% 
 
0% 
83% (98%) 
79% 
(97%) 
 PilV pilus protein C'  
(alternative 3' tip) 
 PilV pilus protein C' 
 (alternative 3' tip) 
          
  
Gene 
name 
ID 
Direction 
of coding 
Co-ordinates 
No 
of aa 
DNA 
identity 
pO26-vir 
DNA identity  
ColIb-P9 
Protein 
Homolog 
Function Notes 
Shufflon 
B 
pCT_098  79799-80062 87 0% 70%  PilV pilus protein C'  
 
Shufflon B 
pilV pCT_099  80072-81337 421 99% 73% (13%) PilV Type IV prepilin  
pilU pCT_101  81355-81981 208 99% 0% PilU Prepilin peptidase  
pilT pCT_102  81997-82482 161 100% 0% PilT Transglycosylase  
pilS pCT_103  82577-83063 178 100% 0% PilS Type IV prepilin  
pilR pCT_104  83125-84219 364 99% 0% PilR Pilus biogenesis  
pilQ pCT_105  84221-85729 502 99% 74% (4%) PilQ Nucleotide binding protein  
pilP pCT_106  85832-86290 152 99% 0% PilP Pilus biogenesis protein  
pilO pCT_107  86280-87575 431 99% 0% PilO Pilus biogenesis protein  
pilN pCT_108  87596-89215 539 99% 83% (2%) PilN Secretin  
pilM pCT_109  89247-89684 145 99% 0% PilM Pilus biogenesis protein  
pilL pCT_110  89688-90758 356 99% 0% PilL Lipoprotein  
 pCT_111  90985-91341 122 100% 0%  Hypothetical protein  
pilI pCT_112  91437-91679 80 100% 0% PilI   
* pCT_113  91760-91864 564 100% 0%  Hypothetical protein  
traC pCT_114  92170-92832 220 94% 0% TraC Regulator of transfer  
traB pCT_115  92972-93613 213 99% 67% (81%) TraB Regulator of transfer  
 
 
 
 
 
 
Pseudogenes are denoted with *;   
The percentage DNA identify to pO26_vir and ColIb-P9 is followed by the percentage coverage in brackets, 
aa, amino acid. 
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3.5.4 Antibiotic resistance and virulence genes 
Annotation of the pCT sequence showed an absence of any genes known to 
contribute to virulence of the host bacterium. The only antimicrobial resistance gene 
identified was β-lactamase blaCTX-M-14 through which the plasmid was first identified.  
3.5.4.1 The genetic context of blaCTX-M-14 on pCT 
The genomic organisation of the pCT blaCTX-M-14 and flanking insertion sequences 
ISEcp1 and IS903 was found to correspond largely with other described plasmid 
encoded blaCTX-M-14 genes (Eckert et al., 2006). ISEcp1 (pCT_086) was found 249 bp 
upstream of blaCTX-M-14 on pCT, with the characteristic 42 bp directly upstream and an 
additional 207 bp found downstream of ISEcp1. ISEcp1 had a G+C content 
averaging 33.95%, characteristic of a mobile genetic element (Figure 3.5). IS903 
(pCT_084) was found downstream of blaCTX-M-14 in the same position as described 
(Eckert et al., 2006), with an average G+C content of 50.45%, more closely 
resembling the average for pCT as a whole.  
The ISEcp1-blaCTX-M-14-IS903 insertional feature was positioned within a pseudogene 
encoding a putative protein (pCT_083). This pseudogene had a considerably lower 
average percentage GC content (39.53%) than both the adjacent IS903 and 
surrounding upstream and downstream tra regions (53%) (Figure 3.5). It also 
appeared to be unique to pCT, as similar genes could not be found in other plasmids 
or in any bacterial chromosome sequences deposited in Genbank. A more general 
view suggests that the ISEcp1-blaCTX-M-14-IS903 element has inserted into the tra 
locus (next to traL and traK), which has been suggested to be a common region for 
genetic variation in IncIα plasmids (Leyton et al., 2003).  
  
Figure 3.5. GC % of blaCTX-M-14 gene and surrounding regions  
 
 
 
 
Arrows represent pCT coding regions blaCTX-M-14 and the surrounding ORFs, indicating the size of each coding region and  the 
direction of transcription. The GC percentage of each coding region is shown by the line graph above.  A GC content over 50% 
is represented by a point above the straight line, and GC% is represented by a point below this line.  
GC% 
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3.5.5 Replication genes 
Replication initiator gene repZ and positive regulator repY were found at the 
beginning of the sequence (pCT_001 and pCT_002). This IncI group replication 
system relies on inhibition of pseudoknot formation providing antisense RNA-
mediated inhibition, and resembles the replication system CopA/R of plasmid R100 
(Kato and Mizobuchi, 1994). The same RepY/Z system can be identified in IncIα 
plasmid ColIb-P9 (AB021078) (Asano et al., 1999) with 100% DNA homology (Table 
3.2). Also encoded in the pCT genome is the remnant of repA, an alternative 
replication initiator gene, which is annotated as a pseudogene and unlikely to be 
functional. Other pCT coding sequences (CDSs) likely to be involved in successful 
replication such as ssb (pCT_033), ardA (pCT_039) and psiB/A (pCT_036 and 
pCT_037) also have 98-99% identity to replication genes found in IncI plasmid ColIb-
P9 and R64 (AP005147); indicating the highly conserved nature of these replication 
related operons. The CDS encoding a DNA primase (pCT_082) has much less 
homology to its counterpart in plasmid ColIb-P9. Protein alignments show the 
homolog to be either SogL in associated plasmids or TraC in IncPα type plasmids. In 
related plasmids such as R64, sogL is adjacent to sogS. sogS is believed to be the 
sogL regulator involved in suppressing dnaG mutations (Merryweather et al., 1986); 
however, the R64 sogS appears to be absent in pCT. DNA primases are the only 
proteins to have been demonstrated to be transported from the donor to recipient 
cells during conjugation, and are believed to help generate RNA primers for DNA 
synthesis (Rees and Wilkins, 1989). 
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3.5.6 Stability and persistence genes 
pCT CDSs postulated to be involved in stable inheritance of the plasmid include 
yacA/B (pCT_006 and pCT_007), parB (pCT_057) and pndA (pCT_065). pCT YacA 
and YacB have homologues in the IncPβ plasmid B8 coding for a putative 
toxin/antitoxin system, however pCT seems to be missing corresponding yacC found 
in IncFII plasmids such as pHK01 (HM355591) and IncI plasmid ColIb-P9.  
The parB region of pCT encodes a ParB-„like‟ protein but the gene does not 
resemble the parB DNA sequences from R64 or ColIb-P9. A parA-like (pCT_013) 
gene was also found elsewhere on the pCT genome but likewise shares no 
homology with the R64 parA. As these genes are unlike the fully characterised R64 
par regions, and are not adjacent to one another, it is unclear whether they play a 
functional role in plasmid partitioning.   
3.5.6.1 impA/B/C UV protection or mutation repair genes 
The imp operon affords a mechanism to repair DNA damage resultant from UV 
exposure. Although the annotation and presence of an adjacent transposase 
suggests the UV protection gene cluster in pCT (pCT_014, pCT_015 and pCT_016) 
is within a transposon, this gene region is frequently found within plasmids of the 
IncIα complex. impA/B and C are in a similar formation to the arrangement detailed 
by Lodwick et al. (1990) in plasmid TP110 when the third component (impC) was first 
recognised and the protein products showed between 48% and 55% similarity to 
UmuDC and MucAB mutation repair proteins found in IncP plasmids.   
3.5.7 Transfer and conjugation genes 
pCT has two large conjugation systems encoded within the genome, the tra and pil 
operons (Figure 3.6) both controlled in part by the expression of trbABC.  
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3.5.7.1 tra operon 
The tra operon is believed to be essential for conjugation both in liquid and on a solid 
surface and encodes a thick, rigid pilus (Bradley, 1984). The tra genes found on pCT 
are separated into three regions. The first is from traY to traL where the DNA primase 
gene is found and the blaCTX-M-14 has inserted. The second is from traK to traE with an 
interruption by the shufflon and pil region (rci – pilI); the third is made up of traC and 
traB at the end of the sequence (Figure 3.6). This organisation can be found in a 
number of other IncI complex plasmids (with the exception of the inserted blaCTX-M-14 
gene). However, pCT lacks a traA-like region usually found next to traB. The 
annotation also indicates that the traG CDS is missing. On closer inspection, only 
32% of the region in pCT annotated as traH (pCT_090) shares homology to the traH 
in plasmid ColIb-P9. Although the remaining proportion of the gene has limited amino 
acid similarity to traG there are significant differences between these plasmids in this 
genetic region. The absence of traG is also found in other similar IncI complex 
plasmids such as pR3521 (GU256641).  
3.5.7.2 pil operon 
The second pCT transfer operon is the pil locus, considered a characteristic of the 
IncI plasmids (Bradley, 1984) it encodes a thin flexible pilus believed to increase 
conjugation rates in liquid. The tip of this thin pilus is variable, and believed to 
determine bacterial donor-recipient specificity (Komano et al., 1994). The exact 
nature of the expressed epitope is determined by the orientation of the reversible pilV 
shufflon components (pCT_094-pCT_098), which can be inverted by the action of the 
recombinase Rci protein (pCT_093), encoded downstream of this region. Analysis of 
the pCT plasmid assembly showed that this region is actively recombining with   
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Figure 3.6. CDS organisation of the pCT transfer genes (tra, trb and pil) 
 
   
 
 
 
 
The genomic organisation of the pCT transfer regions.  
Putative coding regions are shown as blue arrows indicating the direction of 
transcription; pseudogenes are represented with grey arrows.  
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multiple forms of this region evident within the reads used to assemble the plasmid 
sequence. Although first detailed in IncI plasmid R64, there is only moderate 
resemblance of this recombination system to the pCT shufflon. pCT shufflon 
segments A, B and C had between 66% and 79% DNA identify to parts of those 
found in R64 (Gyohda et al., 2004) but shufflon segment D (pCT_095) had no 
homology. The entire region had most DNA identity (60%) to the shufflon region of 
IncI plasmid R721 (AP002527) (Kim and Komano, 1992), which encodes an 
alternative shufflon operon, however this plasmid had little homology with the rest of 
the pCT genome (Figure 3.7). 
3.5.8 Other pCT regions 
3.5.8.1 Putative sigma factor 
The pCT CDS pCT_066 shares DNA identity with genes on five closely related 
plasmids (pO26vir; pR3521, pO113, TP113 and pSERB1) but is completely absent in 
all other plasmid sequences deposited in Genbank (As of Sept 2011). The protein 
encoded shows most identity to an RNA polymerase Sigma factor SigB, part of the 
Sigma 70 family found in a Yersinia frederiksenii (ZP_04633307). The presence of a 
sigma factor on a plasmid is unusual and may have implications for expression of 
genes on pCT or of its bacterial host.  
3.5.8.2 Other insertion sequences 
Insertion sequences surrounding the β-lactamase gene and genes encoding UV 
protection proteins were described in sections 3.3.4.1 and 3.3.6.2 however, there 
were other insertional elements found within the pCT sequence. Most prominent are 
the three CDSs which make up IS66 (pCT_025 to pCT_027), a member of the IS66 
  
Figure 3.7. DNA sequence comparison of pCT vs. R721 
  
  
Artemis Comparison Tool (Sanger, UK) was used to compare the complete DNA sequence of pCT, represented as the top 
line of the comparison, with the complete sequence of plasmid R721 (AP002527), represented as the bottom line of the 
comparison. Bands of color indicate homology between sequences. Red/Pink lines show sequence homology in the same 
confirmation; blue lines indicate sequence inversion. Green ORFs in pCT represent the pil operon (pill-pilV). 
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family which have been shown to be mobilisable on E. coli plasmid pB171 (Han et 
al., 2001). Other insertion elements include those from the IstB family, rve 
superfamily and transposase 31 super-family. However, overall, the pCT plasmid 
backbone encodes the relatively small number of seven transposable elements when 
compared to other similar large conjugative plasmids. pCT is also notably lacking 
IS26 which has been observed in a range of blaCTX-M carrying plasmids on many 
different plasmid backbones (Eckert et al., 2006). 
3.5.9 Comparisons with other plasmids within the IncI complex 
Although many of the genes discussed have been compared to homologous regions 
in other plasmids, a comparison of the whole plasmid sequence in relation to other 
IncI complex plasmids was beneficial when considering the evolutionary origin of 
pCT. Unique regions of pCT were identified for further study, and conserved regions 
within the plasmid group determined. For whole plasmid comparisons, comparison 
files of each plasmid were generated using Double ACT and then aligned using the 
Artemis comparison tool. BLASTn was also used to compare whole plasmid 
genomes and individual CDSs.  
Ten complete plasmid genomes were compared to pCT using BLASTn to calculate 
percentage identity and coverage between each pair (Table 3.3). Those plasmids 
with most homology to pCT were pO26_vir (FJ38659) (Figure 3.8), pR3521 (Figure 
3.9), pO113 (AY258503) (Figure 3.10) and the partial sequence of pSERB1 
(AY686591); none of which carry blaCTX-M genes. The greatest homology was found 
between pCT and pO26_vir. 85% of the pCT genome had identity with genes found 
on pO26_vir including the putative sigma factor, the majority of the pil locus and all 
tra genes (Table 3.2). However, pO26_vir is a large plasmid of 168,100 bp  
  
Table 3.3. pCT complete sequence homology across whole genomes of available sequenced plasmids  
 
 
Plasmid Inc type Organism Sorce 
Coverage of 
pCT 
% 
homology Accession no. 
Reference/                    
date deposited 
 
pO26-vir 
 
B 
 
E. coli 
 
Unspecified 
 
85% 
 
99% 
 
FJ386569 
 
31st March 2009 
pR3521 B E. coli Human 83% 100% GU256641 Papagiannitsis et al., 2011 
pO113 Unknown E. coli Human 82% 100% AY258503 Srimanote et al., 2002 
Leyton et al., 2003 
 
 
TP113 B E. coli Unspecified 83% 99% Not deposited Grindley et al., 1972 
R387 K Shigella flexneri 
 
Unspecified 70% 99% Not deposited Shaw et al., 1972 
pSERB1 * K E. coli Human 66% 99% AY686591 Dudley et al., 2006 
pECOED Unknown E. coli Unspecified 62% 99% CU928147 16th December 2008 
pEK204 I1α E. coli EO516 Human 60% 100% EU935740 Woodford et al., 2009 
ColIb-P9 I1α Shigella sonnei 
 
Unspecified 54% 99% AB021078 Mankovich et al., 1986 
R64 I1α S. Typhimurium Human 54% 99% AP005147 
 
Meynell and Datta, 1966   
Sampei et al., 2010 
   
*Incomplete sequence,  
  Plasmids included are those available in Genbank as of Septeber 2011.
  
Figure 3.8. DNA sequence comparison of pCT vs. pO26_vir  
 
 
 
 
Artemis Comparison Tool (Sanger, UK) was used to compare the complete DNA sequence of pCT, represented as the top 
line of the comparison, with the complete sequence of plasmid pO26_vir  (FJ386569), represented as the bottom line of 
the comparison. Bands of color indicate homology between sequences, blue lines indicate sequence inversion.  
As pO26_vir has not been fully annotated and the coding regions not fully defined, the pO26_vir stop and start codes are 
indicated instead, represented as black lines.  
  
 
Figure 3.9. DNA sequence comparison of pCT vs. pR3521 
 
  
 
 
Artemis Comparison Tool (Sanger, UK) was used to compare the complete DNA sequence of pCT, represented as the top 
line of the comparison, with the complete sequence of plasmid pR3521 (GU256641), represented as the bottom line of the 
comparison. Bands of color indicate homology between sequences. Red/Pink lines show sequence homology in the same 
confirmation; blue lines indicate sequence inversion. The pR3521 resistance cassette which encodes seven antibiotic 
resistance genes ((26,382 bp) and is absence in the pCT sequence, is indicated with a red box. 
  
 
Figure 3.10. DNA sequence comparison of pCT vs. pO113  
   
 
Artemis Comparison Tool (Sanger, UK) was used to compare the complete DNA sequence of pCT, represented as the top 
line of the comparison, with the complete sequence of plasmid pO113 (AY258503), represented as the bottom line of the 
comparison. Bands of color indicate homology between sequences. Red/Pink lines show sequence homology in the same 
confirmation; blue lines indicate sequence inversion.  
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encoding at least seven virulence genes not found in pCT. Areas of pCT absent in 
pO26_vir included the blaCTX-M-14 gene and flanking sequences, parts of the shufflon 
region and the shufflon recombinase and other insertion sequences.  
Plasmid pR3521 (110,416 bp) (Papagiannitsis et al., 2011) had less total homology 
with 83% coverage of the pCT genome at 100% similarity. Differences include the 
absence of a shufflon recombinase, where in pR3521 an unrelated hypothetical 
protein can be found downstream of pilV instead; the presence of two CDSs 
encoding putative adhesive threads (yqiJ/K) previously identified in pathogenic E. coli 
(Antao et al., 2009); and the presence of a 26,382 bp multidrug resistance region. 
This cassette appears to have inserted into an ORF which can also be found intact 
on closely related plasmid pO113, further suggesting a recent mobilisation. The MDR 
segment of pR3521 encodes seven antibiotic resistance genes sul1, strA and strB, 
aacC2, blaSCO-1 (class A beta-lactamase), blaACC-4 (Hafnia derived ESBL) and two 
copies of blaTEM-1b. 
Plasmid pO113 (165,548 bp), a very similar plasmid to pR3521, also shares key 
features with pCT including the pil locus (but the shufflon recombinase is absent), the 
putative sigma factor and many transfer genes (Figure 3.8). pSERB1 has 99% 
homology to 66% of the pCT genome, however is only deposited in Genbank as a 
partial sequence therefore the total identity with pCT cannot be assessed.  
When considering which regions of pCT are conserved among the IncI complex 
plasmids it is of benefit to compare the pCT genome to other reference plasmids 
within this group. The best characterised IncI reference plasmid is R64, a conjugative 
plasmid originally isolated from an S. Typhimurium (Table 3.3). 64% of the pCT 
genome was found to have 99% homology with the genome of plasmid R64, 
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primarily with genes involved in replication and conjugation. Although R64 has a 
functional shufflon, when compared to the shufflon and pil locus found in pCT, these 
regions have ~59% DNA homology. R64 does not encode the blaCTX-M-14 gene 
although does encode genes which confer resistance to arsenic, tetracycline and 
streptomycin, which are absent in pCT (Figure 3.11).  
ColIb-P9 (Table 3.2) is a similar plasmid to R64 and shares the same percentage 
identity to pCT. Other reference plasmids compared included those used by the 
Sanger Institute as examples of different incompatibility types. R387 is the IncK 
reference plasmid (Figure 3.12) and while many regions of R387 share high 
percentage identity to pCT, such as the pil and tra loci, many regions of pCT are 
completely absent in R387, including the shufflon region, UV protection locus and the 
sigma factor. TP113 is the Sanger reference plasmid for the IncB group of plasmids 
(this group is also part of the larger IncI complex) and when this plasmid was 
compared to pCT (Figure 3.13) there was more sequence identity between pCT and 
TP113 than between pCT and R387. Those regions in pCT absent in TP113 are the 
blaCTX-M-14 gene, the shufflon region and recombinase and other insertion sequences.  
3.5.10 Comparisons of pCT with other blaCTX-M encoding plasmids 
Within the literature certain blaCTX-M gene variants have been considered to be 
associated with „epidemic‟ plasmids or particular plasmid incompatibility groups 
(Baudry et al., 2009). blaCTX-M-15 is currently the most frequently detected blaCTX-M 
worldwide and is most commonly found on IncFII plasmids. Similarly, both blaCTX-M-9 
and blaCTX-M-32 are suggested to be carried on epidemic plasmids (Cantón and 
Coque, 2006). To identify any common features which may be related to the 
evolutionary success of these plasmids or the acquisition of the blaCTX-M resistance
  
Figure 3.11. DNA sequence comparison of pCT vs. R64  
 
 
 
 
 
Artemis Comparison Tool (Sanger, UK) was used to compare the complete DNA sequence of pCT, represented as the top line 
of the comparison, with the complete sequence of plasmid R64 (AP005147), represented as the bottom line of the comparison. 
Bands of color indicate homology between sequences. Red/Pink lines show sequence homology in the same confirmation; 
blue lines indicate sequence inversion.  
  
Figure 3.12. DNA sequence comparison of pCT vs. R387 
 
 
  
 
 
Artemis Comparison Tool (Sanger, UK) was used to compare the complete DNA sequence of pCT, represented as the top 
line of the comparison, with the complete sequence of plasmid R387 (Shaw et al., 1972), represented as the bottom line of 
the comparison. Bands of color indicate homology between sequences. Red/Pink lines show sequence homology in the 
same confirmation; blue lines indicate sequence inversion.  
  
Figure 3.13. DNA sequence comparison of pCT vs. TP113  
Artemis Comparison Tool (Sanger, UK) was used to compare the complete DNA sequence of pCT, represented as the top 
line of the comparison, with the complete sequence of plasmid TP133 (Grindley et al., 1972), represented as the bottom 
line of the comparison. Bands of color indicate homology between sequences. Red/Pink lines show sequence homology in 
the same confirmation; blue lines indicate sequence inversion.  
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genes, the sequence of pCT was compared to other blaCTX-M carrying plasmids. 
Complete sequences deposited in Genbank of plasmids carrying blaCTX-M genes were 
acquired and compared with pCT using ACT (Figure 3.14). Those plasmids with 
different replication mechanisms such as IncFII plasmids described by Woodford et 
al., (2009) or IncN plasmid pKP96 (Shen et al., 2008) have almost no DNA homology 
to pCT outside the blaCTX-M (Figure 3.14). The only other blaCTX-M carrying IncI 
complex plasmid to be sequenced and deposited in Genbank thus far is a blaCTX-M-3 
carrying IncI plasmid pEK204 (EU935740). pEK204 shares homology to 
approximately 60% of the pCT genome (Figure 3.15, Table 3.3); most of which is 
over IncI related core genes for replication or transfer. Further similarities between 
pEK204 and pCT were the minimal carriage of resistance genes (blaCTX-M-3 and 
blaTEM-1) and the presence of the shufflon/pil operon in both plasmids. In pEK204 the 
shufflon region appears to have been disrupted by insertion sequences IS66 (also 
found within the pCT genome in a different location); therefore it is postulated to be 
non-functional in pEK204. As of Sept 2011, three other complete plasmid sequences 
which encode blaCTX-M-14 had been deposited in Genbank; all belonged to the 
incompatibility group IncFII. pCT and pHK01 (70262 bp; HM355591) (Ho et al., 2011) 
shared very little in common with ~18% similarity in a few regulatory genes such as 
psiB and ssb. The same is true of pKF3-70 (70,057bp, FJ494913.1) (Yi et al., 2010) 
and pTN48 (165,657 bp, FQ482074) (Billard-Pomares et al., 2011), a much larger 
plasmid than pCT which carries numerous antibiotic resistance genes, virulence 
genes and multiple addiction systems. All three plasmids also carried the blaCTX-M-14 
related insertion sequences ISEcp1 and IS903 as in pCT, however, did not have 
adjacent ORFs similar to pCT (e.g. traK, and the pCT pseudogene). 
  
Figure 3.14. DNA sequence comparisons of pCT vs. other blaCTX-M carrying plasmids  
  
 
 
 
 
 
 
Artemis Comparison Tool (Sanger, UK) was used to compare the complete DNA sequence of pCT, represented as the top line of the 
comparison, with the complete sequence of plasmid C15-1a (NC_005327), pCTX-M-3 (AF550415), pKP96 (EU195449) and pIP843 
(AY033516), represented as the bottom line of the comparison. Bands of color indicate homology between sequences. Red/Pink lines 
show sequence homology in the same confirmation; blue lines indicate sequence inversion.  
  
Figure 3.15. DNA sequence comparison of pCT vs. pEK204  
   
 
  
Artemis Comparison Tool (Sanger, UK) was used to compare the complete DNA sequence of pCT, represented as the top 
line of the comparison, with the complete sequence of plasmid pEK204 (EU935740), represented as the bottom line of the 
comparison. Bands of color indicate homology between sequences. Red/Pink lines show sequence homology in the same 
confirmation; blue lines indicate sequence inversion. bla genes on both plasmids are connected by the blue line indicating 
an inversion of this gene. 
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3.6 New diagnostic tool to detect plasmid pCT-like plasmids  
3.6.1 Design of a specific PCR assay for detection of the pCT backbone 
The completion of the pCT sequence annotation and subsequent comparison of the 
pCT genome to other IncI sequenced plasmids allowed insight into which pCT 
genomic regions are conserved and common, and those which were less well 
characterised or unique. Five genes in addition to the blaCTX-M-14 were chosen to form 
the basis of the PCR assay, these included the combination of universal IncI genes 
and more unusual sequences, encoded in different locations on the plasmid. blaCTX-M-
14 was chosen as a positive control, as it was the spread of this gene which was of 
primary interest (primer no. 819/820). The relaxase gene nikB (pCT_052) was 
selected as a universal coding region for amplification, as work described by Francia 
et al. (2004), and Garcillan-Barcia et al. (2009) showed conservation of this gene 
between IncI group plasmids, thus allowing detection of all IncI plasmids using one 
set of primers. Despite an available sequence for primers designed to nikB, 
alignments with pCT and other nikB sequences suggested a better pairing elsewhere 
within the sequence. Therefore these alternative primers were used in this study 
(Table 2.6, primer no. 979/980). The shufflon recombinase gene (rci) (pCT_093) was 
selected for amplification as this gene is only found in plasmids which encode a pil 
locus and corresponding shufflon region, further discriminating between the IncI 
plasmids (primers no. 875/876). The genes encoding the putative sigma factor 
(pCT_066) and pilN (pCT_108) were chosen as they were only found in a few closely 
related plasmids to pCT such as p026_vir but are absent in most other characterised 
IncI and IncK type plasmids (primers no. 868/869 and 916/917). The last region 
chosen for amplification was a unique intergenic region not seen in any other plasmid 
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between CDSs encoding a putative membrane protein and putative serine 
acetlyltransferase (pCT_008-pCT_009)(primer no. 983/984). Sequences were also 
selected to ensure a distribution of target regions for amplification around the pCT 
genome. 
All five PCR assays were initially optimised independently for the annealing 
temperatures and extension times using pCT DNA isolated from DH5α pCT (I755) as 
a template. Once optimised, PCR assays were combined to establish which assays 
could be carried out as a multiplex in the same reaction. Successful amplification of 
the sigma factor gene, pilN, and rci was achieved at an annealing temperature of 
530C in one reaction. As both blaCTX-M group 9 and nikB gene PCR amplimers were 
used for DNA sequencing, these PCR assays remained as monoplexes. The PCR 
assay to amplify pCT008-pCT009 also remained as a monoplex as this region could 
not be amplified when placed with any other reactions. However, the successful 
combination of three PCRs reduced the detection of pCT-like plasmids to four simple 
reactions including the positive control.  
3.6.2 blaCTX-M-14 and flanking regions 
To establish whether the insertion site of ISEcp1-blaCTX-M-14-IS903 was conserved in 
other plasmids, two PCR assays were designed to each end of this insertion element 
(Figure 2.1). Primers were designed to amplify regions from ISEcp1 to external gene 
traK (pCT_087) and from blaCTX-M-14 to the adjacent pseudogene (pCT_083) and 
reactions optimised using pCT DNA from a bacterial lysate.  
A pCT-like plasmid was defined as a plasmid from which an amplimer of the 
expected size was generated in all of the six PCR reactions and shared the same 
blaCTX-M-14 insertion site. 
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3.6.3 Validation of the PCR assay to detect pCT-like plasmids 
In order to validate the PCR assay for the detection of pCT-like plasmids, the assay 
was tested on fifteen lysates made from CTX-M-14 producing E. coli isolates, 
collected from healthy cattle on ten farms distributed across England and Wales 
(Table 2.3, I779-I793), and obtained from collaborators at the Veterinary laboratories 
Agency (VLA). Plasmids within each isolate had been previously characterised for 
incompatibility type, however this data was kept from the investigator at the time of 
testing to prevent bias. Each of the fifteen lysates yielded an amplimer in the control 
PCR for blaCTX-M-14, checked by sequencing to ensure the blaCTX-M type (Figure 3.16A), 
8/15 encoded a nikB sequence (Figure 3.16B) and 4/15 produced an rci amplimer 
(Figure 3.14C). Two isolates (I779 and I780) yielded amplimers for all PCR assays 
therefore, were deemed pCT-like (Figure 3.17). These results were subsequently 
found to be consistent with the Inc type of each plasmid.  
Other isolates which contained IncI type plasmids gave amplimers for nikB and/or rci 
but not the more specific PCRs. The IncFII plasmid from isolate I784 did not yield an 
amplimer for any assay except for blaCTX-M-14, demonstrating the specificity of this 
screening tool (Table 3.4). Of those isolates identified as carrying pCT plasmids, the 
first (I779) was later revealed to be from the same farm in North West Wales that E. 
coli C159/11 and pCT originated, but two years later in 2006 and in a different E. coli 
host sequence type. The second (I780) was isolated in Lancashire in 2008 from a 
farm with no direct known link to the Welsh farm, indicating the spread of this plasmid 
in bacteria from both Welsh and English cattle.   
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Figure 3.16. PCR detection of pCT-like plasmids in veterinary isolates 
 
PCR assays used DNA lysates of E. coli DH5α pCT as a positive control, 1-15, CTX-
M-14 producing E. coli isolates collected from cattle around England and Wales 
(I779-I793) and E. coli DH5α as a negative control (-ve).  
The PCR reactions were as follows:  
A, Detection of group 9 blaCTX-M genes;  
B, Detection of IncI group relaxase gene nikB;  
C , Detection of IncI gene rci shufflon recombinase, the pCT putative sigma factor 
and pil locus secretin pilN ; 
D,  Detection of the pCT specific region pCT008-009 . 
DNA amplimers were visualised using electrophoresis on a 1% agarose gel. 
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Figure 3.17. Amplification of the blaCTX-M-14 insertion region traK to ISEcp1 and 
blaCTX-M-14 to the adjacent pseudogene 
 
 
 
Feature Description 
 
HL1 
 
Hyperladder 1 (Bioline) 
A blaCTX-M-14 to the adjacent pseudogene (1636 bp) 
B ISEcp1 to traK (1037 bp) 
pCT pCT plasmid DNA from a DH5α pCT  
I779 Plasmid DNA from veterinary E. coli isolate I779  
I780 Plasmid DNA from veterinary E. coli isolate I780  
 
PCR used DNA lysates of all positive control E. coli DH5α pCT and test isolates E. 
coli I779 and E. coli I780. A lysates of E. coli DH5α was used as a negative control.  
DNA amplimers were visualised using electrophoresis on a 1% agarose gel   
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Table 3.4. Summary of PCR assays for the detection of pCT-like plasmids 
  Amplimers generated from PCR assays 
Strain/ 
Plasmid 
Inc 
type 
blaCTX-M-14 nikB rci pilN 
Sigma 
Factor 
pCT008 
-pCT009 
traK-ISEcp1 
bla-pseudogene 
pCT K        
I779 K/F        
I780 K/F        
I781 FIA   x x x x x 
I782 F   x x x x x 
I783 -   x x x x x 
I784 -    x x x x 
I785 -  x x x x x x 
I786 I1γ   x x x x x 
I787 -   x x x x x 
I788 -   x x x x x 
I789 -    x x x x 
I790 -   x x x x x 
I791 F   x x x x x 
I792 F   x x x x x 
I793 F   x x x x x 
L125 -  x x x x x x 
386 FII  x x x x x x 
400 FII  x x x x x x 
C574 K        
C559 K        
C567 K        
pRYC105 K        
pRYC110 HI2  x x x x x x 
pOZ174 -        
JIE 052 B        
JIE 081 FII  x x x x x x 
JIE 084 FII  x x x x x x 
JIE 088 I1   x x x x x 
JIE 182 B        
JIE 201 K        
Ticks represent a PCR assay yielding the expected sized amplimer. Shaded rows show 
isolates which have yielded amplimers in all PCR assays, indicating the presence of a pCT-
like plasmid. Dashes, unknown Inc type.  
 122 
 
3.7 pCT global epidemiology 
Previously published CTX-M-14 producing clinical isolates of E. coli were requested 
from twenty research groups globally (Table 2.3). On receipt of each isolate received, 
strains were cultured on LB agar containing 8 µg/ml of cefotaxime, checked for the 
presence of a blaCTX-M-14 using PCR and sequencing, and confirmed to be an E. coli 
by Gram stain, API and culture on XLD agar. Fifteen CTX-M-14 producing E. coli 
clinical isolates from England, Germany (Cullik et al., 2010), Spain (Vinue et al., 
2008; Valverde et al., 2009), Australia (Zong et al., 2008) and China (Chanawong et 
al., 2002) were acquired and examined for the presence of pCT using PCR assays. 
PCR did not detect pCT-like plasmids in isolates from England or Germany. 
However, 4/5 clinical isolates from Spain (C559;C567;C574;FEC383), 3/6 isolates 
from Australia (JIE052; JIE182; JIE201) and the isolate from China (E. coli 8-CH13) 
contained pCT-like plasmids; amplifying the expected sized fragment in each of the 
PCR assays (Table 3.4). Each of the eight pCT-like plasmids also had identical 
blaCTX-M-14 insertion regions (blaCTX-M-14 to the pseudogene and ISEcp1 to traK).  
3.7.1 Phylogenetic analysis using nikB sequences  
Amplicons generated by PCR amplification of nikB revealed all ten of the pCT-like 
plasmids had nikB sequences with >98% DNA identity to pCT. These sequences, 
along with other IncI nikB sequences collected from Genbank were used to construct 
a nikB phylogenetic tree. pCT-like plasmids were found to cluster together with pCT 
regardless of origin, while the non-pCT-like plasmids clustered further away (Figure 
3.18).  
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Figure 3.18. Relaxase phylogenetic typing 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Phylogenetic analysis of nikB in IncI complex plasmids. DNA sequences of nikB PCR 
amplicons and sequences obtained from public resources were aligned and analysed using 
MEGA 4.0. A neighbor-joining tree was constructed using the maximum composite likelihood 
method and was linearised. Circles, nikB sequences from plasmids isolated from E. coli 
veterinary isolates from the United Kingdom; triangles, nikB sequences of plasmids from E. 
coli isolated from humans; squares, nikB sequences of plasmids obtained from 
GenBank/Sanger Institute; shaded shapes, plasmids identified as pCT-like by using PCR in 
this study; asterisks, plasmids encoding blaCTX-M-14. The scale bar indicates nucleotide 
substitutions per site.  
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3.7.2 Further characterisation of the pCT-like plasmids 
In order to further compare the ten identified pCT-like plasmids to pCT, each was 
extracted from the original E. coli host and transformed into E. coli DH5α electro-
competent cells by selecting on agar containing 8 µg/ml of cefotaxime (Appendix 2). 
All ten pCT-like plasmids conferred resistance to β-lactams only, and were not found 
to confer resistance to ciprofloxacin, kanamycin, gentamicin, erythromycin, 
tetracycline, chloramphenicol or faropenem (Table 3.5). This suggests that these 
plasmids do not encode any other commonly plasmid mediated resistance genes 
(other than blaCTX-M-14) and that, as in pCT, blaCTX-M-14 is likely to be the only antibiotic 
resistance gene encoded. All pCT-like plasmids were also able to conjugate from 
donor DH5α to recipient DH5α rifR (Table 3.5).  
3.8 Discussion 
Plasmid pCT isolated from veterinary E. coli strain C159/11 was successfully 
transformed into E. coli DH5α and transferred to E. coli J53-2, E. coli 3950 (C159/11 
pCT cured strain) and S. Typhimurium SL1344 rifR by conjugation. The only antibiotic 
resistance phenotype found to be transferrable by both transformation and 
conjugation of pCT was resistance to β-lactam antibiotics. This indicates that genes 
responsible for C159/11 resistance to the other classes of antibiotic are either 
chromosomally encoded or carried on other plasmids, and that blaCTX-M-14 was likely 
to be the only resistance gene carried on plasmid pCT. This was confirmed by 
sequencing of the pCT genome, however contradicts the previous publication on this 
plasmid which suggested that pCT also encoded a streptomycin resistance gene. A 
lack of prior knowledge of the S. Typhimurium strain used as a recipient for 
conjugation by Liebana et al. (2006) is likely to have led to this error.  
  
Table 3.5. Further characterisation of pCT-like plasmids, the ability to conjugate and transferable resistance profiles  
 
Lab code Plasmid Conjugation
α 
Minimum Inhibitory Concentration (µg/ml) 
CTX AMP CIP KAN GEN ERY TET CHL FAR 
            
I825 Host strain E. coli DH5α 0.03 2 0.0015 0.5 0.12 32 1 1 0.25 
            
I755 pCT  16 256 0.0015 0.5 0.12 32 1 1 0.5 
I779 pI779  16 256 0.0015 0.5 0.12 32 1 1 0.5 
I780 pI780  8 256 0.0015 0.5 0.12 32 1 1 0.5 
I801 pC559  8 256 0.0015 0.5 0.12 32 1 1 0.5 
I802 pC567  16 256 0.0015 0.5 0.12 32 1 1 0.5 
I803 pC574  16 256 0.0015 0.5 0.12 32 1 1 0.25 
I853 pRYC105  32 256 0.0015 0.5 0.12 32 1 1 0.25 
I832 pOZ174  16 256 0.0015 0.5 0.12 32 1 1 0.25 
I849 pJIE052  8 256 0.0015 0.5 0.12 32 1 1 0.25 
I850 pJIE201  8 256 0.0015 0.5 0.12 32 1 1 0.25 
I865 pJIE182  8 256 0.0015 0.5 0.12 32 1 1 0.25 
CTX, cefotaxime; AMP, ampicillin; CIP, ciprofloxacin; KAN, kanamycin; GEN, gentamicin; ERY, erythromycin, TET, tetracycline; CHL, 
chloramphenicol; FAR, faropenem. Bold type MIC data, resistance conferred by the plasmid. α, from E. coli DH5α to E. coli DH5α rifR.
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Through complete sequencing, pCT was shown to be a 93,629 bp plasmid, 
harbouring 115 putative open reading frames. Replication genes identified within the 
sequence agreed with the previous assessment detailed by Liebana et al., (2006) 
that pCT is an IncK plasmid within the IncI complex group. The plasmid backbone 
itself may at first glance be regarded as unremarkable as no known virulence genes 
were identified and no additional antimicrobial resistance genes detected. The 
majority of the putative coding CDSs were as typical for this class of plasmid 
backbone. The UV protection operon, while possibly located within a transposon, is 
found on a variety of IncI plasmids and has probably been situated on these plasmids 
for some time. Similarly, the entire tra locus appeared to be conserved within this 
group of plasmids with minimal differences in ORFs found on pCT when compared to 
reference plasmids (Table 3.1).  
The pil locus and shufflon region are also characteristic for the IncI group (Bradley, 
1980), however on closer inspection this region on pCT shares only moderate 
identity to the corresponding locus on reference plasmid R64, where the pil locus and 
corresponding shufflon was first detailed (Komano et al., 2000). The uncharacterised 
shufflon second segment has no known homologue, and segment D can only be 
identified in the alternative shufflon of R721 to which pCT‟s shufflon has most 
homology. From the sequence analysis all components of the pCT shufflon region 
are intact and a complete recombinase is present. From the analysis of the plasmid 
assembly data the pCT shufflon region was found to be present in multiple forms, 
consistent with site-specific recombination mediated by the pCT shufflon Rci 
recombinase. This shows that the shufflon region and pil locus are actively varying at 
a level that can be easily detected within a single bacterial culture, indicating that the 
 127 
 
shufflon region of the pil locus is functional. This differs from all other closely related 
plasmids (pO113, pO26_vir, pR3521 and pSERB1) as each of these appears to have 
an inactive shufflon either due to an absent recombinase or an insertion, suggesting 
that the pCT shufflon is more unique than first thought. Much discussion over the role 
of this type IV pilus and its shufflon is documented in the literature. Data from Bradley 
et al. (1984) indicated that the thin pilus anchored donor and recipient cells aiding 
conjugation in liquid media. However the study of pSERB1 by Dudley et al. (2006) 
showed the type IV pilus system increased adhesion of the host bacterium to 
surfaces and eukaryotic epithelial cells in vitro, and allowed more robust biofilm 
formation. As E. coli isolate C159/11 was originally found to persist within the slurry 
and the floor of the cow sheds during the longitudinal farm study of which it was 
identified (Teale et al., 2005) these aspects of the type IV pilus may have contributed 
to the persistence of pCT within the farm environment. The absence of the shufflon 
recombinase and pilV components in pO26_vir, pR3521 and pO113 may suggest 
that the thin pilus encoded on these plasmids may not have the ability to determine 
host mating specificity using pilV conformational genomic changes, which may have 
implications for the dissemination of these plasmids both in liquid media, or through 
mixed species populations when compared to pCT. 
There was an absence of any integrons carried on pCT and only a small number of 
insertion sequences/transposases were identified, unusual for a plasmid of this size. 
This correlates with the single encoded antibiotic resistance gene, and may suggest 
the pCT backbone is unfavourable to recombination events or is a potential ancestral 
backbone rather than a mosaic plasmid, as is believed for plasmid pBP136 
(Accession no. AB237782) (Kamachi et al., 2006). From the current sequence data 
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available, it appears that IncI complex plasmids undergo less recombination and 
insertions than some of the other plasmid groups such as IncFII (Iredell et al., 2011). 
This may be associated with the bacterial hosts in which these plasmids reside, 
transfer between bacterial hosts (Lawrence et al., 1992), or with currently 
undiscovered plasmid or integron genes or regulators which may influence the 
frequency of recombination. Similarly, it appeared from the initial annotation that pCT 
lacked any large post segregational killing genes or addiction operons such as 
parA/B or kor/mck found in R64. However, on later re-annotation and further close 
investigation, a putative toxin-antitoxin CDS, pndA (pCT_065), was revealed as a 
possible toxin but seemed to lack annotation of a regulator (pndC) or antisense 
antitoxin (pndB). Alignments of the toxin-antitoxin systems found in plasmid pO113 
and R64 revealed that the pnd system is encoded on pCT in its entirety. Therefore, is 
potentially a fully functional post segregational killing system; thus providing a 
candidate locus which may contribute to the successful persistence of pCT. 
Using comparative genomic analysis, regions of pCT with little homology to reference 
plasmids were also identified. Most notably the putative sigma factor (pCT_066) can 
only be found in the five other very closely related plasmids and has only limited 
identity to its homolog SigB in Yersinia frederiksenii. Other weak protein matches 
show some homology to the extra cytoplasmic function (ECF) sigma factors which 
are small regulatory proteins divergent in sequence to most of the other sigma 
factors involved in global regulation of transcription. It is also similar to the 
Bacteroides thetaiotamicron VP1-5482 ECF putative RNA polymerase (AE015928). 
Both examples are chromosomally encoded. Although sigma factors of this group 
have previously been noted on plasmids, there are few publications on their role or 
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function. A possible regulatory role, potentially controlling transcription of plasmid or 
bacterial host chromosomal genes makes this CDS particularly interesting. The rarity 
of pCT_066 within currently available sequenced plasmids also allowed this element 
to lend itself to the rapid identification of plasmids closely related to pCT in 
conjunction with other ORFs. The putative serine-O-aceyltransferase gene 
(pCT_009) also had no homology with any of the other plasmids examined and may 
be involved in breakdown of serine within host cells. 
When comparing the genome of pCT to other blaCTX-M encoding plasmids, a lack of 
any conserved regions outside the antibiotic resistance gene were found. Therefore, 
it is unlikely that any one genomic factor contributes to the spread of blaCTX-M genes 
on epidemic plasmids or that any one particular genetic factor encoded within these 
plasmids led to the acquisition of blaCTX-M genes from their origin. This correlates with 
the widely believed hypothesis that multiple acquisitions of blaCTX-M genes onto 
various different plasmids took place. The pCT site at which ISEcp1-blaCTX-M-14-IS903 
has inserted is an unusual pseudogene. This hypothetical protein cannot be found in 
any of the other reference plasmids or similar plasmids such as pO26_vir, pR3521 or 
pO113, or from any bacterial chromosomes deposited in Genbank. However, in all 
the pCT-like plasmids identified, the blaCTX-M-14 cassette appears to have inserted into 
this pseudogene as in pCT. The pseudogene has a considerably lower G+C content 
than the downstream insertion sequence IS903 and to the surrounding IncI plasmid 
„backbone‟ genes sogL and tra genes (Figure 3.4) perhaps indicating a divergent 
origin of this pseudogene to the plasmid „core‟ genome. Its location upstream of the 
ISEcp1 transposase, believed to be responsible for mobilisation of blaCTX-M-14 
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(Nordmann et al., 2008), would suggest that this gene was not mobilised with blaCTX-
M-14. Therefore, its residence on pCT is likely to pre-date that of blaCTX-M-14.  
A high degree of homology was found between pCT and four plasmids deposited in 
Genbank. Relatively little is known about pO26_vir other than it‟s identification in a 
shiga toxin producing E. coli strain 026:HII and the presence of an abundance of 
virulence genes, including genes for the production of a hydrolase, catalase, and a 
haemolysin transport protein in addition to the homology found within pCT. More is 
known about plasmid pO113, which was isolated from another haemolysin producing 
EHEC 0113:H21 E. coli isolate from a patient in Australia (Srimanote et al., 2002; 
Leyton et al., 2003) and plasmid pR3521 identified in an E. coli isolate from a patient 
in Greece. pR3521 encodes potential virulence genes ygiJ and ygiK which encode 
putative adhesive threads, and a large repertoire of resistance genes, found within a 
cassette situated next to the plasmid transfer operon. Papagiannitsis et al. (2011) 
hypothesised various mechanisms for how this cassette was composed over time, 
showing that a large resistance cassette is easily constructed on this type of plasmid 
backbone. While this suggest that plasmid pCT may be able to acquire any number 
of antibiotic resistance genes such as on pR3521, the question of why pCT has only 
acquired or stably integrated one antibiotic resistance gene becomes even more 
prominent. The presence of virulence genes on closely related plasmids also allows 
the potential for homologous recombination between pCT and these plasmids 
creating mobile elements carrying both virulence genes and the blaCTX-M-14 resistance 
gene. 
pCT was found to have most homology with IncB plasmids pO26_vir, pR3251 and 
TP113 and two of the pCT-like plasmids identified from Australia were also found to 
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be from the IncB group rather than IncK. Although IncK and IncB plasmids are very 
closely related (sharing 94% similarity over the genomic replication regions) they are 
still compatible within the same cell (Praszkier et al., 1991). Both types of plasmid 
encode an antisense RNA mediated inhibition system used to control replication and 
copy number; where the RNAi prevents formation of a long distance RNA 
pseudoknot required for the ribosome binding to repZ. In the case of IncK, the RNAi 
sequesters the repY (leader peptide) ribosomal binding site therefore blocking its 
translation. A lack of RepY prevents activation and translation of repZ, resulting in the 
prevention of pseudoknot formation and subsequent replication of the plasmid. 
Differences between IncK and IncB are found most importantly in stable stem and 
loop structures (Figure 3.19) as a similar loop (as found between IncZ and IncI1) 
would allow crosstalk and interference in copy number control of each plasmid.  
When examining the DNA sequences for the loop region of pCT (IncK) and IncB 
plasmid pR3521, both correspond with the reference sequences provided by 
Praszkier et al., (1991) (Figure 3.19), suggesting that these closely related plasmids 
can be very similar at a genetic level (e.g. 83% homologous), yet have differing 
replication systems due to SNPs in the stem-loop region. This finding also suggests 
that pCT-like plasmids found in Australian E. coli isolates JIE182 and JIE052 are 
likely to be a pCT backbone with a differing IncB replicon. The most likely explanation 
for this difference, is a homologous recombination event with another plasmid which 
has allowed the replacement of one replicon for another (e.g. IncK-IncB or vice 
versa). Current sequence data may suggest that the pCT backbone has changed 
from an IncB to an IncK before disseminating in its current form, as most of the 
known homologous plasmids are of an IncB type and pCT shows considerably  
  
Figure 3.19. Comparison of pCT (IncK) and pR3521 (IncB) antisense loop sequence and structure 
 
 
 
 
 
 
 
 
 
 
A) Alignment of the DNA sequence of the stem-loop 
predicted to encode the RNAi molecules of pCT 
with IncK reference sequence and pR3521 with 
IncB reference sequence. 
Stars indicate sequence homology. 
 
B) Sequences of the stem-loop structures predicted 
for RNAi molecular of IncB and IncK plasmids. 
Taken from Praszkier et al. (1991). 
B
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less similarity to IncK plasmid R387. A current lack of other IncK plasmid sequences 
prevents further investigation of this hypothesis. An incompatibility type switch of this 
nature would allow co-habitation within a bacterial cell with a plasmid of its original 
Inc group, or may cause a change in copy number of the plasmid, which in certain 
environments may be beneficial. Another hypothesis is that pCT-like plasmids 
predate the evolutionary divergence of IncK and IncB plasmids, or that mutation from 
one stem loop sequence to another has occurred over time. This explanation seems 
unlikely as nine SNPs exist throughout the loop sequence. The idea that replicons 
associated with particular backbones may be interchangeable corresponds with the 
presence of multiple replicons on a number of sequence plasmids, indicating that it 
may be beneficial for a plasmid to be able to switch replication and copy number 
control. It is clear that incompatibility type alone is not sufficient to distinguish 
between plasmid, to ascertain any evolutionary relationships (Hawkey and Jones, 
2009) or to inform about the plasmid backbone. At worst, replicon typing may be 
misleading, as the exclusion of plasmids with dissimilar Inc types may miss similar 
backbones within a screen, as demonstrated in this study with IncB pCT-like 
plasmids.  
The complete sequencing of pCT allowed the development of PCR assays designed 
to amplify genes distributed around the genome. Reactions to amplify nikB, pilN and 
the shufflon recombinase (rci) were successfully combined creating an efficient and 
rapid multiplex for high throughput screening of other CTX-M-14 producing isolates 
for identification of other pCT-like plasmids which share these loci. Initially pCT-like 
plasmids were identified in bacteria isolated in 2006 from the index farm and from a 
farm in Lancaster in 2008. More recently this series of six PCR assays have been 
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used to identify a further five pCT-like plasmids from E. coli isolated from cattle, nine 
from turkeys, and seven clinical E. coli isolates from patients in England and Wales 
(Coldham et al., 2011; Stokes et al., 2011). In my study, 4/5 clinical isolates collected 
from Spanish hospitals also carried pCT-like plasmids with the identical blaCTX-M-14 
insertion location (Figure 3.20). Since 2000, when CTX-M-14 was first identified in 
bacteria from Spain, it has rapidly become one of the most commonly detected β-
lactamase enzymes in Spanish human and veterinary E. coli isolates (Navarro et al., 
2007; Blanc et al., 2008). A previous study conducted in Spanish hospitals suggested 
an association between blaCTX-M-14 and IncK plasmids. Valverde et al., (2009) isolated 
an IncK plasmid, later named pRYC105 (from strain FEC383) from at least twenty-
five E. coli lineages. Isolates were predominantly collected from community acquired 
infections such as urinary tract infections, and from the environment in different 
geographical regions across Spain. These authors hypothesised that pRYC105 
shared identity with the plasmid isolated in the UK by Liebana et al., (pCT). My study 
has shown this hypothesis to be correct as pRYC105 was pCT-like by PCR and nikB 
sequencing. Human isolate E. coli (8) CH13 isolated in 1998 from China, contained 
plasmid pOZ174 which encodes the first described blaCTX-M-14 (Chanawong et al., 
2002). pOZ174 was also shown to be pCT-like with an identical blaCTX-M-14 insertional 
region, suggesting that pCT has existed in its current form since at least 1998. As 
China and Spain are locations where CTX-M-14 is the most frequently identified 
ESBL, further investigation using this molecular test will determine whether pCT is 
the dominant vector of blaCTX-M-14 in these areas, and whether pCT has disseminated 
to other ecosystems or bacterial species.  
  
Figure 3.20. Summary map of the epidemiology of pCT-like plasmid identified from E. coli isolates (as of Sept 2011) 
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From the small sample of veterinary isolates we assembled from the UK (fifteen 
isolates), it is clear that pCT is not the predominant blaCTX-M-14 vector as many other 
Inc type plasmids were found to carry this gene. However all blaCTX-M-14 carrying IncK 
plasmids tested to date have been shown to be pCT-like, indicating that pCT is the 
dominant IncK vector of blaCTX-M-14. Both IncB plasmids tested were also shown to be 
pCT-like. The identical insertion site for blaCTX-M-14 in each of the investigated pCT-like 
plasmids strongly suggests a single capture of this β-lactamase gene onto the 
backbone and subsequent spread of the plasmid. Alternatively, this pseudogene may 
provide a „hot spot‟ for ISEcp1 insertion, promoting this insertional event, or is 
mobilisable with the blaCTX-M-14 cassette.  
The alignment and analysis of nikB from IncI plasmids was a useful tool to determine 
the similarity between this plasmid group. It also provided a rapid method for 
identifying closely related plasmids by a single PCR and DNA sequencing. pCT-like 
plasmids all demonstrated nikB sequence identity of >98% and clustered together 
with pCT within a phylogenetic tree. Plasmids identified from whole genome 
comparisons as similar to pCT (pO26_vir, pR3521 and pSERB1) also clustered more 
closely than the other IncI plasmids. It would appear for this plasmid, a similar nikB 
sequence is a good predictor of whole plasmid homology. Relaxase or nikB typing 
would also provide a suitable locus in recently developed plasmid MLST (pMLST) 
characterisation, currently not developed for IncK plasmids.  
In conclusion, the complete sequence of pCT allowed an understanding of its 
backbone and facilitated the identification of genes of interest for further study. The 
sequence revealed the presence of a single antibiotic resistance gene indicating that 
the success of pCT cannot be attributed to co-selection in the presence of other  
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antibiotic classes. The sequence analysis also highlighted candidate genes which 
may contribute to the successful persistence and/or spread of pCT. Subsequent PCR 
assays successfully showed that pCT-like plasmids are spread globally in bacteria 
isolated from humans, animals and the environment.  
3.9 Further work 
At the beginning of this study in October 2008, a major limiting factor was the amount 
of plasmid sequence data, particularly annotated data available for comparison to 
pCT. As the study progressed other complete plasmid sequences were deposited in 
online databases providing an ever growing data source. As more plasmids are 
sequenced the future integration of new plasmid sequence data into the pCT analysis 
may elucidate answers to questions raised within my work. For instance, further 
sequencing of a range of IncK and IncB plasmids would reveal whether pCT is a 
typical IncK plasmid or whether it relates better to other IncB plasmids as suggested 
in this work. Whether regions identified for the PCR assays on pCT are truly unique 
or simply unusual would also be elucidated.  
The hypothesis that plasmids can change incompatibility type could be explored 
further by replacing the pCT repZ/Y region with an IncB stem loop DNA region and 
investigating the changes to plasmid replication. Investigation of whether this change 
influences copy number could also be more simply examined, initially by comparing 
the copy number of pCT-like IncB Australian plasmids (pJIE182 and pJIE052) to that 
of pCT and the other IncK pCT-like plasmids. 
The PCR assay designed in this study to identify pCT-like plasmids could be used in 
a range of environments to establish the true distribution of pCT, as only a small 
sample was examined here. The PCR assay could be used to interrogate samples 
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for example from the environment, for the prevalence of pCT-like plasmids which do 
not carry blaCTX-M-14, as currently only CTX-M-14 producing E. coli have been 
examined. The distribution of pCT without blaCTX-M-14 would give further clues to the 
evolutionary past of this plasmid, and the potential contribution of the antibiotic 
resistance gene in the spread of pCT. The PCR assay could also be used to in 
combination with primers designed to other common antibiotic resistance or virulence 
genes to reveal whether pCT is able to incorporate large antibiotic resistance 
cassettes as in pR3521.  
Whether the blaCTX-M-14 insertion element is now stably incorporated on pCT, or 
whether it is still mobilisable under certain circumstances could be investigated by 
the addition of another IncK plasmid to a cell already containing pCT. This new 
plasmid should encode a non-mobilisable antibiotic resistance gene, therefore both 
the new plasmid and blaCTX-M-14 could be selected within the growth media and 
incompatibility should remove pCT. If blaCTX-M-14 is transferrable this experiment 
would select for its translocation onto the new IncK plasmid. An experiment of this 
type would also inform on whether the pseudogene (the gene in which blaCTX-M-14 is 
inserted) is able to mobilise with this resistance gene, whether it provides a „hot spot‟ 
for insertion, or whether its association with the blaCTX-M-14 on the pCT-like plasmids is 
incidental.  
Future work could also attribute function to the hypothetical proteins identified in the 
pCT annotation by systematic inactivation and biological investigation of each open 
reading frame, as any of these CDSs could potentially have fundamental roles in 
plasmid biology.  
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3.10 Key findings 
o The plasmid pCT genome was completely sequenced, annotated and 
interrogated for candidate genes which may contribute to the spread and 
persistence of this plasmid. 
o The blaCTX-M-14 gene was found to be the only resistance gene encoded on the 
plasmid and β-lactam resistance, the only transferrable phenotype.   
o Comparisons of pCT to other blaCTX-M carrying plasmids revealed no commonality 
between these plasmids outside of the β-lactamase genes.  
o Comparisons of pCT with closely related plasmids revealed conserved genomic 
regions and those pCT regions unusual or unique when compared to current 
literature. These included the presence of a putative sigma factor and a 
functional shufflon within the pil locus. 
o A PCR assay to detect pCT-like plasmids was developed and validated using UK 
cattle E. coli isolates, identifying two pCT-like plasmids. 
o Eight pCT-like plasmids were identified in E. coli clinical isolates from Europe, 
Australia and Asia including one isolate from 1998 and a widely distributed 
previously characterised Spanish plasmid pRYC105. These data suggest global 
distribution of pCT in bacteria from humans, animals and the environment. 
o IncK and IncB pCT-like plasmids were identified.  
o The pCT-like plasmids were all found, like pCT, to be transferrable through 
conjugation and to confer resistance to β-lactams only. Other similar plasmid 
sequences extracted from Genbank indicate that similar plasmids are able to 
acquire multiple antibiotic resistance genes and virulence genes.  
o nikB sequencing was successfully used to compare plasmids and was found to 
be a useful typing tool in this study.  
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4. Factors affecting plasmid pCT persistence, and fitness of its 
bacterial hosts 
4.1 Background 
Assessment of the fitness cost or benefit of plasmids upon their bacterial host has 
been notoriously complex (Petersen et al., 2009), due in part to the ever changing 
relationship between plasmids, the bacterial host and environmental conditions. The 
cost/benefit of genes in the plasmid accessory genome such as antibiotic resistance 
genes must also be considered (Lenski et al., 1994). Analysis of the pCT genome 
showed the presence of a single antibiotic resistance gene (blaCTX-M-14), but no other 
genes associated with plasmid conferred fitness costs or benefits were identified.  
4.2 Hypotheses and Aims 
Plasmid pCT does not confer a fitness burden on host bacterial cells and increases 
the evolutionary fitness of the host by modifying its phenotype, therefore ensuring the 
persistence of both plasmid and host. In addition, aspects of the pCT biology such as 
stability and transfer rate contribute to the plasmid‟s success.  
The aims of this section were to: 
 Measure the phenotypic effects conferred when pCT is added to four different 
bacterial host strains, 
 Investigate whether pCT confers a growth fitness cost or benefit when host 
strains (+/- pCT) were competed in a 1:1 ratio in vitro, 
 Investigate basic plasmid biological functions of pCT, such as transfer and 
persistence which may affect plasmid success, 
 Investigate whether sub-inhibitory concentrations of cefotaxime affect pCT 
transfer rates. 
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4.3 The effect of the addition of pCT on bacterial host phenotype  
4.3.1 Growth of bacterial host strains +/- pCT  
The growth rates of all four parental strains E. coli DH5α (I825), J53-2 (I847) and 
3950 (I823) and Salmonella Typhimurium SL1344 rifR (L1078) were compared with 
and without pCT (I755, I855, I834 and L1079). To minimise co-evolution of host and 
plasmid or changes to the parental strain, each strain was removed from the -80C 
freezer, cultured on agar, then passaged once only without the addition of antibiotic. 
These cultures were used to inoculate LB broth (three biological and four technical 
repeats) and the optical density (600 nm) was measured using the automated 
FLUOstar OPTIMA (BMG Labtech, UK) for a period of twelve hours. The addition of 
pCT had no statistically significant effect on the growth rate or generation times of the 
host strains during logarithmic phase (Figure 4.1, Appendix 4). However E. coli DH5α 
pCT and J53-2 pCT had consistently extended lag phases (an additional ~20 minutes 
and ~12 minutes respectively) when compared to parental strain E. coli DH5α.  
4.3.2 Co-culture of bacterial host strains +/- pCT 
Host strains E. coli 3950, E. coli DH5α and E. coli J53-2 with and without pCT were 
mixed in a 1:1 ratio in vitro and cultured for 72 hours with four passages, in the 
absence of β-lactam pressure on three separate occasions. The proportion of 
bacteria carrying pCT at each time point was calculated allowing the measurement of 
the progression or „success‟ of pCT in each population. In host strain E. coli 3950 the 
proportion of bacteria carrying pCT steadily increased over time from 50% at time 
zero to 100% after 72 hours (Figure 4.2A). In E. coli DH5α, pCT remained in ~50% of 
the bacteria until the second passage where in all three biological replicates the 
proportion of bacteria carrying pCT increased to ~84% (Figure 4.2B). 
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Figure 4.1. Growth kinetics of host strains +/- pCT 
  
The growth kinetics of each bacterial host strain +/- pCT were measured using the 
FLUOstar OPTIMA using at least three biological and four technical repeats. 
Generation times were calculated between hours 1-2 (Appendix 4). 
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Figure 4.2. The proportion of pCT carrying strains within a population 
 
 
The percentage of plasmid pCT carrying bacteria was calculated over time when E. coli 
strains +/- pCT were co-cultured in a 1:1 ratio in vitro (Appendix 5). A, The proportion of pCT 
carrying bacteria in a 3950 +/- pCT co-culture; B, The proportion of pCT carrying bacteria in a 
DH5α +/- pCT co-culture; C, The proportion of pCT carrying bacteria in a J53-2 +/- pCT co-
culture. Cultures were passaged into fresh broth at hour 12, 24, 48 and 72. 
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In host E. coli J53-2 a different pattern was observed, the proportion of bacteria 
carrying pCT reduced after the first passage at 12 hours (Figure 4.2C) to 30% at 24 
hours and 12% at 72 hours indicating loss of the plasmid or a considerable pCT 
fitness burden on E. coli J53-2 cells (Appendix 5).  
4.3.3 In vitro competition between E. coli DH5α and DH5α pCT (non-transferrable) 
In order to directly compare the fitness of pCT carrying bacterium compared with a 
plasmid free counterpart, a non conjugative pCT (pCT7; described and characterised 
in Chapter 6) was used to remove the confounding factor of plasmid transfer within 
the competition assay. E. coli DH5α pCT7 and DH5α without plasmid were competed 
in a 1:1 ratio in vitro over a 72 hour period. At each time point the strains remained in 
a 1:1 ratio (Competition index of DH5α pCT7 = 0.99829) suggesting that the 
presence of pCT within E. coli DH5α confers neither a fitness cost nor a fitness 
benefit in the absence of antibiotic selective pressure (Figure 4.3). As pCT7 could not 
be transferred by conjugation or transformation to the other host backgrounds the 
pCT7 fitness burden on E. coli 3950 or E. coli J53-2of pCT7 could not be assessed. 
4.3.4 The ability of bacterial host strains (+/- pCT) to cause infection 
The effect of pCT upon the ability of bacterial host strains to cause infection was 
assessed using two models of infection. The first measured the ability of S. 
Typhimurium SL1344 rifR and S. Typhimurium SL1344 rifR containing pCT (L1079) to 
adhere to, and invade, human embryonic intestinal cells (INT-407) within a 
monolayer. The second model measured the rate at which nematode C. elegans 
were killed when fed on cultures of S. Typhimurium SL1344 rifR or E. coli 3950 +/-
pCT.  
  
Figure 4.3. Pairwise competitive growth in vitro between E. coli DH5α and DH5α containing pCT7 (non-conjugative pCT)  
 
Competition index of DH5α pCT7 at 12 hours (before first passage) = 0.94448,  P = 0.742 (no significant change)  
Competition index of DH5α pCT7 at 72 hours (after three passages) = 0.99829,  P = 0.359 (no significant change)  
 
The percentage of bacteria carrying plasmid pCT7 over time was invetigated when E. coli DH5α +/- pCT7 were co-cultured in 
a 1:1 ratio in vitro. Cultures were passaged at hour 12, 24 and 48. The competition index was calculated from averages 
generated from at least three separate experiments. 
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S. Typhimurium SL1344 was chosen as the primary host strain to investigate 
pathogenicity as its use in both models has been well documented in the literature 
and has been optimised in our laboratory. E. coli 3950 was selected as a 
representative pathogenic E. coli strain (the natural host of pCT) to control for any S. 
Typhimurium specific effects within these assays. The ability of S. Typhimurium 
SL1344 rifR (rpoB mutation) to cause infection was also compared to that of wild-type 
SL1344. The latter strain was used as a control in all experiments due to the large 
amount of previous data available for this strain in our laboratory (Blair et al., 2009; 
Bailey et al., 2010). In each experiment if positive control strain S. Typhimurium 
SL1344 was not found to associate with INT-407 cells within predetermined 
confidence intervals (1.2 x 106 to 1.1 x 107 CFU/ml), the experiment was rejected and 
repeated. Rifampicin resistant S. Typhimurium SL1344 was slightly attenuated when 
compared to wild-type SL1344 in its ability to adhere to and invade tissue culture 
cells although not to a statistically significant level (Adhesion, P = 0.10, Invasion, P = 
0.11) (Figure 4.4, Appendix 6). However, S. Typhimurium SL1344 rifR killed C. 
elegans at a significantly faster rate than SL1344 (TD50= 3.5 vs 3.9 P = 0.015) 
(Figure 4.5, Appendix 7). Therefore, when assessing the effects of pCT on the ability 
of host S. Typhimurium SL1344 rifR to cause infection, comparisons were made to 
the direct parental strain (SL1344 rifR; L1078) and not wild-type SL1344 (L354).  
The number of S. Typhimurium SL1344 rifR and S. Typhimurium SL1344 rifR pCT 
bacteria able to adhere to and invade the INT-407 cells was not significantly different 
(Adhesion, P = 0.93; Invasion, P = 0.23). Addition of pCT had no effect on the rate at 
which host strain E. coli 3950 killed the nematodes in the C. elegans model (P = 
0.89)  and  the  TD50  of  the  nematodes  remained  unchanged  (TD50  =  4. 76 days)   
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Figure 4.4. The ability of S. Typhimurium SL1344, SL1344 rifR and SL1344 rifR 
containing pCT to adhere to and invade human intestinal cells 
 
 
 
The number of S. Typhimurium SL1344 and SL1344 rifR pCT bacterium to adhere to (A) and 
invade (B) INT-407 human intestinal cell is represented as a percentage of the number of S. 
Typhimurium SL1344 rifR able to do so under test conditions (Appendix 6). Data are 
displayed as a mean of three separate experiments all performed with four technical repeats.  
Values returning a P value of <0.05 from a Student‟s T-test were considered statistically 
significant are represented with an asterix.  
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Figure 4.5. The ability of bacterial hosts +/- pCT to cause infection in C. elegans  
 
 
 
 
Survival curves were constructed using a Kaplan Mier calculation showing the 
probability of C. elegans survival each day when fed continuously on the tested 
bacterial strains.  
A significance difference was found in the killing rate between S. Typhimurium 
SL1344 rifR and S. Typhimurium SL1344 (P = 0.0154). A significant difference in 
killing rate was defined as a P value <0.05 (Appendix 7).  
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(Figure 4.5, Appenix 6). The addition of pCT to S. Typhimurium SL1344 rifR also had 
no significant effect on the hosts ability to cause infection in the C. elegans model, 
although the average TD50 was reduced from 3.5 to 3.15 days. 
4.4 Plasmid pCT persistence and transfer  
4.4.1 Persistence of pCT in bacterial host cells 
The stability of plasmid pCT was measured by growing pure cultures of each pCT 
containing strain (E. coli C159/11; E. coli DH5α pCT; E. coli J53-2 pCT and S. 
Typhimurium SL1344 rifR pCT) in LB broth. Cultures were grown over a 96-hour 
period including four passages, calculated from viable counts to be ~70 generations, 
with and without antibiotic selection (cefotaxime 8 µg/ml). The proportion of bacteria 
containing pCT was calculated every two hours during the first 12 hours and after 
each passage on three separate occasions. For each strain, pCT was stably 
maintained in 100% of the bacteria examined, both with and without cefotaxime and 
at each time point measured. 
4.4.2 pCT transfer rates 
4.4.2.1 Optimisation of pCT conjugation methods 
In order to establish the optimum time required to measure differences in the rate of 
transfer of pCT, initial experiments determined conjugation frequencies at 2 hours, 3 
hours, 4 hours and 6 hours into various host strains (Figure 4.6; Appendix 8). At 2 
hours the frequency of pCT transfer to recipient strain S. Typhimurium SL1344 rifR 
was too low to provide reliable data, as the number of colonies obtained on agar 
plates when culturing from the conjugation mixture was less than 30 per plate. The 
number of transconjugants isolated from the mating pair with the highest rate of 
transfer, donor E. coli C159/11 to recipient E. coli DH5α, after 4 and 6 hours were 
  
Figure 4.6. pCT conjugation frequency time optimisation on solid media  
 
 
 
The pCT conjugation frequencies were measured from donor strains E. coli C159/11 and E. coli DH5α during a 2,3,4 and 6 
hour period to optimise the the timing for future conjugation experiments (Appendix 8) on a minimum of three separate 
occasions. 
. 
Blue line = Conjugation frequencies of pCT from donor E. coli C159/11 to an E. coli DH5α recipient 
Red line = Conjugation frequencies of pCT from donor E. coli C159/11 to a S. Typhimurium SL1344 rifR recipient 
Green line = Conjugation frequencies of pCT from donor E. coli DH5α pCT to a S. Typhimurium SL1344 rifR recipient  
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near to the number of recipient cells suggesting pCT saturation within the population. 
It is also likely by this time transconjugants may themselves donate pCT to pCT-free 
bacterial cells. Therefore, 3 hours was chosen for all further conjugation frequency 
experiments.    
4.4.2.2 Frequency of pCT conjugative transfer to various recipient bacterial strains 
The pCT transfer frequency was measured from donor strain E. coli DH5α to 
recipient strains E. coli J53-2 (I847), E. coli DH5α rifR (I754) and E. coli 3950 (I823) 
and S. Typhimurium SL1344 rifR (L1078) on filters placed on LB agar plates (filter) 
and in LB broth (liquid). Each experiment was repeated on at least three separate 
occasions. The conjugation frequency of pCT ranged from 7.44 x 10-6 to 1.49 x 10-2 
per donor cell over the three hour period. pCT transferred at the highest rate to 
recipient E. coli J53-2 on a filter, in liquid the conjugation frequency was reduced two 
fold. A large difference was also found between the conjugation frequency of pCT on 
solid and liquid media to recipient E. coli 3950 where the conjugation was at a higher 
rate in liquid than on a filter. pCT transfer to S. Typhimurium recipient SL1344 rifR 
was at similar levels in liquid and on a filter, as were the conjugation frequencies into 
recipient E. coli DH5α rifR (Figure 4.7, Appendix 9). The conjugation frequency of pCT 
from donor strain E. coli C159/11 to recipients E. coli DH5α rifR and E. coli J53-2 
were consistently lower than from donor E. coli DH5α (Figure 4.8, Appendix 9), 
however, pCT transfer from E. coli C159/11 to recipient S. Typhimurium SL1344 rifR 
was at a higher frequency than from donor E. coli DH5α both on a filter and in broth. 
These data suggest both donor and recipient strain specific effects, but that pCT can 
be transferred between a range of bacterial strains including a S. Typhimurium strain.  
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Figure 4.7. Conjugation frequencies of pCT from donor E. coli DH5α to various 
recipients on solid and in liquid media  
 
 
 
 
 
 
The conjugation frequency of pCT from donor bacterial strain E. coli DH5α to 
recipient strains E. coli J53-2, E. coli DH5α, E.coli 3950 and S. Typhimurium SL1344 
rifR  was measured over a three hour time period, on a filter (blue bars) and in liquid 
media (red bars). Conjugation frequencies were calculated from the mean of at least 
three separate experiments (Appendix 9A).  
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Figure 4.8. Conjugation frequencies of pCT from donor E. coli C159/11 to 
various recipients on solid and in liquid media  
 
 
 
 
 
The conjugation frequency of pCT from donor bacterial strain E. coli C159/11 to 
recipient strains E. coli J53-2, E. coli DH5α and S. Typhimurium SL1344 rifR  was 
measured over a three hour time period, on a filter (blue bars) and in liquid media 
(red bars). Conjugation frequencies were calculated from the mean of at least three 
separate experiments (Appendix 9B).  
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4.5 pCT conjugation rates in the presence and absence of cefotaxime 
The frequency of pCT transfer from donor E. coli DH5α to recipients E. coli J53-2, E. 
coli 3950, E. coli DH5α rifR and S. Typhimurium SL1344 rifR were measured in the 
presence of sub-inhibitory concentrations of cefotaxime (0.003 µg/ml and 0.006 
µg/ml) and compared to the same donor and recipient pairs in the absence of 
antibiotic. The pCT conjugation frequencies to all recipient strains were not 
significantly different in the presence of sub-inhibitory concentrations of cefotaxime 
either on a filter (Figure 4.9, Appendix 10) or in liquid (Figure 4.10, Appendix 11), 
suggesting that the presence of sub-inhibitory concentrations of antibiotics does not 
impact conjugation rates of pCT.  
4.6 Discussion 
Traditionally, the relative fitness of bacterial strains has been investigated by 
comparing their growth rates and generation times in pure culture, as differential 
growth has been shown to be a strong indicator of bacterial fitness (Andersson and 
Hughes, 2010). Therefore, in my study the fitness cost/benefit of pCT upon three 
„pCT naive‟ bacterial hosts E. coli DH5α, E. coli J53-2 and S. Typhimurium SL1344 
rifR, and on E. coli 3950 (derived from C159/11 and pCT „cured‟) was initially 
assessed by comparing growth kinetics. The addition of pCT had no significant effect 
on the generation time of the four host strains, revealing that in the absence of 
antibiotic pressure, pCT conferred neither a growth benefit or growth defect on the 
host bacterium. These findings contradict those of Zünd and Lebek (1980), who 
showed that the majority of large plasmids (>80 kb) increased the generation times of 
their new host strains. 
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Figure 4.9. Conjugation frequencies on solid media of pCT in the presence of 
sub-inhibitory concentrations of cefotaxime  
 
 
 
The conjugation frequency of pCT in the presence of sub-inhibitory concentration of 
cefotaxime (CTX) was compared to conjugation frequency in the absence of 
antibiotic. Frequencies were measured from donor bacterial strain E. coli DH5α to 
recipient strains E. coli J53-2, E. coli DH5α, E.coli 3950 and S. Typhimurium SL1344 
rifR on a filter placed on an agar containing either no cefotaxime (Black bars); 
0.003µg/ml cefotaxime (Blue bars) or 0.006µg/ml cefotaxime (Red bars).  
 
Conjugation frequencies were calculated from the mean of at least three separate 
experiments (Appendix 10). Values returning a P value of <0.05 from a Student‟s T-
test were considered statistically significant are represented with an asterix.  
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Figure 4.10. Conjugation frequencies in liquid media of pCT in the presence of 
sub-inhibitory concentration of cefotaxime 
 
 
 
The conjugation frequency of pCT in the presence of sub-inhibitory concentration of 
cefotaxime (CTX) was compared to conjugation frequency in the absence of 
antibiotic. Frequencies were measured from donor bacterial strain E. coli DH5α to 
recipient strains E. coli J53-2, E. coli DH5α, E.coli 3950 and S. Typhimurium SL1344 
rif
R
 in LB broth containing either no cefotaxime (Black bars); 0.003µg/ml cefotaxime 
(Blue bars) or 0.006µg/ml cefotaxime (Red bars).  
Conjugation frequencies were calculated from the mean of at least three separate 
experiments (Appendix 11). Values returning a P value of <0.05 from a Student‟s T-
test were considered statistically significant are represented with an asterix.   
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My data is also inconsistent with the consensus within the literature that before a 
period of co-evolution, an initial fitness and growth burden will be conferred by a 
plasmid to a naive host (Bouma and Lenski, 1988; Modi and Adams, 1991; 
McDermott et al., 1993). An increased E. coli lag time due to carriage of plasmids (as 
shown in E. coli DH5α pCT and J53-2 pCT) has been observed previously by others, 
for example the addition of pBluescript (2691 bp) was shown to increased the lag 
phase of E. coli XL1 blue cells from 90 to 126 minutes (Smith and Bidochka, 1998). 
The E. coli DH5α strain used in my study has had a considerable number of 
passages and laboratory modification (Table 2.1), therefore, it may be that these 
strains were the most susceptible to changes in growth, and therefore a good 
indicator of fitness effects, but perhaps unrepresentative of natural host strains.  
Another commonly used method to investigate comparative fitness of bacterial 
strains is pair-wise competitive growth, where two strains compete for resources in 
the same culture (Pope et al., 2010). Direct competition of E. coli DH5α pCT against 
its parental strain E. coli DH5α was not possible due to transfer of pCT to plasmid 
free cells. Therefore, a non-transferable pCT mutant (pCT7, traXY::aph; Chapter 6) 
was used. These experiments showed that E. coli DH5α cells with and without 
pCT(7) remained in a 1:1 ratio for 72 hours when directly competed in vitro. This 
suggests that non-transferable pCT conferred neither a fitness cost nor benefit to E. 
coli DH5α cells. Although the costs associated with conjugation could not be taken 
into account using pCT7, the experimental method allowed for simple assessment of 
the plasmid burden/benefit on the host bacterial cell, and was considered simpler 
than other protocols which adjust for the ratio of transconjugants within the culture 
(Yates et al., 2006; Subbiah et al., 2011). To investigate how plasmid transfer 
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affected the proportion of pCT harbouring cells in a population over time, plasmid 
free and plasmid bearing bacteria strains were placed in a 1:1 ratio in the absence of 
antibiotic pressure, this time using wild-type pCT. By 72 hours pCT was present in 
the majority of both E. coli DH5α and E. coli 3950 cells. As E. coli DH5α pCT(7) did 
not outcompete E. coli DH5α, it is likely that the reduction in the number of plasmid 
free bacteria is due to transfer of pCT and subsequent spread through the population 
rather than expansion of DH5α pCT. The reduction in E. coli J53-2 plasmid carrying 
cells when co-cultured with E. coli J53-2 indicated a fitness burden conferred by pCT 
to the host rather than plasmid „loss‟, as when J53-2 pCT was cultured alone, pCT 
was stably maintained in all bacteria over the same time period.  
Why pCT has a detrimental effect on E. coli J53-2 fitness and not E. coli 3950 or E. 
coli DH5α is unclear. Several other studies have highlighted strain or species-specific 
differences in fitness costs of particular plasmids, however, no explanations or 
hypotheses have been provided (Enne and Bennett, 2006; De Gelder et al., 2007; 
Subbiah et al., 2011). The simplest explanation is a differential pCT copy number in 
different bacterial host strains, as the reduction of copy number has been shown to 
reduce the metabolic cost conferred to the host cell (Bentley et al., 1990; Smith and 
Bidochka, 1998). The increase in the number of E. coli DH5α containing pCT cells 
between 24 hours (51%) and 48 hours (84%) when E. coli DH5α and E. coli DH5α 
pCT were co-cultured, also appeared to be strain-specific. This may be suggestive of 
a pCT or host encoded plasmid transfer control mechanism. While potential 
Enterococcus spp. recipients can produce pheromones which induce conjugation of 
certain plasmids from the donor strain (Wardal et al., 2010), the initiation of 
conjugative transfer and the role of cell density, quorum-sensing mechanisms and 
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constitutively expressed genes in other species or IncI plasmids has not been 
investigated. The pCT genome contains pCT_010 (annotated originally as yafB). This 
CDS closely resembles genes that encode conjugation repressors ydbA in IncI 
plasmid R64 and finO of IncF plasmids (Frost et al., 1994; Sampei et al., 2010). 
Therefore, there may be differential regulation or expression of this pCT gene in 
different host strains, which would modify the nature of pCT dissemination (and 
conjugation frequency) in a naive population (Meynell and Datta, 1966; Dionisio et 
al., 2002).  
In order to study pCT in a S. Typhimurium host background, pCT was transferred by 
conjugation to a rifampicin resistant SL1344 (L1078) as transformation of pCT into 
wild-type SL1344 (L354) was unsuccessful on numerous occasions, probably in part 
due to the size of the plasmid. SL1344 rifR was chosen as a suitable S. Typhimurium 
SL1344 recipient as the pCT natural host strain C159/11 was found to be susceptible 
to rifampicin, and the transferrable antibiotic resistance determinants carried on pCT 
were yet to be determined. When compared to wild-type S. Typhimurium SL1344 
(L354), S. Typhimurium SL1344 rifR (L1078) was slightly attenuated in its ability to 
adhere to and invade tissue culture cells. This is consistent with previous literature 
detailing the effects of rifampicin resistance determinant rpoB mutations on host 
fitness, growth and pathogenicity (Bjorkman et al., 1998; Marianelli et al., 2004; Enne 
et al., 2005). In the C. elegans model however, S. Typhimurium SL1344 rifR was 
found to kill the nematodes at a faster rate than wild-type SL1344. pCT did not 
significantly modify the ability of the host bacteria S. Typhimurium SL1344 rifR or E. 
coli 3950 to cause infection in either of the infection models. This corresponds with 
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the lack of identified virulence genes within the pCT genome (Chapter 3). It may also 
be predicted that pCT has no effect on expression of host strain virulence factors.  
Use of the tissue culture infection model to measure the ability of bacterial strains to 
cause infection, is simple, standardised and measures the direct pathogen 
interactions with a single eukaryotic cell type. It also allows exploration of molecular 
mechanisms of cell adhesion and invasion without much of the complexity of 
studying infection in a whole animal (Hurley and McCormick, 2003). Data from the C. 
elegans infection model allowed assessment of the ability of bacterial strains to 
cause infection within a whole organism, therefore complementing data collected 
from the tissue culture assays. The advantages of studying infection using the C. 
elegans is it is low cost when compared to other animal models, and as bacterial 
mutants which have attenuated virulence in other animal models also kill nematodes 
at a slower rate, it is an apt initial model for generation of hypotheses which could be 
explored further in other animal models to substantiate any findings. (Aballay et al., 
2000; Labrousse et al., 2000; Tenor et al., 2004). There are obvious limitations when 
studying the ability of bacteria to cause infection within a single cells type, or within 
an animal with no adaptive immune system such as the C. elegans, however these 
model provide a use tool in the study of the ability of bacteria to cause infection.  
A relevant difference between the two models is the temperature at which the 
experiments are conducted. While bacterial cells are incubated within tissue culture 
cells at 37C, C. elegans are cultured at 25C. Temperature has been hypothesised 
to alter expression of bacterial virulence factors, perhaps accounting for differences 
seen between bacterial strains or pathogenicity models (Lavigne et al., 2006). 
Therefore if a significant change in host pathogenicity had been identified when pCT 
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was added to host strains, alternative models to clarify the findings may have been 
useful next step (Future work).   
In the absence of antibiotic pressure, pCT was stably maintained in 100% of bacteria 
in pure culture in all four bacterial hosts over 96 hours (approx. 70 generations). 
These data indicate that pCT either has no negative fitness impact on the host cell, 
and so is able to remain stable within a population, and/or, pCT encodes genes to 
ensure its persistence. Such genes could encode an addiction and partitioning 
system.  
Another factor that influences plasmid and host fitness is the frequency of plasmid 
conjugation. The rate of pCT transfer was measured from two donors, „pCT naive‟ 
strain E. coli DH5α and its natural host E. coli C159/11 to both E. coli and S. 
Typhimurium recipients. The highest rate of transfer from both donors was to 
recipient E. coli J53-2 on a filter, although transfer was lower to the same recipient in 
liquid. Conversely, transfer to recipient E. coli 3950 was higher in liquid than on solid 
media. As the conjugation frequency of nearly all plasmid incompatibility types can 
be easily measured on a solid surface (Bradley, 1980), the filter method has become 
relatively standardised in the literature (Hartskeerl et al., 1985). Plasmid transfer 
rates in liquid however have been measured using many different protocols 
(differences in aeration, volume and cell density) therefore it is difficult to compare 
between studies or to experiments on solid media. Bradley et al., (1980) showed that 
while plasmids which encode a thick rigid pilus (e.g. IncP/N) can transfer at rates up 
to 2,000 times higher on agar than in broth, IncI type plasmids (IncI/K) such as pCT, 
which express both thick (tra locus) and thin pili (pil locus) could transfer equally well 
in both conditions. Bradley et al. conducted their conjugation experiments over a one 
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hour period from E. coli K12 (nalS) to K12 (nalR) and so are not directly comparable 
with the frequencies in my study (in a 3 hour period to various recipients). However, 
their data does show the high frequency of transfer in liquid of these IncI plasmids. It 
may be that pCT transfer into E. coli 3950 is higher in liquid than on a filter because 
E. coli 3950, which is derived from pCT‟s original host C159/11, has adapted to 
accommodate pCT conjugation. The extensive use of E. coli J53 as a conjugation 
recipient in the laboratory may over time also have inadvertently selected for a 
capacity for high receipt of plasmid during conjugation on agar as seen in this study 
and compared to the other strains. My study also highlights that the choice of donor 
strain and recipient strain has an impact on the conjugation frequency. Therefore 
experiments with one strain should not be extrapolated to all other bacterial hosts or 
recipients, even of the same species. The frequency of transfer of pCT from E. coli 
DH5α to S. Typhimurium SL1344 rifR was lower than to E. coli recipients J53-2 or 
DH5α rifR. These data reflect previous findings that inter-species conjugation occurs 
at a lower rate than between bacteria of the same species (Hunter et al., 2008). 
However, pCT transfer from donor E. coli C159/11 to S. Typhimurium SL1344 rifR 
was at a higher rate than from E. coli DH5α pCT to S. Typhimurium SL1344 rifR or E. 
coli C159/11 to E. coli DH5α rifR. This finding could have clinical implications, as it 
implies that pCT can easily transfer to S. Typhimurium from its natural host E. coli 
C159/11 on both a solid surface and in liquid, thereby also transferring the blaCTX-M-14. 
While there is no evidence to date that pCT has transferred from an E. coli donor to a 
S. Typhimurium recipient in nature, S. Typhimurium strains have not been 
investigated for the presence of pCT-like plasmids, therefore the frequency of 
transfer between these hosts in nature is currently unknown. 
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Due to the metabolic burden of DNA replication and pili production, but also the 
increased risk of bacteriophage infection due to exposure of additional pili, the ability 
of a plasmid to conjugate at a high frequency has been postulated to have an 
increased cost to the host bacterial cell (Novotny et al., 1968; Haft et al., 2009). 
However, Stewart and Levin (1977) argued that a certain level of plasmid transfer is 
required in order for a plasmid to persist within a population (Stewart and Levin, 
1977). Therefore, it seems that natural plasmids achieve a balance between 
horizontal and vertical transfer (Turner et al., 1998). Some plasmids maximise the 
rate at which they can conjugate, leading to rapid dissemination, perhaps most 
beneficial in a heterogeneous population with a high density of potential recipients 
(Dionisio et al., 2002). These plasmids are likely to confer a larger metabolic cost 
upon the host, therefore reducing the chances of success of the plasmid-carrying 
strain over its plasmid free counterparts (Turner et al., 1998). Other plasmids may 
have a reduced horizontal transfer rate but ensure vertical transmission by conferring 
a reduced or no fitness burden on the host bacterium (Ferdy and Godelle, 2005). In 
some cases resulting in a plasmid which loses its ability to conjugate, but is very 
stable within a particular bacterial strain (Rankin et al., 2011).  
In my study, the pCT transfer rate was generally lower from donor E. coli C159/11 
and to recipient E. coli 3950 than to and from „pCT naive‟ strains, suggesting that this 
co-evolved host and plasmid may have adapted to attain a refined (and lower) 
conjugation frequency and to ameliorate fitness costs.  
In the presence of a β-lactam, bacterial cell filamentation has been hypothesised to 
increase conjugation frequency as the larger average cell length increases contact 
between cells (Barr et al., 1986). In this study however, no difference was found 
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between conjugation frequency of pCT with and without the presence of cefotaxime, 
suggesting the presence of low levels of β-lactams does not significantly increase the 
spread of plasmid pCT.     
In conclusion, pCT was stably maintained in all daughter cells of each host strain 
over ~70 generations and conferred no fitness cost or benefit on hosts E. coli 3950 
and E. coli DH5α in the absence of antibiotic selective pressure. pCT did however 
appear to reduce the competitive ability of E. coli J53-2 pCT when co-cultured with its 
plasmid free parental strain. The pCT transfer rates suggest that liquid mating may 
be equally, if not more important for the spread of this plasmid as conjugation on a 
solid surface, particularly within the natural host derivative E. coli 3950 and C159/11.  
4.7 Further work 
In my study, pCT remained stable in all four host strains over ~70 generations, 
however a recent study of IncA/C plasmids showed that they too remained stable up 
to 800-1200 generations after which plasmid loss was seen (Subbiah et al., 2011). 
Therefore, further work could examine the stability of pCT over a greater number of 
generations to examine the long term effects on plasmid maintenance. The in vitro 
competition experiments could also be carried out over a greater period of time to 
assess the long term fitness burden or advantage of pCT. This will also allow 
investigation of whether adaption of the host/plasmid partnership will increase or 
decrease host fitness when in competition with the plasmid free parental strain. This 
experiment may be particularly important for host E. coli J53-2 where the observed 
pCT cost upon this host may be ameliorated over time.  
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The lack of a fitness cost or benefit conferred by pCT to E. coli hosts DH5α and 3950 
in vitro could be explored further to assess how the addition of pCT affects host 
fitness in vivo. A competition assay using the C. elegans model was proposed. By 
feeding the animals on a mixed culture of S. Typhimurium (or E. coli 3950) with and 
without pCT at a 1:1 ratio, the proportion of each strain that persists within the gut 
could be assessed. However, this experiment was not carried out as two problems 
were highlighted. The first, that pCT would transfer within the bacterial culture, 
therefore leading to the dominance of pCT carrying bacteria, secondly, pCT7 could 
not be transferred by conjugation or transformation to S. Typhimurium SL1344 rifR or 
E. coli 3950 and so could not be used in this experiment. Although the culture fed to 
the C. elegans could be controlled so as strains were in a 1:1 ratio, there was also no 
way to guarantee that the nematodes would consume the same amount of each 
strain. This would increase the number of nematodes needed in the experiment 
making it practically impossible to carry out.  
Other in vivo models to consider for further work on bacterial comparative fitness, but 
also the infection ability of bacterial hosts and to measure pCT conjugation 
frequencies in vivo are wax moth larvae (Galleria melonella), mouse models, and 
bovine oral infection using calves (Timoney and Linton, 1982; Jarrett and 
Stephenson, 1990; Savkovic et al., 2005; Lim et al., 2008). All three models have the 
advantage that a specific infective dose of each bacterial strain can be administered 
either orally or by injection into the abdomen. Use of the calf model may also be the 
closest available model to the natural farm environment where pCT was first 
identified and found to successfully persist (Liebana et al., 2006).  
 166 
 
Alternative bacterial species that can act as recipients for pCT conjugation and stably 
maintain pCT by facilitating plasmid replication could be established to define the 
pCT host range. Other serovars of S. enterica could be explored followed by 
alternative Enterobacteriaceae of clinical relevance such as Shigella spp., Klebsiella 
spp,. Acinetobacter baumannii and Pseudomonas aeruginosa to aid future screening 
for pCT in these potential hosts. These experiments alongside further use of the pCT 
PCR detection test (Chapter 3), will inform whether pCT and the blaCTX-M-14 gene it 
encodes are found in other species, in multidrug resistant strains or whether pCT has 
adapted primarily to an E. coli host (Sherley et al., 2003; Norberg et al., 2011). 
A fundamental question not addressed within this study is the pCT copy number, and 
whether this differs within the various host strains tested. As the metabolic load of a 
plasmid is associated with the copy number, this factor is strongly linked to any 
fitness burden a plasmid confers upon its host (Loftie-Eaton and Rawlings, 2010). 
Due to segregation and plasmid maintenance however, a low copy number plasmid 
may be less likely to persist within a population. Loftie-Eaton and Rawlings (2010) 
showed that when strains carrying an IncQ plasmid with differing copy numbers were 
co-cultured in vitro, the strain containing the lower copy number plasmid was 
outcompeted each time. Therefore, how the pCT copy number correlates with fitness 
is not clear and may depend upon both the host strain and the environmental 
conditions. To effectively measure a plasmid copy number, many methods are 
outlined within the literature. These include protocols to quantify gene products such 
as β-lactamases (Miller and Cohen, 1993), fluorescence proteins such GFP (Wong 
Ng et al., 2010) and LUX (Coronado et al., 1994); quantification of the plasmid DNA 
extracted from a defined number of bacterial cells; or comparison of the amount of 
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plasmid and chromosomal DNA extracted from a culture (Schmidt et al., 1996; 
Friehs, 2004). Contemporary methods have used quantitative PCR or real time PCR 
to assess the ratio of amplified plasmid genes to chromosomal genes (Lee et al., 
2006; Lee et al., 2006). For example, both studies by Lee et al., (2006) and Lee et 
al., (2006) quantified the bla gene found on pBR322 and a chromosomal gene (16s 
rDNA and dxs) to calculate the copy number of pBR322. For investigation of the pCT 
copy number in various hosts, a single copy chromosomal gene from each host 
should be selected and used as the baseline measurement (for example gyrB in E. 
coli). Various pCT genes (e.g. blaCTX-M-14, nikB, traX, pilS) were all shown to be 
encoded on pCT in single copies, and any one could be quantified using QPCR 
allowing the ratio between plasmid and chromosomal DNA to be calculated. The 
main limitation of this method is that if the DNA extraction favours either plasmid or 
chromosomal DNA over the other then an accurate copy number estimation will not 
be obtained. In order to assess this confounder a plasmid of known copy number 
such as pBR322 (~20 per cell) should be used as a positive control in a quantified 
number of bacterial cells to assess chromosomal vs. plasmid DNA extraction yields. 
At this stage, the lack of pCT „housekeeping‟ genes or genes known to be expressed 
at a constant level means that the use of real-time PCR to calculate copy number 
would be considerably more complicated than QPCR.  
Real-time PCR could also be used to determine whether the putative conjugation 
repressor, ydbA, is expressed and whether it actively regulates conjugation. By 
measuring the expression of pil and tra locus genes compared to levels of ydbA 
mRNA, hypotheses may be generated about the control of conjugation in different 
host strains and under different conditions such as on a solid surface and in liquid.  
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4.8 Key findings 
o The addition of pCT to host cells had no significant effect on host phenotype, 
- pCT did not modify the ability of host strains to cause infection, 
- pCT had no significant effect on the generation times of all host strains. 
o Non-transferrable pCT (pCT7) did not confer a fitness burden or benefit on E. 
coli DH5α cells in competition with the plasmid free E. coli DH5α parent strain. 
o When added to a population of potential recipient bacteria, pCT disseminated 
through cultures of E. coli 3950 and E. coli DH5α within 96 hours. 
o pCT was lost from a culture of E. coli J53-2 pCT and E. coli J53-2 indicating a 
cost of the plasmid to this bacterial host strain. 
o pCT persisted in 100% of bacterial cells in all four host strains over 96 hours. 
o pCT was successfully transferred by conjugation from donors E. coli DH5α 
and E. coli C159/11 to E. coli and S. Typhimurium recipient strains. 
o The pCT transfer frequencies were 
o donor and recipient dependent, 
o higher to recipient E. coli J53-2 on a filter than in broth, 
o lower to recipient E. coli 3950 on a filter than in broth, 
o lower from donor E. coli C159/11 than E. coli DH5α into the E. coli 
recipient strains, 
o higher from donor E. coli C159/11 than E. coli DH5α into recipient S. 
Typhimurium SL1344 rifR. 
o The presence of sub-inhibitory concentrations of cefotaxime had no significant 
effect on the pCT conjugation rate. 
K 
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5. The contribution of blaCTX-M-14 to the biology of pCT 
5.1 Background 
The obvious benefit to plasmids and their bacterial host strains of acquiring antibiotic 
resistance genes is that the host is able to survive antibiotic challenge and survive at 
the detriment of cells which do not possess a resistance gene. Under these 
conditions, plasmids which carry antibiotic resistance genes are stably maintained 
within the bacterial population as the resistome is essential for survival. Therefore, 
the successful spread of antibiotic resistance carrying plasmids has been 
conventionally attributed to the presence of antibiotic compounds which create a 
selective pressure and drive both persistence and dissemination of these plasmid 
vectors (O'Brien, 2002).  
In the absence of antibiotic selective pressure, the majority of studies conducted 
have shown that antibiotic resistance mechanisms carry an initial fitness cost on the 
host bacterium when compared to their susceptible counterparts (Lenski, 1998; 
Andersson, 2006; Andersson and Hughes, 2010). For example, mutation in 
chromosomally encoded E. coli streptomycin resistance gene rpsL can result in a 
reduction in the rate of translation and therefore growth, conferring a fitness defect 
when compared to those cells encoding a wild-type gene (Paulander et al., 2009). 
The fitness costs associated with antibiotic resistance genes have also been shown 
to have detrimental effects on the ability of bacterial cells to colonise the upper 
respiratory tract of rats (Trzcinski et al., 2006), to invade tissue culture cells, and to 
survive and replicate intra-cellularly (Morosini et al., 2000; Abromaitis et al., 2005). 
Early studies on antibiotic resistance plasmids, both in vitro and in vivo (within the 
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human intestinal tract) indicated that removal of the antibiotic selective pressure 
resulted in the loss of these plasmids and hence their antibiotic resistance genes 
from the bacterial strains (Anderson, 1974; Andersson and Levin, 1999). This was 
due to the inherent fitness costs of these plasmids which allowed susceptible strains 
to outcompete the resistant ones. Contrary to these findings, Lenski et al., (1994) 
showed that the fitness benefit conferred by plasmid pACYC184 to its E. coli host 
after a period of co-evolution was reversed when the tetracycline resistance gene 
(tetC) was removed or inactivated. These data suggest an additional role of this 
antibiotic resistance gene in the plasmid and host interaction (Lenski et al., 1994).  
Therefore, the contribution of antibiotic resistance genes to the evolutionary success 
and dissemination of large natural plasmids is still largely undetermined.  
Despite strategies to removal or reduce antibiotic selective pressure by limitation of 
antibiotic usage through stewardship or „cycling‟ and therefore decrease the number 
of resistant strains, the majority of studies have shown that the resistance 
determinants remain within the bacterial populations (Kollef, 2006). This suggests 
that interactions between the antibiotic resistance genes, their vectors, the host 
bacteria and the real world are complex.  
5.2 Hypotheses and Aims 
The presence of the antibiotic resistance gene blaCTX-M-14 plays an important role in 
the evolutionary success of plasmid pCT as it confers either a neutral or beneficial 
effect on pCT or the host strain, allowing the plasmid to persist both in the presence 
and absence of antibiotic pressure.  
The aims of this work were to: 
 Develop a method for the targeted inactivation of plasmid encoded genes, 
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 Use this method to inactivate blaCTX-M-14 on pCT by insertion of a kanamycin 
resistance gene, aph, and green fluorescent protein gene, gfp, 
 Measure the biological effects of inactivation of blaCTX-M-14 on pCT and its 
bacterial host strains. 
 Assess the effect of removal of the blaCTX-M-14 upstream insertion element ISEcp1 
has on host susceptibility to β-lactam antibiotics cefotaxime and ceftiofur. 
5.3 Development of a method to inactivate pCT blaCTX-M-14  
Conventional methods to inactivate genes on plasmids have previously used random 
insertion of transposons followed by screening to identify the disrupted gene of 
interest. Site specific methods have been devised for the inactivation of bacterial 
chromosomal genes using homologous recombination (Datsenko and Wanner, 
2000), however, targeted approaches to inactivating specific plasmid genes have not 
been well documented in the literature. Initially, a protocol based upon methods for 
chromosomal gene inactivation outlined by Datsenko and Wanner (2000) were 
followed. Briefly, recombination of a resistance marker amplified by PCR with regions 
of homology to blaCTX-M-14 at either end of the amplimer, required the transformation 
of plasmid pKD46, encoding a lambda-red recombinase, into a pCT containing 
bacterial strain.  Problems with co-location and maintenance of both pKD46 and pCT 
within a single cell led to the development of a novel method which used a 
chromosomally based lambda-red recombinase, removing the need for a double 
transformation and maintenance of both plasmids. E. coli strain SW102 (I759) 
encoding the chromosomal lambda-red recombinase was kindly donated by Dr 
Howard Bayliss (University of Cambridge). 
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5.4 Inactivation of pCT blaCTX-M-14 by insertion of aph 
PCR primers were designed with 20 bp homology to L109 (previously recombined 
with aph amplified from pKD4) in order to amplify the kanamycin resistance gene 
aph, and 40 bp of homology to the outer regions of blaCTX-M-14 (Table 2.7, primer nos. 
823/824). Homologous recombination of this PCR product with pCT allowed the 
removal of 606 bp of blaCTX-M-14 including the sequence encoding the enzyme‟s active 
site, and its replacement with aph. Initially, pCT DNA and the PCR amplimer 
encoding aph were co-transformed together by electroporating both plasmid and 
PCR amplimer into freshly made competent E. coli SW102 cells at the same time. 
The low frequency of pCT transformation in addition to the low frequency of 
recombination meant no recombinant plasmids were obtained. Therefore, the method 
was modified to include a two step process where pCT was transformed and 
selected in E. coli SW102 first (SW102 pCT), followed by subsequent electroporation 
of the PCR construct. This allowed the establishment of pCT in E. coli SW102 and 
maximised the chance of recombination. Using this new strain, E. coli SW102 pCT 
(I879), twenty colonies grew on kanamycin containing agar (50 µg/ml), indicating 
successful recombination of pCT and aph had taken place. Each colony was sub-
cultured onto fresh agar containing kanamycin and cell lysates made for each one. 
Lysates were used as the DNA template in a PCR reaction with primers designed 
upstream and downstream of the recombination region (Table 2.7, primer no. 
819/820). With wild-type pCT DNA it was expected that these primers would yield 
amplimers of 876 bp. However if the aph gene had been successfully recombined, an 
amplimer of 1764 bp would be obtained. PCR resulted in both 876 bp and 1765 bp 
amplimers from all twenty lysates (Figure 5.1), therefore indicating the presence of 
both wild-type (pCT) and a recombinant plasmid (pCT blaCTX-M-14::aph). 
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Figure 5.1. PCR amplimers from SW102 colonies containing putative mutated 
pCT (blaCTX-M-14::aph)  
 
 
 
 
Feature Description 
 
HL1 
 
Hyperladder 1 (Bioline) 
 
1-20 E. coli SW102 candidate colonies  
putatively containing pCT2 (blaCTX-M-14::aph) 
 
pCT Wild-type control 
 
-ve Negative water control 
Twenty colonies containing putative mutated pCT after recombination were selected 
and used as the DNA template in a PCR reaction with primers designed upstream 
and downstream of the recombination region. In each reaction the presence of a 
mutated plasmid was indicated by the presence of a 1756 bp amplier, however the 
presence of a 875 bp amplier also suggested the presence of wild-type pCT in each 
lysate. Amplimers were visualised using electrophoresis on a 1% agarose gel. 
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Plasmid DNA was harvested from colony 14 as visualisation of PCR amplimers after 
electrophoresis on an agarose gel indicated the presence of relatively less wild-type 
pCT within this colony (Figure 5.1), and the plasmid DNA transformed again into E. 
coli DH5α. This removed the possibility of further recombination from residual ʎ-red 
recombinase activity in E. coli SW102 cells. Both wild-type pCT and mutant plasmid 
were still detected using PCR within the E. coli DH5α colonies selected on 
kanamycin. Therefore, a colony was selected and „cycled‟ on LB agar containing 50  
µg/ml kanamycin so that upon segregation of each bacterial cell, the aph containing 
plasmid would be selected and those bacterial cells containing wild-type pCT only 
would be inhibited. Each day, colonies were chosen at random and lysates used in a 
PCR to amplify the blaCTX-M-14 region. After six days this PCR only amplified 
fragments of 1764 bp in size in all colonies tested, and when replica plated onto fresh 
agar, colonies were also unable to grow in the presence of 8 µg/ml of cefotaxime. 
Plasmid DNA was harvested from this strain and transformed into E. coli DH5α cells 
to remove any effects on the host from serial passaging. A colony was chosen, 
checked for the presence of pCT blaCTX-M-14::aph only, and named E. coli DH5α pCT2 
(I778). DNA sequencing of PCR amplimers from this colony showed the outer coding 
regions of blaCTX-M-14, the recombining sites and the aph gene in the expected 
positions, verifying successful recombination (Figure 5.2). pCT2 was also conjugated 
into recipient E. coli strains J53-2 (I847), E. coli 3950 (I823) and S. Typhimurium 
SL1344 rifR (L1078) creating strains E. coli J53-2 pCT2 (I856), E. coli 3950 pCT2 
(I835) and S. Typhimurium SL1344 rifR pCT2 (L1244).  
To further confirm the inactivation of blaCTX-M-14 in pCT2, the chromogenic β-lactam 
nitrocefin was used to detect the production of β-lactamase. Lysates of E. coli 
C159/11, E. coli DH5α pCT and S. Typhimurium SL1344 rifR pCT (L1079) containing  
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Figure 5.2. DNA sequence showing the successful insertion of the aph gene 
into blaCTX-M-14 on pCT  
 
 
GCTGGGCAGCGCGCCGCTTTATGCGCAGACGAGTGCGGTGCAGCAAAAGCTGGCGGCGTGTAGGCTGG
AGCTGCTTCGAAGTTCCTATACTTTCTAGAGAATAGGAACTTCGGAATAGGAACTTCAAGATCCCCCA
CGCTGCCGCAAGCACTCAGGGCGCAAGGGCTGCTAAAGGAAGCGGAACACGTAGAAAGCCAGTCCGCA
GAAACGGTGCTGACCCCGGATGAATGTCAGCTACTGGGCTATCTGGACAAGGGAAAACGCAAGCGCAA
AGAGAAAGCAGGTAGCTTGCAGTGGGCTTACATGGCGATAGCTAGACTGGGCGGTTTTATGGACAGCA
AGCGAACCGGAATTGCCAGCTGGGGCGCCCTCTGGTAAGGTTGGGAAGCCCTGCAAAGTAAACTGGAT
GGCTTTCTTGCCGCCAAGGATCTGATGGCGCAGGGGATCAAGATCTGATCAAGAGACAGGATGAGGAT
CGTTTCGCATGATTGAACAAGATGGATTGCACGCAGGTTCTCCGGCCGCTTGGGTGGAGAGGCTATTC
GGCTATGACTGGGCACAACAGACAATCGGCTGCTCTGATGCCGCCGTGTTCCGGCTGTCAGCGCAGGG
GCGCCCGGTTCTTTTTGTCAAGACCGACCTGTCCGGTGCCCTGAATGAACTGCAGGACGAGGCAGCGC
GGCTATCGTGGCTGGCCACGACGGGCGTTCCTTGCGCAGCTGTGCTCGACGTTGTCACTGAAGCGGGA
AGGGACTGGCTGCTATTGGGCGAAGTGCCGGGGCAGGATCTCCTGTCATCTCACCTTGCTCCTGCCGA
GAAAGTATCCATCATGGCTGATGCAATGCGGCGGCTGCATACGCTTGATCCGGCTACCTGCCCATTCG
ACCACCAAGCGAAACATCGCATCGAGCGAGCACGTACTCGGATGGAAGCCGGTCTTGTCGATCAGGAT
GATCTGGACGAAGAGCATCAGGGGCTCGCGCCAGCCGAACTGTTCGCCAGGCTCAAGGCGCGCATGCC
CGACGGCGAGGATCTCGTCGTGACCCATGGCGATGCCTGCTTGCCGAATATCATGGTGGAAAATGGCC
GCTTTTCTGGATTCATCGACTGTGGCCGGCTGGGTGTGGCGGACCGCTATCAGGACATCGCGTTGGCT
ACCCGTGATATTGCTGAAGAGCTTGGCGGCGAATGGGCTGACCGCTTCCTCGTGCTTTACGGTATCGC
CGCTCCCGATTCGCAGCGCATCGCCCTCTATCGCCTTCTTGACGAGTTCTTCTGAGCGGGACTCTGGG
GTTCGAAATGACCGACCAAGCGACGCCCAACCTGCCATCACGAGATTTCGATTCCACCGCCGCCTTCT
ATGAAAGGTTGGGCTTCGGAATCGTTTTCCGGGACGCCGGCTGGATGATCCTCCAGCGCGGGGATCTC
ATGCTGGAGTTCTTCGCCCACCCCAGCTTCAAAAGCGCTCTGAAGTTCCCATACTTTCTAGAGAATAG
GAACTTCGGAATAGGAACTAAGGAGGATATTCATATGGACCATGGCTAATTCCCCGACTACGGCACCA
CCAATGATATTGCGGTGATCTGGCCGCAGGGTCGTGCGCCGCTGGTTCTGGTGACCTATTTTACCCA 
 
The kanamycin resistance gene aph was recombined with pCT gene blaCTX-M-14.  
PCR amplification across this genomic region and sequencing of the amplimer generated 
was used to confirm successful recombination.  
 
Red text, DNA sequence homologous to the blaCTX-M-14 gene, 
Black text, DNA sequence homologous to the aph gene region in L109, 
Green highlighted text, DNA region where homologous recombination has taken place.  
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wild-type pCT turned nitrocefin red, demonstrating the production of a β-lactamase 
(Figure 5.3). Host strains E. coli DH5α (I825) and S. Typhimurium SL1344 rifR 
(L1078) without plasmid did not produce a colour change with nitrocefin. Both strains 
containing pCT2 were also unable to produce β-lactamase, failing to cause a colour 
change of nitrocefin from yellow to red. 
5.5 Inactivation of pCT blaCTX-M-14 with a gfp  
In order to mark pCT with a constitutively expressed gfp for rapid detection and 
tracking of the plasmid, the gfpmut2 gene was inserted into blaCTX-M-14 using the 
same method as previously described in Section 5.4. Plasmid pUA66pacpP encoding 
adjacent aph and gfp genes was fully digested using restriction enzymes to prevent 
carry-over of intact plasmid into the PCR mixture, and reducing the selection of 
colonies which carried pUA66pacpP instead of a modified pCT. Digested plasmid 
DNA was the template for amplification of aph-gfpmut2 with primers designed with 20 
bp homology to upstream and downstream of the aph-gfpmut2 region on 
pUA66pacpP and with the same 40 bp homology to blaCTX-M-14 as previously 
described (Table 2.7, primer nos. 1038/1039). PCR yielded a 2438 bp fragment. 
Recombination using amplified aph-gfpmut2 was technically more difficult than with 
aph alone, probably due to the increased size of the PCR fragment (2,361 bp vs 
1,256 bp), therefore a higher yield of the PCR amplimer (aph-gfpmut2) (0.2 ng/ml of 
DNA) was required. Transformation of amplimers into freshly made competent and 
activated E. coli SW102 pCT (I879) cells produced seven kanamycin resistant 
colonies which fluoresced under excitation with light at 395 nm. All seven colonies 
were sub-cultured and their plasmid DNA harvested for PCR. Using primers external 
to the recombination region (Table 2.7, primer nos. 819/820), wild-type pCT  
 177 
 
Figure 5.3. Nitrocefin test for β-lactamase production 
 
 
 
 
 
Well 
No 
Laboratory 
number 
Strain (description) 
β-lactamase 
activity 
 
1 
 
I753 
 
E. coli C159/11 
 
+ 
2 I755 E. coli DH5α pCT  + 
3 L1079 S. Typhimurium SL1344 rif
R pCT + 
4 I778 E. coli DH5α pCT2 (blaCTX-M-14::aph) - 
5 L1244 S. Typhimurium  
SL1344 rifR pCT2  (blaCTX-M-14::aph) 
- 
6 I825 E. coli DH5α - 
7 L1078 S. Typhimurium SL1344 rif
R - 
 
β-lactamase production in each strain was investigated using synthetic indicator 
nitrocefin. Production of β-lactamase enzyme was indicated by a colour change from 
yellow (-) to red (+) <5 minutes after the addition of nitrocefin. Non β-lactamase 
producers failed to produce a colour change and remained yellow (-).  
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Figure 5.4. PCR amplimers from E. coli SW102 colonies containing putative 
mutated pCT2b (blaCTX-M-14::aph-gfpmut2) separated by electrophoresis  
 
 
Feature Description 
 
HL1 
 
Hyperladder 1 
 
1-7 SW102 candidate colonies putatively containing  
pCT2b (blaCTX-M-14::aph-gfpmut2 ) 
 
pCT Positive control (wild-type) 
 
-ve Negative control (water) 
 
Successful recombination of the aph-gfpmut2 PCR construct with pCT blaCTX-M-14 was 
indicated by the amplification of a large 2,631 bp PCR amplimer from putative mutant 
plasmids (Candidate colonies 1-7) when compared to a wild-type product of 876 bp.  
Ampliers were visualised using electrophoresis on a 1% agarose gel. 
 
876 bp 
2,631 bp 
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generated a fragment of 876 bp compared with putative inactivated plasmids, all of 
which produced amplimers of 2631 bp only (Figure 5.4). The PCR amplimer yielded 
from colony 1 was sequenced and showed the outer regions of blaCTX-M-14, the 
recombination sites and internal aph and gfpmut2 genes in the expected positions 
(Appendix 12). Therefore, plasmid DNA from colony 1 was extracted and transformed 
into E. coli DH5α. A colony from this transformation was stored and named E. coli 
DH5α pCT2b (blaCTX-M-14::aph-gfpmut2) (I826). pCT2b was also transferred by 
conjugation to recipient strains E. coli J53-2, E. coli 3950 and S. Typhimurium 
SL1344 rifR creating strains E. coli J53-2 pCT2b (I857), E. coli 3950 pCT2b (I836) 
and S. Typhimurium SL1344 rifR pCT2b (L1235). 
5.6 Removal of blaCTX-M-14 upstream insertion sequence ISEcp1 
It has been suggested that in the absence of a promoter region directly upstream of 
blaCTX-M, that a promoter sequence situated in the adjacent ISEcp1 element may 
allow expression or up-regulation of the β-lactamase (Poirel et al., 2003). To 
investigate the influence of ISEcp1 on pCT, 1008 bp of the ISEcp1 region was 
removed using the recombination technique described (Section 5.4), and replaced 
with the kanamycin resistance gene, aph. Due to primer design constraints only two 
of the three putatively identified promoter regions could be removed using this 
method. The altered plasmid was verified by PCR and sequencing (Appendix 13) and 
transformed into E. coli DH5α; this strain was named E. coli DH5α pCT6 
(ISEcp1::aph) (I830). pCT6 was also transferred by conjugation into E. coli J53-2 
(I847), E. coli 3950 (I823) and S. Typhimurium SL1344 rifR (L1078), creating strains 
E. coli J53-2 pCT6 (I861); E. coli 3950 pCT6 (I838) and S. Typhimurium SL1344 rifR 
pCT6 (L1245).  
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5.7 Effects on pCT plasmid biology of inactivating blaCTX-M-14  and ISEcp1 
5.7.1 Stability of plasmids pCT2, pCT2b and pCT6 in host cells 
Wild-type pCT was stably maintained in 100% of bacterial cells without the presence 
of antibiotic selection over ~70 generations (Chapter 4). To assess whether 
inactivation of the blaCTX-M-14 gene and removal of ISEcp1 affected the maintenance 
and persistence of pCT, E. coli DH5α, E. coli J53-2, E. coli 3950 and S. Typhimurium 
SL1344 rifR containing plasmids pCT2 (blaCTX-M-14::aph), pCT2b (blaCTX-M-14::aph-gfp) 
and pCT6 (ISEcp1::aph) were grown in isogenic cultures over 96 hours in LB broth 
without antibiotics with passage into fresh broth after 12 hours, and subsequently 
every 24 hours. Over the 96 hours all three plasmids were stably maintained within 
100% of the four bacterial host strains, showing that inactivation of the blaCTX-M-14 had 
no detrimental effect on pCT persistence under these conditions. 
5.7.2 Conjugative transfer of pCT2, pCT2b and pCT6 compared to pCT 
The conjugation frequency of each mutant plasmid was measured from donor E. coli 
DH5α cells to recipient bacteria over a three hour period at 370C both on solid 
(Figure 5.5, Appendix 14) and in liquid media (Figure 5.6, Appendix 15). Inactivation 
of blaCTX-M-14 (pCT2) and removal of ISEcp1 (pCT6) had no significant effect on the 
frequency of pCT conjugation to any of the recipient hosts, in liquid or a solid surface. 
The addition of gfpmut2 (pCT2b) reduced the frequency of pCT transfer to recipient 
E. coli J53-2, but did not affect conjugation into the other recipient strains (E. coli 
3950 and S. Typhimurium SL1344 rifR). Therefore, these data suggest that 
inactivation of blaCTX-M-14 had no affect on the ability of pCT to conjugate to the 
recipient strains tested in the absence of antibiotic pressure.  
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Figure 5.5. Conjugation frequencies of pCT and blaCTX-M-14 mutants pCT2, 
pCT2b and pCT6 on solid media to various recipients 
 
 
 
 
The conjugation frequency of pCT2 (blaCTX-M-14::aph)(purple), pCT2b (blaCTX-M-14::aph-
gfpmut2)(green) and pCT6 (ISEcp1::aph)(yellow) were compared to the conjugation 
frequency of wild-type pCT (red) from donor bacterial strain E. coli DH5α to recipient 
strains S. Typhimurium SL1344 rifR, E. coli J53-2 and E.coli 3950 on a filter. 
Conjugation frequencies were calculated from the mean of at least three separate 
experiments (Appendix 14). Values returning a P value of <0.05 from a Student‟s T-
test were considered statistically significant are represented with an asterix.  
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Figure 5.6. Conjugation frequencies of pCT and blaCTX-M-14 mutants pCT2, 
pCT2b and pCT6 in liquid media to various recipients 
 
 
 
 
 
The conjugation frequency of pCT2 (blaCTX-M-14::aph)(purple), pCT2b (blaCTX-M-14::aph-
gfpmut2)(green) and pCT6 (ISEcp1::aph)(yellow) were compared to the conjugation 
frequency of wild-type pCT (red) from donor bacterial strain E. coli DH5α to recipient 
strains S. Typhimurium SL1344 rifR, E. coli J53-2 and E.coli 3950 in liquid media. 
Conjugation frequencies were calculated from the mean of at least three separate 
experiments (Appendix 15). Values returning a P value of <0.05 from a Student‟s T-
test were considered statistically significant are represented with an asterix.  
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5.8 Effects of pCT2, pCT2b and pCT6 upon the bacterial host strain 
compared to wild-type pCT 
5.8.1 Susceptibility to cefotaxime and ceftiofur 
The MIC of cefotaxime and ceftiofur for each host strain containing plasmids pCT2, 
pCT2b and pCT6 were compared to that of host strains containing wild-type pCT. 
pCT was shown to confer resistance to both cefotaxime and ceftiofur when 
transferred to a new bacterial host therefore these drugs were selected to represent 
commonly used clinical and veterinary third generation cephalosporins respectively. 
In all hosts, the inactivation of blaCTX-M-14 (pCT2 and pCT2b) reduced the MIC of both 
drugs back to that for the corresponding strain with no pCT (Table 5.1). This 
confirmed that this gene conferred resistance to cefotaxime. Inactivation of the 
blaCTX-M-14 upstream element ISEcp1 had no effect on host susceptibility to 
cefotaxime or ceftiofur as the MIC of these agents was found to be the same for all 
host strains containing pCT and pCT6 (Table 5.1).  
5.8.2 Growth rate of host bacteria containing pCT2, pCT2b and pCT6 
To establish whether blaCTX-M-14 modification had an effect on host strain growth, the 
growth kinetics of host strains containing pCT2, pCT2b and pCT6 were compared to 
those containing pCT. The optical densities (600 nm) of three biological and four 
technical repeats for each strain, were measured automatically by a FLUOstar 
OPTIMA (BMG Labtech, UK) every ten minutes for 16 hours. From these data the 
generation times during mid-logarithmic phase were calculated and compared. The 
inactivation of the pCT blaCTX-M-14 by the addition of aph or aph-gfpmut2 (pCT2 and 
pCT2b) and the removal of pCT ISEcp1 (pCT6) had no significant effect on the 
generation times of E. coli hosts 3950 (Figure 5.7, Appendix 16) or E. coli J53-2 
(Figure 5.8, Appendix 17). The generation times of host E. coli DH5α containing 
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Table 5.1. Minimum inhibitory concentrations of two β-lactam antibiotics for 
hosts containing pCT and blaCTX-M-14 modified plasmids pCT2, pCT2b and pCT6 
Laboratory 
number Strain 
MIC of cefotaxime 
(µg/ml) 
MIC of ceftiofur 
(µg/ml) 
  
 
 
I753 C159/11 32 64 
I825 DH5α 0.03 0.25 
I755 DH5α pCT  16 32 
I778 DH5α pCT2 (blaCTX-M-14::aph) 0.03 0.5 
I826 DH5α pCT2b (blaCTX-M-14::aph-gfpmut2) 0.03 0.25 
I830 DH5α pCT6 (ISEcp1::aph) 16 32 
I847 J53-2  0.03 0.5 
I834 J53-2 pCT 16 32 
I856 J53-2 pCT2 (blaCTX-M-14::aph) 0.03 0.5 
I857 J53-2 pCT2b (blaCTX-M-14::aph-gfpmut2) 0.03 0.5 
I861 J53-2 pCT6 (ISEcp1::aph) 16 32 
I823 3950 0.03 0.5 
I855 3950 pCT 16 64 
I835 3950 pCT2 (blaCTX-M-14::aph) 0.03 0.5 
I836 3950 pCT2b (blaCTX-M-14::aph-gfpmut2) 0.03 0.5 
I838 3950 pCT6 (ISEcp1::aph) 16 64 
L1078 SL1344 rifR  0.06 1 
L1079 SL1344 rifR pCT 64 64 
L1244 SL1344 rif
R pCT2 (blaCTX-M-14::aph) 0.03 1 
L1235 
SL1344 rifR pCT2b                        
(blaCTX-M-14::aph-gfpmut2) 
0.03 
  1 
L1245 SL1344 rif
R pCT6 (ISEcp1::aph) 64 64 
MICs were taken as the modal value of at least three separate experiments with an 
acceptable error of one doubling dilution. Bold text indicated a change in MIC due to 
inactivation of blaCTX-M-14. 
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Figure 5.7. Growth kinetics of E. coli 3950 containing plasmids pCT2, pCT2b 
and pCT6 compared to E. coli 3950 pCT 
 
 
 
The growth kinetics of bacterial host strain E. coli 3950 containing either pCT, pCT2 
(blaCTX-M-14::aph), pCT2b (blaCTX-M-14::aph-gfpmut2) or pCT6 (ISEcp1::aph) were 
measured using the FLUOstar OPTIMA using at least three biological and four 
technical repeats. Generation times were calculated between hours 1-2 (Appendix 
16). 
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Figure 5.8. Growth kinetics of E. coli J53-2 containing plasmids pCT2, pCT2b 
and pCT6 compared to E. coli J53-2 pCT 
 
 
 
 
The growth kinetics of bacterial host strain E. coli J53-2 containing either pCT, pCT2 
(blaCTX-M-14::aph), pCT2b (blaCTX-M-14::aph-gfpmut2) or pCT6 (ISEcp1::aph) were 
measured using the FLUOstar OPTIMA using at least three biological and four 
technical repeats. Generation times were calculated between hours 1-2 (Appendix 
17). 
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Figure 5.9. Growth kinetics of E. coli DH5α containing plasmids pCT2, pCT2b 
and pCT6 compared to E. coli DH5α pCT 
 
 
 
   
The growth kinetics of bacterial host strain E. coli DH5α containing either pCT, pCT2 
(blaCTX-M-14::aph), pCT2b (blaCTX-M-14::aph-gfpmut2) or pCT6 (ISEcp1::aph) were 
measured using the FLUOstar OPTIMA using at least three biological and four 
technical repeats. Generation times were calculated between hours 1-2 (Appendix 
18). The generation time during mid-logarithmic phase of E. coli DH5α pCT2b was 
found to be statistically significantly different from that of E. coli DH5α pCT (P = 0.02) 
when a P value of <0.05 was returned using the Student‟s T test (Appendix 18).   
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Figure 5.10. Growth kinetics of S. Typhimurium rifR containing plasmids pCT2, 
pCT2b and pCT6 compared to S. Typhimurium rifR SL1344 pCT 
 
 
 
 
The growth kinetics of bacterial host strain S. Typhimurium SL1344 rifR containing 
either pCT, pCT2 (blaCTX-M-14::aph), pCT2b (blaCTX-M-14::aph-gfpmut2) or pCT6 
(ISEcp1::aph) were measured using the FLUOstar OPTIMA using at least three 
biological and four technical repeats. Generation times were calculated between 
hours 1-2 (Appendix 19). The generation time during mid-logarithmic phase of S. 
Typhimurium SL1344 rifR pCT6 was found to be statistically significantly different 
from that of E. coli S. Typhimurium SL1344 rif
R
 pCT (P = 0.036) when a P value of 
<0.05 was returned using the Student‟s T test (Appendix 19). 
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pCT2 and pCT6 were unchanged when compared to E. coli DH5α pCT, however E. 
coli DH5α pCT2b (blaCTX-M-14::aph-gfpmut2) had a significantly decreased generation 
time during mid-logarithmic phase (Figure 5.9, Appendix 18). In S. Typhimurium host 
SL1344 rifR (Figure 5.10), inactivation of blaCTX-M-14 (pCT2 and pCT2b) had no effect 
on generation times, however, the removal of ISEcp1 (pCT6) resulted in a statistically 
significant increase (P = 0.036) in the generation time of during mid-logarithmic 
phase (Figure 5.10, Appendix 19). 
5.8.3 The effect of pCT2, pCT2b and pCT6 on the ability of bacterial host strains to 
cause infection   
The effect of inactivating pCT blaCTX-M-14 and removal of ISEcp1 on the ability of host 
strains to cause infection when compared to hosts containing wild-type pCT were 
investigated using tissue culture and C. elegans models of infection. Inactivation of 
blaCTX-M-14 by insertion of aph alone (pCT2) had no significant effect on the ability of 
S. Typhimurium SL1344 rifR to adhere to, or invade intestinal cells (Figure 5.11, 
Appendix 20); likewise there was no significant difference in the rate of C. elegans 
killing (Figure 5.12, Appendix 21). Inactivation of blaCTX-M-14 with aph and gfpmut2 
(pCT2b) also had no effect on the host strains ability to kill C. elegans (Figure 5.12) 
however did reduce the number of S. Typhimurium SL1344 rifR able to adhere to and 
invade INT-407 cells when compared to S. Typhimurium SL1344 rifR pCT (Figure 
5.11B). Lastly, E. coli 3950 pCT6 killed C. elegans at the same rate as 3950 pCT 
(Figure 5.12B). However, S. Typhimurium SL1344 rifR pCT6 killed C. elegans at a 
significantly slower rate than S. Typhimurium SL1344 rifR pCT (Chi squared test, P = 
0.0001) (Figure 5.12A) and was impaired in its ability to adhere to and invade INT-
407 cells (Figure 5.11, Appendix 20) (Adhesion, P = 0.0003, Invasion, P = <0.0001).  
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Figure 5.11. The ability of S. Typhimurium SL1344 rifR with wild-type pCT and 
blaCTX-M-14 modified plasmids to adhere to and invade human intestinal cells 
  
 
The number of S. Typhimurium SL1344 rifR containing pCT2 (purple) pCT2b (green) 
or pCT6 (yellow) able to adhere to (A) and invade (B) INT-407 human intestinal cell is 
represented as a percentage of the number of S. Typhimurium SL1344 rifR pCT (red) 
able to do so under test conditions (Appendix 20). Data are displayed as a mean of 
three separate experiments all performed with four technical repeats.  
Values returning a P value of <0.05 from a Student‟s T-test were considered 
statistically significant are represented with an asterix.  
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Figure 5.12. The ability of bacterial hosts containing pCT2, pCT2b and pCT6 to 
cause infection the C. elegans 
 
  
 
Survival curves were constructed using a Kaplan Mier calculation showing the 
probability of C. elegans survival each day when fed continuously on the tested 
bacterial strains.  
A significance difference was found in the killing rate between S. Typhimurium 
SL1344 rifR pCT and S. Typhimurium SL1344 rifR pCT6 (ISEcp1::aph) (P = 0.0001). 
A significant difference in killing rate was defined as a P value <0.05 (Appendix 21).  
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5.9 Pair-wise competition in vitro of hosts containing pCT and pCT2 
To assess the competitive fitness of pCT +/- the blaCTX-M-14 gene in E. coli strains, 
pCT2 containing bacteria were competed in a 1:1 ratio against the corresponding 
host containing wild-type pCT in vitro on three separate occasions. During the first 
twelve hours, samples were collected every two hours and the proportion of bacteria 
carrying each plasmid calculated. After this time, samples were taken and the mixture 
was passaged into fresh LB broth every 24 hours for up to 96 hours, ~70 
generations. In all three E. coli host strains (DH5α, J53-2 and 3950) the plasmids 
remained in a 1:1 ratio during the first 12 hours, before the first passage (Figure 5.13, 
Appendix 22). Plasmids competed in E. coli DH5α remained in a 1:1 ratio throughout 
the experiment and after four passages. In E. coli 3950 pCT and pCT2 also remained 
in a 1:1 ratio, however, there was more variation in the values obtained. In E. coli 
J53-2 the proportions of bacteria containing pCT2 increased during the experiment 
such that after 72 hours (three passages) pCT2 was found in 87% (Competition 
Index = 1.071).   
5.10 In vitro competition between E. coli J53-2 and E. coli J53-2 pCT2 
In chapter 4, wild-type pCT was shown to confer a fitness cost on E. coli host strain 
J53-2. In Section 5.9 of this chapter, E. coli J53-2 pCT2 was shown to have a 
competitive advantage over E. coli J53-2 pCT suggesting that pCT2 may confer less 
of a fitness cost to this host than pCT. Therefore, E. coli J53-2 pCT2 was competed 
in a 1:1 ratio with parental strain E. coli J53-2 to assess the fitness burden conferred 
by pCT2 (blaCTX-M-14::aph) on E. coli J53-2 (Figure 5.14).  
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Figure 5.13. Competition between E. coli hosts carrying pCT and pCT2 
 
 
 
 
The percentage of plasmid pCT2 carrying bacteria was calculated over time when E. coli 
strains carrying pCT or pCT2 were co-cultured in a 1:1 ratio  in vitro (Appendix 22). A, The 
proportion of pCT2 carrying bacteria in a DH5α pCT:pCT2 co-culture; B, The proportion of 
pCT carrying bacteria in a 3950 pCT:pCT2 co-culture; C, The proportion of pCT carrying 
bacteria in a J53-2 pCT:pCT2 co-culture. Cultures were passaged into fresh broth at hour 12, 
24, 48, 72 and 96 hours.  
CI, competition index of the pCT containing strain in each pairing. An asterix represent a 
statistically significant change in the proportion of bacteria containing pCT (P <0.005). 
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Figure 5.14. Pair-wise competitive growth in vitro between E. coli J53-2 and E. coli J53-2 pCT2 (blaCTX-M-14::aph)  
 
Competition index of E. coli J53-2 pCT2 at 12 hours (before first passage) = 1.0037, P = 0.414 (no significant change) 
Competition index of E. coli J53-2 pCT2 at 96 hours (after three passages) = 0.9996, P = 0.286 (no significant change) 
 
The percentage of E. coli J53-2 bacteria carrying pCT2 over time was calculated when E. coli J53-2 +/- pCT2 was co-
cultured in a 1:1 ratio in vitro. Cultures were passaged at hour 12, 24, 48 and 72 hours. The competition index was 
calculated from averages generated from at least three separate experiments.  
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The proportion of bacteria containing pCT2 remained at a 1:1 ratio throughout the 
duration of the experiment (CI = 0.9996 at 96 hours). This data suggests that the 
inactivation of the pCT blaCTX-M-14 gene (or the presence of the aph gene) decreases 
the pCT fitness burden on host strain E. coli J53-2, however did not alleviate the cost 
to allow spread of pCT throughout the population, as seen in host strains E. coli 
DH5α or E. coli 3950 (Figure 4.2). 
5.11 Discussion 
The relative advantages and disadvantages of a resident antibiotic resistance gene 
on the ability of large natural plasmids such as pCT to persist and spread in the 
absence of selective pressure is largely unknown. In order to assess the role of the 
sole pCT resistance gene, blaCTX-M-14, in the evolutionary fitness of the plasmid in the 
absence of antibiotic pressure, this gene was inactivated and the biological effects on 
plasmid and bacterial host were investigated.  
To inactivate blaCTX-M-14 on pCT, a novel protocol was designed which allowed easy 
and rapid targeted inactivation using a chromosomally based ʎ-red recombinase.  
This method was also shown to be effective in inactivating ISEcp1 and five additional 
pCT genes (Chapter 6). Although optimised to inactivate pCT genes, this 
straightforward protocol could be applied to the inactivation of genes found on any 
plasmid which can be successfully transformed and extracted from E. coli SW102. A 
problem encountered post-recombination was the presence of both wild-type and 
mutant plasmid within the same bacterium, either co-existing or as a monomer. Wild-
type pCT was successfully removed from bacteria by cycling cells in the presence of 
kanamycin. It is possible that exposure to the Gam component of the ʎ-red 
recombinase (which inhibits host nucleases) caused problems in plasmid replication 
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which may have led to monomer formation (Silberstein and Cohen, 1987; Katashkina 
et al., 2009). During repeated use of this method this problem was not encountered 
again, suggesting that it was not a common event (Chapter 6). 
The biological effects of inactivating blaCTX-M-14 and ISEcp1 on pCT plasmid stability 
and conjugative transfer were assessed. blaCTX-M-14 and ISEcp1 did not contribute to 
the inherent ability of pCT to be maintained within a bacterial population as pCT2, 
pCT2b and pCT6 remained stable over ~70 generations in the absence of antibiotic 
pressure. These data suggest that pCT stability is determined by other plasmid 
encoded factors for example, possible functional partitioning or addiction systems 
(Hayes, 2003). The inactivation of blaCTX-M-14 and ISEcp1 on pCT also had no 
statistically significant effect on pCT‟s capacity to transfer to plasmid free bacterial 
strains. Of interest, pCT2 and pCT6 consistently conjugate at a higher rate than pCT, 
and their transfer frequencies were very similar under many of the conditions tested. 
As both plasmids gained additional DNA during the recombination process (pCT2 
was 888 bp and pCT6 was 484 bp larger than wild-type pCT after recombination) it 
may have been predicted that these plasmids would take longer to transfer than pCT 
due to a longer replication time, although this effect may have been modest. The 
simplest explanation for increased frequency of conjugation is that the addition of the 
kanamycin resistance gene aph, which is common to both plasmids, had a positive 
effect on the conjugation process perhaps affecting a repressive regulatory 
mechanism (Haft et al., 2006). Alternatively, it is tempting to speculate that the 
inactivation of blaCTX-M-14 (pCT2) and removal of a possible promoter (pCT6) may 
have alleviated a metabolic cost on the donor cell. This may allow a more rapid 
frequency of transfer (or altered transfer regulation).  
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pCT2b had a decreased conjugation frequency when compared to pCT. As pCT2b is 
1485 bp larger than wild-type pCT (due to the insertion of aph-gfpmut2) and encodes 
a constitutively expressed stable GFP, it may be that pCT2b confers a larger cost on 
the host bacterial cell. Wendland and Bumann (2005) showed that the production of 
GFP conferred a metabolic burden and became toxic to host cells when expressed at 
high levels. As the copy number of pCT and pCT2b has not been determined it is 
unclear how many copies of gfpmut2 were present in each cell and therefore whether 
production of GFP is likely to have reached toxic levels. However, there is little 
evidence in the literature that production of GFP has a negative effect on conjugation 
rates, and published studies have marked plasmids with gfp in order to measure 
plasmid transfer (Dahlberg et al., 1998; Sorensen et al., 2005). In my study, there 
was a reduction in the rate of pCT2b transfer in particular to recipient E. coli J53-2, 
suggesting host specific factors either related to the typically high transfer rate into 
this recipient or perhaps greater sensitivity to GFP.  
The effects of inactivating blaCTX-M-14 on pCT host phenotypes were assessed by 
measuring pathogenicity in two infection model systems, growth kinetics and 
competitive fitness. Bacterial host strains containing pCT2 adhered to, and invaded 
tissue culture cells and killed C. elegans at an equivalent rate to strains containing 
pCT. These data suggest that inactivation of the blaCTX-M-14 gene had no effect on the 
ability of the bacterial host to cause infection when compared to hosts containing 
pCT. This corresponds with the findings of Dubois et al. (2009) who showed that the 
addition of blaCTX-M-1 to E. coli DH5α did not confer a change in virulence when 
measured in human brain micro-vascular endothelial cells and in a mouse meningitis 
model. S. Typhimurium SL1344 rif
R
 pCT2b invaded human intestinal cells at a 
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significantly lower rate than SL1344 rifR pCT. The less invasive nature of GFP 
producing bacteria is well documented in the literature and is suggested to be a 
result of a reduction in the ability of the GFP producing bacterium to adapt to the 
stress of intracellular life due to the extra stress already imposed by GFP (Knodler et 
al., 2005). 
The effect of inactivating blaCTX-M-14 on pCT host growth in the absence of cefotaxime 
was initially assessed by comparing the growth rates and generation times during the 
mid-logarithmic phase of each host strain harbouring either pCT or pCT2. No 
significant difference was found in any of the four bacterial host strains investigated. 
Recombination of blaCTX-M-14 with aph-gfpmut2 also had no effect on host growth, 
except in host E. coli DH5α where the addition of pCT2b resulted in a decreased 
generation time, compared to E. coli DH5α pCT. However, it should be noted that this 
finding was not replicated when growing DH5α pCT2b continuously shaking in larger 
volumes. It is important to note that the generation times calculated from growth in 
the FLUOstar OPTIMA do not necessarily reflect the generation times in other growth 
conditions due to reduced aeration, shaking and smaller culture volumes, therefore 
generation values are only comparable and relative to one another.  
My data indicates that in vitro growth of host bacteria containing pCT was unaffected 
by the presence or absence of blaCTX-M-14, suggesting this gene confers neither a 
fitness cost nor benefit to the host bacterium in the absence of antibiotic selective 
pressure. This was further supported by the finding that pCT and pCT2 remained in a 
1:1 ratio when cultured together in host strains E. coli DH5α and E. coli 3950, 
confirming that the inactivation of blaCTX-M-14 had no affect on the plasmids 
competitive fitness in these strains in the absence of antibiotic selective pressure. 
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However, in the third host E. coli J53-2, pCT2 had a significant fitness benefit over E. 
coli J53-2 pCT. pCT2 was also shown to confer less of a fitness cost upon host strain 
E. coli J53-2 than pCT, suggesting that the inactivation of blaCTX-M-14 (or/and addition 
of the aph gene) reduces the burden of the plasmid on this host strain.  
There are many examples of β-lactamases which confer a metabolic cost upon their 
host bacteria. Those β-lactamase genes under inducible promoters, for example 
blaAMP-C, are often found to have less of a fitness cost than when the same genes 
were constitutively expressed (Morosini et al., 2000; Moya et al., 2008). Similarly, 
blaCMY-7 had a higher fitness cost when located on high copy number plasmids than 
on low copy number plasmids or on the chromosome (Hossain et al., 2004). The 
copy numbers of pCT and pCT2 in the various host strains were not determined in 
this study. If differences exist in the pCT copy number when in different hosts, or 
between pCT and pCT2 in the same host, this will determine how many copies of the 
blaCTX-M-14 gene are present in one cell. If pCT has a higher copy number than pCT2 
in E. coli J53-2 this would result in a greater metabolic burden and may explain the 
results obtained. Mroczkowska and Barlow (2008) showed an enzyme specific effect 
when bacteria encoding blaTEM-1 outcompeted the same host carrying blaTEM-10 and 
blaTEM-12. Similarly, blaSME-1 and blaAMP-C conferred a greater fitness burden in certain 
bacterial host strains (E. coli K12 and S. Typhimurium SL1344 respectively)(Morosini 
et al., 2000; Marciano et al., 2007).  
Interaction between plasmid and chromosomal resistance genes has also been 
shown to have a fitness effect on the host bacteria. Silva et al. (2011) examined 
epistasis between plasmid and chromosomally encoded antibiotic resistance genes. 
In many cases the fitness burden when carrying both chromosomal and plasmid 
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antibiotic resistance genes did not amount to the sum of the costs of these antibiotic 
resistance determinants when found separately. In one case the presence of gyrA 
mutation D87G and carriage of IncB plasmid R16 (conferring antibiotic resistance to 
ampicillin, kanamycin, streptomycin and sulphonamides tetracycline) alleviated the 
burden imposed by either plasmid or chromosomal mutation alone (Silva et al., 
2011). These findings may have implications in this study as E. coli J53-2 also has 
an rpoB mutation, it may be that interaction between pCT and/or blaCTX-M-14 with 
resistance genes found on the E. coli J53-2 chromosome account for the differences 
seen when using this host strain.  
Despite the high conjugation rate of pCT to E. coli J53-2 recipients observed in the 
conjugation assays, the data collected during the pair-wise competition assay may 
suggest that pCT and pCT2 do not conjugate to plasmid free bacteria under these 
conditions.  This may explain why if pCT also confers a fitness cost upon host E. coli 
J53-2, this plasmid is rapidly lost from a mixed population when it appears stable 
when grown isogenically. It would also explain why E. coli J53-2 pCT2 remains in a 
1:1 ratio with J53-2 instead of disseminating to plasmid free bacteria as seen with the 
other E. coli bacterial host strains. Alternatively the results from co-culture of E. coli 
J53-2 and E. coli J53-2 pCT2 may reflect a balance of the rate of plasmid transfer 
with the rate at which E. coli J53-2 pCT2 is outcompeted by E. coli J53-2.  
A limitation to measuring relative fitness of strains carrying plasmids using a direct 
pair-wise competition in vitro is the potential transfer of plasmids within the assay, 
thereby preventing the accurate assessment of the proportion of cells for example E. 
coli DH5α pCT vs. E. coli DH5α pCT2. To resolve this issue the proportion of host 
strains carrying either pCT or pCT2 at each time point was measured rather than the 
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hosts themselves. A more complex study design to examine competitive fitness could 
have marked host strains either within the chromosomal DNA (Grant et al., 2008) or 
using fluorescence markers (e.g. gfp, rfp). This stategy may have elucidated the level 
and nature of transfer within each pair-wise competition experiment; however 
ensuring each combination of variables (e.g. marker, plasmid and resistance gene) 
did not have a different fitness cost on the host strain would have been very difficult. 
Therefore the simpler experimental design was used and deemed sufficient to 
answer whether pCT2 was more or less evolutionary fit than wild-type pCT.  
Another limitation of this study was that blaCTX-M-14 was inactivated by replacement 
with an alternative resistance gene (aph) rather than complete removal of blaCTX-M-14. 
This strategy was used due to the technical difficulties associated with genetic 
manipulation without a selective marker, but also so that kanamycin could be used to 
ensure maintenance of the plasmid and selection between hosts harbouring pCT or 
pCT2 during the competition experiments. Similarly, the marking of pCT by the 
addition of gfp was controlled for by recombining this gene into blaCTX-M-14 so any gfp 
specific effects would be highlighted when comparing pCT2b to pCT2. 
When insertion sequence ISEcp1, was placed upstream of blaCTX-M-19 (a single point 
mutation variant of blaCTX-M-14) the expression of this antibiotic resistance gene was 
up-regulated (Poirel et al., 2003). It has been proposed that ISEcp1 also up-regulates 
blaCTX-M-14 when located upstream of this gene on plasmids. To investigate whether 
ISEcp1 has an influence on pCT fitness or the susceptibility of host strains to β-
lactams, 1,008 bp of this element was removed and replaced with aph (pCT6). Host 
strains containing this plasmid had a comparable susceptibility to β-lactam antibiotics 
as hosts harbouring wild-type pCT, indicating that ISEcp1 has no significant effect on 
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the β-lactamase gene. S. Typhimurium SL1344 rifR pCT6 had altered growth kinetics 
and was also attenuated in both the C. elegans killing model and in its ability to 
adhere to and invade tissue culture cells when compared to S. Typhimurium SL1344 
rifR pCT. An explanation for this effect is difficult as the same effect was not observed 
with pCT2, therefore it is unlikely to be due to a down regulation of β-lactamase gene 
expression. It is possible that the ISEcp1 transposase can interact with the S. 
Typhimurium SL1344 rifR chromosome.  
Analysis of the pCT sequence showed the presence of three putative promoter 
regions encoded within the pCT ISEcp1 (Figure 5.15), the first of which shows the 
most homology with the proposed ISEcp1 promoter of blaCTX-M-19 (Poirel et al., 2003; 
Poirel et al., 2005). Therefore inactivation of ISEcp1 focused on these putative 
promoter sequences. Further investigation of this region revealed a fourth putative 
promoter sequence found 116 bp upstream of blaCTX-M-14 (-35 TTGAAA and -10 
TGTTACAAT) previously not described in other blaCTX-M carrying plasmids (as of 
September 2011). While the 42 bp found directly upstream of the pCT blaCTX-M-14 are 
homologous to the upstream region of almost all described blaCTX-M-14 genes (Kim et 
al., 2011), the further 207 bp found within the pCT spacer region are unusual. This 
fourth promoter region is predicted to be a strong promoter of blaCTX-M-14 due to its 
proximity to the start codon and the high level of homology to the consensus 
promoter sequence. It is hypothesised that this fourth promoter is primarily 
responsible for the expression of blaCTX-M-14. If this is the case then promoter 
sequences within ISEcp1 become less important for pCT than in other published 
plasmids, and possibly accounts for an absence of a biological effect on inactivating 
the pCT ISEcp1.  
 203 
 
Figure 5.15. Sequence of the pCT ISEcp1 element and downstream spacer 
region marked with putative promoters and the site for recombination 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Black text, ISEcp1 sequence remaining after recombination with aph PCR construct, 
White text, DNA removed by recombination with the aph PCR construct, 
Pink highlighted text, predicted promoter regions (-35 and -10), 
Yellow highlighted text, binding regions of recombination primers, 
Grey text, 249 bp spacer region between ISEcp1 and blaCTX-M-14, 
Blue text, blaCTX-M-14. 
ATGATTAATAAAATTGATTTCAAAGCTAAGAATCTAACATCAAATGCAGGTCTTT
TTCTGCTCCTTGAGAATGCAAAAAGCAATGGGATTTTTGATTTTATTGAAAATGA
CCTCGTATTTGATAATGACTCAACAAATAAAATCAAGATGAATCATATAAAGACC
ATGCTCTGCGGTCACTTCATTGGCATTGATAAGTTAGAACGTCTAAAGCTACTTC
AAAATGATCCCCTCGTCAACGAGTTTGATATTTCCGTAAAAGAACCTGAAACAGT
GTCACGGTTTCTAGGAAACTTCAACTTCAAGACAACCCAAATGTTTAGAGACATT
AATTTTAAAGTCTTTAAAAAACTGCTCACTAAAAGTAAATTGACATCCATTACGA
TTGATATTGATAGTAGTGTAATTAACGTAGAAGGTCATCAAGAAGGTGCGTCAAA
AGGATATAATCCTAAGAAACTGGGAAACCGATGCTACAATATCCAATTTGCATTT
TGCGACGAATTAAAAGCATATGTTACCGGATTTGTAAGAAGTGGCAATACTTACA
CTGCAAACGGTGCTGCGGAAATGATCAAAGAAATTGTTGCTAACATCAAATCAGA
CGATTTAGAAATTTTATTTCGAATGGATAGTGGCTACTTTGATGAAAAAATTATC
GAAACGATAGAATCTCTTGGATGCAAATATTTAATTAAAGCCAAAAGTTATTCTA
CACTCACCTCACAAGCAACGAATTCATCAATTGTATTCGTTAAAGGAGAAGAAGG
TAGAGAAACTACAGAACTGTATACAAAATTAGTTAAATGGGAAAAAGACAGAAGA
TTTGTCGTATCTCGCGTACTGAAACCAGAAAAAGAAAGAGCACAATTATCACTTT
TAGAAGGTTCCGAATACGACTACTTTTTCTTTGTAACAAATACTACCTTGCTTTC
TGAAAAAGTAGTTATATACTATGAAAAGCGTGGTAATGCTGAAAACTATATCAAA
GAAGCCAAATACGACATGGCGGTGGGTCATCTCTTGCTAAAGTCATTTTGGGCGA
ATGAAGCCGTGTTTCAAATGATGATGCTTTCATATAACCTATTTTTGTTGTTCAA
GTTTGATTCCTTGGACTCTTCAGAATACAGACAGCAAATAAAGACCTTTCGTTTG
AAGTATGTATTTCTTGCAGCAAAAATAATCAAAACCGCAAGATATGTAATCATGA
AGTTGTCGGAAAACTATCCGTACAAGGGAGTGTATGAAAAATGTCTGGTATAATA
AGAATATCATCAATAAAATTGAGTGTTGCTCTGTGGATAACTTGCAGAGTTTATT
AAGTATCATTGCAGCAAAGATGAAATCAATGATTTATCAAAAATGATTGAAAGGT
GGTTGTAAATAATGTTACAATGTGTGAGAAGCAGTCTAAATTCTTCGTGAAATAG
TGATTTTTGAAGCTAATAAAAAACACACGTGGAATTTAGGGAATACTGATGTAAC
ACGGATTGACCGTATTGGGAGTTTGAGATGGTGACAAAGAGAGTGCAACGGATGA 
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In conclusion, inactivation of ESBL gene blaCTX-M-14 on plasmid pCT restored host 
susceptibility to β-lactam antibiotics but had no significant effect on the stability and 
transfer frequency of the plasmid, on growth rates of host bacterial strains or the 
ability of host bacteria to cause infection. Inactivation of blaCTX-M-14 conferred neither 
a fitness cost or fitness benefit when pCT2 was directly competed with the wild-type 
pCT in vitro in two out of three E. coli hosts. Replacement of the ISEcp1 element and 
associated promoter sequences with aph had no effect on host susceptibility to 
cefotaxime and had no biological effect on E. coli DH5α, J53-2 and 3950 host strains. 
These data indicate that this resistance gene has little effect on plasmid and host 
biological functions, and in the absence of antibiotic pressure is unlikely to have 
made a significant contribution to the success of pCT. Therefore, as blaCTX-M-14 is the 
only antibiotic resistance gene encoded on pCT, other plasmid backbone factors will 
determine persistence, dissemination and success of pCT in the absence of antibiotic 
pressure.  
5.12 Further work 
Several questions were raised by the inactivation of blaCTX-M-14 and upstream 
insertion sequence ISEcp1. To further investigate interactions between hosts, 
plasmids and blaCTX-M-14, this gene could be cloned or recombined into other plasmid 
backbones, either a well characterised molecular vector such as pBR322 (as in the 
early fitness experiments)(Lee and Edlin, 1985); or onto another large natural 
plasmid which lacks a β-lactamase gene. The fitness effects of blaCTX-M-14 on a naive 
plasmid and other bacterial host strains could then be assessed to suggest whether 
pCT may have adapted to accommodate the resistance gene after acquisition, or 
whether blaCTX-M-14 inherently confers no or little cost in the absence of selective 
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pressure. The integration of other clinically relevant resistance genes such as blaNDM-
1, blaCTX-M-15 or blaCMY-2 into the pCT genome would also allow the investigation of 
whether pCT has co-evolved to tolerate blaCTX-M-14 specifically or whether the 
backbone is unperturbed by the addition of potentially costly resistance genes.  
If this study were to be repeated with the knowledge that the plasmid remains stable 
in the absence of selective pressure over at least 70 generations, complete removal 
of blaCTX-M-14 may have been a better study design. After recombination with aph, 
pCP20 as is described by Datsenko and Wanner (2000) would be used to remove 
the aph cassette. While technically difficult this would allow a cleaner assessment of 
the role of blaCTX-M-14 in pCT success. Alternatively, inactivation of the blaCTX-M-14 gene 
could use a range of selective markers e.g. chloramphenicol resistance gene cat or 
tetracycline resistance gene tetO to further investigate the effects of inactivating 
blaCTX-M-14 versus the insertion of a new resistance marker.  
Another key question remaining is whether blaCTX-M-14 is differentially expressed, 
either in different hosts, under different growth conditions, and when putative 
promoters within the ISEcp1 element have been removed. To investigate this RNA 
should be extracted from each host strain containing pCT, pCT2 and pCT6 and the 
levels of blaCTX-M-14 mRNA compared using RT-PCR. There are inherent problems 
with this straightforward method. The first is that a change in plasmid copy number 
would increase the level of mRNA within a cell therefore confounding the data. To get 
around this, copy number in each of the conditions tested should also be measured 
using the expression levels of various genes around the plasmid genome (as 
discussed in chapter 4). One interesting aspect of an experiment of this kind would 
be investigation of the role the additional „fourth‟ putative promoter found 116 bp 
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upstream of blaCTX-M-14 on expression of this resistance gene. Expression could be 
assessed by removing the promoter DNA sequence and using RT-PCR to measure 
expression changes; or by cloning this DNA region into an expression vector to first 
establish whether it is indeed functional. Investigation of whether the plasmid copy 
number changes when inactivating blaCTX-M-14 or ISEcp1 (particularly in E. coli J53-2 
and S. Typhimurium SL1344 rifR respectively) would also be of value during future 
work. 
In this study blaCTX-M-14 was found to remain stable on the pCT genome in all 
experiments conducted. However, strains were typically cultured for no more than 70- 
100 generations during persistence and fitness assays.  In a recent study examining 
the fitness burden of blaCMY-2 carrying IncA/C plasmids, the loss of resistance genes 
was only seen after ~1000 generations (Subbiah et al., 2011). Therefore if pCT 
carrying strains were cultured over this extended period in the absence of antibiotic it 
may be that resistance gene loss is also observed from pCT.  
Due to the decreased pCT2b transfer rate in some of the conditions tested, any 
results obtained from this gfp marked pCT could not reliably be extrapolated to wild-
type pCT. Marking pCT by insertion of gfp into an intergenic region (e.g. between 
pCT008 and pCT009) was proposed as a method for measuring pCT transfer in vivo, 
e.g. within the C. elegans intestinal tract and pCT in-situ migration within a biofilm 
(Hausner and Wuertz, 1999; Sorensen et al., 2005). A gfp marked pCT could also 
have been used in high throughput transfer experiments using flow cytometry to 
detect the number of transconjugants under a range of conditions (Arango Pinedo 
and Smets, 2005). However, the observed reduction in pCT2b transfer compared to 
pCT and pCT2 in some of the conditions tests suggested that any results obtained 
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using a gfp tagged plasmid may not be applicable to wild-type pCT, therefore this 
plasmid was not created for investigation, but provides an interesting avenue for 
further work. 
It has been hypothesised that in some instances β-lactamase enzymes may have a 
role in cell wall metabolism such as cell wall recycling (Bishop and Weiner, 1992; 
Alonso et al., 2001), which may have a positive effect on the fitness of the bacterium 
and select for the maintenance of these genes in the absence of selective pressure.  
For further work investigating the role of blaCTX-M-14 in plasmid success, the cell wall 
integrity of hosts +/- pCT could be measured to look for positive effects of CTX-M-14. 
Similarly Kluyvera georgiana β-lactamase genes klug1 could be functionally 
inactivated to look for signs of interaction with the cell wall integrity in their postulated 
natural host. These experiments may give further clues as to the evolutionary path of 
blaCTX-M genes and the possible benefits they may confer to their hosts.  
5.13 Key findings 
o A novel and rapid method to inactivate genes on large conjugative plasmids was 
developed using a chromosomally encoded ʎ-red recombinase.  
o blaCTX-M-14 on pCT was inactivated by recombination with an aph construct. 
o Plasmid pCT was also successfully marked with gfp within blaCTX-M-14. 
o Inactivation of blaCTX-M-14 on pCT 
 restored host susceptibility to β-lactam cefotaxime, confirming the role of this 
gene in the resistant phenotype, 
 did not impair pCTs ability to persist within 100% of cells within a culture, 
 did not significantly change the pCT transfer frequency, 
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 had no affect on the ability of host strains to cause infection,  
 had no significant effect on the growth rate of host strains grown isogenically, 
 did not confer a fitness cost or benefit when host strains E. coli DH5α and E. 
coli 3950 containing either pCT or pCT2 were competed in a 1:1 ratio.  
o Therefore inactivation of blaCTX-M-14 does not appear to confer either a fitness cost 
or benefit on pCT plasmid function or on host fitness (with the exception of host 
E. coli   J53-2) 
o E. coli J53-2 pCT2 was found to have a significant competitive advantage over E. 
coli J53-2 pCT when strains were placed in competition in vitro, and conferred 
less of a fitness burden on host strain E. coli J53-2 than pCT. 
o The addition of gfp to pCT was shown to reduce conjugation frequency, 
particularly to recipient E. coli J53-2, and to impair the ability of S. Typhimurium 
SL1344 rifR to adhere to and invade tissue culture cells. 
o Insertion sequence ISEcp1 was found to encode three putative promoters, two of 
which were removed by recombination with aph. Inactivation of ISEcp1 had no 
effect on pCT stability, no significant effect on transfer rate despite a small 
consistent increased frequency into all recipient hosts, and had no effect on 
growth or the ability of E. coli 3950 to cause infection. Host growth was also 
unaffected in E. coli J53-2 and E. coli DH5α.  
o Inactivation of ISEcp1 (pCT6) in host S. Typhimurium SL1344 rifR showed 
attenuation in both infection models and a decreased growth rate when 
compared to S. Typhimurium SL1344 rifR pCT.  
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6. The role of five pCT genes in the “success” of pCT 
6.1 Hypotheses and Aims 
In previous chapters pCT was reported to have spread around the world and showed 
to confer no fitness cost or benefit upon host bacterial strains E. coli DH5α and E. coli 
3950. Inactivation of antibiotic resistance gene blaCTX-M-14 also had no effect on the 
ability of pCT to persist and disseminate in the absence of antibiotic pressure in 
these host strains. Therefore it was hypothesised that genes other than blaCTX-M-14 
encoded within the pCT backbone have contributed to the „success‟ of this plasmid.    
The aims of this section were to: 
 Select and inactivate five genes hypothesised to contribute to pCT success, 
 Investigate the contribution of pndACB in pCT persistence, 
 Investigate the role of the pil and tra locus in pCT conjugation, 
 Investigate the biological effects of inactivating the putative sigma factor gene, 
 To explore other aspects of fitness such as biofilm formation and aggregation. 
6.2 Inactivation of five pCT „backbone‟ genes  
6.2.1 Selection of genomic regions for further investigation 
Through the pCT sequence analysis, comparative genomics and review of the 
literature, outlined in Chapter 3, five pCT genomic regions emerged as possible 
contributors to the successful spread and persistence of pCT.  
6.2.1.1 Putative sigma factor  
The putative RNA polymerase sigma factor encoded by pCT_066 was unusual 
compared to other sigma factors of the same family (σ70). The lack of available 
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literature on the role of plasmid encoded sigma factors, and the potential for this 
gene to regulate transcription of plasmid or host genes made pCT_066 a candidate 
for further investigation.  
6.2.1.2 The pil locus and pilS 
In chapter 4 the relevance of pCT conjugation in both liquid media and on a solid 
surface was demonstrated. Previous studies have shown that the pil locus of IncI 
type plasmids is required for conjugation in liquid (Bradley, 1984; Yoshida et al., 
1999). Production of a thin pilus has also been associated with increased adherence 
to eukaryotic cells, polystyrene surfaces, other bacterial cells and to biofilm formation 
(Dudley et al., 2006). pilS (pCT_103) was selected for inactivation, as it encodes a 
pre-pilin subunit (22 kDa) which is processed into a 19 kDa major structural pilin 
component. Removal of this gene in other IncI plasmids (R64 and pSERB1) 
prevented successful assembly of the type IV pilus (Dudley et al., 2006; Shimoda et 
al., 2008) thereby allowing investigation of the role of this conjugation apparatus.  
6.2.1.3 Shufflon region and shufflon recombinase (rci) 
The pCT shufflon region was inferred to be active due to the multiple forms of the 
pilV region within the plasmid sequence assembly data. It is likely that the shufflon 
regions of five closely related plasmids to pCT (pO113, pO26_vir, pR3521 and 
pSERB1) are static due to a missing rci or insertions within this region, therefore 
making the active nature of this feature in pCT distinct from other closely related 
plasmids. Komano et al., (2005) showed that the functioning shufflon region of 
plasmid R64 influenced the conjugation frequency of the plasmid in liquid, and 
determined recipient specificity. Inactivation of the pCT shufflon recombinase (rci) 
should result in the fixing of the pilV shufflon components into one particular 
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conformation, preventing switching between the different organisations. Therefore, 
the effects resulting from an inactive shufflon region on the transfer of pCT and host 
fitness examined.  
6.2.1.4 The tra locus and traY 
The tra locus is required for plasmid transfer in liquid and on solid surfaces (Kim et 
al., 1993), therefore this region was disrupted to create a non-conjugative pCT 
mutant and to assess the contribution of the thick pilus to pCT dissemination and 
„success‟. traY was selected for inactivation as it encodes an essential integral 
membrane protein required for successful pilus formation (Komano et al., 2000; 
Sampei et al., 2010).  
6.2.1.5 Putative addiction system pndACB 
pCT was stable in the absence of antibiotic pressure in four different bacterial hosts, 
including E. coli J53-2 in which pCT had a fitness cost (Chapter 4). These data 
suggest that pCT encodes a mechanism for effective partitioning, or an addiction 
system which ensures effective vertical plasmid transfer to all daughter cells. The 
initial annotation of the pCT sequence did not elucidate any complete addiction or 
partitioning systems. However, re-analysis of the sequence highlighted pCT_065 
(pndA) which was annotated as a possible stability toxin but which seemed to lack a 
regulator (pndC) or antisense antitoxin (pndB). Alignments of pCT with characterised 
pndACB operons in plasmids R64, R483 and pO113 revealed that pCT did encode a 
complete pndACB operon, which had been incorrectly annotated (Nielsen and 
Gerdes, 1995; Furuya and Komano, 1996). In R64 the inactivation of pndACB had an 
extreme detrimental effect on plasmid stability (Furuya and Komano, 1996), therefore 
pndACB was selected for inactivation to assess the role of this gene in pCT stability.  
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6.2.2 Inactivation of five pCT genes and verification 
Inactivation of the five selected genes (pCT_066, rci, pilS, traY and pndACB) by 
recombination with aph was achieved using the method developed in Chapter 4 
(Table 2.7; Appendix 23-28). In the case of traY, the upstream primer was designed 
with homology to adjacent CDS traX to obtain an optimum primer pair (Appendix 26). 
The DNA of each candidate mutant plasmid (each from one randomly selected 
colony) was extracted and transformed into E. coli DH5α creating strains E. coli 
DH5α pCT3 (Sigma factor::aph; I827), E. coli DH5α pCT4 (rci::aph; I828), E. coli 
DH5α pCT5 (pilS::aph; I829), E. coli DH5α pCT7 (traXY::aph; I846) and E. coli DH5α 
pCT8 (pndACB::aph; I877). 
Recombination of aph into the pCT pndACB operon generated 380 colonies which 
were able to grow in the presence of kanamycin, indicating successful recombination. 
However, the majority of these colonies ceased to grow after approximately 12 hours 
(~1 mm in size), and when replica plated onto fresh agar plates (LB and LB 
containing 50 µg/ml kanamycin) or cultured in LB broth, no growth was observed. 
Ten colonies out of the 380 continue to grow to >3 mm in size, therefore one of these 
colonies was selected and the plasmid DNA extracted.  
Inactivation of each of the five genes was verified by PCR amplification across the 
genomic region and DNA sequencing (Appendix 23-28). The mutant plasmids (with 
the exception of pCT7 traXY::aph) were transferred by conjugation to E. coli host 
strains J53-2 (I847) and 3950 (I823), and to S. Typhimurium SL1344 rifR 
(L1078)(Figure 6.1). pCT7 was unable to conjugate to recipients, and multiple 
attempts to transform this plasmid into all three alternative hosts were unsuccessful 
(Figure 6.1).  
  
Figure 6.1. pCT genes selected for inactivation 
 
 
 
 
 
 
 
 
Plasmid Inactivated gene pCT ID Resistance 
marker 
Laboratory codes of plasmid containing host strains 
DH5α J53-2 3950 SL1344 rifR 
 
pCT3 
 
Putative sigma factor 
 
pCT_066 
 
aph I827 I858 I837 L1236 
pCT4 Shufflon recombinase (rci) pCT_093 aph I828 I859 I831 L1259 
pCT5 pilS pCT_103 aph I829 I860 I841 L1260 
pCT7 traXY pCT_069 aph I846 - - - 
pCT8 pndACB pCT_065 aph I877 I893 I894 L1397 
pCT9 traXY and pndACB pCT_069/065 aph and cat I878 - - - 
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6.2.3 Creation of a mutant with both traXY and pndACB inactivated 
In order to assess the effect of inactivation of pndACB on plasmid persistence and 
vertical transfer only, pndACB was also insertionally inactivated in non-transferrable 
pCT7 (in addition to pCT). pCT7 was transformed into the ʎ-red recombinase 
encoding E. coli strain SW102, to create strain E. coli SW102 pCT7 (I880). The same 
primers designed to inactivate pndACB with aph (Table 2.7,  primers 1354/1355) 
were used to amplify the chloramphenicol resistance gene cat from the chromosome 
of S. Typhimurium L829 (L828 tolC::cat). The resulting PCR amplimer was 
recombined with the pCT7 pndACB as described previously (Section 6.2.2). 
Approximately 500 colonies grew on selective agar plates, however, as with the 
previous pndACB disruption (pCT8), only 18 colonies grew after 24 hours. The DNA 
was extracted from a randomly selected growing colony and transformed into E. coli 
DH5α, creating strain E. coli DH5α pCT9 (I878). DNA amplification and sequencing 
of traXY and pndACB verified the presence of aph and cat in appropriate regions.  
6.3 Effects on pCT plasmid biology of inactivating the five genes 
6.3.1 Stability of pCT3, pCT4, pCT5, pCT7, pCT8 and pCT9 in bacterial cells 
The effects of inactivating the five selected genes on the ability of pCT to persist and 
to remain stable within a bacterial population without antibiotic selection was 
assessed in vitro as previously described (Section 4.4.1). The six plasmids (pCT3-5 
and 7-9) were stably maintained in 100% of bacteria in the four host strains (E. coli 
DH5α, E. coli J53-2, E. coli 3950 and S. Typhimurium SL1344 rifR) over 96 hours 
(~70 generations). These data suggest that none of the selected pCT genes 
(including pndACB) are required for the successful short term persistence of pCT.  
 215 
 
6.3.2 Conjugative transfer of pCT3, pCT4, pCT5, pCT7, pCT8 and pCT9  
Plasmids pCT7 (traXY::aph) and pCT9 (traXY::aph, pndACB::cat), both lacking a 
functional traY were unable to transfer by conjugation to any of the recipient strains 
over 48 hours in broth or on a solid surface.  
The conjugation frequencies of the other mutant plasmids (pCT3, pCT4, pCT5 and 
pCT8) were measured over a three hour period at 370C from donor E. coli DH5α to 
recipients E. coli J53-2, E. coli 3950 and S. Typhimurium SL1344 rifR, in liquid and on 
a solid surface on three separate occasions (Figure 6.2; Appendix 29). Transfer of 
pCT3-5 and pCT8 to recipient E. coli J53-2 was at a similar rate to that of pCT, 
suggesting that inactivation of the putative sigma factor, pndACB and pil locus 
related genes (pilS and rci) are not essential for pCT transfer to this recipient strain. 
Inactivation of pilS (pCT5) did not affect the frequency of transfer on a solid surface. 
However, the conjugation frequency of pCT5 (pilS::aph) to recipients E. coli 3950 
(6.73 x 10-8) and S. Typhimurium SL1344 rifR (7.69 x 10-8) in liquid was lower than of 
wild-type pCT (1.39 x 10-4, 9.33 x 10-6 respectively).  
Inactivation of the shufflon recombinase gene (pCT4) had no effect on conjugation to 
the E. coli recipient strains. However, there was consistently less transfer of pCT4 
(rci::aph) on a filter and to a greater extent in liquid, to recipient S. Typhimurium 
SL1344 rifR (Figure 6.2, Appendix 29). In every condition tested, the conjugation 
frequency of pCT3 (Sigma factor::aph) was consistently higher than that of pCT, 
however this difference was not found to be statistically significant. 
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Figure 6.2. Conjugation frequencies of plasmids from donor E. coli DH5α to 
recipients E. coli J53-2, E. coli 3950 and S. Typhimurium SL1344 rifR 
  
 
 
 
Solid bars represent conjugation frequencies on filters and faded bars represent the 
conjugation frequency in liquid; an asterix denotes a statistically significant difference 
compared to pCT. Gene names in brackets show the inactivated gene on each plasmid.  
1.00E-09 
1.00E-08 
1.00E-07 
1.00E-06 
1.00E-05 
1.00E-04 
1.00E-03 
1.00E-02 
1.00E-01 
1.00E+00 
pCT pCT2 pCT3 pCT4 pCT5 pCT7 pCT8 pCT9 
C
o
n
ju
g
a
ti
o
n
 f
re
q
u
e
n
c
y
 /
 
d
o
n
o
r 
c
e
ll
 
J53-2 
1.00E-09 
1.00E-08 
1.00E-07 
1.00E-06 
1.00E-05 
1.00E-04 
1.00E-03 
1.00E-02 
1.00E-01 
1.00E+00 
pCT pCT2 pCT3 pCT4 pCT5 pCT7 pCT8 pCT9 
C
o
n
g
u
a
ti
o
n
 f
re
q
u
e
n
c
y
 /
 
d
o
n
o
r 
c
e
ll
 
3950 
* * 
1.00E-09 
1.00E-08 
1.00E-07 
1.00E-06 
1.00E-05 
1.00E-04 
1.00E-03 
1.00E-02 
1.00E-01 
1.00E+00 
pCT pCT2 pCT3 pCT4 pCT5 pCT7 pCT8 pCT9 
C
o
n
ju
g
a
ti
o
n
 f
re
q
u
e
n
c
y
 /
 
d
o
n
o
r 
c
e
ll
 
SL1344 rifR 
(traXY) (pndACB) (traXY; 
pndACB) 
(pilS)    (rci) (Sigma     
factor) 
(blaCTX-M-14) 
* * 
(traXY) (pndACB) (traXY; 
pndACB) 
(pilS)    (rci) (Sigma  
factor) 
(blaCTX-M-14) 
(traXY) (pndACB) (traXY; 
pndACB) 
(pilS)    (rci) (Sigma    
factor) 
(blaCTX-M-14) 
 217 
 
6.4 Effects of pCT3, pCT4, pCT5, pCT7, pCT8 and pCT9 upon bacterial 
host strains  
6.4.1 Susceptibility of strains containing mutant plasmids to cefotaxime and ceftiofur 
The susceptibilities of E. coli DH5α, E. coli J53-2, E. coli 3950 and S. Typhimurium 
SL1344 rifR containing the six mutant plasmids to cefotaxime and ceftiofur were 
compared to that of host strains containing wild-type pCT using the agar doubling 
dilution method. The MIC of the two β-lactams against strains containing plasmids 
pCT3, pCT5 and pCT7-9 were equivalent to that for pCT containing strains (Table 
6.1). This indicates that the pCT sigma factor, pil, tra and pndACB loci have no effect 
on host susceptibility to β-lactams. Inactivation of the pCT shufflon recombinase 
(pCT4) resulted in a consistently increased MIC of cefotaxime by at least one 
doubling dilution in host strains E. coli J53-2, E. coli 3950 and S. Typhimurium 
SL1344 rifR on five separate occasions (Table 6.1). However, as the error within this 
method is +/- one doubling dilution it is unclear whether this is a significant finding. 
6.4.2 Growth kinetics of host strains containing pCT3-5 and pCT7-9  
To assess whether inactivation of the five pCT genes had an effect on host growth in 
vitro, the growth kinetics and generation times of the host strains containing pCT and 
the six mutant plasmids were measured using a FLUOstar OPTIMA (Figure 6.3 and 
Figure 6.4). With the exception of S. Typhimurium SL1344 rifR pCT3, no significant 
differences were found in the generation times of all hosts containing the six 
plasmids compared to hosts containing wild-type pCT. These data suggest that 
inactivation of the pCT sigma factor, rci, pilS, traXY, pndACB has no detrimental or 
beneficial effect on host growth in a pure culture. 
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Table 6.1. Minimum inhibitory concentrations of cefotaxime and ceftiofur for 
hosts containing pCT and the other modified plasmids  
 
Laboratory 
number Strain 
MIC of 
cefotaxime 
(µg/ml) 
MIC of 
ceftiofur 
(µg/ml) 
I755 DH5α pCT  16 32 
I827 DH5α pCT3 (Sigma factor::aph) 16 32 
I828 DH5α pCT4 (rci::aph) 16 32 
I829 DH5α pCT5 (pilS::aph) 16 32 
I846 DH5α pCT7 (traXY::aph) 16 32 
I877 DH5α pCT8 (pndACB::aph) 16 32 
I878 DH5α pCT9 (traXY::aph; pndACB::cat) 16 32 
I834 J53-2 pCT 16 32 
I858 J53-2 pCT3 (Sigma factor::aph) 16 64 
I859 J53-2 pCT4 (rci::aph) 32 64 
I860 J53-2 pCT5 (pilS::aph) 16 64 
I893 J53-2 pCT8 (pndACB::aph) 16 64 
I855 3950 pCT 16 64 
I837 3950 pCT3 (Sigma factor::aph) 16 64 
I831 3950 pCT4 (rci::aph) 32 64 
I841 3950 pCT5 (pilS::aph) 16 64 
I894 3950 pCT8 (pndACB::aph) 16 64 
L1079 SL1344 rif
R 
pCT 64 64 
L1236 SL1344 rif
R
 pCT3 (Sigma factor::aph) 32 64 
L1259 SL1344 rif
R
 pCT4 (rci::aph) 256 128 
L1260 SL1344 rif
R
 pCT5 (pilS::aph) 32 64 
L1397 SL1344 rif
R
 pCT8 (pndACB::aph) 32 128 
The MIC of each antibiotic is the mode of values obtained on at least three separate 
occasions, bold text denotes an altered MIC. 
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Figure 6.3. Growth kinetics of E. coli DH5α containing pCT, pCT3-9 
 
The growth kinetics of bacterial host strain E. coli DH5α containing either pCT, pCT3 
(Sigma factor::aph), pCT4 (rci::aph), pCT5 (pilS::aph), pCT7 (traXY::aph), pCT8 
(pndACB::aph) or pCT9 (traXY::aph;pndACB::cat) were measured using the 
FLUOstar OPTIMA using at least three biological and four technical repeats. 
Generation times were calculated between hours 2-3 (Appendix 30). Values returning 
a P value of <0.05 from a Student‟s T-test were considered statistically significant 
and are denoted by an asterix. 
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Figure 6.4. Growth kinetics of host strains containing pCT, pCT3-5  
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The growth kinetics of bacterial host strains containing either pCT, pCT3 (Sigma factor::aph), 
pCT4 (rci::aph) or pCT5 (pilS::aph) were measured using the FLUOstar OPTIMA using at least 
three biological and four technical repeats. Generation times were calculated between hours 1-2 
(Appendix 31).  
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6.4.3 The effect of pCT3, pCT4, pCT5 and pCT8 on the ability of bacterial host 
strains to cause infection   
To investigate whether the pCT putative sigma factor, pil locus, functional shufflon 
and the pndACB genes influence the ability of host bacteria to cause infection, the 
ability of bacterial hosts containing pCT3, 4, 5 and 8 to adhere to, and invade INT-
407 tissue culture cells, and to kill C. elegans was determined (Figure 6.5, Appendix 
32 and Figure 6.6, Appendix 33). In the C. elegans model, E. coli 3950 containing all 
four plasmids killed the nematodes at a comparable rate to E. coli 3950 pCT (Figure 
6.6), suggesting no association of these genes with the virulence of E. coli 3950. The 
ability of S. Typhimurium SL1344 rifR containing pCT3 and pCT5 to adhere to and 
invade tissue culture cells was also unimpaired when compared to S. Typhimurium 
SL1344 rifR pCT. However, the ability of S. Typhimurium SL1344 rifR pCT4 and S. 
Typhimurium SL1344 rifR pCT8 to invade the eukaryotic cells (INT-407 cells) was 
significantly reduced. S. Typhimurium SL1344 rifR containing pCT3, pCT4, pCT5 and 
pCT6 (and ISEcp1::aph; chapter 4) also killed C. elegans at a slower rate than S. 
Typhimurium SL1344 rif
R
 pCT. On further analysis the rate of killing of these strains 
was comparable to that of S. Typhimurium SL1344 rifR (without plasmid), it appears 
that carriage of wild-type pCT increases the ability of S. Typhimurium SL1344 rifR 
pCT to cause infection in the C. elegans whereas carriage of the other pCT mutant 
plasmids results in a similar ability to cause infection in the C. elegans model as 
parental host strain S. Typhimurium SL1344 rifR without plasmid. This might suggest 
that addition of aph onto pCT, or an affect of the recombination technique itself 
attenuates any small pathogenicity effects that wild-type pCT confers to the S. 
Typhimurium SL1344 rifR host. 
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Figure 6.5. The ability of S. Typhimurium SL1344 rifR containing wild-type pCT, 
pCT3, pCT4, pCT5 and pCT8 to adhere to and invade human intestinal cells 
 
 
 
The number of S. Typhimurium SL1344 rifR containing pCT3 pCT4, pCT5 or pCT8 
able to adhere to (A) and invade (B) INT-407 human intestinal cell is represented as 
a percentage of the number of S. Typhimurium SL1344 rifR pCT able to do so under 
test conditions (Appendix 32). Data are displayed as a mean of three separate 
experiments all performed with four technical repeats.  
Values returning a P value of <0.05 from a Student‟s T-test were considered 
statistically significant are represented with an asterix.  
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Figure 6.6. The ability of bacterial hosts containing pCT3, pCT4, pCT5 and 
pCT8 to cause infection in C. elegans 
 
 
 
Survival curves were constructed using a Kaplan Mier calculation showing the 
probability of C. elegans survival each day when fed continuously on the tested 
bacterial strains.  
A significance difference was found in the killing rate between S. Typhimurium 
SL1344 rifR pCT and S. Typhimurium SL1344 rifR pCT3 (Sigma factor::aph) (P = 
0.023), S. Typhimurium SL1344 rifR pCT4 (rci::aph) (P = <0.001) and S. Typhimurium 
SL1344 rifR pCT5 (pilS::aph) (P = 0.0037). A significant difference in killing rate was 
defined as a P value <0.05 (Appendix 33).  
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6.5 Competition of pCT3- 9 against wild-type pCT in vitro 
To investigate whether inactivation of the genes on plasmids pCT3-9 had any effect 
on the plasmid‟s competitive fitness within an in vitro population, E. coli DH5α 
containing plasmids pCT3-9 were directly competed in a 1:1 ratio with E. coli DH5α 
pCT as in section 5.9. An E. coli DH5α host was chosen for this experiment to allow 
assessment of all the mutant plasmids. pCT2 was used as a positive control as this 
plasmid was previously shown to remain in a 1:1 ratio during competition with pCT 
(chapter 5). All of the plasmid pairings remained in roughly equal proportions over the 
course of each 72 hour experiment and each plasmid mutant showed a competition 
index within 1.5 x10-3 of 1 (Figure 6.7, Appendix 34). These data indicate that the 
genes inactivated in plasmids pCT2-9 had no direct effect on pCT competitive fitness 
in vitro in the short term.  
6.6 Pair-wise competition between E. coli DH5α and DH5α pCT9 in vitro 
Previously in section 4.3.4, E. coli DH5α pCT7 was shown to remain at a 1:1 ratio 
when co-cultured with its plasmid free parental strain. As pCT7 cannot transfer to 
plasmid free cells, and remains stable within the same time period in pure culture, it 
was hypothesised that pCT7 confers no fitness cost or benefit to the host cell. To 
investigate whether the inactivation of pndACB altered the stability of pCT7 and 
determine whether there is a role for pndACB in persistence, E. coli DH5α pCT9 
(traXY::aph; pndACB::aph) was competed in a 1:1 ratio with parental strain E. coli 
DH5α on three separate occasions. Within 12 hours, the proportion of E. coli DH5α 
pCT9 cells in the culture was 30%, and at 72 hours was 12% (Figure 6.8). 
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Figure 6.7. Competition Index of plasmids pCT3-9 when competed in vitro 
against wild-type pCT 
 
 
 
 
Each pair-wise competition was conducted between E. coli DH5α pCT and DH5α 
containing the test plasmid in vitro. CI, competition index was calculated based on 
the mean values of at least three separate experiments (Appendix 34).  
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Figure 6.8. Pair-wise competitive growth in vitro between E. coli DH5α and E. coli DH5α pCT9 (tra::aph; pndAC::cat) 
Competition index of DH5α pCT9 at 12 hours (before first passage) = 0.9807, P = <0.001 (A significant change)* 
Competition index of DH5α pCT9 at 72 hours (after three passages) = 0.9859, P = <0.001 (A significant change)* 
 
The percentage of bacteria carrying plasmid pCT9 over time was calculated when E. coli DH5α +/- pCT9 were co-
cultured in a 1:1 ratio in vitro. Cultures were passaged at hour 12, 24 and 48. The competition index was calculated from 
averages generated from at least three separate experiments. 
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As pCT9 remained stable in a pure culture in vitro under the same conditions, these 
data cannot be attributed to plasmid loss. Instead these date indicate that E. coli 
DH5α pCT9 cells were outcompeted by the host alone over this short time period. 
6.7 The role of pCT and the pil and tra locus in host biofilm formation 
and aggregation 
The ability of a bacterial strain to aggregate or to form a biofilm can be considered a 
factor in its fitness or success; perhaps increasing its pathogenicity or broadening the 
range of environmental niches in which it can persist or thrive (Parsek and Singh, 
2003; Pope et al., 2010). The production of conjugation pili has been associated with 
the initiation, formation and stability of bacterial biofilms (Molin and Tolker-Nielsen, 
2003). Therefore, the role of pCT and the production of pCT conjugation pili in biofilm 
formation and aggregation was investigated. 
6.7.1 The ability of host strains containing pCT and pCT2-7 to form a biofilm  
The biofilm formation of the four host strains E. coli DH5α, E. coli J53-2, E. coli 3950 
and S. Typhimurium SL1344 rifR +/- pCT and the pCT mutants (pCT2-7) was 
investigated using the crystal violet biofilm assay, and by culturing these strains on 
agar containing Congo red to determine the production of E. coli and Salmonella 
biofilm components curli and cellulose. 
6.7.1.1 Crystal violet staining 
The natural veterinary E. coli isolate C159/11, and host strains S. Typhimurium 
SL1344 rifR, E. coli J53-2 and E. coli 3950 formed poor biofilms in the presence or 
absence of both pCT and the pCT mutants (pCT2-7), revealing that the addition of 
pCT did not confer the ability to produce a biofilm to these host strains. E. coli 3950 
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pCT5 and E. coli 3950 pCT6 produced significantly more biofilm when compared to 
E. coli 3950 pCT. However, as the parental strain formed little biofilm it is unclear 
whether this small but consistent increase is a result of increased formation of a 
complex biofilm or just better adhesion (Figure 6.9, Appendix 35).  
E. coli DH5α formed a significant biofilm and the addition of pCT, pCT2 and pCT4-7 
did not affect its ability to do so (Figure 6.10, Appendix 35). E. coli DH5α pCT3 
(Sigma factor::aph) had a significantly increased ability to biofilm and E. coli DH5α 
pCT2b (blaCTX-M-14::aph-gfpmut2) appeared to have a reduced biofilming ability. As 
this effect was not seen in E. coli DH5α pCT2 (blaCTX-M-14::aph), the result is unlikely 
to be due to the inactivation of blaCTX-M-14, and may be due to an effect of the 
production of GFP.  
Plasmids pCT and pCT2-6 were also transferred via conjugation to S. Typhimurium 
strain 14028S (L828 rifR) a strain which produces high levels of biofilm, and the ability 
of these new strains to biofilm was measured. Addition of all seven plasmids had no 
effect on the ability of 14028S to biofilm. Therefore, pCT does not appear to increase 
or decrease the ability of a bacterium to form biofilms in strains that already do so, 
and changes in biofilm formation are not likely to result from the carriage of pCT.   
6.7.1.2 The production of curli and cellulose using Congo red staining 
Biofilm formation was also investigated by observing the colony morphology of each 
host strain (+/- pCT and the pCT plasmid mutants) when grown on LB agar without 
salt, supplemented with 40 mg/L of Congo red (Figure 6.11). All E. coli J53-2 
colonies were of a pink, dry and smooth morphology suggesting low production of 
curli and cellulose; addition of the pCT plasmids had no effect in this strain. Similarly, 
the addition of pCT and pCT2-6 had no effect on colony morphology  
  
Figure 6.9. Biofilm formation of C159/11 and 3950 containing the plasmids pCT and pCT2-6 
  
The ability of each bacterial strain to produce biofilm was measured by staining each biofilm with crystal violet and using 
optical density (OD600) to quantify each biofilm.  Optical density values of four technical repeats and at least four biological 
repeats were compared using a student T test where a P value of <0.05 from a Student‟s T-test were considered statistically 
significant. Those strains found to have significantly different values compared to strains containing plasmidpCT are denotes 
with an astrix (Appendix 35).  
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Figure 6.10. Biofilm formation of DH5α containing the plasmids pCT and pCT2-7  
 
The ability of each bacterial strain to produce biofilm was measured by staining each biofilm with crystal violet and using 
optical density (OD600) to quantify each biofilm.  Optical density values of four technical repeats and at least four biological 
repeats were compared using a student T test. Values returning a P value of <0.05 from a Student‟s T-test were considered 
statistically significant. Those strains found to have significantly different values compared to strains containing plasmidpCT 
are denotes with an astrix (Appendix 35). S. Typhimurium 14028S was used as a positive control. 
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of the S. Typhimurium strains SL1344 rifR and 14028S rifR which were red, dry and 
rough (rdar) indicating the production of curli and cellulose. Veterinary strain E. coli 
C159/11 had a classic rdar phenotype, however E. coli 3950 (pCT cured derivative of 
C159/11) and E. coli 3950 containing pCT and pCT2-6 had a pinker and smoother 
morphology, particularly E. coli 3950 pCT4 (rci::aph) and E. coli 3950 pCT5 
(pilS::aph). The E. coli DH5α strains also differed in their appearance, as E. coli 
DH5α pCT3 (Sigma factor::aph) and E. coli DH5α pCT7 (traXY::aph) appeared 
smoother than other strains. However, it was noted that no change in morphology 
due to the presence of any particular plasmid was seen consistently in all hosts 
(Figure 6.11).  
6.7.2 Aggregation of bacterial hosts containing plasmids pCT and pCT2-6 
To determine whether the addition of pCT and the pCT mutants pCT2-6 affected the 
ability of host strains S. Typhimurium SL1344 rifR and E. coli J53-2 to aggregate, 
settle assays were performed. Overnight cultures of each strain were kept stationary 
for 24 hours. During the first 12 hours and at 24 hours a sample was removed from 
the top of each culture and the optical density was measured. Strains able to 
aggregate, such as positive control E. coli 042, showed a rapid reduction in optical 
density as the cells aggregated within the broth. The addition of pCT, the pCT pil 
locus mutants (pCT4 and pCT5) and pCT2, pCT3 and pCT6 had no effect on the 
host strain‟s ability to aggregate (Figure 6.12, Figure 6.13 and Figure 6.14, Appendix 
36). These data suggest that pCT does not confer either an increased or decreased 
aggregative ability to host strains. 
  
Figure 6.11. Colony morphology of bacterial hosts strains containing plasmid pCT and plasmid mutants (pCT2-7) 
grown on LB agar containing Congo red 
 
 
 
 
 
 
 
 
 
Colony morphology: red, dry and rough colonies (rdar) indicate curli and cellulose production; Brown, dry and rough (bdar) 
colonies indicate curli production without cellulose; Pink, dry and rough (pdar) colonies indicate cellulose production without curli 
and white and smooth colonies (saw) indicate a lack of both curli and cellulose production. 
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Figure 6.12. The aggregative ability of S. Typhimurium SL1344 rifR and E. coli 
J53-2 +/- pCT 
 
 
 
Bacterial strains were left in a stationary culture over a 24 hour period. The optical 
density of these cultures was monitored over this time and expressed as a 
percentage of the starting optical density. A drop in optical density suggested 
bacterial cell aggregation. Average optical density changes of strains +/- pCT were 
compared using a Student‟s T-test. Values returning a P value of <0.05 were 
considered statistically significant and are denoted with an astrix (Appendix 36) 
 E. coli 042 was used as a positive control. 
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Figure 6.13. The aggregative ability of S. Typhimurium SL1344 rifR and E. coli 
J53-2 +/- pCT4 and pCT5 
 
 
 
Bacterial strains were left in a stationary culture over a 24 hour period. The optical 
density of these cultures was monitored over this time and expressed as a 
percentage of the starting optical density. A drop in optical density suggested 
bacterial cell aggregation. Average optical density changes of strains containing 
pCT4 and pCT5 were compared to strains containing pCT using a Student‟s T test. 
Values returning a P value of <0.05 were considered statistically significant and are 
denoted with an astrix (Appendix 36) 
E. coli 042 was used as a positive control. 
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Figure 6.14. Aggregative ability of S. Typhimurium SL1344 rifR and E. coli J53-2 
+/- pCT2, pCT2b, pCT3 and pCT6 
 
 
 
 
 
Bacterial strains were left in a stationary culture over a 24 hour period. The optical 
density of these cultures was monitored over this time and expressed as a 
percentage of the starting optical density. A drop in optical density suggested 
bacterial cell aggregation.Average optical density changes of strains containing 
pCT2, pCT2b, pCT3 and pCT6 were compared to strains containing pCT using a 
Student‟s T-test. Values returning a P value of <0.05 were considered statistically 
significant and are denoted with an astrix (Appendix 36) 
E. coli 042 was used as a positive control. 
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6.7.3 Visualisation of cells using Scanning Electron Microscopy (SEM) 
 To investigate the effects of adding pCT, and inactivating pCT genes rci, pilS and 
traXY on E. coli DH5α and S. Typhimurium SL1344 rifR host strain pili production, 
bacterial host strains were grown in LB broth to late-logarithmic phase, and overnight 
on an LB agar plate, and visualised using scanning electron microscopy. 
Visualisation of cells at magnification of x 15,000 to x 80,000 consistently revealed 
two distinct cell morphologies named in this study as „smooth cells‟ and „cells with 
protrusions‟ (Figure 6.15). Both cell types were enumerated for each strain (Table 
6.2). The cells taken from colonies grown on agar plates were of the smooth 
morphology. E. coli DH5α and S. Typhimurium SL1344 rifR cells (without pCT) grown 
in broth were also smooth in appearance. However, E. coli DH5α pCT and S. 
Typhimurium SL1344 rifR pCT cells consists of both morphologies (52% and 11% 
showing protrusions, respectively) suggesting a direct association between the 
presence of pCT and cell protrusions (Figure 6.15, Figure 6.16). Strain S. 
Typhimurium SL1344 rifR pCT4 (rci::aph) had a similar proportion of smooth cells and 
cells with protrusions to S. Typhimurium SL1344 rifR pCT (13%) but S. Typhimurium 
SL1344 rifR pCT5 (pilS::aph) had no cells with protrusions.  
E. coli DH5α containing pilus mutant plasmids pCT5 and pCT7 also had a reduced 
number of cells with protrusions compared to E. coli DH5α pCT, although a few were 
still present. While these observations, particularly in S. Typhimurium SL1344 rifR 
suggest that the protrusion morphology is linked to pilus formation, the E. coli DH5α 
pCT5 (pilS::aph) and pCT7 (traXY::aph) cells with protrusions of suggests that this is 
may not be a direct association. Additional observations were that E. coli DH5α pCT7 
(traXY::aph) cells grown on agar were connected by irregular chain like structures,  
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Figure 6.15. Scanning electron microscopy images of DH5α +/- pCT from LB broth 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
All images were taken using scanning electron microscopy (SEM). Cells were 
prepared by growing strains in LB broth to late-logarithmic phase and then fixed. 
Panels A and B show E. coli DH5α cells without plasmid pCT showing the smooth 
morphology  
Panels C, D and E show E. coli DH5α pCT cells with protrusions seen in ~50% of 
DH5α cells containing pCT but in no cells which do not carry plasmid pCT. 
A B 
C D 
E 
„Protrusion‟ 
E 
  
Table 6.2. The proportion of cells with protrusions visualised using scanning electron microscopy  
 
Cell 
Prep 
Species 
Lab 
 code 
Strain Number of 
cell examined 
Number of cells 
with protrusions 
Percentage 
(%) 
Broth  
E. coli 
I753 C159/11 600 0 0 
I825 DH5α 300 0 0 
I755 DH5α pCT 200 104 52 
I829 DH5α pCT5 (pilS::aph) 200 10 5 
I846 DH5α pCT7 (traXY::aph) 200 8 4 
S. Typhimurium 
L1078 SL1344 rifR 300 0 0 
L1079 SL1344 rifR pCT 200 22 11 
L1259 SL1344 rif
R pCT4 (rci::aph) 200 26 13 
L1260 SL1344 rif
R pCT5 (pilS::aph) 200 0 0 
       
Agar E. coli 
I753 C159/11 200 0 0 
I825 DH5α 200 0 0 
I755 DH5α pCT 200 0 0 
I829 DH5α pCT5 (pilS::aph) 200 0 0 
I846 DH5α pCT7 (traXY::aph) 200 0 0 
 
The effect of pCT7 on cell morphology could not be observed in S. Typhimurium SL1344 rifR as conjugation and transformation of pCT7 
into this strain was unsuccessful. The effect of pCT4 on cell morphology was visualised in host strain S. Typhimurium SL1344 rifR as 
inactivation of rci modified the susceptibility of this host strain to cefotaxime and reduced the pCT conjugation rate to this recipient. The 
same effects were not observed in E. coli host strain DH5α.    
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Figure 6.16. SEM images of S. Typhimurium SL1344 rifR cells +/- pCT from LB broth 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
All images were taken using scanning electron microscopy (SEM). Cells were 
prepared by growing strains in LB broth to late-logarithmic phase and then fixed. 
Panel A shows S. Typhimurium SL1344 rifR cells without plasmid pCT showing the 
smooth morphology  
Panel B shows S. Typhimurium SL1344 rif
R
 pCT cells, 1/15 showing the protrusions.  
A 
B 
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not seen with any of the other strains (Figure 6.17). As pCT7 had an inactivated tra 
locus component, these chains may be the result of a misassembled, but still 
produced, thick pilus. E. coli C159/11 (pCT) grown on agar and in broth were also 
visualised; this revealed no cells with protrusions in either growth condition (Figure 
6.18). 
6.8 Discussion 
Data presented in section 5.9 showed that in the absence of antibiotic pressure, 
resistance gene blaCTX-M-14 conferred neither a fitness cost nor benefit to host strains 
E. coli DH5α and E. coli 3950. Plasmid pCT itself neither increased nor decreased 
the fitness of the host bacterium, was stably maintained within all daughter cells and 
easily transferred by conjugation. These data suggest that factors encoded within the 
pCT backbone may contribute to the evolutionary „fitness‟ of this plasmid. Therefore, 
understanding of the pCT DNA sequence and annotation (Chapter 3) was used to 
select and systematic inactivate chosen genes, in order to assess their functional 
genomics and their contribution to the „success‟ of pCT. The lack of similarity with 
other sigma factors such as SigZ encoded by IncI plasmid R64, and the absence of 
available data on plasmid borne sigma factors made pCT_066 an interesting 
candidate for investigation. Inactivation of the pCT putative sigma factor (pCT3) had 
no effect on host growth, either in pure culture or when competed with bacteria 
containing wild-type pCT; the ability of host bacteria to cause infection, susceptibility 
to β-lactams, or the ability of pCT to persist. A small but consistent non statistically 
significant increase in the conjugation frequency of pCT3 compared to pCT was seen 
in all the conditions tested. 
  
Figure 6.17. Scanning electron microscopy images of E c.oli DH5α pCT and E. coli DH5α pCT7 cells from LB agar 
 
  
   
All images were taken using scanning electron microscopy (SEM). 
Cells were prepared by growing strains on LB agar overnight, 
resuspending in PBS and then fixing them onto glass. 
Panel A shows E. coli DH5α pCTs cells with a smooth morphology.  
Panels B and C show E. coli DH5α pCT7 cells(traXY::aph) showing 
regular chain like structures between cells. 
 
A 
B 
C 
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Figure 6.18. SEM images of E. coli C159/11 from broth and agar 
 
 
 
A 
B 
Panel A shows E. coli C159/11 (pCT) cells grown in LB broth 
Panel B shows E. coli C159/11 (pCT) cells grown on LB agar 
Both show smooth cells without protrusions despite carrying plasmid pCT 
A 
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Although there is little reference to the direct control of conjugation by sigma factors 
within the literature, a Sigma 70 binding site has been identified directly upstream of 
a pili biogenesis regulatory gene (traA) in plasmid R64 (Kim et al., 1993), suggesting 
that there may be some association in R64. Inactivation of the pCT putative sigma 
factor gene also significantly increased the ability of E. coli DH5α to biofilm. 
Chromosomally encoded sigma factors can influence bacterial biofilm formation and 
the expression of curli biosynthetic genes, for example, in response to environmental 
changes or stressers (Gualdi et al., 2008). Therefore it may be that the small effects 
of inactivating the pCT putative sigma factor observed during my in vitro experiments, 
may be amplified in a natural and stressful environment (Stockwell and Loper, 2005). 
Similarly, non-essential extra-cytoplasmic function sigma factors (ECF) encoded by 
Bacillus subtilis facilitate a more rapid cellular response to stress (Asai et al., 2008). If 
their non essential nature has allowed ECF sigma factors to become mobile (for 
example on conjugative plasmids), and to confer an advantage in stressful 
environments it is conceivable that this would increase the fitness and persistence of 
these plasmids in certain conditions, which were not necessarily reproduced in the 
laboratory in the present study. Host bacterial chromosomally encoded sigma factors 
are essential for plasmid replication (Wado et al., 1987), and their availability can be 
a limiting factor in plasmid DNA synthesis and copy number control (Schmidt et al., 
1996). Therefore, provision of a plasmid encoded sigma factor has the potential to 
alleviate reliance on the host cell σ70 expression, allow better copy number control, 
or widen the plasmid host range. Although no clear phenotype was attributed to the 
pCT sigma factor, a subtler effect of plasmid encoded sigma factors on the ability of 
host bacteria to biofilm, on pili expression or copy number control is possible.  
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To investigate the contribution of thick (tra) and thin (pil) pili on pCT dissemination 
and host fitness, the effects of inactivating the major structural proteins of each pilus 
(traY and pilS) were assessed. Inactivation of traY prevented all pCT transfer as 
previously described for R64 (Komano et al., 2000). These data confirm the role of 
the thick pilus in pCT conjugation in liquid and on a surface. The inactivation of thin 
pilus gene, pilS, reduced the frequency of pCT conjugation in liquid to recipients E. 
coli 3950 and S. Typhimurium SL1344 rifR but did not preclude transfer. These data 
suggest that the thin pilus is not required for pCT conjugation, but does increase the 
frequency with which pCT can conjugate to certain recipient hosts. As inactivation of 
pilS had no effect on pCT transfer on a filter to E. coli recipients, the role of the thin 
pilus in conjugation on a solid surface is less clear. However, inactivation of pilS and 
rci (which determines the epitope found at the tip of the thin pilus) reduced the rate of 
transfer to recipient S. Typhimurium SL1344 rifR. These data indicate that the thin 
pilus may be more important for conjugation into particular host strains, and that an 
active rci gene may allow variation in the bacterial host range.  
Inactivation of both conjugation systems had no significant effect on host generation 
times, on the competitive index of the plasmid when placed in a 1:1 ratio with wild-
type pCT, or on the ability of pCT to persist within host bacteria. Disruption of the 
pCT pil loci also had no effect on the host bacterium‟s ability to adhere to eukaryotic 
cells, to aggregate or to form a biofilm. These results are in concordance with 
Srimanote et. al. (2002) who found that the pil locus of IncI plasmid pO113 was not 
responsible for bacterial adhesion to eukaryotic cells. However, they are inconsistent 
with the finding of Dudley et al. (2006) who showed that inactivation of pilS on IncK 
plasmid pSERB1 (potentially a pCT-like plasmid) reduced host adherence to cells by 
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75% and reduced biofilm formation by up to 50%, strongly suggesting an adhesive 
role for the thin pilus. As pCT, pO113 and pSERB1 are very similar plasmids sharing 
analogous pil loci, it may be that the differing adhesion abilities conferred are due to 
the different bacterial host strains (pO113 host strain O113:H21 STEC 98NK2 and 
pSERB1 host EAEC C1096) or interactions between other plasmid and host factors. 
If this were the case, the pCT pil locus may confer increased adhesion or biofilm 
forming ability to STEC or EAEC strains. Dudley et al., (2006) also showed using 
scanning electron microscopy that most of the EAEC C1096 cells containing wild-
type plasmid pSERB1 displayed „surface pili‟. These appear very similar to the 
structures named in my study as „protrusions‟. In bacterial cells containing pSERB1 
with an inactivated pilS a similar number of protrusion bearing cells were seen as in 
E. coli DH5α pCT5 (pilS::aph), suggesting that the cell morphology observed in my 
study is reproducible and applicable to other similar plasmids. Dudley et al., 
concluded that the structures were a direct result of pil locus expression. However, 
my study shows a more complex picture, as inactivation of pCT traXY (pCT7) 
resulted in a similar reduction of bacterial cells expressing protrusions as inactivation 
of pCT pilS (pCT5). The decrease, but not absence, of protrusion expressing E. coli 
DH5α pCT5 and E. coli DH5α pCT7 is also hard to explain if the structures are 
directly related to pili expression. Further study of the literature did not reveal any 
alternative convincing suggestions as to what the protrusions may be; other 
suggestions included bacterial nanotubules (Sanchez, 2011), glycocalyx (capsule 
structures) (Morck et al., 1987) and tubular spinae (Bayer and Easterbrook, 1991). 
Once again the production of protrusions appears to be host specific (E. coli C159/11 
cells did not produce protrusions despite containing pCT), and the effect was also 
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only seen in samples prepared in LB broth. Therefore, it may be that the conditions 
used in my study favour protrusion production for particular strains, and that if 
bacteria were grown in an alternative manner a different result might be obtained. 
Whilst inactivation of either the pil or tra loci had no phenotypic effects beyond 
conjugation, the SEM data show both can alter the expression of the „protrusions‟, 
although their precise nature remains to be elucidated.   
Associated with the pil locus is the shufflon recombinase (rci) which facilitates the 
recombination of pilV DNA components, thereby producing alternate protein variants 
found at the tip of the thin pilus. Different pilV shufflon conformations in plasmid R64 
determine the affinity of the pilus for LPS molecules expressed on recipient surfaces 
thereby establishing host specificity (Komano et al., 1995; Komano et al., 2000). 
Inactivation of rci did not affect the conjugation rate or any of the host phenotypes in 
host strains E. coli J53-2 or E. coli 3950, with the exception of susceptibility to 
cefotaxime. The conjugation frequency of pCT4 (rci::aph) to recipient S. Typhimurium 
SL1344 rifR was reduced on both a solid surface and particularly in liquid media. 
These data suggest that the conformation of the fixed pilV shufflon components has 
a lower affinity for S. Typhimurium SL1344 binding receptors than for E. coli.  
The arrangement of the wild-type pCT shufflon components from the DNA sequence 
read data had most similarity to the functional shufflon region of IncI plasmid R64 in 
the B‟ conformation (Figure 6.19). Komano et al., (1995) found that a fixed R64 
shufflon in this conformation had a generally lower frequency of conjugation, but a 
higher transfer rate into S. Typhimurium LT2 than the other fixed conformations 
(Komano et al., 1995). It is possible that if the DNA sequence assembly was based 
on the predominant shufflon order encoded within the reads, that the higher than  
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Figure 6.19. The DNA sequence of the pCT of shufflon region  
 
aatttgagccaaacgctgatcccggtaagtggcgatatcaacggtggtgatttcatccatatag
cgctcggccatagggtgacgtttaatcacattgacgcgataaaactcctgcagatgaccttttt
tgtggatggatactgtcttcaggtatttgtccagcgcccggttgagagtcattttgcgaatttt
tatttttcgaaacatatctgccttccacgataaatccgaggaaggtaggaatactgaatcagaa
atgcaatgtctctgtgccaatccggtgtgtggcgaacgattggtgcacctgacggaagttacag
caatctgggttctcaccggggaacatttaacgggagaaataacggcagaggaactttgtttgtg
tacgcttccggtggaaatggtgccggtggcggtgattgcgccaacacatcaaatcttcagggct
atgtgaacggcgctttcattggtatgaatgccagcaataacccctcctacggaaagacagcatt
tatttcatttgccgtgccagtgggagcgtcatatcaaatcatctccagaccaacacaaaattac
gcctgtggtaacggtgttttctctgtgtatgcctatcagatgtgagtccctagctggctttaac
aatgtagttgaatgcaatatttttgggacgcatttctgtggtactcccctgtgcccagtatggc
ataccactatgatgccctttcagccatccgccacgttcgtgatagacgcctgattgatcggcct
gataactcaggagttgtctgttccgatcaccatcaagtcccttcccattatcccagccacggat
aaaaacaccgcgcagatcgggcaatttacagctaggataagcacgggcaagctgaggataccgg
gaacaggaaaacgactggccgttcatcaacagatagccttgtggaggagtggcagatggccacg
ggatagggcttcccacagggtaggattcaaagccaacccacacaccggattggcacggaggcca
gtgccaatccggtcggtggtctggtggcaataaagtgaactactccgcctgtaagtggtatcaa
tcatctgtagcaatgaatcacttcattggcgggaaaagtggaggatctatctactacaaaccca
ttcaatgcccgaccggatttatcatgacaggtacacgcatgtatggcattggtgatggcgttga
tgaggaacacgttgatgcttattgttgccccttcggttaaatcccagcaccaggaagattcagg
catgtaacagtaattgtgccgccggactcataatttccccacgcataattattcacataccaaa
ccttgttttggtcggagtatacctgctgaaacccaccaaaaggcgcaccattaaggtatgtcca
cgaacagtacgcatgtacgccaatgctcagatttcgggtgtttttcccgatattgtacgtactg
gtagtgaagttcacttttgccgttgtccagataccggattggcactggcctccgtgccaatccg
gtacgtggaaaaaaattggcgcaggtgatagccaaattgttaccgcttcagctactgcgtggcg
ttggcctggagcaacggcaacatgtccatctggcaagaaagtcattggtggaggcggtcaatgc
agatcaaataccggatttatatggctcacgcgttccatgccttcaggcaacaatgcatggactg
ccagttgcgacacgaccgaagatcaaaatggttccattacagtttacgccatttgccagtgacg
atacttatcactggcaaaccacgatgtaactacatttccccgacaggtcagttcggtgagtacc
gccataaaagttgtattcgtcatagaagccgcatttcacaattcgattggcatcataggttgca
actgaccccgcaaaataattcggcttccacccgtgcggattttctgcattactgacactccagg
tacactggctggcagaaaaaccagatggcaatgggatctgttgtccatttgctatttttcctgt
cagaacagtgctacctgatgcccttctccacgtaccggattggcacgaaagtattgcccctttg
ctgtcacggcctacaagtccatctggtgaacactttgtatttgctacggctgttttatccagct 
 
 
A, rci, red; pCT_094 variable region A, light green; pCT_095 variable region C‟, light 
blue; pCT_096 variable region C‟, yellow; pCT_097 variable region C, purple; 
pCT_098 variable region B, orange; pCT_099 pilV, dark green; Grey highlighted, 
identified predicted sfx shufflon binding regions; Light grey, conserved sfx 
regions. 
 
B, The genetic organisation of R64 shufflon components in the B‟ conformation 
Adapted from Komano et al., 1995.   
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expected pCT conjugation frequency to recipient S. Typhimurium SL1344 rifR in liquid 
and from E. coli donor C159/11 (chapter 4) may be attributed to the predominant 
production of thin pili with a tip protein encoded by the B‟ shufflon organisation. The 
affinity of particular Rci proteins for the different recombination sequences is also 
thought to determine the abundance of the different thin pilus tip proteins (Tam 
2005), therefore it may be that the rci gene determines the predominant shufflon 
organisation and therefore recipient binding and plasmid host range. S. Typhimurium 
SL1344 rifR pCT4 (rci::aph) was significantly less able to invade human tissue culture 
cells (P = 0.018) and was the most attenuated strain in the C. elegans infection 
model. The MIC of cefotaxime required to inhibit all host bacteria containing pCT4 
was also consistently a minimum of one doubling dilution higher than bacterial strains 
containing wild-type pCT. As the same effect was not observed in the pilS inactivated 
plasmid these result cannot be attributed to a lack of pilus binding, however it may be 
that the absence of the recombinase itself leads to a change in bacterial phenotype 
when compared to effects conferred by wild-type pCT.  
There is homology between the IncI plasmid C shufflon component and pilV2 of S. 
Typhi SP17 (Komano, 1999; Morris et al., 2003) and further examples in the literature 
of chromosomally based recombination sites, typically where a promoter is inverted 
by a recombinase varying expression of downstream genes such as Salmonella 
flagellen genes (H1/H2) or a type I pilus system found in E. coli (Freitag et al., 1985; 
Johnson and Simon, 1985). Many targets for recombination are also genes which 
encode membrane proteins. Therefore, interaction between plasmid shufflon 
recombinase and host chromosomal recombination sites may alter binding or entry of 
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cefotaxime into the cells, accounting for the changes to host phenotype observed in 
this study (Gyohda et al., 2004).  
The last of the pCT genes investigated was the pndABC region identified as a 
putative toxin anti-toxin system and shown in R64 by Furuya and Komano (1996) to 
contribute to plasmid stability. Inactivation of pndACB was the most complex of the 
five selected genes, as the majority of the kanamycin resistant colonies once visible, 
became non-viable. The simplest explanation for this phenomenon is that during 
growth both toxin and anti-toxin RNA were present within the dividing cells. However, 
as the toxin mRNA remains stable for longer, when the anti-toxin RNA was 
degraded, toxin was produced and the cells were killed. Those cells found to 
continue growing may have, by chance, not received a copy of the toxin mRNA upon 
division. The main problem with this hypothesis is that typically mRNA has a half life 
of 1-2 minutes. Although pndACB anti-toxin mRNA of R483 has been estimated to 
have a half life of 20 minutes (Nielsen et al., 1991), this is still too short a time to 
explain the findings as colonies grew for approximately 6-10 hours. It may be that 
residual wild-type plasmid was present alongside the mutant plasmid over multiple 
generations due to a high copy number or the formation of plasmid monomers. 
Cessation of the growth of the majority of colonies suggested that the pCT pndA 
toxin was active, and able to kill the bacterial host cell in the absence of the anti-
toxin. Therefore, if a molecule or compound was found that could inhibit the 
transcription of the pndB anti-toxin or prevent binding of pndB RNA to the pndA toxin 
mRNA this may provide an effective anti-plasmid (and anti-bacterial) treatment 
option.  
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In R64 when pndACB was inactivated, ~50% of bacteria lost the plasmid after 60 
generations. In a double inactivation not dissimilar to pCT9 (inactivation of pndACB 
and part of the R64 tra locus) ~80% of bacteria had lost R64 within this time frame 
(Furuya and Komano, 1996). The same was not observed when pndACB was 
inactivated in pCT as both pCT8 and pCT9 remained stable over approx 70 
generations in all host strains. This was perhaps the most surprising for host E. coli 
J53-2 where it was hypothesised that pCT conferred a fitness burden (chapter 4). 
Therefore, these data suggest that pndACB is not the only gene locus encoding 
stability and persistence genes on pCT, and that multiple regions are involved in 
ensuring vertical transfer of this plasmid. Such regions in the pCT genome are yet to 
be identified. 
E. coli DH5α pCT8 and pCT9 (pndACB::) remained in a 1:1 ratio when competed 
against E. coli DH5α pCT, however, E. coli DH5α pCT9 (traXY::aph and 
pndACB::cat) was out-competed when grown with E. coli DH5α alone. As pCT7 
(traXY::aph) was able to compete with the E. coli DH5α, this suggests inactivation of 
both transfer and persistence regions of pCT together had a detrimental effect on the 
success of pCT. These data add weight to the hypothesis that the fitness of pCT, is 
in part, due to both successful vertical and horizontal transfer.  
Biofilm formation was also investigated as the capacity to form this structure may 
increase the bacterial strain‟s ability to survive and persist within diverse and hostile 
environments as well as enhance resistance to antimicrobials and sterilisation (Hall-
Stoodley et al., 2004), thereby increasing bacterial „fitness‟ (Pope et al., 2010). 
Biofilms are also particularly important when considering persistence of E. coli and 
Salmonella strains within the farm environment, and their adherence to food 
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products, as these factors have implications for both animal and human health 
(Solomon et al., 2005). Despite successfully persisting within the index farm (Liebana 
et al., 2006), E. coli C159/11 (which contains pCT) produced very little biofilm. The 
addition of pCT and the pCT mutants to the other bacterial host strains also had no 
effect on the ability of bacterial host strains to form a biofilm. Although several studies 
have shown that plasmids can contribute to the initial stages of biofilm formation 
through the production of conjugative pili (Ghigo, 2001; May et al., 2010), this does 
not appear to be the case for pCT. The increased cell to cell contact within a biofilm 
also increases plasmid conjugation frequency of some plasmids (Parsek and Singh, 
2003). Therefore, an additional experiment to determine whether pCT transfer is 
affected by the production of host cell biofilm would be of interest.  
In conclusion, inactivation of the five selected pCT genes had no universal effect on 
plasmid persistence, plasmid competitive fitness against wild-type pCT or host strain 
growth kinetics and the ability of all the host bacterial strains tested to cause 
infection. Inactivation of the pili genes traXY prevented pCT conjugative transfer, and 
inactivation of pilS reduced the frequency of pCT conjugation to recipient S. 
Typhimurium SL1344 rifR  particularly in liquid, potentially revealing a role for the thin 
pilus in pCT transfer to selected hosts. Inactivation of these pCT pilus genes also 
reduced the number of E. coli DH5α and S. Typhimurium cells which produced 
protrusions, visualised using SEM.  
Natural pCT host strain, E. coli C159/11 was not able to form a biofilm, and the 
addition of wild-type pCT and the pCT mutants also had no effect the ability of all 
host strains to produce a biofilm or to aggregate together in any of the conditions 
tested in my study.  
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6.9 Further work 
A targeted approach to inactivating pCT genes was taken as the sequence analysis 
and previous literature suggested that the seven genes selected (blaCTX-M-14, ISEcp1, 
a putative sigma factor gene, rci, pilS, traXY and pndACB) may be associated with 
plasmid persistence and success. An alternative method which could be considered 
for future work is the systematic disruption of all the pCT CDSs using TraDIS 
(transposons-directed insertion site sequencing). TraDIS uses the insertion of a Tn5 
derivative with outwardly orientated promoters to allow subsequent rapid 
identification of the disrupted genomic region using DNA sequencing (Langridge et 
al., 2009). Conventionally this method has been used to identify essential 
chromosomal genes for bacterial growth and survival (in vitro and in vivo) or genes 
required when the bacterial cell is placed under certain conditions e.g. in the 
presence of bile (Langridge et al., 2009; Eckert et al., 2011). Phan (2009) used 
TraDIS to identify genes on a S. Typhi plasmid pHCM1 (IncHII) and its bacterial host, 
responsible for stable maintenance of this plasmid. Serial passage (~60 generations) 
of the estimated 1.1 x 109 mutant strains revealed those which lost the plasmids, 
therefore identifying the mutations which perturbed the stability of pHCM1 (Phan, 
2009). A similar approach using TraDIS to create a pCT mutant library could be used 
to investigate which genes are required for pCT stability or genes involved in 
conjugation by measuring the ability of each mutant to conjugate. Genes required for 
the persistence and dissemination of pCT in vivo could also be identified in a similar 
approach to that of Eckert et al., (2011) for E. coli 0157:H7, by administering bacteria 
containing the pCT mutant library to C. elegans, cattle or mice and monitoring which 
strains are less able to survive in an in vivo environment.  
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A global overview of pCT and bacterial host gene expression in differing conditions is 
also a desirable future experiment. The most appropriate technology currently 
available to do so is Whole Transcriptome Shotgun Sequencing (WTSS) or RNA-seq, 
which allows the characterisation of the bacterial transcriptome under various 
different conditions using sequencing of mRNA (Wang et al., 2009; Pinto et al., 
2011). Although RNA-seq has almost exclusively been used to identify mRNA of 
chromosomal genes, Isabella and Clark (2011) showed that plasmid pJD1 from 
Neisseria gonorrhoeae differentially expressed repA (replication gene), vapDX (toxin 
antitoxin operon), and mobAB (mobilisation genes) when the host strain was grown 
in aerobic/anaerobic conditions (Isabella and Clark, 2011). Therefore, this technology 
could be used initially to determine changes in the bacterial host gene expression 
when pCT is present or absent, to determine the pCT CDSs which are functional and 
therefore expressed, and to measure changes in pCT gene expression within 
different bacterial host strains or when host strains are grown in different 
environments. Investigation of the pCT transcriptome will also show whether the pCT 
putative sigma factor is expressed, and if so under what conditions, informing on the 
possible role of this unusual plasmid gene.  
Other future work could consider anti-plasmid treatment options (Section 1.4.5), by 
screening for molecules which are able to prevent the transcription or bind to anti-
toxin component pndB. Such molecules should be easier to identify than curing 
agents as successful inhibition of the antitoxin will result in cell death, detectable both 
in culture and using flow cytometry with a viable cell dye.  
The confirmed production and clear importance of the pCT conjugation apparatus 
provides an opportunity for targeted blocking of either one or both of the pCT pili 
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using bacteriophages. This could potentially provide a feasible anti-plasmid 
prophylactic or therapeutic treatment to prevent pCT dissemination. Although many 
phage have been identified that absorb to either the tip or the shaft of pili produced 
by IncI type plasmids (Hedges and Datta, 1973; Coetzee et al., 1980), phages Iα, If1, 
I2-2 and PR64F8 are all unable to absorb to pili produced by IncK and IncB plasmids 
(Coetzee et al., 1982). Therefore screening for a phage able to absorb to the pCT 
thick or thin pilus and reduce conjugation could be undertaken, perhaps by collection 
of samples from diverse environments such as soils. The outer protein coat of any 
candidate phage should also be investigated for an ability to bind to pCT pili, as 
crude phage protein preparation have been shown to have anti-conjugation action, 
and would be extremely desirable as a treatment option (Lin et al., 2011). Phage 
which absorb to, and are internalised by pCT pili could also be used to deliver other 
potential anti-plasmid DNA or RNA to bacterial host cells, for example to bind to the 
antitoxin RNA of the PSK system pndACB allowing production of the toxin PndA and 
subsequent killing of the bacterial cell. In addition, if the S. Typhimurium LPS 
receptor for the pCT pilV epitope of the thin pilus was identified, blocking this 
receptor may prevent the efficient transfer of pCT to pathogenic S. Typhimurium 
strains and act as a anti-salmonella strategy at specific outbreak sites.  
6.10 Key findings 
o The pCT pndACB region is not the exclusive factor which allows pCT to 
persist within host cells. 
o Inactivation of the pCT putative sigma factor had little effect on host fitness 
and plasmid success. 
o The tra locus is essential for pCT transfer by conjugation. 
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o The active pil locus is not required for pCT liquid conjugation although it does 
increase the transfer of frequency in liquid and on a solid surface to recipient 
S. Typhimurium SL1344 rifR. 
o The residence of pCT and corresponding pil locus did not affect the host 
bacterium‟s ability to form a biofilm, to aggregate or to adhere to eukaryotic 
cells 
o Addition of wild-type pCT modified the appearance of E. coli DH5α and S. 
Typhimurium SL1344 rifR cells when visualised by scanning electron 
microscopy. The protrusions seen may be linked to tra and pil pilus production. 
  
  
 
 
Chapter 7: 
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7. Overall Discussion 
The ability of plasmids to acquire and disseminate genetic material has facilitated the 
rapid horizontal transfer of clinically relevant antibiotic resistance and virulence genes 
to new strains, and between bacterial species. Plasmids are also instrumental in the 
accumulation of antibiotic resistance determinants, resulting in multi-drug resistant 
(MDR) bacteria which pose a threat to the continued treatment of infections using 
antibiotics in the future (Maltezou, 2009; Bush and Fisher, 2011). While the use of 
antimicrobials both clinically and in agriculture has undoubtedly led to the increased 
prevalence of antibiotic resistant bacterial strains and genes (Davies and Davies, 
2010; Dhanji et al., 2010; Walsh et al., 2011), a better understanding of the 
mechanisms by which conjugative plasmid backbones are able to persist and 
disseminate within bacterial populations will aid in efforts to manage and treat 
antibiotic resistant bacterial infections and delay the surge of pan-resistant bacterial 
strains. 
In my study blaCTX-M-14 carrying plasmid, pCT, was chosen for detailed investigation. 
Previous data had shown that pCT conferred resistance to third generation 
cephalosporins and successfully persisted and spread within livestock and the 
environment on a dairy farm over a three year period (Liebana et al., 2006). pCT was 
also present in at least six different E. coli host strains on the index farm, indicating 
extensive plasmid transfer rather than a clonal expansion of a particular host strain, 
making pCT a suitable candidate for further study of factors influencing plasmid 
success.  
Complete DNA sequencing and annotation revealed that pCT was 93,629 bp in size 
and encoded all three IncI group associated regions, the repYZ, tra and pil loci. 
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Comparison of the pCT genome to other blaCTX-M encoding plasmids showed no 
conserved regions with the exception of the antibiotic resistance gene itself. 
Therefore, it seems no one common genomic factor enabled the acquisition or 
maintenance of blaCTX-M genes on these conjugative plasmids, supporting the 
hypothesis of multiple acquisitions of blaCTX-M genes by various different plasmid 
backbones. Further comparison of the sequence of pCT with other, similar plasmid 
sequences deposited in genbank allowed the identification of conserved DNA regions 
found in similar IncI and IncK reference plasmids R64 and R387, respectively, but 
also novel and unique regions when compared to the four plasmids with the highest 
degree of homology to pCT (pO26_vir, pR3521, pO113 and pSERB1). The detailed 
analysis of the pCT genome facilitated the development of specific PCR assays 
designed to amplify a selection of pCT genes situated around the genome. This test 
provided a rapid and high-throughput pCT detection test which was able to 
discriminate the presence of pCT from other plasmids to a much greater degree than 
currently used Inc typing methods. The analysis of plasmid nikB sequences also 
proved to be a very useful tool to identify homology and relationships between IncI 
plasmids. In my study use of the PCR assay identified ten pCT-like plasmids in UK 
veterinary isolates and human clinical isolates from China, Australia and Spain, 
including plasmid pRYC105 which is distributed throughout Spain in both community 
acquired infections and in the environment (Valverde et al., 2009). A subsequent 
study by the Animal Health and Veterinary Laboratories Agency using the same PCR 
tests showed a further twenty-one pCT-like plasmids from UK cattle and turkey farms 
and clinical isolates from Wales (Stokes et al., Submitted). These data together 
reveal that plasmid pCT is widespread globally, and is a common vector for 
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dissemination of blaCTX-M-14 in bacteria isolated from humans, animals and the 
environment. They also show direct evidence for the movement of this mobile genetic 
element between bacteria within these different niches.  
The pCT genome analysis also showed blaCTX-M-14 to be the only antibiotic resistance 
gene encoded on the plasmid; therefore persistence and spread of pCT could not be 
attributed to co-selection associated with pressure from non β-lactam antimicrobial 
drugs. This finding suggested that either pCT containing bacteria had been 
constantly exposed to β-lactam antibiotic compounds, which due to its widespread 
distribution in many different environments seems unlikely; or that pCT is able to 
remain stably persist and disseminate in the absence of antibiotic selective pressure. 
To investigate this hypothesis the stability of plasmid pCT and any fitness cost or 
benefit the plasmid conferred upon bacterial host strains „pCT naive‟ E. coli DH5α, E. 
coli J53-2 and S. Typhimurium SL1344 rifR, and the pCT „cured‟ C159/11 derivative, 
E. coli 3950, were assessed.   
pCT was stably maintained in the absence of β-lactam antibiotic pressure, in the four 
bacterial host strains over approximately 70 generations. Similarly, each pCT mutant 
(pCT2-9) remained stable over this time period indicating that the genes selectively 
inactivated (blaCTX-M-14, putative sigma factor, rci, pilS, ISEcp1, traXY and pndACB) 
were not individually responsible for the short term maintenance of pCT. This was 
perhaps the most surprising in the case of pCT8 and pCT9 which had an inactivated 
putative toxin-antitoxin system pndACB, which appeared to be active during the 
construction of these plasmid mutants. When a homologous pndACB operon was 
inactivated on plasmid R64, this significantly reduced the stability of the plasmid, so 
much so that after approx 100 generation the majority of bacterial cells were R64 free 
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(Furuya and Komano, 1996). Therefore, my data infers that pCT either encodes 
another currently unknown addiction or partitioning system which possibly works 
together with pndACB, or, other mechanisms such as a low fitness burden conferred 
upon the host, or high pCT copy number allow maintenance of this plasmid in all 
daughter bacterial cells without addiction.  
To investigate the fitness burden/benefit of pCT, growth kinetics were measured for 
each bacterial host strain +/- pCT. The addition of pCT had no significant effect on 
the generation time of the four host strains grown isogenically and pCT7 (non-
conjugative pCT mutant) appeared to confer neither a competitive advantage or 
disadvantage to E. coli host DH5α cells when grown in competition with the plasmid 
free parental strain. These results suggested that pCT does not confer a fitness cost 
or benefit to the pCT „naive‟ bacterial host strain E. coli DH5α despite the lack of a 
period of co-evolution between bacterial host and plasmid. Therefore, the stability of 
pCT and absence of a fitness burden on host bacteria strains E. coli DH5α (and E. 
coli 3950) predicts that in the absence of antibiotic pressure, pCT will persist once 
established in bacterial populations regardless of antibiotic administration or 
stewardship; and that amplification will occur if exposed to selective antibiotics. 
Although pCT remained stable and did not affect the generation times of the third 
host strain, E. coli J53-2, competition assays revealed that wild-type pCT conferred a 
fitness burden on this bacterial host. However, further investigation showed that 
pCT2 conferred less of a fitness cost on E. coli J53-2 than wild-type pCT, inferring 
that at least part of the pCT burden was caused by the presence of the blaCTX-M-14 
gene.  
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Other competition data showed that E. coli DH5α containing the pCT mutant 
plasmids pCT3 - 9 remained in a 1:1 ratio when competed against E. coli DH5α 
containing wild-type pCT, indicating the inactivation of the selected pCT genes 
neither increased nor decreased the competitive fitness of the E. coli DH5α host 
strain. The addition of pCT also had no significant effect on bacterial host 
pathogenicity, on the ability of bacterial host strains to form a biofilm, or to aggregate. 
Therefore, with the exception of resistance to β-lactams and the extracellular 
protrusions observed using scanning electron microscopy, the acquisition of pCT 
conferred no major changes to the host strain phenotypes.  
The conjugation frequency of pCT was measured from two donor E. coli strains to 
several recipient strains (E. coli and S. Typhimurium) in a liquid and on a solid 
surface. Comparative transfer rates of pili inactivated mutant plasmids pCT5 
(pilS::aph) and pCT7 (traXY::aph) were also assessed to establish the role of these 
pili in the conditions tested. Data collected indicated that transfer to host recipient E. 
coli J53-2 was exclusively by the thick pilus and conjugation to E. coli J53-2 was at a 
high rate, particularly on a solid surface. pCT conjugation in liquid was more frequent 
than on a solid surface to recipients E. coli 3950 (derived from E. coli C159/11) and 
S. Typhimurium SL1344 rifR, and involved conjugation by both the thick and thin pili. 
Inactivation of the shufflon recombinase (pCT4) and pilS (pCT5), preventing 
conformational changes at the tip of the thin pilus and pilus production respectively, 
had a detrimental effect on pCT conjugation frequency to recipient S. Typhimurium. 
Therefore, it seems that the pil locus and conjugation in liquid is most important for 
the transfer of pCT to recipient strain S. Typhimurium SL1344 rifR, and that the pCT 
pil locus may play a role in expanding the host range of this plasmid. The ease with 
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which pCT was able to conjugate to S. Typhimurium SL1344 rifR in my experiments 
may have clinical or veterinary implications as the acquisition of antibiotic resistance 
genes (and virulence genes on other similar plasmids) by pathogenic Salmonella 
enterica strains may lead to significant treatment failures. Within the farm 
environment, E. coli and Salmonella strains are very often co-located (Poppe et al., 
2005) and may be exposed to low level β-lactams such as ceftiofur (Daniels et al., 
2009), potentially selecting for the spread of pCT between these two species. As 
screening for pCT-like plasmids in S. enterica strains was beyond the scope of this 
project the prevalence of pCT in this species is currently unknown. The importance of 
the pil locus in pCT transfer to S. Typhimurium lends itself to possible treatment 
options which target this pilus, potentially useful in an outbreak situation to prevent 
further spread of pCT-like plasmids to more pathogenic bacterium.  
The generation of a novel method to specifically and rapidly inactivate targeted 
plasmid genes allowed analysis of the consequences arising from the disruption of 
seven pCT gene regions. While inactivation of these genes had little effect on the 
host phenotypes investigated within my study, development of the method will allow 
examination of other genes of interest both on pCT (for example the annotated 
hypothetic proteins) or genes on other large conjugative plasmids in a similar way, 
opening up a functional genomics approach which will be useful as many more 
plasmid genomes are sequenced. 
A common theme during this project was bacterial host specific differences seen 
throughout all my experiments. I found that the bacterial host strain determined the 
conjugation frequency and the fitness cost of both plasmid and antibiotic resistance 
gene. Therefore the bacterial host strain influenced the success of pCT. Bacterial 
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strain specific differences have probably been underestimated in previous studies of 
plasmids, especially when using one particular strain (typically E. coli J53 or E. coli 
DH5α/K12) and extrapolating the findings to other host strains or other plasmids.  
Therefore, continued study of plasmids must take into account host diversity. 
Investigation to determine the bacterial host or plasmid factors which create these 
differences is also an interesting avenue for further work. While my project examined 
just one conjugative plasmid, within four different bacterial hosts, my data alludes to 
the extensive variation and complex nature of the relationship between plasmid and 
bacterial host. It may be that particular host strain and plasmid backbone 
partnerships are better suited to different environment conditions. For example, a 
notable host and plasmid pairing is epidemic strain E. coli O25:H4-ST131 and IncF 
plasmids (often encoding blaCTX-M-15) found in both human and veterinary samples 
(Ewers et al., 2010; Xu et al., 2011). E. coli ST131 is a pathogenic strain which 
typically carries numerous antibiotic resistance genes (both chromosomally and 
plasmid encoded), causing major treatment issues and often leading to the use of 
last resort antibiotics, carbapenems (Woodford et al., 2009; Peirano and Pitout, 
2010). It may be that this type of multidrug resistant strain/plasmid combination is 
better adapted to environments where antibiotic selective pressures are numerous.  
Conversely, pCT-like plasmids have been shown to be present in >10 different E. coli 
clonal types (Liebana et al., 2006; Coldham et al., 2011) and have no association 
with one particular bacterial strain. Host strains containing pCT-like plasmids have 
largely been isolated from community acquired urinary tract and infections, as 
commensals of healthy patients and in the farm environment (Valverde et al., 2004; 
Liebana et al., 2006; Valverde et al., 2009) where a constant antibiotic presence is 
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unlikely. Therefore, it seems that pCT is a promiscuous plasmid, able to conjugate 
and persist within many different Enterobactericeae host strains without a constant 
antibiotic presence. This may be in part due to the apparent lack of a fitness cost 
conferred to even naive bacterial hosts (E. coli DH5α), which in combination with the 
postulated addiction systems, may allow the rapid establishment and vertical 
transmission of pCT. These factors contribute to the hypothesis that pCT has 
adapted to persist in the absence of antibiotic pressures, probably prior to the 
acquisition of the blaCTX-M-14 gene and the use of third generation cephalosporins, and 
that stable incorporation of this single antibiotic resistance gene has had little effect 
on plasmid function or the niche that it occupies.  This hypothesis corresponds with 
recent work by Iredell et al. (2011) who showed that plasmids which did not encode 
antibiotic resistance genes were common within samples and had similar backbones 
to many plasmids which do carry common antibiotic resistance genes (Iredell et al., 
2011).   
The high frequency of pCT transfer in liquid, the importance of the pil locus, and lack 
of E. coli C159/11 biofilm production may also suggest that plasmid pCT (and host) 
have adapted to a liquid environment. Rather than surviving within a static biofilm, 
rapid liquid conjugation to a number of different hosts may allow better spread and 
survival of the plasmid itself. It is conceivable that the combination of efficient 
dissemination of pCT to a variety of bacterial host strains, followed by successful 
stability within these bacteria due to a low fitness cost and the hypothesised 
presence of multiple addiction systems has aided this plasmid in its worldwide 
dissemination and persistence.  
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Data and hypotheses collated within my project strongly indicate that simple 
cessation or limitation of the use of antibiotics through antibiotic stewardship is 
unlikely to remove the antibiotic resistance gene vectors from bacterial populations, 
leading to the amplification of these plasmids when use of the antibiotic is 
recommenced. Therefore, the control of plasmids such as pCT, by limiting the 
dissemination and prevalence of these plasmids may be a more realistic therapeutic 
strategy, particularly in hospitals and agricultural environments. This could be 
achieved by the identification of anti-plasmid curing agents, compounds which allow 
the production of toxins encoded within the toxin-antitoxin systems (such as 
pndACB), leading to cell death, or by prevention of conjugation by targeting the pili 
apparatus or relaxase mechanisms. These measures would lower the risk of plasmid 
transmission to a) more clinically relevant pathogens such as toxigenic E. coli strains 
or S. enterica b) to bacteria already containing plasmids encoding virulence or other 
antibiotic resistance genes with which pCT could recombine (e.g. pO26_vir), or c) 
multi-drug resistant bacterial strains. 
In conclusion, plasmid pCT was shown to be widely distributed in E. coli isolated from 
humans and animals. Success of this plasmid is postulated to be due to a 
combination of subtle factors rather than one particular gene or phenotypic benefit 
conferred to host strains. These factors include stability within a range of hosts, a 
lack of a fitness burden conferred to new host strains allowing establishment of the 
plasmid, and the proficient conjugation of pCT to a range of bacterial hosts in both 
liquid and on solid media.  There is still much to learn about the complex nature of 
plasmid and bacterial host strain interactions with regard to plasmid functions such 
as conjugation and stability, plasmid and bacterial host gene expression and how 
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different phenotypes affect the overall evolutionary fitness of plasmid and host in 
different conditions. Therefore, the hypotheses and methods developed during my 
study using plasmid pCT provide a resource for further investigation.  
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Appendix 
  
Appendix 1. Sequence of CTX-M Group 9 PCR amplicon derived from pCT aligned with known blaCTX-M-14 sequence 
 
  
 
blaCTX-M-14    gatgatgttc gcggcggcgg cgtgcattcc gctgctgctg ggcagcgcgc cgctttatgc gcagacgagt gcggtgcagc 
pCT sequence  CGGATATGTT GCGGCGGCGG CGTGCATTCC GCTGCTGCTG GGAAGAGCGC CGCTTTATGC GCATACGAGT GCGGTGCAGC 
 
blaCTX-M-14   aaaagctggc ggcgctggag aaaagcagcg gagggcggct gggcgtcgcg ctcatcgata ccgcagataa tacgcaggtg 
pCT sequence    AAAAGCTGGC GGCGCTGGAG AAAAGCAGCG GAGGGCGGCT GGGCGTCGCG CTCATCGATA CCGCAGATAA TACGCAGGTG 
 
blaCTX-M-14   ctttatcgcg gtgatgaacg ctttccaatg tgcagtacca gtaaagttat ggcggccgcg gcggtgctta agcagagtga 
pCT sequence  CTTTATCGCG GTGATGAACG CTTTCCAATG TGCAGTACCA GTAAAGTTAT GGCGGCCGCG GCGGTGCTTA AGCAGAGTGA 
 
blaCTX-M-14   aacgcaaaag cagctgctta atcagcctgt cgagatcaag cctgccgatc tggttaacta caatccgatt gccgaaaaac 
pCT sequence  AACGCAAAAG CAGCTGCTTA ATCAGCCTGT CGAGATCAAG CCTGCCGATC TGGTTAACTA CAATCCGATT GCCGAAAAAC 
 
blaCTX-M-14   acgtcaacgg cacaatgacg ctggcagaac tgagcgcggc cgcgttgcag tacagcgaca ataccgccat gaacaaattg 
pCT sequence  ACGTCAACGG CACAATGACG CTGGCAGAAC TGAGCGCGGC CGCGTTGCAG TACAGCGACA ATACCGCCAT GAACAAATTG 
 
blaCTX-M-14   attgcccagc tcggtggccc gggaggcgtg acggcttttg cccgcgcgat cggcgatgag acgtttcgtc tggatcgcac 
pCT sequence  ATTGCCCAGC TCGGTGGCCC GGGAGGCGTG ACGGCTTTTG CCCGCGCGAT CGGCGATGAG ACGTTTCGTC TGGATCGCAC 
 
blaCTX-M-14   tgaacctacg ctgaataccg ccattcccgg cgacccgaga gacaccacca cgccgcgggc gatggcgcag acgttgcgtc 
pCT sequence  TGAACCTACG CTGAATACCG CCATTCCCGG CGACCCGAGA GACACCACCA CGCCGCGGGC GATGGCGCAG ACGTTGCGTC 
 
blaCTX-M-14   agcttacgct gggtcatgcg ctgggcgaaa cccagcgggc gcagttggtg acgtggctca aaggcaatac gaccggcgca 
pCT sequence  AGCTTACGCT GGGTCATGCG CTGGGCGAAA CCCAGCGGGC GCAGTTGGTG ACGTGGCTCA AAGGCAATAC GACCGGCGCA 
 
blaCTX-M-14   gccagcattc gggccggctt accgacgtcg tggactgtgg gtgataagac cggcagcggc gactacggca ccaccaatga 
pCT sequence  GCCAGCATTC GGGCCGGCTT ACCGACGTCG TGGACTGTGG GTGATAAGAC CGGCAGCGGC GACTACGGCA CCACCAATGA 
 
blaCTX-M-14   tattgcggtg atctggccgc agggtcgtgc gccgctggtt ctggtgacct attttaccca gccgcaacag aacgcagaga 
pCT sequence  TATTGCGGTG ATCTGGCCGC A?GGTCGTGC GCCGCTGGTT CTGGTGACCT ATTTTACCCA GCCGCAACAG AACGCAGAGA 
 
blaCTX-M-14   gccgccgcga tgtgctgg 
pCT sequence  GCCGCCGCGA TGTGCTGG 
 
 
Amplicons sequenced from CTX-M Group 9 PCR were homologous to known blaCTX-M-14 nucleotide sequences accessed from  
genbank accession no. AF252622 highlighted in grey.   
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Appendix 2.  pCT-like plasmid E. coli DH5α transformants 
 
Lab code Strain Plasmid Inc type 
I779 DH5α pI779 pI779 K/F 
I780 DH5α pI780 pI780 K/F 
I801 DH5α pC559 pC559 K 
I802 DH5α pC567 pC567 K 
I803 DH5α pC574 pC574 K 
I853 DH5α pRYC105 pRYC105 K 
I832 DH5α pOZ174 pOZ174 - 
I849 DH5α pJIE052 pJIE052 B 
I850 DH5α pJIE201 pJIE201 K 
I865 DH5α pJIE182 pJIE182 B 
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Appendix 3. C. elegans culture media 
Nemotode Growth Media (NGM)  
Make up to 1 litre in SDW  
- 17 g of bacteriological agar 
- 2.5 g of peptone 
- 2.5 g of peptone 
- 1ml of cholesterol* (5 mg/ml) in EtOH 
Autoclave, cool to 500C then add: 
- 25 ml of PBS (pH6)  
- 1ml of CaCl (1 M) 
- 1ml of MgSO4 (1 M)  
M9 Buffer 
Made up to 1 litre in SDW  
- 3 g of KH2PO4 
- 6 g of Na2HPO4 
- 5 g NaCl 
Autoclave, cool to 500C and add: 
- 1ml of  MgSO4  (1 M) 
- 1ml of  CaCl2 (1 M) 
 
*Cholesterol, Sigma Aldrich, UK, Cat. no. EC 200-353-2 
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Appendix 4. Generation times of host strains +/- pCT 
 
Lab 
code Strain 
Generation 
time (mins) SD 
Student 
T-test (P) 
 
L1078 
 
S. Typhimurium SL1344 rifR  
 
88.21 
 
6.00 
 
 
L1079 
 
S. Typhimurium SL1344 rifR pCT 
 
94.15 
 
11.70 
 
0.45 
I823 E. coli 3950  64.72 2.06  
I834 E. coli 3950 pCT 67.94 4.52 0.28 
I825 E. coli DH5α 92.61 6.70  
I755 E. coli DH5α pCT 94.15 9.06 0.94 
I847 E. coli J53-2 63.45 4.70  
I855 E. coli J53-2 pCT 67.81 3.75 0.18 
 
Growth of each bacterial host strain +/- pCT was measured using the FLUOstar 
OPTIMA using at least three biological and four technical repeats. Generation times 
were calculated between hours 1-2 (Figure 4.1, page 142). 
Values returning a P value of <0.05 from a Student‟s T-test were considered 
statistically significant and are represented with bold text.  
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Appendix 5. The proportion of pCT carrying strains within a population  
 
 
 
 
 
E. coli pairing 
Percentage of bacteria containing pCT 
 12h (before passage) 72h (after three passages) 
    
A 3950 + 3950 pCT  63% 100% 
B DH5α + DH5α pCT 51% 84% 
C J53-2 + J53-2 pCT 46% 12% 
 
 
 
 
The percentage of plasmid pCT carrying bacteria when E. coli strains +/- pCT were 
co-cultures in a 1:1 ratio in vitro (Figure 4.2, page 143) 
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Appendix 6. The ability of S. Typhimurium SL1344, SL1344 rifR and SL1344 rifR 
containing pCT to adhere to and invade human intestinal cells 
 
 
 
 SL1344 rifR SL1344 SL1344 rifR pCT 
 (L1078) (L354) (L1079) 
A: Adhesion 100% 307% (P = 0.10) 93% (P = 0.93) 
    
B: Invasion 100% 1300% (P = 0.11) 168% (P = 0.23) 
 
 
The number of S. Typhimurium SL1344 and SL1344 rifR pCT bacterium to adhere to 
(A) and invade (B) INT-407 human intestinal cell is represented as a percentage of 
the number of S. Typhimurium SL1344 rifR able to do so under test conditions (Figure 
4.4, p147). Data are displayed as a mean of three separate experiments all 
performed with four technical repeats.  
Values returning a P value of <0.05 from a Student‟s T-test were considered 
statistically significant and are represented with bold text.  
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Appendix 7. The ability of bacterial hosts +/- pCT to cause infection in                
C. elegans 
 
Lab 
number Strain 
TD50 
(Days) 
Chi2 between 
curves P value  
Significance 
(<0.05) 
L1078 
L1079 
SL1344 rifR 
SL1344 rifR pCT 
3.5 
3.15 
 
3.385794 
4.87133 
 
0.0658 
0.0154 
 
Not significant 
Significant L354 SL1344  3.9 
I823 3950 4.75 
0.0186159 0.8915 Not significant 
I834 3950 pCT 4.75 
 
 
Survival curves were constructed using a Kaplan Mier calculation showing the 
probability of C. elegans survival each day when fed continuously on the tested 
bacterial strains (Figure 4.5, page 148).  
TD50 = time taken for 50% of the nematodes to die,  
A significance difference in killing rate was defined as a P value <0.05 denoted by 
bold text.  
 
 
  
  
Appendix 8. pCT conjugation frequency time optimisation on solid media 
 
 
 
   Conjugation frequency / donor cell 
 pCT donor strain Recipient strain 2 hours 3 hours 4 hours   6 hours 
 E. coli C159/11 (pCT)  E. coli DH5α 4.19 x 10-5 5.60 x 10-3 8.80 x 10-4 6.80 x 10-2 
 E. coli DH5α pCT  S. Typhimurium SL1344 rifR 8.5 x 10-8 7.30 x 10-7 1.30 x 10-6 6.67 x 10-7 
 E. coli C159/11  (pCT) S. Typhimurium SL1344 rifR 2.00 x 10-6 4.10 x 10-6 1.10 x 10-5 1.26 x 10-5 
 
 
The pCT con jugation frequencies were measured from donor strains E. coli C159/11 and E. coli DH5α during a 2,3,4 and 6 
hour period to optimise the the timing for future conjugation experiments (Figure 4.6, page 150) on a minimum of three 
separate occasions.  
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Appendix 9. Conjugation frequencies of pCT on solid and in liquid media 
A, Conjugation from donor E. coli DH5α (pCT) to various recipients 
Recipient Media 
Average conjugation 
frequency 
Standard 
deviation 
E. coli J53-2 
(rifampicinR) 
Filter 
 
1.70 x 10-2 1.65 x 10-2 
Liquid 9.10 x 10-5 6.06 x 10-5 
E. coli DH5α 
(rifampicinR) 
 
Filter 9.65 x 10-5 4.53 x 10-5 
Liquid 2.90 x 10-4 9.76 x 10-5 
E. coli 3950 
(tetracylcineR) 
 
Filter     6.12 x 10-6  1.27 x 10-6 
Liquid    1.39 x 10-4  1.52 x 10-4 
S. Typhimurium 
SL1344 rifR 
(rifampicinR) 
 
Filter     1.07 x 10-5  6.92 x 10-6 
Liquid     9.33 x 10-6  7.69 x 10-6 
(Figure 4.7, page 152) 
B, Conjugation from donor E. coli C159/11 (pCT) to various recipients 
Recipient Media 
Average conjugation 
frequency 
Standard 
deviation 
E. coli J53-2 
(rifampicinR) 
 
Filter 
 
1.51 x 10-3 1.37 x 10-3 
Liquid 9.59 x 10-7 4.50 x 10-7 
E. coli DH5α 
(rifampicinR) 
 
Filter 1.56 x 10
-6 8.66 x 10-7 
Liquid 9.31 x 10-8 9.70 x 10-8 
S. Typhimurium 
SL1344 rifR 
(rifampicinR) 
 
Filter  3.58 x 10-5 1.20 x 10-5 
Liquid 1.63 x 10-4 1.30 x 10-4 
(Figure 4.8, page 153) 
 
Conjugation frequencies were calculated from the mean of at least three separate 
experiments for each mating pair on a solid surface (filter) and in liquid media. 
 276 
 
Appendix 10. Conjugation frequencies on solid media of pCT in the presence of 
sub-inhibitory concentrations of cefotaxime 
 
 
Recipient 
Concentration of 
Cefotaxime (µg/ml) 
Average conjugation 
frequency 
Standard 
deviation 
P 
value 
E. coli J53-2 
(rifampicinR) 
No CTX 
 
4.88 x 10-5 
 
4.82 x 10-5 
 
 
0.003 3.40 x 10
-5 1.58 x 10-5 0.904 
 0.006 2.43 x 10
-5 6.02 x 10-6 0.610 
E. coli DH5α 
(rifampicinR) 
No CTX 4.87 x 10
-5 4.26 x 10-5  
0.003 2.04 x 10
-5 2.18 x 10-5 0.364 
 0.006 1.20 x 10
-5 1.06 x 10-5 0.222 
E. coli 3950 
(tetracylineR) 
No CTX 4.00 x 10
-6 9.84 x 10-7  
0.003 3.05 x 10
-6 1.08 x 10-6 0.081 
 0.006 2.73 x 10
-5 3.36 x 10-5 0.314 
 
S. Typhimurium 
SL1344 rifR 
(rifampicinR) 
No CTX 1.10 x 10
-5 7.32 x 10-6  
0.003 1.72 x 10
-5 8.40 x 10-6 0.389 
0.006 1.97 x 10
-5 6.32 x 10-6 0.195 
 
 
The conjugation frequency of pCT in the presence of sub-inhibitory concentration of 
cefotaxime (CTX) was compared to conjugation frequency in the absence of 
antibiotic. Frequencies were measured from donor bacterial strain E. coli DH5α to 
recipient strains E. coli J53-2, E. coli DH5α, E.coli 3950 and S. Typhimurium SL1344 
rifR on a filter placed on an agar containing either no cefotaxime; 0.003µg/ml 
cefotaxime or 0.006µg/ml cefotaxime 
.  
Conjugation frequencies were calculated from the mean of at least three separate 
experiments (Figure 4.9, page 155). Values returning a P value of <0.05 from a 
Student‟s T-test were considered statistically significant and are in bold text. 
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Appendix 11. Conjugation frequencies in liquid  media of pCT in the presence 
of sub-inhibitory concentrations of cefotaxime 
 
 
Recipient 
Concentration of 
Cefotaxime (µg/ml) 
Average conjugation 
frequency 
Standard 
deviation 
P 
value 
E. coli J53-2 
(rifampicin
R
) 
No CTX 4.88 x 10
-5 4.82 x 10-5  
0.003 3.40 x 10
-5 1.58 x 10-5 0.692 
 0.006 2.43 x 10
-5 6.02 x 10-6 0.509 
E. coli DH5α 
(rfiampicin
R
) 
No CTX 1.47 x 10
-4 2.01 x 10-4  
0.003 2.91 x 10
-5 9.05 x 10-6 0.495 
 0.006 3.05 x 10
-5 2.69 x 10-5 0.359 
E. coli 3950 
(tetracyline
R
) 
No CTX 3.07 x 10
-5 9.99 x 10-7  
0.003 1.16 x 10
-4 2.99 x 10-5 0.525 
 0.006 1.66 x 10
-4 1.15 x 10-5 0.143 
 
S. Typhimurium 
SL1344 
(rifampicin
R
) 
No CTX 6.55 x 10
-6 4.47 x 10-6  
0.003 1.01 x 10
-5 2.26 x 10-6 0.225 
0.006 8.90 x 10
-6 2.95 x 10-6 0.405 
 
 
The conjugation frequency of pCT in the presence of sub-inhibitory concentration of 
cefotaxime (CTX) was compared to conjugation frequency in the absence of 
antibiotic. Frequencies were measured from donor bacterial strain E. coli DH5α to 
recipient strains E. coli J53-2, E. coli DH5α, E.coli 3950 and S. Typhimurium SL1344 
rifR in LB broth containing either no cefotaxime; 0.003µg/ml cefotaxime or 0.006µg/ml 
cefotaxime.  
 
Conjugation frequencies were calculated from the mean of at least three separate 
experiments (Figure 4.10, page 156). Values returning a P value of <0.05 from a 
Student‟s T-test were considered statistically significant are in bold text. 
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Appendix 12. DNA sequence showing the successful insertion of the aph-gfp 
construct into blaCTX-M-14 on pCT (construction of pCT2b) 
 
GGCGTGCATTCCGCTGCTGCTGGGCAGCGCGCCGCTTTATGCGCAGACGAGTGCGGTGCAGCAAAAGC
TGGCGGCCAGGAGTCCAAGCGAGCTCTCGAACCCCAGAGTCCCGCTCAGAAGAACTCGTCAAGAAGGC
GATAGAAGGCGATGCGCTGCGAATCGGGAGCGGCGATACCGTAAAGCACGAGGAAGCGGTCAGCCCAT
TCGCCGCCAAGCTCTTCAGCAATATCACGGGTAGCCAACGCTATGTCCTGATAGCGGTCCGCCACACC
CAGCCGGCCACAGTCGATGAATCCAGAAAAGCGGCCATTTTCCACCATGATATTCGGCAAGCAGGCAT
CGCCATGGGTCACGACGAGATCCTCGCCGTCGGGCATGCGCGCCTTGAGCCTGGCGAACAGTTCGGCT
GGCGCGAGCCCCTGATGCTCTTCGTCCAGATCATCCTGATCGACAAGACCGGCTTCCATCCGAGTACG
TGCTCGCTCGATGCGATGTTTCGCTTGGTGGTCGAATGGGCAGGTAGCCGGATCAAGCGTATGCAGCC
GCCGCATTGCATCAGCCATGATGGATACTTTCTCGGCAGGAGCAAGGTGAGATGACAGGAGATCCTGC
CCCGGCACTTCGCCCAATAGCAGCCAGTCCCTTCCCGCTTCAGTGACAACGTCGAGCACAGCTGCGCA
AGGAACGCCCGTCGTGGCCAGCCACGATAGCCGCGCTGCCTCGTCCTGCAGTTCATTCAGGGCACCGG
ACAGGTCGGTCTTGACAAAAGAACCGGGCGCCCCTGCGCTGACAGCCGAAACACGGCGGCATCAGAGC
AGCCGATTGTCTGTTGTGCCCAGTCATAGCCGAATAGSCTCTCCACCCAAGCGGCGGAGAACCTGCGT
GCATCCATCTTGTTCAATMATGCGAACGATCCTCATCCTGTCTCTTGATCAGATCTTGATCCCCTGCS
CATCAGATCCTTGGCGGCAARAAGCCATCCAGTTTACTTTGCAGGCTCCCAACTACARAGGGCGCCCA
GCTGGCATTCGACGTCTAGAACCATWTWWCWGRAMTTACTWAAATAGCGTWWCMGAGCTTCGCTTMMC
YCRCAGTCTGSGTMMCTCGCGCGCCMAGATCGCCACGGTGCATCTGATCGMGAAGMGCTACTMMGGKG
ACCTGCAGTGACSGGGATACTGTCTGACGAATTGCAATGTYCWGTGCSCACTGCGGGTWGGACATATT
ATTGC...............................................................
........................................GTCCMCYGGSTGACACRGATATCACGST
GTMTYCGMKMTCGAGAMGTTYMTSCAGGTACTGCATGAGCGGGATTACTGTRCGGATGCCAAAKTCWG
TGGSCSCAKTGSTGTAGATAWATWGSCAAKGWTSSGTATGGGTAGGCTCAATACGKAAATCGKGTAGA
CTGCGGATTAGTGCATTTCACATTTWMMTACGAACMTCSGAAGSRGTTGATAGATTAGAGTAKRGCMT
ATCGAGAACGCGTAGAAATATCGSGACAGCTGGSGTAGCAGGAGAGTACCACAATSCTCTTCGTGAAG
ACCTGGCGSGGATCTCTAGATTAGAGGAGATATACATWTGAGTAAAGGAGAGACTTTCACTGGAGTGT
CCCATCTGTGAATAGATGTGATGTTAATGGCACAAATTTCTGTCAGTGGAGAGGKGAAGGTGATGCAA
CATACGGAAACTTACCCTTAAATTTATTGCACTACTGGAAAACTACCTGTCCCATGGCCAACACTTGT
CACTACTTTCGCGTATGGTCTTCAATGCTTGCGAGATACCCAGATCATATGAAACAGCATGACTTTTC
AAGAGTGCCATGCCCGAAGGTTATGTACAGGAAAGAACTATATTTTTCAAAGATGACGGGAACTACAA
GACACGTGCTGAAGTCAAGTTTGAAGGTGATACCCTTGTTAATAGAATCGAGTTAAAAGGTATTGATT
TTAAAGAAGATGGAAACATTCTTGGACACAAATTGGAATACAACTATAACTCACACAATGTATACATC
ATGGCAGACAAACAAAAGAATGGAATCAAAGTTAACTTCAAAATTAGACACAACATTGAAGATGGAAG
CGTTCAACTAGCAGACCATTATCAACAAAATACTCCAATTGGCGATGGCCCTGTCCTTTTACCAGACA
ACCATTACCTGTCCACACAATCTGCCCTTTCGAAAGATCCCAACGAAAAGAGAGACCACATGGTCCTT
CTTGAGTTTGTAACAGCTGCTGGGATTACACATGGCATGGATGAACTATACAAATAGATGTCCAGACC
TGCAGGCATGCAAGCTCTAGAGGCATCAAATAAAACGAAAGGCTCAGTCGAAAGACTGGGCCTTTCGT
TTTATCTGTTGTTTGTCGGTGAACGCTCTCCTCGACTACGGCACCACCAATGATATTGCGGTGATCTG
GCCGCAGGGTCGTGCGCCGCTGGTTCTGGTGACCTATTTTACCCAGCCGCAACAGAACGCAGAGAGCC 
 
 
Red text, DNA sequence homologous to the blaCTX-M-14 gene, 
Orange text, sequence homologous to pUA66pacpP PCR construct to the aph gene, 
Green text, sequence homologous to pUA66pacpP PCR construct to the gfp gene, 
Blue highlighted text, DNA region where homologous recombination has taken place.  
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Appendix 13. DNA sequence showing the successful insertion of the aph gene 
into ISEcp1 on pCT (construction of pCT6) 
 
 
CMGRAKYWATGGGGGATTTTTGATTTTATTGAAATGACCTCGTATTTGGATAATGACTCAAC
AAATAAAATCAAGATGAATCATATAAAGACCATGCTCTGGTGTAGGCTGGAGCTGCTTCGAA
GTTCCTATACTTTCTAGAGAATAGGAACTTCGGAATAGGAACTTCAAGATCCCCCACGCTGC
CGCAAGCACTCAGGGCGCAAGGGCTGCTAAAGGAAGCGGAACACGTAGAAAGCCAGTCCGCA
GAAACGGTGCTGACCCCGGATGAATGTCAGCTACTGGGCTATCTGGACAAGGGAAAACGCAA
GCGCAAAGAGAAAGCAGGTAGCTTGCAGTGGGCTTACATGGCGATAGCTAGACTGGGCGGTT
TTATGGACAGCAAGCGAACCGGAATTGCCAGCTGGGGCGCCCTCTGGTAAGGTTGGGAAGCC
CTGCAAAGTAAACTGGATGGCTTTCTTGCCGCCAAGGATCTGATGGCGCAGGGGATCAAGAT
CTGATCAAGAGACAGGATGAGGATCGTTTCGCATGATTGAACAAGATGGATTGCACGCAGGT
TCTCCGGCCGCTTGGGTGGAGAGGCTATTCGGCTATGACTGGGCACAACAGACAATCGGCTG
CTCTGATGCCGCCGTGTTCCGGCTGTCAGCGCAGGGGCGCCCGGTTCTTTTTGTCAAGACCG
ACCTGTCCGGTGCCCTGAATGAACTGCAGGACGAGGCAGCGCGGCTATCGTGGCTGGCCACG
ACGGGCGTTCCTTGCGCAGCTGTGCTCGACGTTGTCACTGAAGCGGGAAGGGACTGGCTGCT
ATTGGCGAAGTGCCGGGGCAGGATCTCCTGTCATCTCACCTTGCTCCTGCCGAGAAAGTATC
CATCATGGCTGATGCAATGCGGCGGCTGCATACGCTTGATCCGGCTACCTGCCCATTCGACC
ACCAAGCGAAACATCGCATCGAGCGAGCACGTACTCGGATGGAAGCCGGTCTTGTCGATCAG
GATGATCTGGACGAAGAGCATCAGGGGCTCGCGCCAGCCGAACTGTTCGCCAGGCTCAAGGC
GCGCATGCCCGACGGCGAGGATCTCGTCGTGACCCATGGCGATGCCTGCTTGCCGAATATCA
TGGTGGAAAATGGCCGCTTTTCTGGATTCATCGACTGTGGCCGGCTGGGTGTGGCGGACCGC
TATCAGGACATAGCGTTGGCTACCCGTGATATTACTGAAGAGCTTGGCGGCGAATGGGCTGA
CCGCTTCCTCGTGCTTTACGGTATCGCCGCTCCCGATTCGCAGCGCATCGCCTTCTATCGCC
TTCTTGACGAGTTCTTCTGAGCGGGACTCTGGGGTTCGAAATGACCGACCAAGCGACGCCCA
ACCTGCCATCACGAGATTTCGATTCCACCGCCGCCTTCTATGAAAGGTTGGGCTTCGGAATC
GTTTTCCGGGACGCCGGCTGGATGATCCTCCAGCGCGGGGATCTCATGCTGGAGTTCTTCGC
CCACCCCAGCTTCAAAAGCGCTCTGAAGTTCCTATACTTTCTAGAGAATAGGAACKTCGGAA
TAGGAACTAAGGAGGATATTCATATGGACCATGGCTAWTCCCAATCAAAACCGCAAGAATWK
KWWTWYCKSSMYC 
 
 
Red text, DNA sequence homologous to the ISEcp1, 
Black text, DNA sequence homologous to the aph gene region in L109, 
Blue highlighted text, DNA region where homologous recombination has taken place.  
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Appendix 14. Conjugation frequencies of pCT and blaCTX-M-14 mutants pCT2, 
pCT2b and pCT6 on solid media to various recipients 
 
 
Donor: E. coli DH5α, Recipient: S. Typhimurium SL1344 rif
R  
 
Average frequency SD Student‟s T-test value (P) 
pCT 5.95 x 10
-6 
5.39 x 10
-6
  
pCT2 2.27 x 10
-5
 9.34 x 10
-6
 0.0525 
pCT2b 3.38 x 10
-6
 5.74 x 10
-6
 0.6018 
pCT6 2.28 x 10
-5
 1.18 x 10
-5
 0.0876 
 
 
Donor: E. coli DH5α, Recipient: E. coli J53-2 
  
 
Average frequency SD Student‟s T-test value (P) 
pCT 1.70 x 10
-2
 1.41 x 10
-2
  
pCT2 3.40 x 10
-2
 2.28 x 10
-2
 0.226 
pCT2b 3.41 x 10
-4
 1.88 x 10
-4
 0.144 
pCT6 2.74 x 10
-2
 2.74 x 10
-2
 0.066 
 
 
Donor: E. coli DH5α, Recipient: E. coli 3950 
  
 
Average frequency SD Student‟s T-test value (P) 
pCT 6.12 x 10
-6
 1.27 x 10
-6
  
pCT2 8.71 x 10
-6
 6.86 x 10
-6
 0.555 
pCT2b 1.55 x 10
-5
 2.53 x 10
-5
 0.556 
pCT6 7.51 x 10
-6
 1.30 x 10
-5
 0.162 
 
 
The conjugation frequency of pCT2 (blaCTX-M-14::aph), pCT2b (blaCTX-M-14::aph-
gfpmut2) and pCT6 (ISEcp1::aph) were compared to the conjugation frequency of 
wild-type pCT from donor bacterial strain E. coli DH5α to recipient strains S. 
Typhimurium SL1344 rifR, E. coli J53-2 and E.coli 3950 on a filter. 
Conjugation frequencies were calculated from the mean of at least three separate 
experiments (Figure 5.5, page 182). Values returning a P value of <0.05 from a 
Student‟s T-test were considered statistically significant and are in bold text.  
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Appendix 15. Conjugation frequencies of pCT and blaCTX-M-14 mutants pCT2, 
pCT2b and pCT6 in liquid media to various recipients 
 
Donor: E. coli DH5α, Recipient: S. Typhimurium SL1344 rif
R
 
 Average frequency SD Student‟s T-test value (P) 
pCT 5.25 x 10
-6
 5.92 x 10
-6
  
pCT2 1.5 x 10
-5
 1.89 x 10
-5
 0.179 
pCT2b 3.09 x 10
-6
 3.16 x 10
-6
 0.699 
pCT6 3.74 x 10
-5
 2.98 x 10
-5
 0.0725 
 
 
Donor: E. coli DH5α, Recipient: E. coli J53-2 
  
 Average frequency SD Student‟s T-test value (P) 
pCT 7.28 x 10
-5
 6 6.14 x 10
-5
  
pCT2  2.59 x 10
-4
 3. 29 x 10
-4
 0.309 
pCT2b 5.45 x 10
-6
 5. 57 x 10
-6
 0.069 
pCT6 1.991 x 10
-3
    1.95 x 10
-3
 0.098 
 
 
Donor: E. coli DH5α, Recipient: E. coli 3950 
  
 
Average frequency SD Student‟s T-test value (P) 
pCT 1.394 x 10
-5
 1.52 x 10
-4
  
pCT2 3.14 x 10
-4
 5.08 x 10
-3
 0.177 
pCT2b 2.90 x 10
-4
 3.13 x 10
-4
 0.411 
pCT6 3.327 x 10
-3
 3.62 x 10
-3
 0.0835 
 
The conjugation frequency of pCT2 (blaCTX-M-14::aph), pCT2b (blaCTX-M-14::aph-
gfpmut2) and pCT6 (ISEcp1::aph) were compared to the conjugation frequency of 
wild-type pCT from donor bacterial strain E. coli DH5α to recipient strains S. 
Typhimurium SL1344 rifR, E. coli J53-2 and E.coli 3950 in liquid media. 
Conjugation frequencies were calculated from the mean of at least three separate 
experiments (Figure 5.6, page 183). Values returning a P value of <0.05 from a 
Student‟s T-test were considered statistically significant and are denoted in bold text.  
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Appendix 16. Generation times of E. coli 3950 containing plasmids pCT2, 
pCT2b and pCT6 compared to E. coli 3950 pCT  
 
 
Lab 
code Strain 
Generation 
time (mins) SD 
Student 
T-test (P) 
 
I855 
 
E. coli 3950 pCT 
 
68.73 
 
5.527 
 
 
I835 
 
E. coli 3950 pCT2 (blaCTX-M-14::aph) 
 
69.21 
 
5.129 
 
0.377 
I836 E. coli 3950 pCT2b (blaCTX-M-14::aph-gfp) 68.26 5.958 0.600 
I838 E. coli 3950 pCT6 (ISEcp1::aph) 68.20 5.933 0.234 
 
The growth kinetics of bacterial host strain E. coli 3950 containing either pCT, pCT2 
(blaCTX-M-14::aph), pCT2b (blaCTX-M-14::aph-gfpmut2) or pCT6 (ISEcp1::aph) were 
measured using the FLUOstar OPTIMA using at least three biological and four 
technical repeats. Generation times were calculated between hours 1-2 (Figure 5.7, 
page 185). Values returning a P value of <0.05 from a Student‟s T-test were 
considered statistically significant and are denoted in bold text. 
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Appendix 17. Generation times of E. coli J53-2 containing plasmids pCT2, 
pCT2b and pCT6 compared to E. coli J53-2 pCT 
 
Lab 
code Strain 
Generation 
time (mins) SD 
Student 
T-test (P) 
 
I834 
 
E. coli J53-2 pCT 
 
67.14 
 
3.75 
 
 
I856 
 
E. coli J53-2 pCT2 (blaCTX-M-14::aph) 
 
63.28 
 
5.84 
 
0.952 
I857 E. coli J53-2 pCT2b (blaCTX-M-14::aph-gfp) 67.30 2.06 0.334 
I861 E. coli J53-2 pCT6 (ISEcp1::aph) 71.19 5.66 0.057 
 
The growth kinetics of bacterial host strain E. coli J53-2 containing either pCT, pCT2 
(blaCTX-M-14::aph), pCT2b (blaCTX-M-14::aph-gfpmut2) or pCT6 (ISEcp1::aph) were 
measured using the FLUOstar OPTIMA using at least three biological and four 
technical repeats. Generation times were calculated between hours 1-2 (Figure 5.8, 
page 186). Values returning a P value of <0.05 from a Student‟s T-test were 
considered statistically significant and are denoted in bold text. 
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Appendix 18. Generation times of E. coli DH5α containing plasmids pCT2, 
pCT2b and pCT6 compared to E. coli DH5α pCT 
 
Lab 
code Strain 
Generation 
time (mins) SD 
Student 
T-test (P) 
 
I755 
 
E. coli DH5α pCT 
 
92.61 
 
6.70 
 
 
I778 
 
E. coli DH5α pCT2 (blaCTX-M-14::aph) 
 
95.15 
 
9.06 
 
0.94 
I826 E. coli DH5α pCT2b (blaCTX-M-14::aph-gfp) 79.80 6.56 0.0198 
I830 E. coli DH5α pCT6 (ISEcp1::aph) 99.64 6.03 0.121 
   
The growth kinetics of bacterial host strain E. coli DH5α containing either pCT, pCT2 
(blaCTX-M-14::aph), pCT2b (blaCTX-M-14::aph-gfpmut2) or pCT6 (ISEcp1::aph) were 
measured using the FLUOstar OPTIMA using at least three biological and four 
technical repeats. Generation times were calculated between hours 1-2 (Figure 5.9, 
page 187). Values returning a P value of <0.05 from a Student‟s T-test were 
considered statistically significant and are denoted in bold text. 
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Appendix 19. Generation times of S. Typhimurium rifR containing plasmids 
pCT2, pCT2b and pCT6 compared to S. Typhimurium rifR SL1344 pCT 
 
Lab 
code Strain 
Generation 
time (mins) SD 
Student 
T-test (P) 
 
L1079 
 
S. Typhimurium SL1344 rifR  pCT 
 
95.15 
 
11.7 
 
 
L1244 
 
S. Typhimurium SL1344 rifR pCT2 
(blaCTX-M-14::aph) 
 
100.73 
 
9.77 
 
0.278 
L1235 S. Typhimurium SL1344 rif
R pCT2b 
(blaCTX-M-14::aph-gfp) 
102.73 10.52 0.145 
L1245 S. Typhimurium SL1344 rif
R pCT6 
(ISEcp1::aph) 
110.91 16.74 0.036 
 
The growth kinetics of bacterial host strain S. Typhimurium SL1344 rifR containing 
either pCT, pCT2 (blaCTX-M-14::aph), pCT2b (blaCTX-M-14::aph-gfpmut2) or pCT6 
(ISEcp1::aph) were measured using the FLUOstar OPTIMA using at least three 
biological and four technical repeats. Generation times were calculated between 
hours 1-2 (Figure 5.10, page 188). Values returning a P value of <0.05 from a 
Student‟s T-test were considered statistically significant and are denoted in bold text. 
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Appendix 20. The ability of S. Typhimurium SL1344 rifR with wild-type pCT and 
blaCTX-M-14 modified plasmids to adhere to and invade human intestinal cells 
 
 
 
SL1344 rifR 
pCT 
SL1344 rifR 
pCT2 
SL1344 rifR 
pCT2b 
SL1344 rifR 
pCT6 
SL1344 rifR 
 
 (L1079) (L1244) (L1235) (L1245) (L1078) 
A: Adhesion 
(% of SL13444 rif
R
 pCT) 
100% 168% 23% 54.67% 63.3% 
      
B: Invasion 
(% of SL13444 rif
R
 pCT) 
100% 93.25% 22% 18.47% 43% 
 
The number of S. Typhimurium SL1344 rifR containing pCT2 pCT2b or pCT6 able to 
adhere to (A) and invade (B) INT-407 human intestinal cell is represented as a 
percentage of the number of S. Typhimurium SL1344 rifR pCT able to do so under 
test conditions (Figure 5.11, p190). Data are displayed as a mean of three separate 
experiments all performed with four technical repeats.  
Values returning a P value of <0.05 from a Student‟s T-test were considered 
statistically significant and are represented with bold text.  
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Appendix 21. The ability of bacterial hosts containing pCT2, pCT2b and pCT6 
to cause infection the C. elegans 
 
  Lab 
no 
Strain 
TD50 
(Days) 
Chi 
squared 
P value 
A 
 
L1079 
 
S. Typhimurium SL1344 rifR pCT 3.15   
L1244 S. Typhimurium SL1344 rifR pCT2 3.5 1.6 0.2059 
L1235 S. Typhimurium SL1344 rifR pCT2b 3.0 0.017 0.8963 
L1245 S. Typhimurium SL1344 rifR pCT6 3.8 15.09 0.0001 
B 
I855 E. coli 3950 pCT 5.75   
I835 E. coli 3950 pCT2 5.75 0.294 0.5877 
I838 E. coli 3950 pCT6 5.6 0.3518 0.5531 
 
Survival curves were constructed using a Kaplan Mier calculation showing the 
probability of C. elegans survival each day when fed continuously on the tested 
bacterial strains (Figure 5.12, page 191).  
TD50 = time taken for 50% of the nematodes to die,  
A significance difference in killing rate was defined as a P value <0.05 denoted in 
bold text. 
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Appendix 22. Competition between E. coli hosts carrying pCT and pCT2 
 
 
 
E. coli pairing 
pCT2 CI at 12h 
(before passage) 
pCT2 CI at 72h/96h 
(after 3/4 passages) 
T-test  
P value 
 
DH5α pCT + DH5α pCT2 0.989 1.000 0.477 
3950 pCT + 3950 pCT2 1.005 0.999 0.217 
J53-2 pCT + J53-2 pCT2 1.003 1.071 0.038 
 
 
 
CI, competition index of the pCT containing strain in each pairing. Values in bold 
represent a statistically significant change in the proportion of bacteria containing 
pCT (P <0.005).  
 
Table of data corresponding with Figure 5.13 (page 193). 
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Appendix 23. DNA sequence showing the successful insertion of the aph gene 
into pCT_006 putative Sigma factor gene on pCT (construction of pCT3) 
 
CTCAAACACATCAAGTGTAGGCTGGAGCTGCTTCGAAGTTCCTATACTTTCTAGAGAAYAGRAACTTC
GGAATAGGAACTTCAAGATCCCCCACGCTGCCGCAAGCACTCAGGGCGCAAGGGCTGCTAAAGGAAGC
GGAACACGTAGAAAGCCAGTCCGCAGAAACGGTGCTGACCCCGGATGAATGTCAGCTACTGGGCTATC
TGGACAAGGGAAAACGCAAGCGCAAAGAGAAAGCAGGTAGCTTGCAGTGGGCTTACATGGCGATAGCT
AGACTGGGCGGTTTTATGGACAGCAAGCGAACCGGAATTGCCAGCTGGGGCGCCCTCTGGTAAGGTTG
GGAAGCCCTGCAAAGTAAACTGGATGGCTTTCTTGCCGCCAAGGATCTGATGGCGCAGGGGATCAAGA
TCTGATCAAGAGACAGGATGAGGATCGTTTCGCATGATTGAACAAGATGGATTGCACGCAGGTTCTCC
GGCCGCTTGGGTGGAGAGGCTATTCGGCTATGACTGGGCACAACAGACAATCGGCTGCTCTGATGCCG
CCGTGTTCCGGCTGTCAGCGCAGGGGCGCCCGGTTCTTTTTGTCAAGACCGACCTGTCCGGTGCCCTG
AATGAACTGCAGGACGAGGCAGCGCGGCTATCGTGGCTGGCACGACGGGCGTTCCTTGCGCAGCTGTG
CTCGACGTTGTCACTGAAGCGGGAAAGGACTGGCTGCTATTGTGCGAAGTGCCGGGGCAGGATCTCCT
GTCATCTCACCTTGCTCCTGCCGAGAAAGTATCCATCATGGCTGATGCAATGCGGCGGCTGCATACGC
TTGATCCGGCTACCTGCCCATTCGACCACCAAGCGAAACATCGCATCGAGCGAGCACGTACTCGGATG
GAAGCCGGTCTTGTCGATCAGGATGATCTGGACGAAGAGCATCAGGGGCTCGCGCCAGCCGAACTGTT
CGCCAGGCTCAAGGCGCGCATGCCCGACGGCGAGGATCTCGTCGTGACCCATGGCGATGCCTGCTTGC
CGAATATCATGGTGGAAAATGGCCGCTTTTCTGGATTCATCGACTGTGGCCGGCTGGGTGTGGCGGAC
CGCTATCAGGACATAGCGTTGGCTACCCGTGATATTGCTGAAGAGCTTGGCGGCGAATGGGCTGACCG
CTTCCTCGTGCTTTACGGTATCGCCGCTCCCGATTCGCAGCGCATCGCCTTCTATCGCCTTCTTGACG
AGTTCTTCTGAGCGGGACTCTGGGGTTCGAAATGACCGACCAAGCGACGCCCAACCTGCCATCACGAG
ATTTCGATTCCACCGCCGCCTTCTATGAAAGGTTGGGCTTCGGAATCGTTTTCCGGGACGCCGGCTGG
ATGATCCTCCAGCGCGGGGATCTCATGCTGGAGTTCTTCGCCCACCCCAGCTTCAAAAGCGCTCTGAA
GTTCCTATACTTTCTAGAGAATAGGAACTTCGGAATAGGAACTAAGGAGGATATTCATATGGACCATG
GCTAATTCCCACCGAATGACCTTGRGTCTCACGAGAATAAAAAGTAATGCAGGTCGCAAATGGGCACA
TACTCGAGGATGGGGATGGTTGTCATATGAA 
 
 
Red text, DNA sequence homologous to the pCT_066 putative Sigma factor gene, 
Black text, DNA sequence homologous to the aph gene region in L109, 
Blue highlighted text, DNA region where homologous recombination has taken place.  
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Appendix 24. DNA sequence showing the successful insertion of the aph gene 
into shufflon recombinase (rci) gene on pCT (construction of pCT4) 
 
 
AYGTCACCCTATGGCCGAGCGCTATATGGATGAAATCACCACCGTTGATATCG
CCACTTACCGGGATCAGCGTTTGGCTCAAATTAACCCACGAACAGGGCGTCAA
ATCACCGGAAACACCGTCCGTCTTGAACTTGCTCTTTTATMATCATTATTCAA
TATCGCCAGTGTGGAATGGGGGACATGCCGTATGAATCCTGTTGAACTGGTCC
GAAAGTGTAGGCTGGAGCTGCTTCGAAGTTCCTATACTTTCTAGAGAATAGGA
ACTTCGGAATAGGAACTTCAAGATCCCCCACGCTGCCGCAAGCACTCAGGGCG
CAAGGGCTGCTAAAGGAAGCGGAACACGTAGAAAGCCAGTCCGCAGAAACGGT
GCTGACCCCGGATGAATGTCAGCTACTGGGCTATCTGGACAAGGGAAAACGCA
AGCGCAAAGAGAAAGCAGGTAGCTTGCAGTGGGCTTACATGGCGATAGCTAGA
CTGGGCGGTTTTATGGACAGCAAGCGAACCGGAATTGCCAGCTGGGGCGCCCT
CTGGTAAGGTTGGGAAGCCCTGCAAAGTAAACTGGATGGCTTTCTTGCCGCCA
AGGATCTGATGGCGCAGGGGATCAAGATCTGATCAAGAGACAGGATGAGGATC
GTTTCGCATGATTGAACAAGATGGATTGCACGCAGGTTCTCCGGCCGCTTGGG
TGGAGAGGCTATTCGGCTATGACTGGGCACAACAGACAATCGGCTGCTCTGAT
GCCGCCGTGTTCCGGCTGTCAGCGCAGGGCGCCCGGTTCTTTTTGTCAGACCG
ACCTGTCCGGTGCCCTGAATGACTGCAGGACGAGGCAGCGCGGCTATCGKGCT
GGCMCGACGGGCGTTCCTTGCGCAGCTGTGCTCGAC 
 
 
Red text, DNA sequence homologous to the shufflon recombinase (rci) gene, 
Black text, DNA sequence homologous to the aph gene region in L109, 
Blue highlighted text, DNA region where homologous recombination has taken place.  
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Appendix 25. DNA sequence showing the successful insertion of the aph gene 
into pili structural protein pilS gene on pCT (construction of pCT5) 
 
 
TTAACTGYMTGGTTTCCAGTTTGATAGTAGTTTTATCTGCGTTACATACTGTAGACGGGTCA
ACTTTATTCGTCACATTGCCGTTGATTTTTGTAAACATGGATGAACTGCGCAGGCTGGTGAC
CAGATCAATACAGTTTTTCTTCGGCACATTGCTGTGTAGGCTGGAGCTGCTTCGAAGTTCCT
ATACTTTTAGAGAATAGGAACTTCGGAATAGGAACTTCAAGATCCCCTCACGCTGCCGCAAG
CACTCAGGGCGCAAGGGCTGCTAAAGGAAGCGGAACACGTAGAAAGCCAGTCCGCAGAAACG
GTGCTGACCCCGGATGAATGTCAGCTACTGGGCTATCTGGACAAGGGAAAACGCAAGCGCAA
AGAGAAAGCAGGTAGCTTGCAGTGGGCTTACATGGCGATAGCTAGACTGGGCGGTTTTATGG
ACAGCAAGCGAACCGGAATTGCCAGCTGGGGCGCCCTCTGGTAAGGTTGGGAAGCCCTGCAA
AGTAAACTGGATGGCTTTCTTGCCGCCAAGGATCTGATGGCGCAGGGGATCAAGATCTGATC
AAGAGACAGGATGAGGATCGTTTCGCATGATTGAACAAGATGGATTGCACGCAGGTTCTCCG
GCCGCTTGGGTGGAGAGGCTATTCGGCTATGACTGGGCACAACAGACAATCGGCTGCTCTGA
TGCCGCCGTGTTCCGGCTGTCAGCGCAGGGGCGCCCGGTTCTTTTTGTCAAGACCGACCTGT
CCGGTGCCCTGAATGAACTGCAGGACGAGGCAGCGCGGCTATCGTGGCTGGCCACGACGGGC
GTTCCTTGCGCAGCTGTGCTCGACGTTGTCACTGAAGCGGGAAGGGACTGGCTGCTATTGGG
CGAAGTGCCGGGGCAGGATCTCCTGTCATCTCACCTTGCTCCTGCCGAGAAAGTATCCATCA
TGGCTGATGCAATGCGGCGGCTGCATACGCTTGATCCGGCTACCTGCCCATTCGACCACCAA
GCGAAACATCGCATCGAGCGAGCACGTACTCGGATGGAAGCCGGTCTTGTCGATCAGGATGA
TCTGGACGAAGAGCATCAGGGGCTCGCGCCAGCCGAACTGTTCGCCAGGCTCAAGGCGCGCA
TGCCCGACGGCGAGGATCTCGTCGTGACCCATGGCGATGCCTGCTTGCCGAATATCATGGTG
GAAAATGGCCGCTTTTCTGGATTCATCGACTGTGGCCGGCTGGGTGTGGCGGACCGCTATCA
GGACATAGCGTTGGCTACCCGTGATATTGCTGAAGAGCTTGGCGGCGAATGGGCTGACCGCT
TCCTCGTGCTTTACGGTATCGCCGCTCCCGATTCGCAGCGCATCGCCTTCTATCGCCTTCTT
GACGAGTTCTTCTGAGCGGGACTCTGGGGTTCGAAATGACCGACCAAGCGACGCCCAACCTG
CCATCACGAGATTTCGATTCCACCGCCGCCTTCTATGAAAGGTTGGGCTTCGGAATCGTTTT
CCGGGACGCCGGCTGGATGATCCTCCAGCGCGGGGATCTCATGCTGGAGTTCTTCGCCCACC
CCAGCTTCAAAAGCGCTCTGAAGTTCCTATACTTTCTAGAGAATAGGAACTTCGGAATAGGA
ACTAAGGAGGATTTCATATGGACCATGGCTAATTCCCTTTCTGGGCTTTCATTTTGGTGGCG
ATTGTCTGCAGGTTTTTGAGTTCCTTCTGGTTGTCTGSAGAGGACAGGGTATCGGACATAAG
TCCCATCACGGCACCAATAACAATGGCAMCGACGACCAGAACACCGAGGACTTCCAGCAGGG
TCATGCCTTTATCATCGTM 
 
 
Red text, DNA sequence homologous to the pilS gene, 
Black text, DNA sequence homologous to the aph gene region in L109, 
Blue highlighted text, DNA region where homologous recombination has taken place.  
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Appendix 26. DNA sequence showing the successful insertion of the aph gene 
into pili structural protein traXY gene on pCT (construction of pCT7) 
 
 
GAAAGGGGGGAGGACCAATSTAATGACGGATTCCGAACTGGGCCGGCGGCTGCGACGTCACA
CGATGTTTTGGTCGCCWGGATTTTTTTTGATSACGAGACCGGTATTCCTGCTGTGTGGTATG
GCCCTTCCGGCCTCCGCACTGCCGGTCATTCCCCTGATACTTATCCTGACCTGCCTGTTACT
GATGAKTACCATTGCKCGTGTARGCTGGAKCTGCTTCKAAKTTCCTATACTTTCTARAKAAT
AGGAWCTTCSGAATAKGAACTTCAMGATCCCCCACKCYGCCKCAWGCACTCAKGGCGCAAGG
GCTGCTARATGAAGCGGAWTACKTATAAAGCCWKTTCGCYRAAACGGTGCTGACCCCGGATG
ATTGTCWGCTATTGGGCTATCTGGATAGGGAAAACGCACYCGCAAAGACAAAGCAGGTAGCT
TGCACTGGGCTTACATGGCSATATCTASACTGGGCGGTTTTATGGACARCMMGCRAACCGGA
ATTGCCAGCSGGGGCGCCCTCTGGTAAYGTTGGGAAKCCCTGCMAWGTAAWTGGATGGCTTT
CTTGCCSCCAAGGATCTSATGGCGCATAGGATCMMKATCTGATCAWGAKACARGATGAGGAT
CGTTCGCATGATTGAAAAKATGGATTGCACGYAGTTCTCCKGCCGCTTGGSTGGAGAGGCYA
TTCSGCTATGACTGGWCWCRACARACAATCRGCTGCTCTTGATGCCGCCTGTTCCGGCTGTC
WGCGCATGGGCGCTCGGTTCTTTTTGCTMGACCGACCTGYCCSGYGCCCTGAATGAACTGCA
GACTACGCAGCGCGKCTATC-TGGCTGGCCACGACGG-CGTTCCTTGCCYATCTGTGCTC-
ACKTTGTCCTGAKCKGAWGGACTGKCTGCTATTGGCKATTGCCGKGCMSGATCTCCTGTC-
TCTCAC..TTGCTC..TGY.......GAAAARKATCCATCATGCTGATGCCATGTGC.....
............GCTGMACGCTTGWWCCGKCTACCTGCCATTY...................
..............................................................
.....................WMCWCCAGGGTATCGCCGCTCCMGATTCGCAGCGCATMGCA
TTSTASGTTTCTGACGAGTTYTTMTGAGCGGGACTAGGGGTKMGAAAYGACMGASCAAGCGA
CGCCCAACCTACCATCACGAGATTTKGATTCCACCGCCGCCWTCTAWGAAAGKYTGGGSTTM
GGAGTMGTTTTCCGGGATGCMGWCTGGATGATCCTCCAGCGCGGGGATWTCATRCTGGAGTT
MTTCGCCCACCCCAGCTTCAAAAGCGMTMTGAAGTTCMTATACTTTYTAGAGAATAGGAACT
TCGGAATAGGAAMTAAGGAGGATATTCATATGGACCATGGCTAATTCCCCCACCACTSTSCT
TCCTGCWGTTTTKGCTGTTTTGTGCCGGTTTTTCGTTATCCATTTACCKGCCGTTWATCCSG
TTWATMTTCWGGATGACCGGCATCGGCAACWGGATAGTCAGMGTAMTGAWWGGAKGTGWACT
GGCCCCCTGWGGGCCGCCACCCATSWGGGAACAAGTCAGGACCGGGGAAGCCGGGCCGMTTA
CGKTTACAATACGTGATRGACAGCATGATCAGGCCGATGGAGAACGTGTTTGGGTTCGTGGW
TGWATCAGTCGCCATCGKGGCCGGCGGCACAATCMTGAAAAGGGGYTATGSKAWGCAMWGAT
GAAKGTCCAGATAAASTTGGAGGGGGTAATCAAKCATGGGRGGGAATTTTTATTAAGTTTGA 
 
Red text, DNA sequence homologous to the traXY genes, 
Black text, DNA sequence homologous to the aph gene region in L109, 
Blue highlighted text, DNA region where homologous recombination has taken place.  
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Appendix 27. DNA sequence showing the successful insertion of the aph gene 
into putative toxin anti-toxin operon pndACB on pCT (construction of pCT8) 
 
 
GCGGCGGGCGCTTGAGGCTGTATGCCGAAAGCGTTTTGTGGACGGCATGTAGCAGAAAGCCC
CAGGCGATTTTTTTATCAATCAACCCAGGGCCCACTGTGTGTAGGCTGGAGCTGCTTCGAAG
TTCCTATACTTTCTAGAGAATAGGAACTTCGGAATAGGAACTTCAAGATCCCCACGCTGCCG
CAAGCACTCAGGGCGCAAGGGCTGCTAAAGGAAGCGGAACACGTAGAAAGCCAGTCCGCAGA
AACGGTGCTGACCCCGGATGAATGTCAGCTACTGGGCTATCTGGACAAGGGAAAACGCAAGC
GCAAAGAGAAAGCAGGTAGCTTGCAGTGGGCTTACATGGCGATAGCTAGACTGGGCGGTTTT
ATGGACAGCAAGCGAACCGGAATTGCCAGCTGGGGCGCCCTCTGGTAAGGTTGGGAAGCCCT
GCAAAGTAAACTGGATGGCTTTCTTGCCGCCAAGGATCTGATGGCGCAGGGGATCAAGATCT
GATCAAGAGACAGGATGAGGATCGTTTCGCATGATTGAACAAGATGGATTGCACGCAGGTTC
TCCGGCCGCTTGGGTGGAGAGGCTATTCGGCTATGACTGGGCACAACAGACAATCGGCTGCT
CTGATGCCGCCGTGTTCCGGCTGTCAGCGCAGGGGCGCCCGGTTCTTTTTGTCAAGACCGAC
CTGTCCGGTGCCCTGAATGAACTGCAGGACGAGGCAGCGCGGCTATCGTGGCTGGCCACGAC
GGGCGTTCCTTGCGCAGCTGTGCTCGACGTTGTCACTGAAGCGGGAAGGGACTGGCTGCTAT
TGGGCGAAGTGCCGGGGCAGGATCTCCTGTCATCTCACCTTGCTCCTGCCGAGAAAGTATCC
ATCATGGCTGATGCAATGCGGCGGCTGCATACGCTTGATCCGGCTACCTGCCCATTCGACCA
CCAAGCGAAACATCGCATCGAGCGAGCACGTACTCGGATGGAAGCCGGTCTTGTCGATCAGG
ATGATCTGGACGAAGAGCATCAGGGGCTCGCGCCAGCCGAACTGTTCGCCAGGCTCAAGGCG
CGCATGCCCGACGGCGAGGATCTCGTCGTGACCCATGGCGATGCCTGCTTGCCGAATATCAT
GGTGGAAAATGGCCGCTTTTCTGGATTCATCGACTGTGGCCGGCTGGGTGTGGCGGACCGCT
ATCAGGACATAGCGTTGGCTACCCGTGATATTGCTGAAGAGCTTGGCGGCGAATGGGCTGAC
CGCTTCCTCGTGCTTTACGGTATCGCCGCTCCCGATTCGCAGCGCATCGCCTTCTATCGCCT
TCTTGACGAGTTCTTCTGAGCGGGACTCTGGGGTTCGAAATGACCGACCAAGCGACGCCCAA
CCTGCCATCACGAGATTTCGATTCCACCGCCGCCTTCTATGAAAGGTTGGGCTTCGGAATCG
TTTTCCGGGACGCCGGCTGGATGATCCTCCAGCGCGGGGATCTCATGCTGGAGTTCTTCGCC
CACCCCAGCTTCAAAAGCGCTCTGAAGTTCCTATACTTTCTAGAGAATAGGAACTTCGGAAT
AGGAACTAAGGAGGATATTCATATGGACCATGGCTAATTCCCGGACATCTGCCGCCGGRTTG
TTGCGAAGGCTGACCTCAATGCGCCTTGTTTGTCTTTTTTACCGGACGACTGCTGGTTGCTG 
 
 
Red text, DNA sequence homologous to the pndACB operon, 
Black text, DNA sequence homologous to the aph gene region in L109, 
Blue highlighted text, DNA region where homologous recombination has taken place.  
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Appendix 28. DNA sequence showing the successful insertion of the cat gene 
into putative toxin anti-toxin operon pndACB on pCT7 (construction of pCT9) 
 
 
GGGCGCTTGAGGCTGTATGCCGAAAGCGTTTTGTGGACGGCATGTAGCAGAAAGCCCCAGGC
GATTTTTTTAWMAATCAACCCAGGGCCCACTGTGTGTAGGCTGGAGCTGCTTCGAAGTTCCT
ATACTTTCTAGAGAATAGGAACTTCGGAATAGGAACTTCATTTAAATGGCGCGCCTTACGCC
CCGCCCTGCCACTCATCGCAGTACTGTTGTATTCATTAAGCATCTGCCGACATGGAAGCCAT
CACAAACGGCATGATGAACCTGAATCGCCAGCGGCATCAGCACCTTGTCGCCTTGCGTATAA
TATTTGCCCATGGTGAAAACGGGGGCGAAGAAGTTGTCCATATTGGCCACGTTTAAATCAAA
ACTGGTGAAACTCACCCAGGGATTGGCTGARACGAAAAACATATTCTCAATAAACCCTTTAG
GGAAATAGGCCAGGTTTTCACCGTAACACGCCACATCTTGCGAATATATGTGTAGAAACTGC
CGGAAATCGTCGTGGTATTCACTCCAGARCGATGAAAACGTTTCAGTTTGCTCATGGAAAAC
GGTGTAACAAGGGTGAACACTATCCCATATCACCAGCTCACCGTCTTTCATTGCCATACGTA
ATTCCGGATGARCATTCATCAGGCGGGCAAGAATGTGAATAAAGGCCGGATAAAACTTGTGC
TTATTTTTCTTTACGGTCTTTAAAAAGGCCGTAATATCCAGCTGAACGGTCTGGTTATAGGT
ACATTGAGCAACTGACTGAAATGCCTCAAAATGTTCTTTACGATGCCATTGGGATATATCAA
CGGTGGTATATCCAGTGATTTTTTTCTCCATTTTAGCTTCCTTAGCTCCTGAAAATCTCGAC
AACTCAAAAAATACGCCCGGTAGTGATCTTATTTCATTATGGTGAAAGTTGGAACCTCTTAC
GTGCCGATCAACGTCTCATTTTCGCCAAAAGTTGGCCCAGGGCTTCCCGGTATCAACAGGGA
CACCAGGATTTATTTATTCTGCGAAGTGATCTTCCGTCACAGGTAGGCGCGCCGAAGTTCCT
ATACTTTCTAGAGAATAGGAACTTCGGAATAGGAACTAAGGAGGATATTCATATGGACCATG
GCTAATTCCCGGACATCTGCCGCCGGRTTGTTGCGAAGGCTGACCTCAATGCGCCTTGTTTG
TCTTTTTTACCGGACGACTGCTGGT-GCTGCG--TCGGC 
 
 
Red text, DNA sequence homologous to the pndACB operon, 
Black text, DNA sequence homologous to the cat gene region in L829, 
Blue highlighted text, DNA region where homologous recombination has taken place.  
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Appendix 29. Conjugation frequencies of plasmids from donor E. coli DH5α to 
recipients E. coli J53-2, E. coli 3950 and S. Typhimurium SL1344 
 
Recipient Plasmid 
Filter mating Broth mating 
Average 
conjugation 
frequency 
Standard 
deviation 
P= 
Average 
conjugation 
frequency 
Standard 
deviation 
P= 
E. coli J53-2 
(rifampicin
R
) 
pCT 1.70E-02 1.66E-02  9.10E-05 6.07E-05 
 
pCT2 3.40E-02 2.29E-02 0.36 3.34E-04 3.58E-04 0.31 
pCT3 4.81E-02 2.61E-02 0.16 4.51E-03 7.36E-03 0.36 
pCT4 3.27E-02 4.27E-02 0.58 4.59E-04 5.17E-04 0.29 
pCT5 1.28E-01 1.49E-01 0.27 2.96E-03 4.95E-03 0.37 
pCT7 0 0 0.15 0 0 0.06 
pCT8 1.13E-02 2.55E-03 0.59 1.44E-05 4.75E-06 0.09 
pCT9 0 0 0.15 0 0  0.06 
E. coli 3950 
(tetracyline
R
) 
pCT 6.12E-06 1.27E-06  1.39E-04 1.52E-04 
 
pCT2 8.71E-06 6.86E-06 0.55 3.14E-03 4.08E-03 0.17 
pCT3 5.23E-04 8.21E-04 0.34 3.23E-03 4.01E-03 0.12 
pCT4 1.20E-04 2.02E-04 0.38 5.44E-03 1.19E-02 0.36 
pCT5 5.97E-06 9.39E-06 0.97 6.73E-08 9.57E-08 0.11 
pCT7 0 0 0.00 0 0 0.11 
pCT8 2.10E-04 2.40E-05 0.21 5.24E-03 5.50E-04 0.06 
pCT9 0 0 0.00 0 0 0.11 
 
S. 
Typhimurium 
SL1344 
(rifampicin
R
) 
pCT 1.07E-05 6.92E-06  9.33E-06 7.69E-06 
 
pCT2 6.85E-04 1.16E-03 0.37 7.14E-04 1.13E-03 0.34 
pCT3 4.87E-05 3.93E-05 0.17 1.20E-04 1.21E-04 0.19 
pCT4 6.162E-07 6.00E-07 0.06 6.87E-09 1.19E-08 0.10 
pCT5 3.93E-06 6.55E-06 0.29 7.69E-08 8.02E-08 0.10 
pCT7 0 0 0.05 0 0 0.10 
pCT8 2.54E-06 9.99E-07 0.12 2.85E-06 1.50E-06 0.23 
pCT9 0 0 0.05 0 0 0.10 
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Appendix 30. Generation times of E. coli DH5α containing pCT, pCT3-9 
 
Lab 
code Strain 
Generation 
time (mins) SD 
Student‟s 
T-test (P) 
 
I755 
 
 E. coli DH5α pCT 
 
67.27 
 
6.62 
 
 
 
I846 
 
 E. coli DH5α pCT3 (Sigma factor::aph) 
 
59.74 
 
5.33 
 
0.097 
I877  E. coli DH5α pCT4 (rci::aph) 59.92 7.46 0.078 
I878  E. coli DH5α pCT5 (pilS::aph) 67.34 10.0 0.360 
I846  E. coli DH5α pCT7 (traXY::aph) 72.71 10.5 0.066 
I877  E. coli DH5α pCT8 (pndACB::aph) 75.97 12.1 0.067 
I878  E. coli DH5α pCT9 (traXY::aph; pndACB::cat) 61.89 12.3 0.473 
 
The growth kinetics of bacterial host strain E. coli DH5α containing either pCT, pCT3 
(Sigma factor::aph), pCT4 (rci::aph), pCT5 (pilS::aph), pCT7 (traXY::aph), pCT8 
(pndACB::aph) or pCT9 (traXY::aph;pndACB::cat) were measured using the 
FLUOstar OPTIMA using at least three biological and four technical repeats. 
Generation times were calculated between hours 2-3 (Figure 6.3, page 219). Values 
returning a P value of <0.05 from a Student‟s T-test were considered statistically 
significant and are denoted in bold text. 
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Appendix 31. Generation times of host strains containing pCT, pCT3-5 
 
Lab 
code Strain 
Generation 
time (mins) SD 
Student 
T-test (P) 
 
I847 
 
E. coli J53-2 pCT 
 
67.14 
 
3.75 
 
 
I858 
 
E. coli J53-2 pCT3 
 
69.23 
 
3.87 
 
0.173 
I859 E. coli J53-2 pCT4 64.78 3.76 0.64 
I860 E. coli J53-2 pCT 65.00 2.01 0.51 
I834 E. coli 3950 pCT 67.93 5.527  
I837 E. coli 3950 pCT3 70.34 3.32 0.21 
I831 E. coli 3950 pCT4 66.10 4.60 0.63 
I841 E. coli 3950 pCT5 67.67 2.58 0.42 
L1079 S. Typhimurium SL1344 rif
R pCT 94.15 11.7  
L1236 S. Typhimurium SL1344 rif
R pCT3 114.6 22.4 0.02 
L1259 S. Typhimurium SL1344 rif
R pCT4 116.04 43.7 0.09 
L1260 S. Typhimurium SL1344 rif
R pCT5 108.28 15.25 0.06 
 
The growth kinetics of bacterial host strains containing either pCT, pCT3 (Sigma 
factor::aph), pCT4 (rci::aph) or pCT5 (pilS::aph) were measured using the FLUOstar 
OPTIMA using at least three biological and four technical repeats. Generation times 
were calculated between hours 1-2 (Figure 6.4, page 220). Values returning a P 
value of <0.05 from a Student‟s T-test were considered statistically significant and 
are denoted in bold text. 
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Appendix 32. The ability of S. Typhimurium SL1344 rifR containing wild-type 
pCT, pCT3, pCT4, pCT5 and pCT8 to adhere to and invade human intestinal 
cells 
 
 
 
SL1344 rifR 
pCT 
SL1344 rifR 
pCT3 
SL1344 rifR 
pCT4 
SL1344 rifR 
pCT5 
SL1344 rifR 
pCT8 
 (L1079) (L1236) (L1259) (L1260) (L1397) 
A: Adhesion 100% 50.5% 32.2% 55.5% 38.5% 
      
B: Invasion 
 
100% 43.58% 8.17% 48.19% 4.05% 
 
The number of S. Typhimurium SL1344 rifR containing pCT3 pCT4, pCT5 or pCT8 
able to adhere to (A) and invade (B) INT-407 human intestinal cell is represented as 
a percentage of the number of S. Typhimurium SL1344 rif
R 
pCT able to do so under 
test conditions (Figure 6.5, page 222). Data are displayed as a mean of three 
separate experiments all performed with four technical repeats.  
Values returning a P value of <0.05 from a Student‟s T-test were considered 
statistically significant and are represented with bold text.  
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Appendix 33. The ability of bacterial hosts containing pCT3, pCT4, pCT5 and 
pCT8 to cause infection in C. elegans 
 
Lab number Strain TD50 (Days) Chi squared P value  
L1079 S. Typhimurium SL1344 rif
R 
pCT
 
3.15   
L1078 S. Typhimurium SL1344 rif
R
  3.5 3.39 0.0658 
L1236 S. Typhimurium SL1344 rif
R
 pCT3 3.7 5.17 0.0230 
L1259 S. Typhimurium SL1344 rif
R 
pCT4 3.9 27.9 <0.001 
L1260 S. Typhimurium SL1344 rif
R 
pCT5 3.6 8.45 0.0037 
I855 E. coli 3950 pCT 4.75   
I823 E. coli 3950 4.75 0.019 0.8915 
I837 E. coli 3950 pCT3 4.7 0.29 0.5902 
I831 E. coli 3950 pCT4 4.8 0.14 0.7083 
I841 E. coli 3950 pCT5 5.25 0.70 0.4028 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Survival curves were constructed using a Kaplan Mier calculation showing the 
probability of C. elegans survival each day when fed continuously on the tested 
bacterial strains (Figure 6.6, page 223).  
TD50 = time taken for 50% of the nematodes to die,  
Significance with respect to SL1344 rifR pCT is denoted with bold text.  
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Appendix 34. Competition Index of plasmids pCT3-9 when compared in vitro 
against wild-type pCT 
 
 pCT2 pCT3 pCT4 pCT5 pCT6 pCT7 pCT8 pCT9 
         
% at 72 
hours 
45% 53% 52% 51% 43% 46% 51% 47% 
SD 8.2% 3.0% 8.5% 8.4% 6.2% 3.8% 1.2% 8.3% 
CI 0.99985 1.0006 1.0012 1.0006 0.9985 0.9992 1.0002 0.9996 
 
 
Each pair-wise competition was conducted between E. coli DH5α pCT and DH5α 
containing the test plasmid in vitro. CI, competition index was calculated based on 
the mean values of at least three separate experiments.
  
Appendix 35. Biofilm formation of strains containing pCT and pCT 2-6 
 
          
Strain C159/11 3950 3950 
pCT 
3950 
pCT2 
3950 
pCT2b 
3950 
pCT3 
3950 
pCT4 
3950 
pCT5 
3950 
pCT6 
Optical density 
(OD600) 
         
0.0462 0.0476 0.0339 0.0473 0.1492 0.1188 0.1416 0.3635 0.0795 
 
SD 0.0756 0.0379 0.0223 0.0221 0.3331 0.2930 0.2981 0.0812 0.0464 
P value 
(compared  
to 3950 pCT) 
0.55 0.22 - 0.079 0.152 0.228 0.120 <0.001 <0.001 
  
 
14028S DH5α 
DH5α 
pCT 
DH5α 
pCT2 
DH5α 
pCT2b 
DH5α 
pCT3 
DH5α 
pCT4 
DH5α 
pCT5 
DH5α 
pCT6 
DH5α 
pCT7 
Optical 
density 
(OD600) 
          
1.7855 1.2328 1.0247 1.2041 0.1370 1.2607 1.0915 0.9151 1.2690 1.2432 
 
SD 0.3972 0.2977 0.3678 0.7120 0.1400 0.2506 0.2601 0.3479 0.2494 0.2571 
P value 
(compared  
to DH5α pCT) 
- 0.07 - 0.35 <0.001 0.03 0.53 0.37 0.07 0.06 
The amount of biofilm each bacterial strain produced was measured by staining each biofilm with crystal violet and using 
optical density (OD600) to quantify each biofilm.  Optical density values of four technical repeats and at least four biological 
repeats were compared using a student T test. Significant values compared to strains containing plasmidpCT are denotes with 
bold text. 
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Appendix 36. The aggregative ability of S. Typhimurium SL1344 rifR and E. coli 
J53-2 +/- pCT and the pCT mutants  
A) S. Typhimurium SL1344 rifR and E. coli J53-2 +/- pCT  
 
 
   Percentage of the start optical density  
Time (hours) 
Student‟s 
T-test 
Lab no. Strain 0 1 6 12 24 (P value) 
I845 E. coli 042 100% 68% 58% 32% 21%  
L1079 SL1344 rifR pCT 100% 89% 80% 72% 67%  
L354 SL1344 rifR 100% 99% 88% 74% 39% 0.17 
I834 J53-2 pCT 100% 104% 81% 72% 47%  
I847 J53-2 100% 90% 45% 27% 8% 0.14 
Data corresponding to Figure 6.12 (page 233)  
B)  S. Typhimurium SL1344 rifR and E. coli J53-2 +/- pCT , pCT4 and pCT5 
 
 
   Percentage of the start optical density  
Time (hours) 
Student‟s 
T-test 
Lab no. Strain 0 1 6 12 24 (P value) 
I845 E. coli 042 100% 68% 58% 32% 21%  
L1079 SL1344 rifR pCT 100% 89% 80% 72% 67%  
L1259 SL1344 rifR pCT4 100% 102% 72% 73% 31% 0.62 
L1260 SL1344 rifR pCT5 100% 95% 76% 73% 51% 0.92 
I834 J53-2 pCT 100% 104% 81% 72% 47%  
I859 J53-2 pCT4 100% 91% 63% 73% 46% 0.66 
I860 J53-2 pCT5 100% 82% 72% 73% 46% 0.89 
Data corresponding to Figure 6.13 (page 234)  
C) S. Typhimurium SL1344 rifR and E. coli J53-2 +/- pCT2, pCT2b, pCT3 and pCT6 
           Percentage of the start optical density  
            Time (hours) 
Student‟s  
T-test 
Lab no. Strain 0 1 6 12 24 (P value) 
I845 E. coli 042 100% 68% 58% 32% 21%  
L1079 SL1344 rifR pCT 100% 89% 80% 72% 67%  
L1244 SL1344 rifR pCT2 100% 80% 87% 59% 36% 0.06 
L1235 SL1344 rifR pCT2b 100% 89% 79% 71% 36% 0.31 
L1236 SL1344 rifR pCT3 100% 96% 82% 78% 37% 0.90 
L1245 SL1344 rifR pCT6 100% 101% 76% 76% 46% 0.95 
I855 J53-2 pCT 100% 104% 81% 72% 47%  
I856 J53-2 pCT2 100% 101% 67% 35% 7% 0.67 
I857 J53-2 pCT2b 100% 97% 74% 49% 17% 0.87 
I858 J53-2 pCT3 100% 114% 78% 44% 18% 0.48 
I861 J53-2 pCT6 100% 112% 73% 39% 21% 0.88 
Data corresponding to Figure 6.14 (page 235)  
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Appendix 37. Restriction map of plasmid pCT digested with EcoR1 on a 1.2% 
agarose gel 
 
 
 
HL1 = Hyperladder 1 sizing marker 
HL4 = Hyperladder 4 sizing marker 
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